0001493152-23-039346.txt : 20231103 0001493152-23-039346.hdr.sgml : 20231103 20231103170035 ACCESSION NUMBER: 0001493152-23-039346 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 52 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20231103 DATE AS OF CHANGE: 20231103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SMX (Security Matters) Public Ltd Co CENTRAL INDEX KEY: 0001940674 STANDARD INDUSTRIAL CLASSIFICATION: MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT [3590] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41639 FILM NUMBER: 231377176 BUSINESS ADDRESS: STREET 1: MESPIL BUSINESS CENTRE, MESPIL HOUSE STREET 2: SUSSEX ROAD CITY: DUBLIN 4 STATE: L2 ZIP: D04 T4A6 BUSINESS PHONE: 353 1 920 1000 MAIL ADDRESS: STREET 1: MESPIL BUSINESS CENTRE, MESPIL HOUSE STREET 2: SUSSEX ROAD CITY: DUBLIN 4 STATE: L2 ZIP: D04 T4A6 FORMER COMPANY: FORMER CONFORMED NAME: Empatan Public Ltd Co DATE OF NAME CHANGE: 20220801 6-K 1 form6-k.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 6-K

 

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2023

 

Commission File Number: 001-41639

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

(Exact Name of Registrant as Specified in Charter)

 

Mespil Business Centre, Mespil House

Sussex Road, Dublin 4, Ireland

Tel: +353-1-920-1000

(Address of Principal Executive Offices) (Zip Code)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐

 

 

 

 

 

 

This Report on Form 6-K of SMX (Security Matters) Public Limited Company (the “Company”) includes (1) a Management’s Discussion and Analysis of Financial Condition and Results of Operations of the Company for the six months ended June 30, 2023 and 2022 and (2) attaches as Exhibit 99.1 the unaudited interim condensed consolidated financial statements and related notes of the Company as and for the six months ended June 30, 2023.

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

Certain statements in this Current Report on Form 6-K or attached as exhibits hereto may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this Current Report on Form 6-K may include, for example, statements about:

 

  the Company’s need and ability to raise or access additional capital;
     
  the ability to maintain the Company’s listing of its Ordinary Shares on Nasdaq;
     
  changes in the Company’s strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans;
     
  the Company’s ability to develop and launch new products and services;
     
  the Company’s ability to successfully and efficiently integrate future expansion plans and opportunities;
     
  the Company’s ability to grow its business in a cost-effective manner;
     
  the Company’s product development timeline and estimated research and development costs;
     
  the implementation, market acceptance and success of the Company’s business model;
     
  developments and projections relating to the Company’s competitors and industry;
     
  the Company’s approach and goals with respect to technology;
     
  the Company’s expectations regarding its ability to obtain and maintain intellectual property protection and not infringe on the rights of others;
     
  the impact of adverse public health developments on the Company’s business, including any lingering impact of the COVID-19 pandemic;
     
  changes in applicable laws or regulations; and
     
  the outcome of any known and unknown litigation and regulatory proceedings.

 

These forward-looking statements are based on information available as of the date of this Current Report on Form 6-K, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

 

 

 

 

As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include:

 

  the outcome of any legal proceedings that may be instituted against the Company;
     
  the ability to maintain the Company’s listing of its Ordinary Shares on Nasdaq;
     
  changes in applicable laws or regulations;
     
  lingering effects of the COVID-19 pandemic on the Company’s business;
     
  the ability to implement business plans, forecasts, and other expectations after the completion of the proposed transaction, and identify and realize additional opportunities;
     
  the risk of downturns and the possibility of rapid change in the highly competitive industry in which the Company operates;
     
  the risk that the Company and its current and future collaborators are unable to successfully develop and commercialize its products or services, or experience significant delays in doing so;
     
  the risk that the Company may never achieve or sustain profitability;
     
  the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all;
     
  the risk that the Company experiences difficulties in managing its growth and expanding operations;
     
  the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations;
     
  the risk that the Company is unable to secure or protect its intellectual property;
  the risk that the Company’s operations are disrupted by world events, including new and ongoing hostilities between Israel, where the Company has operations, and its neighbors;
     
  the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; and
     
  other risks and uncertainties that may be described in this Current Report on Form 6-K or in other reports filed by the Company with the Securities and Exchange Commission from time to time, which are available on the SEC website at www.sec.gov.

 

 

 

 

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis provide information which our management believes is relevant to an assessment and understanding of the Company’s consolidated results of operations and financial condition. This discussion and analysis should be read together with our unaudited interim condensed consolidated financial statements and related notes as of June 30, 2023 included elsewhere in this Report on Form 6-K, and the audited consolidated financial statements and related notes as of December 31, 2022 of our company and our predecessor companies included in our Annual Report on Form 20-F filed with the Securities and Exchange Commission on May 1, 2023. This discussion and analysis should also be read together with the section of the Annual Report on Form 20-F entitled “Item 4. Information of the Company.” In addition to historical financial information, this discussion and analysis contains forward-looking statements based upon current expectations that involve risks, uncertainties and assumptions. See the section entitled “Cautionary Statement Regarding Forward-Looking Statements” above. Actual results and timing of selected events may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under “Risk Factors” or elsewhere in the Annual Report on Form 20-F.

 

Business

 

SMX integrates chemistry, physics, and computer science to give materials memory and create a culture of transparency and trust across multiple industries. The Company’s nearly 100 patents support unique marking, measuring, and tracking technologies allowing clients to seamlessly deploy transparency at all levels of development and provide stakeholders with a complete provenance of material composition and history, from virgin material to recycled, to address manufacturing challenges and ESG goals while maintaining sustainable growth. As a result, SMX’s technologies are designed and developed to help companies address ESG commitments and transition more successfully to a low-carbon economy.

 

The Company’s technology seeks to enable global companies across various industries to transition more successfully to a sustainable circular economy. By adopting our technology, they would be able to tangibly measure and track the raw material from origination, through the supply chain and at the end of life—where the amount of material recycled/reused from that product item can be measured and as well as the number of times that specific material/item has been recycled/reused.

 

The Company provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

 

Its proprietary marker system embeds a permanent or removable (depending on the needs of the customer) mark on solid, liquid or gaseous objects or materials. Each marker is comprised of a combination of marker codes such that each marker is designed to be unique and unable to be duplicated. The marker system is coupled with an innovative patented reader that responds to signals from the marker and, together with a patented algorithm, captures the details of the product retrieved and stored on a blockchain digital ledger. Each marker can be stored, either locally on the reader and on private servers, cloud servers or on a blockchain ledger, to protect data integrity and custody.

 

History

 

SMX Security Matters Ltd. (Israel Corporate Number 515125771) (“SMX Israel”) was incorporated in 2014 to provide brand protection and supply chain integrity solutions to businesses. It provides these solutions through the commercialization of the initial technology of tracking and tracing materials by observing and identifying markers (the “Source IP”). SMX Israel’s Source IP was initiated from the Soreq Nuclear Research Center, an Israeli government research and development institute for nuclear and photonic technologies under the Israeli Atomic Energy Commission (“Soreq”). In January 2015, SMX Israel entered into the Isorad License Agreement with Isorad Ltd. (an IP holding company of Soreq) to license the Source IP and develop and commercialize the technology (the “Isorad License Agreement”). Under the Isorad License Agreement, as amended, the Source IP can be utilized in almost any industry and with any product.

 

SMX Israel merged into Security Matters PTY Ltd., an Australian company with Australian Company Number (ACN) 626 192 998 (“Security Matters PTY”), to effect a listing on the Australian Securities Exchange under the symbol “ASX: SMX.” At that time, Security Matters PTY had three wholly-owned subsidiaries: Security Matters Ltd. (Israel), SMX Fashion and Luxury (France), and SMX Beverages Pty Ltd. (Australia). It also held 50% of Yahaloma Technologies Inc., a Canadian company and, as of October 3, 2023, 51.9% of trueGold Consortium Pty Ltd., an Australian company.

 

 

 

 

On March 7, 2023 (the “Closing Date”), the Company consummated its previously announced business combination with Lionheart III Corp (“Lionheart”) pursuant to which, among other things (the “Business Combination”):

 

  Security Matters PTY proposed a scheme of arrangement under Part 5.1 of the Corporations Act (“Scheme”) and Capital Reduction which resulted in all shares in Security Matters Limited being cancelled in return for the issuance of the Company’s Ordinary Shares, with the Company being issued one share in Security Matters PTY (“Security Matters Shares”) (this resulted in Security Matters PTY becoming a wholly owned subsidiary of the Company);
   
   
     
  Security Matters PTY proposed an option scheme of arrangement under Part 5.1 of the Corporations Act (“Option Scheme”), which resulted in the Security Matters PTY options held by participants in the Option Scheme being subject to a cashless exercise based on a Black-Scholes valuation, in exchange for Security Matters Shares. Under the Scheme those shares were cancelled and the participants received Ordinary Shares on the basis of the Scheme consideration;
     
  Security Matters PTY shareholders received consideration under the Scheme of 1 Ordinary Share per 10.3624 Security Matters Shares having an implied value of $10.00 per Ordinary Share and the Company became the holder of all of the issued shares in Security Matters PTY and Lionheart, with Security Matters PTY being delisted from the Australian Stock Exchange;
     
  A newly-formed, wholly-owned subsidiary of the Company merged with and into Lionheart, with Lionheart surviving the merger as a wholly owned subsidiary of the Company;
     
  Existing Lionheart stockholders received Ordinary Shares in exchange for their existing Lionheart shares and existing Lionheart warrant holders had their warrants automatically adjusted to become exercisable in respect of Ordinary Shares instead of Lionheart shares; and
     
  The Company’s Ordinary Shares were listed on NASDAQ under the ticker SMX and the Public Warrants were listed under the ticker SMXWW.

 

As a result of the Business Combination, the Company owns the entire share capital of Security Matters PTY. Accordingly, for financial reporting purposes, Security Matters PTY (the legal subsidiary) is the accounting acquirer and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the Business Combination, and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference between the fair value of the shares deemed to have been issued by Security Matters PTY and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date.

 

Key Factors Affecting Operating Results

 

The Company believes that its performance and future success depend on several factors that present significant opportunities for us but also pose risks and challenges, including those discussed below and in the risk factors of the Company included from time to time in the Company’s filings with the Securities and Exchange Commission.

 

Commercial Agreements

 

The Company’s technology seeks to enable global companies across various industries to transition more successfully to a sustainable circular economy. By adopting our technology, they can be able to tangibly measure and track the raw material from origination, through the supply chain and at the end of life—where the amount of material recycled/reused from that product item can be measured and as well as the number of times that specific material/item has been recycled/reused.

 

Due to the fact that we aim our sales efforts at large international market-makers conglomerates, our sale cycle is relatively slow and there is a larger risk that at any time, due to many reasons that are beyond our control, the sale cycle will be broken and all efforts will be lost.

 

 

 

 

The Company has received interest in its technology from several international market-makers conglomerates as well as parties interested in making such technology a market standard, which will greatly assist the creation of future income. Any delays in the successful completion of projects or the creation of a market standard, as well as the materialization of any of the risks described in the section entitled “Risk Factors” above may impact the ability to generate revenue.

 

Components of Operating Results

 

The results of operations presented below should be reviewed in conjunction with the consolidated financial statements and notes included elsewhere in this Report and in the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2022.

 

Revenue

 

To date, we have not yet generated significant revenue from the sale of our technology, partly as a result of focusing on onboarding a client portfolio, building the foundation to be an industry standard and best practice and to be ready for full and fast deployment to commercial global service.

 

Operating Expenses

 

The Company’s current operating expenses consist of the following components: research and development expenses, general and administrative expenses and selling and marketing expenses. The Company has proven an ability to maintain discipline on expense over time with creating greater delivery and outcome.

 

Research and Development Expenses, net

 

The Company’s research and development expenses consist primarily of wage and salary related expenses, subcontractors and consultants, depreciation and amortization of equipment, research expenses and share-based compensation expenses. The Company expects that its research and development expenses will increase as the Company continues to develop its products and recruit additional research and development employees.

 

The Company is engaged in Proof of Concept (POC) agreements according to which it receives funds for financing research and development expenses from prospective customers. Those funds are reimbursements for expenses and therefore are offset against the related R&D expenses in profit or loss.

 

General and Administrative Expenses

 

General and administrative expenses consist primarily of professional services fees, wages and salary related expenses, share-based compensation, facility-related costs, insurance and other general and administrative expenses. In the six months ended June 30, 2023, general and administrative expenses also include the costs that are related to the Business Combination.

 

Selling and Marketing Expenses

 

Selling and marketing expenses consist primarily of digital advertising and business development consultants.

 

Finance Income and Expenses

 

Finance expenses, net consists primarily of revaluation of financial liabilities at fair value, interest on borrowings, exchange rate difference, fees and commissions to banks and income on short-term deposits.

 

 

 

 

Foreign currency

 

The consolidated financial statements are prepared in US Dollars, which is the presentation currency of the Company. Security Matters PTY’s functional currency is Australian Dollars. The functional currency of SMX Israel is New Israeli Shekels.

 

Transactions and balances in foreign currencies are converted into US Dollars in accordance with the principles set forth by International Accounting Standard (IAS) 21 (“The Effects of Changes in Foreign Exchange Rates”). Accordingly, transactions and balances have been converted as follows:

 

Assets and liabilities – at the rate of exchange applicable at the reporting date;
   
Expense items – at annual average rate at the statements of financial position date.
   
Share capital, capital reserve and other capital movement items were at rate of exchange as of the date of recognition of those items.
   
Accumulated deficit was based on the opening balance for the beginning of the reporting period in addition to the movements mentioned above.
   
Exchange gains and losses from the aforementioned conversion are recognized in the statement of other comprehensive lose in Foreign.

 

Comparison of the Six Months Ended June 30, 2023, and 2022

 

The following table summarizes our historical results of operations for the periods indicated:

 

   Six Months Ended June 30 
U.S. dollars in thousands (except of per share data)  2023   2022 
Research and development expenses   (1,172)   (933)
Selling and marketing expenses   (228)   (378)
General and administrative expenses   (13,350)   (1,200)
Listing expenses   (16,802)   (- )  
Operating Loss   (31,552)   (2,511)
Finance expenses   (2,496)   (36)
Finance income   1,143    105 
Share of net loss of associated companies   (104

)

   - 
Loss before income tax   (33,009)   (2,442)
Income tax        
Loss for the period   (33,009)   (2,442)
Basic and diluted loss per share attributable to shareholders   *(39.46)   **(3.36)

 

* After giving effect to the reverse stock split

** Restated as a result of the Business Combination and after giving effect to the reverse stock split

 

Operating loss for the six months ended June 30, 2023 was $31,552 thousand compared to $2,511 thousand for the six months ended June 30, 2022, an increase of $29,041 thousand, or 1,156%. The major increase is due to the costs that are related to the Business Combination, with listing expenses which amounted to $16,802 thousand and transaction cost which amounted to $7,792 thousand.

 

Research and Development Expenses, net

 

The Company’s research and development expenses for the six months ended June 30, 2023, amounted to $1,172 thousand representing an increase of $239 thousand, or 26%, compared to $933 thousand for the six months ended June 30, 2022. The major changes in research and development expenses were an increase of $169 thousand in Share based compensation, a decrease of 327 thousand in salaries and related expenses and a decrease of $265 thousand in Subcontractors and research expenses that were offset against the reimbursement from paid pilots and proof of concept projects that decreased in $671 thousand.

 

 

 

 

General and Administrative Expenses

 

The Company’s general and administrative expenses amounted to $13,350 thousand for the six months ended June 30, 2023, an increase of $12,150 thousand, or 1,013%, compared to $1,200 for the six months ended June 30, 2022. The increase was primarily attributable to $7,792 thousand in transaction cost, an increase of $1,526 thousand in Advertising, Public and Investors Relations, an increase of $1,723 thousand in share-based compensation, an increase of $375 thousand in travel expenses, an increase of $310 thousand in insurance costs and an increase of $235 thousand in wages and salaries related expenses reflecting an increase in the number of employees and in related salary expenses.

 

Selling and Marketing Expenses

 

The Company’s selling and marketing expenses totaled $228 thousand for six months ended June 30, 2023, a decrease of $150 thousand, or 40%, compared to $378 thousand for the six months ended June 30, 2022, and was primarily due to a decrease in digital advertising cost.

 

Finance Income and Expenses

 

The Company’s finance income for the six months ended June 30, 2023, totaled $1,143 thousand, an increase of $1,038 thousand, or 989%, compared to $105 thousand for the six months ended June 30, 2022. The increase is primarily due to revaluation of financial liabilities, which consist of warrants and a Convertible note, at fair value.

 

The finance expense for the six months ended June 30, 2023, totaled $2,496 thousand, an increase of $2,460 thousand, or 6,833%, compared to $36 thousand for the six months ended June 30, 2022. The increase is related to a revaluation of financial liabilities, which consist of bridge loans, at fair value.

 

Share of Net Profit/Loss of Associated Companies

 

As of June 30, 2023, and December 31, 2022, the carrying amount of the investment in associated companies is $112 thousand and $221 thousand, respectively.

 

Share of net loss of associated companies consists of equity loss from associated joint venture activity for the six months ended June 30, 2023, totaled $104 thousand.

 

Income Tax

 

As of June 30, 2023, the Company estimated carry forward tax losses was $56,106 thousand (June 30, 2022: $19,927 thousand) which may be carried forward and offset against taxable income for an indefinite period in the future. The Company did not recognize deferred tax assets relating to carry forward losses in the financial statements because their utilization in the foreseeable future is not probable.

 

Net Loss attributable to shareholders

 

As a result of the forgoing, our net loss for the six months ended June 30, 2023, was $33,009 thousand, compared to $2,442 thousand for the six months ended June 30, 2022, an increase of $30,567 thousand, or 1,252%.

 

 

 

 

Comparison of the Years Ended December 31, 2022 and December 31, 2021

 

The following table summarizes our historical results of operations for the periods indicated:

 

   Year Ended
December 31,
 
U.S. dollars in thousands (except of per share data)  2022   2021 
         
Research and development expenses   1,898    2,039 
Selling and marketing expenses   569    453 
General and administrative expenses   2,723    2,482 
           
Operating Loss   (5,190)   (4,974)
Finance expenses   (1,128)   (101)
Finance income   28    237 
Share of net profit (loss) of associate companies   106    (101)
           
Loss before income tax   (6,184)   (4,939)
           
Income tax        
           
Loss for the year   (6,184)   (4,939)
           
Basic and diluted loss per share attributable to shareholders**   (8.47)   (7.41)

 

** Restated as a result of the Business Combination and after giving effect to the reverse stock split

 

As a result of the foregoing, our operating loss for year ended December 31, 2022 was $5,190 thousand compared to an operating loss of $4,974 thousand for year ended December 31, 2021, an increase of $216 thousand, or 4.3%.

 

Research and Development Expenses, net

 

The Company’s research and development expenses for the year ended December 31, 2022, amounted to $1,898 thousand, representing a decrease of $141 thousand, or 7%, compared to $2,039 thousand for the year ended December 31, 2021. The major changes in research and development expenses were an increase of $371 thousand in salaries and related expenses that were offset against the reimbursement from paid pilots and proof of concept projects that increased in $335 thousand and Subcontractors and consultants’ expenses that decreased in $257 thousand.

 

General and Administrative Expenses

 

The Company’s general and administrative expenses totaled $2,723 thousand for the year ended December 31, 2022, a net increase of $241 thousand, or 10%, compared to $2,482 for the year ended December 31, 2021. The net increase was primarily attributable to an increase of $183 thousand in wages and salaries related expenses reflecting an increase in the number of employees and an increase of $223 thousand in travel expenses offset by decrease of $194 thousand in share-based compensation expenses.

 

Selling and Marketing Expenses

 

The Company’s selling and marketing expenses totaled $569 thousand for the year ended December 31, 2022, an increase of $116 thousand, or 26%, compared to $453 thousand for the year ended December 31, 2021, and was primarily due to an increase in digital advertising cost associated with our marketing efforts.

 

Finance Income and Expenses

 

The Company’s finance income for the year ended December 31, 2022, totaled $28 thousand, a decrease of $209 thousand, or 88%, compared to $237 thousand for the year ended December 31, 2021. The Company’s finance expenses totaled $1,128 thousand for the year ended December 31, 2022, an increase of $1,027 thousand or 1,017%, compared to $101 thousand for the year ended December 31, 2021.

 

Share of Net Profit/Loss of Associated Companies

 

Shares of net profit of associated companies consists of equity profit from associated joint venture activity for the year ended on December 31, 2022 at the amount of $106 thousand and share of net loss of associated companies consists of equity loss from associated joint venture activity for the year ended on December 31, 2021 at the amount of $101 thousand. As of December 31, 2022 and December 31, 2021, the carrying amount of the investment in associated companies is $221 thousand and $147 thousand, respectively.

 

Income Tax

 

As of December 31, 2022, the Company estimated carry forward tax losses of approximately $24,106 thousand (December 31, 2021: $17,659 thousand) which may be carried forward and offset against taxable income for an indefinite period in the future. The Company and its subsidiaries did not recognize deferred tax assets relating to carry forward losses in the financial statements because their utilization in the foreseeable future is not probable.

 

 

 

 

Net Loss attributable to shareholders

 

As a result of the forgoing, our net loss for the year ended December 31, 2022 was $6,184 thousand, compared to $4,939 thousand for the year ended December 31, 2021, an increase of $1,245 thousand, or 25%.

 

Liquidity and Capital Resources

 

Overview

 

Since our inception through June 30, 2023 and thereafter, the Company has funded its operations principally through the issuance of Ordinary Shares, warrants, convertible notes, loans from investors and related parties and reimbursement from prospected customers for paid pilots and proof-of-concept projects. As of June 30, 2023, the Company had $3,020 thousand in cash and cash equivalents. In addition, in September 2023, the Company raised gross proceeds of approximately $2,500 thousand, before deducting fees and other offering expenses payable by the Company, from the sale of a convertible promissory note and warrants to an institutional investor.

 

The table below presents our cash flows for the periods indicated:

 

   For the Six Months Ended
June 30,
   For the Year Ended
December 31,
 
U.S. dollars in thousands  2023   2022   2022   2021 
Net cash used in operating activities   7,675    2,862    5,223    3,908 
Net cash used in investing activities   393    966    1,127    1,765 
Net cash provided by financing activities   9,703    542    3,846    6,118 
Net increase (decrease) in cash and cash equivalents   1,635    (3,286)   (2,504)   445 

 

Operating Activities

 

Net cash used in operating activities was $7,675 thousand during the six months ended June 30, 2023, compared to net cash used in operating activities of $2,862 thousand during the six months ended June 30, 2022. The increase was primarily used for transaction costs and payments that are related to the Business Combination.

 

Net cash used in operating activities was $5,223 thousand during the year ended December 31, 2022, compared to net cash used in operating activities of $3,908 thousand during the year ended December 31, 2021. The increase was primarily used for payment of salaries and related expenses, travel expenses, research and development, subcontractors, consultants and materials. In addition, the increase in cash used in operating activities derived from a material increase in prepaid expenses related to the Business Combination Agreement, dated as of July 26, 2022, by and among the Company, Security Matters PTY, Lionheart and Aryeh Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (the “BCA”).

 

Investing Activities

 

Net cash used in investing activities was $393 thousand during the six months ended June 30, 2023 and consisted of cost of capitalized development expenses in the amount of $383 thousand and $10 thousand used for purchasing property, plant and equipment. Net cash used in investing activities was $966 thousand during the six months ended June 30, 2022, consisted of cost of capitalized development expenses in the amounts of $783 thousand and $183 thousand, which were used for purchasing property and equipment.

 

Net cash used in investing activities was $1,127 thousand during the year ended December 31, 2022 and consisted of cost of capitalized development expenses in the amount of $975 thousand and $152 thousand used for purchasing property, plant and equipment. Net cash used in investing activities was $1,765 thousand during the year ended December 31, 2021, and consisted of cost of capitalized development expenses in the amounts of $1,468 thousand and $297 thousand, which were used for purchasing property and equipment.

 

Financing Activities

 

Net cash provided by financing activities was $9,703 thousand during the six months ended June 30, 2023, consisted mainly of $3,220 thousand in advance payment for equity, $2,923 thousand for net proceeds from issuance of shares in the Business Combination, an aggregate of $2,811 thousand net proceeds from the issuance of bundled securities, $550 thousand in proceeds from bridge loans and $250 thousand in proceeds from the issuance of a convertible note.

 

 

 

 

Net cash provided by financing activities was $542 thousand during the six months ended June 30, 2022, consisted mainly of $581 thousand in proceeds from the issuance of convertible notes, which was partially offset by payment of $39 thousand for lease liabilities.

 

Net cash provided by financing activities was $3,846 thousand during the year ended December 31, 2022, consisted mainly of $3,310 thousand in proceeds from bridge loans and warrants and $581 thousand of net proceeds from issuance of convertible notes and $182 thousand net issuance of shares, which was partially offset by payment of $172 thousand for loan repayment to related parties. Net cash provided by financing activities was $6,118 thousand during the year ended December 31, 2021, consisted mainly of $5,892 thousand in proceeds from net issuance of shares and warrants and $395 thousand of net proceeds from the exercise of warrants, which was partially offset by payment of $98 thousand for lease liabilities and loan repayment to related parties of $103 thousand.

 

Current Outlook

 

The Company has incurred and continues to incur losses, and continues to generate negative cash flows from operations since inception in 2015. Since the Company’s inception, it has not generated significant revenue from the sale of products.

 

As of June 30, 2023 and December 31, 2022, the Company had $3,020 thousand and $1,398 thousand, respectively, in cash and cash equivalents. The Company expects that its existing cash and cash equivalents, including the approximately $2.5 million in net proceeds raised on September 6, 2023, and along with amounts it may draw down under the SEPA, and receivables from clients once paid, will be sufficient to fund its operations for the foreseeable future but perhaps at a delayed or reduced scope. In addition, the Company has outstanding approximately $12 million in existing payables and other liabilities related to expenses of the Business Combination, of which approximately $8.5 million is deferred through the second quarter of 2024 when such amounts are expected to be paid. The Company expects to fund the payment of such amounts out of available cash, the Yorkville SEPA, referred to below, ongoing activities of the Company and possibly other capital raisings in 2023. Further, the Company’s operating plans may change as a result of many factors that may currently be unknown to it, and it may need to seek additional funds sooner than planned. The Company’s future capital requirements will depend on many factors, including:

 

the progress and costs of our research and development activities;

 

the costs of filing, prosecuting, enforcing and defending patent claims and other intellectual property rights;

 

the potential costs of contracting with third parties to provide marketing and distribution services for us or for building such capacities internally; and

 

the magnitude of our general and administrative expenses.

 

Until the Company can generate significant recurring revenues and profit, the Company expects to satisfy its future cash needs through capital raising and shareholders’ financial support. The Company cannot be certain that additional funding will be available when needed, on acceptable terms, if at all. The Company’s outstanding warrants are either out of the money or have nominal exercise prices; accordingly, the Company does not expect to raise any material additional funds from the exercise of outstanding warrants in at least the short-term. If funds are not available, the Company may be required to delay or reduce the scope of research or development plans.

 

We can give no assurances that we will be able to secure additional sources of funds to support our operations on acceptable terms, or at all, or, if such funds are available to us, that such additional financing will be sufficient to meet our needs. If we raise additional funds by issuing equity or convertible debt securities, including pursuant to the SEPA, it could result in dilution to our existing stockholders or increased fixed payment obligations. In addition, as a condition to providing additional funds to us, future investors may demand, and may be granted, rights superior to those of existing stockholders. If we incur additional indebtedness, we could become subject to covenants that would restrict our operations and potentially impair our competitiveness, such as limitations on our ability to incur additional debt, limitations on our ability to acquire, sell or license intellectual property rights and other operating restrictions that could adversely impact our ability to conduct our business. Additionally, any future collaborations we enter into with third parties may provide capital in the near term but may not be on terms that are favorable to us. Any of the foregoing could significantly harm our business, financial condition and results of operations. If we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may be required to reduce the scope of the commercialization of our planned products or delay, scale back or discontinue the development of one or more of our product candidates.

 

 

 

 

We may also need to take certain other actions to allow us to maintain our projected cash and projected financial position, including but not limited to additional reductions in general and administrative costs, sales and marketing costs, and other discretionary costs. Although we believe such plans, if executed and coupled with the above described sources of liquidity, should provide us with financing to meet our needs, successful completion of such plans is dependent on factors outside of our control.

 

We anticipate that we will continue to incur net losses into the foreseeable future as we continue our development of our product candidates, and expand our corporate infrastructure.

 

Contractual Obligations

 

Reciprocal Standby Equity Purchase Agreement

 

Effective March 7, 2023, we entered into the SEPA with Yorkville, whereby we have the right, but not the obligation, to sell to Yorkville up to $25.0 million of our Ordinary Shares at our request, subject to the terms therein. We have received as loans Pre-Advances of $3.5 million, of which as of the date of this Report on Form 6-K, an aggregate of $1.8 million in principal have been converted into our Ordinary Shares or repaid in cash. We may from time to time offer and sell our Ordinary Shares under the SEPA, which is expected to provide us with an additional source of liquidity.

 

Our decision to make any Advance under the SEPA will depend on a variety of factors to be determined by us from time to time, including, among other things, the trading price of our Ordinary Shares and determination by us that other sources of capital may be more beneficial, and determinations by us as to the appropriate sources of funding for our business and operations.

 

We do not believe that the existence of the SEPA will have any adverse effect on our ability to raise any capital from other sources except that pursuant to the SEPA, we are not permitted to enter into any variable rate transactions during the term of the SEPA, which could result in potential investors declining to consider investing in our Company on terms agreeable to us or at all.

 

Leases

 

SMX Israel is a party to a lease agreement dated January 14, 2020, and amended as of December 24, 2020 (the “Lease”). Under the Lease, it is obligated to pay ILS 253 thousand plus VAT per year. The Lease will expire on May 31, 2027, with an additional option of 5 years, unless terminated by the landlord due to a requirement of a governmental authority to modify or terminate the Lease, pursuant to the terms of the lease.

 

Borrowings

 

On September 19, 2023, the Company amended its loan agreements dated September 7, 2015, by and between the Company, its shareholders and Kamea Fund. Pursuant to the amendment to the loan agreements, Kamea agreed to convert US$657 thousand of indebtedness under the loan agreements into 487,281 ordinary shares (post share reverse split) of the Company, as payment in full for such indebtedness; provided however, that in the event the proceeds received from Kamea with respect to any sales of the shares are not at least equal to the indebtedness amount, the Company will remain liable to Kamea for the balance of the indebtedness amount

 

Additionally, Kibbutz Ketura provides administrative services for SMX Israel for which it was debited $19 thousand and $25 thousand for the six month ended June 30, 2023 and June 30, 2022, respectively.

 

 

 

 

Security Matters PTY and the Company borrowed an aggregate of $3,860 thousand from private investors between September 2022 and February 2023, which loans are due no earlier than May 31, 2024. All of such loans have an interest rate of 10% per annum. Each such lender (except for one lender which lent an amount of $1,000 thousand which is not entitled to the redeemable warrants), further received 20% redeemable 5-year warrant coverage to subscribe for Ordinary Shares at $11.50 per share, plus 5% 5-year bonus warrant coverage to subscribe for Ordinary Shares at $11.50 per share and a first priority security interest in the shares of Security Matters PTY’s interest in trueGold Consortium Pty Ltd. In March 2023, the Company signed an addendum to the Bridge Loans agreements which converted $1,350 thousand into common shares and deferred the remaining cash payments to March 31, 2024.

 

In January 2023, the Company borrowed $250 thousand from a private investor, which loan is due December 31, 2024. Such loan has an interest rate of 15% per annum, and is convertible at a conversion price of $10.00 per share, and the holder further received 5% redeemable 5-year warrant coverage to subscribe for Ordinary Shares at $11.50 per share, plus 5% 5-year bonus warrant coverage to subscribe for Ordinary Shares at $11.50 per share.

 

On September 6, 2023, the Company consummated the transactions pursuant to a Securities Purchase Agreement dated as of September 5, 2023 and issued and sold to an institutional investor a promissory note with a fixed conversion price of $1.6378 and warrants, for gross proceeds to SMX of approximately $2,500 thousand, before deducting fees and other offering expenses payable by the Company. The note is in the principal amount of $4,290 thousand. The actual amount loaned by the investor pursuant to the Note is $2,574 thousand after a 40% original issue discount. The maturity date of the note is the 12-month anniversary of the Effective Date, and is the date upon which the principal amount, as well as any accrued and unpaid interest and other fees, shall be due and payable. Interest accrues in the amount of 12% per year and shall be payable on the maturity date or upon acceleration or by prepayment or otherwise. The investor has the right, at any time, to convert all or any portion of the then outstanding and unpaid principal amount and interest (including any costs, fees and charges) into Ordinary Shares at a fixed conversion price of $1.6378 per share. Any such conversion is subject to customary adjustments and limitations set forth in the note, including for fundamental transactions. Additionally, as part of the transaction, we issued two warrants to the Investor, an “A” Warrant and a “B” Warrant. The A Warrant for 3,929,051 Ordinary Shares has an exercise price of $0.0022 per share, subject to customary adjustments, and may be exercised at any time until the five year anniversary of the A Warrant. The B Warrant for 2,619,367 Ordinary Shares has an exercise price of $1.6378 per share, subject to customary adjustments, and may be exercised at any time until the five year anniversary of the B Warrant. In no case shall the Company convert the note or exercise the A Warrants or the B Warrants if the result of the issuance of Ordinary Shares thereby would result in the beneficial ownership of the investor of ordinary shares in excess of 4.99% of the Company’s issued and outstanding Ordinary Shares.

 

Government Grants

 

As of June 30, 2023 and December 31, 2022, the Company has a contingent liability of $141 and $135 thousand respectively, for government grant it received for the use of research and development activities from Israel Innovation Authority (IIA). The Company is subject to paying 3% of its relevant revenues for the first three years, and 4% of the relevant revenues for further years, until repayment of the entire grant.

 

Isorad License Agreement

 

In January 2015, the Company entered into the Isorad License Agreement with Isorad Ltd. (a company wholly owned by the State of Israel with rights to exclusively commercialize the Soreq Research Center technology for civilian uses), according to which the Company was granted technological license in return for future royalties based on 2.2% of gross sales by the Company and its affiliates and after 25 years the license becomes royalty-free. Upon the occurrence of an M&A event (as such event is defined in the agreement to include mergers, sale of all or substantially all the assets of ours and similar event), in the first M&A event, the Company is to pay a consideration equal to 1% of the amount received or transferred and in the second M&A event, a consideration equal to 2% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.

 

 

 

 

In January 2023, the Company signed an amendment to the Isorad License Agreement that provided for the following: (1) for the BCA with Lionheart, (a) Isorad was issued 864,000 options to purchase shares of the Company, which options were issued in January 2023 and valued using the Black-Scholes pricing model, with the main parameters used being: (1) risk-free rate: 3.42%; (2) expected volatility: 81.92%: (3) expected term: up to 3 years; and (4) expected dividend yield: 0%; and (b) Isorad will be entitled to 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter (to be paid after reaching an aggregated received amount of $27 million, or at the end of such 13 months, the earlier thereof); and (2) Exit fee - in the occurrence of the first M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA, the Company is to pay a cash amount equal to 1.5% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter. In the six months ended June 30, 2023, based on the funds the Company actually received, the Company recognized a technology license intellectual property at the amount of $101 thousand against a liability that reflects the due amount.

 

Quantitative and Qualitative Disclosures about Market Risk

 

The Company is exposed to market risks in the ordinary course of business. Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of U.S. dollar/ILS Israeli Shekels exchange rates, which is discussed in detail in the following paragraph.

 

Foreign Currency Exchange Risk

 

Currency Fluctuations

 

The Company’s operating expenses are denominated in USD and ILS, and therefore are currently subject to foreign currency risk. We have been affected by changes in the rate of ILS currency compared to the U.S. dollar, as the ILS decreased against the U.S. dollar by approximately 6% and 13% in the six months ended June 30, 2023 and June 30 2022, respectively.

 

The Company’s policy is not to enter into any currency hedging transactions, and we cannot assure you that we will not be adversely affected by currency fluctuations in the future.

 

Credit Risk

 

Credit risk is a risk of financial loss if a counterparty or customer fails to meet its contractual obligations. We closely monitor the activities of our counterparties and control the access to its intellectual property which enables it to ensure a prompt collection. Our main financial assets are cash and cash equivalents as well as other receivables and represent the Company’s maximum exposure to credit risk in connection with its financial assets. Wherever possible and commercially practical, the Company holds cash with major and sound financial institutions in Israel and Australia.

 

Liquidity Risk

 

Liquidity risk is the risk that we will encounter in meeting our obligations associated with our financial liabilities that are settled by delivering cash or another financial asset. The Company has procedures to minimize that risk by maintaining sufficient cash and other highly liquid current assets and by having available an adequate amount of committed credit facilities. For more details, please refer to the section titled, “Liquidity and Capital Resources”.

 

Critical Accounting Policies and Estimates

 

Reverse Acquisition Transaction

 

As a result of the Business Combination, the Company owns the entire share capital of Security Matters PTY Ltd. Accordingly, for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY Ltd. and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the transaction ($11,599 thousand), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $16,802 thousand, between the fair value of the shares deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at closing date.

 

 

 

 

The Company is initially consolidated in the financial statements from the Closing Date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($4,921 thousand) and trade and other payables and warrants ($10,127 thousand) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:

 

1. The assets and liabilities of Security Matters PTY have been recognized and measured in the consolidated financial statements of the Company for the six month period ended June 30, 2023, at their pre-combination carrying amounts.
   
2. The retained earnings and other equity balances recognized in the consolidated financial statements of the Company for the six month period ended June 30, 2023, are the retained earnings and other equity balances of Security Matters PTY immediately before the Business Combination.
   
3. The amount recognized as issued equity instruments in the consolidated financial statements of the Company for the six month period ended June 30, 2023, has been determined by adding to the issued equity of Security Matters PTY immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.
   
4. The statement of comprehensive loss in the consolidated financial statements of the Company for the six month period ended June 30, 2023, reflects that of Security Matters PTY for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.

 

Exhibit No.   Description
     
99.1   Interim Condensed Consolidated Financial Statements as of June 30, 2023
     
101.INS*   XBRL Instance Document
     
101.SCH*   XBRL Taxonomy Extension Schema Document
     
101.CAL*   XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF*   XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB*   XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE*   XBRL Taxonomy Extension Presentation Linkbase Document
     
104*   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: November 3, 2023

 

  SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY
   
  By: /s/ Haggai Alon
  Name: Haggai Alon
  Title: Chief Executive Officer

 

 

EX-99.1 2 ex99-1.htm
false 0001940674 185 0001940674 2023-01-01 2023-06-30 0001940674 2023-06-30 0001940674 2022-12-31 0001940674 2022-01-01 2022-06-30 0001940674 ifrs-full:IssuedCapitalMember 2022-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2022-12-31 0001940674 ifrs-full:RetainedEarningsMember 2022-12-31 0001940674 ifrs-full:IssuedCapitalMember 2021-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2021-12-31 0001940674 ifrs-full:RetainedEarningsMember 2021-12-31 0001940674 2021-12-31 0001940674 ifrs-full:IssuedCapitalMember 2023-01-01 2023-06-30 0001940674 SMX:ForeignCurrencyTranslationMember 2023-01-01 2023-06-30 0001940674 ifrs-full:RetainedEarningsMember 2023-01-01 2023-06-30 0001940674 ifrs-full:IssuedCapitalMember 2022-01-01 2022-06-30 0001940674 SMX:ForeignCurrencyTranslationMember 2022-01-01 2022-06-30 0001940674 ifrs-full:RetainedEarningsMember 2022-01-01 2022-06-30 0001940674 ifrs-full:IssuedCapitalMember 2023-06-30 0001940674 SMX:ForeignCurrencyTranslationMember 2023-06-30 0001940674 ifrs-full:RetainedEarningsMember 2023-06-30 0001940674 ifrs-full:IssuedCapitalMember 2022-06-30 0001940674 SMX:ForeignCurrencyTranslationMember 2022-06-30 0001940674 ifrs-full:RetainedEarningsMember 2022-06-30 0001940674 2022-06-30 0001940674 ifrs-full:OrdinarySharesMember 2022-07-26 0001940674 2022-07-26 0001940674 SMX:LionheartMember SMX:BusinessCombinationAgreementMember 2022-07-26 2022-07-26 0001940674 SMX:EquityLineAgreementMember 2023-01-01 2023-06-30 0001940674 SMX:EquityLineAgreementMember 2023-06-30 0001940674 SMX:SecurityMattersPTYLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SecurityMattersPTYLtdMember 2022-01-01 2022-12-31 0001940674 SMX:LionheartIIICorpMember 2023-01-01 2023-06-30 0001940674 SMX:LionheartIIICorpMember 2022-01-01 2022-12-31 0001940674 SMX:SMXCircularEconomyPlatformPTELtdMember 2023-01-01 2023-06-30 0001940674 SMX:SMXCircularEconomyPlatformPTELtdMember 2022-01-01 2022-12-31 0001940674 SMX:SMXIrelandLimitedMember 2023-01-01 2023-06-30 0001940674 SMX:SMXIrelandLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:SMXIsraelLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SMXIsraelLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersCanadaLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SecurityMattersCanadaLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersFranceLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SecurityMattersFranceLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SMXBeveragesPtyLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SMXBeveragesPtyLtdMember 2022-01-01 2022-12-31 0001940674 SMX:YahalomaTechnologiesIncMember 2023-01-01 2023-06-30 0001940674 SMX:YahalomaTechnologiesIncMember 2022-01-01 2022-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-01-01 2023-06-30 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2022-01-01 2022-12-31 0001940674 SMX:ConvertibleNotesMember 2023-01-24 2023-01-25 0001940674 SMX:ConvertibleNotesMember 2023-01-25 0001940674 SMX:ConvertiableNoteAgreementsMember SMX:BonusWarrantsMember 2023-01-24 2023-01-25 0001940674 SMX:ConvertiableNoteAgreementsMember SMX:RedeemableWarrantsMember 2023-01-24 2023-01-25 0001940674 SMX:ConvertiableNoteAgreementsMember SMX:RedeemableWarrantsMember 2023-01-25 0001940674 SMX:ConvertibleNotesMember 2023-01-01 2023-06-30 0001940674 SMX:RedeemableWarrantsMember 2023-01-01 2023-06-30 0001940674 SMX:BridgeLoanAgreementsMember SMX:ElevenLendersMember 2022-08-01 2023-01-31 0001940674 ifrs-full:TopOfRangeMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:BonusWarrantsMember 2022-08-01 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsMember 2022-08-01 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember SMX:RedeemableWarrantsMember 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember ifrs-full:TopOfRangeMember 2023-06-30 0001940674 SMX:BridgeLoanAgreementsMember 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-06-30 0001940674 SMX:BridgeLoanAgreementsMember 2023-01-01 2023-06-30 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 ifrs-full:TopOfRangeMember SMX:BridgeLoanAgreementsMember SMX:NonadjustingEventMember 2023-01-01 2023-12-31 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-03-01 2023-03-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-03-31 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-02-28 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-02-01 2023-02-28 0001940674 SMX:StandbyEquityPurchaseAgreementMember ifrs-full:BottomOfRangeMember 2023-02-01 2023-02-28 0001940674 2023-02-28 0001940674 SMX:FirstInstallmentMember 2023-02-28 0001940674 SMX:SecondInstallmentMember 2023-02-28 0001940674 2023-02-01 2023-02-28 0001940674 SMX:NonadjustingEventMember 2023-07-27 0001940674 SMX:FirstInstallmentMember SMX:NonadjustingEventMember 2023-07-31 0001940674 SMX:NonadjustingEventMember SMX:StandbyEquityPurchaseAgreementMember 2023-07-31 0001940674 SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:WarrantAMember 2023-06-22 0001940674 SMX:UnderwritingAgreementMember SMX:WarrantBMember 2023-06-22 0001940674 2023-06-22 2023-06-22 0001940674 SMX:WarrantAMember 2023-06-22 0001940674 SMX:WarrantBMember 2023-06-22 0001940674 SMX:WarrantBMember 2023-06-22 2023-06-22 0001940674 SMX:UnderwriterWarrantMember 2023-06-22 0001940674 SMX:UnderwriterWarrantMember 2023-06-22 2023-06-22 0001940674 2023-01-31 0001940674 2023-01-01 2023-01-31 0001940674 ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-06-30 0001940674 ifrs-full:OrdinarySharesMember 2023-06-30 0001940674 ifrs-full:OrdinarySharesMember 2022-12-31 0001940674 ifrs-full:PreferenceSharesMember 2023-06-30 0001940674 ifrs-full:PreferenceSharesMember 2022-12-31 0001940674 SMX:DeferredSharesMember 2023-06-30 0001940674 SMX:DeferredSharesMember 2022-12-31 0001940674 SMX:TwentyTwentyTwoConvertibleNotesMember 2023-03-01 2023-03-07 0001940674 SMX:TwentyTwentyTwoConvertibleNotesMember 2023-03-07 0001940674 2023-03-01 2023-03-07 0001940674 SMX:SecurityMattersPTYLtdMember 2023-03-07 0001940674 SMX:SecurityMattersPTYLtdMember ifrs-full:OrdinarySharesMember 2023-03-07 0001940674 ifrs-full:OrdinarySharesMember 2023-03-07 0001940674 SMX:LionheartIIICorpMember 2023-03-07 0001940674 SMX:LionheartIIICorpMember SMX:PrivateWarrantsMember 2023-03-07 0001940674 SMX:LionheartIIICorpMember SMX:PublicWarrantsMember 2023-03-07 0001940674 SMX:LionheartIIICorpMember 2023-03-01 2023-03-07 0001940674 SMX:OrdinarySharesOneMember 2023-03-07 0001940674 SMX:OrdinarySharesOneMember 2023-03-01 2023-03-07 0001940674 SMX:OrdinarySharesTwoMember 2023-03-07 0001940674 SMX:OrdinarySharesTwoMember 2023-03-01 2023-03-07 0001940674 SMX:YorkvilleMember 2023-06-30 0001940674 SMX:YorkvilleMember 2023-05-31 0001940674 SMX:YorkvilleMember 2023-06-01 2023-06-30 0001940674 SMX:YorkvilleMember 2023-05-01 2023-05-31 0001940674 SMX:WarrantAMember 2023-06-30 0001940674 SMX:WarrantBMember 2023-06-30 0001940674 SMX:TwentyTwentyTwoIncentiveEquityPlanMember 2023-04-25 2023-04-25 0001940674 SMX:TwentyTwentyTwoIncentiveEquityPlanMember 2023-04-25 0001940674 SMX:EmployeesDirectorsAndServiceProvidersMember ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-06-30 0001940674 ifrs-full:BottomOfRangeMember ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-06-30 0001940674 ifrs-full:TopOfRangeMember ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-06-30 0001940674 SMX:EmployeesAndServiceProvidersMember 2023-01-01 2023-06-30 0001940674 ifrs-full:BottomOfRangeMember 2023-01-01 2023-06-30 0001940674 ifrs-full:TopOfRangeMember 2023-01-01 2023-06-30 0001940674 ifrs-full:RestrictedShareUnitsMember 2022-12-31 0001940674 ifrs-full:RestrictedShareUnitsMember 2021-12-31 0001940674 ifrs-full:RestrictedShareUnitsMember 2022-01-01 2022-06-30 0001940674 ifrs-full:RestrictedShareUnitsMember 2023-06-30 0001940674 ifrs-full:RestrictedShareUnitsMember 2022-06-30 0001940674 SMX:OptionsOutstandingOneMember ifrs-full:BottomOfRangeMember 2023-06-30 0001940674 SMX:OptionsOutstandingOneMember ifrs-full:TopOfRangeMember 2023-06-30 0001940674 SMX:OptionsOutstandingOneMember 2023-06-30 0001940674 SMX:OptionsOutstandingOneMember 2023-01-01 2023-06-30 0001940674 SMX:OptionsOutstandingTwoMember ifrs-full:BottomOfRangeMember 2023-06-30 0001940674 SMX:OptionsOutstandingTwoMember ifrs-full:TopOfRangeMember 2023-06-30 0001940674 SMX:OptionsOutstandingTwoMember 2023-06-30 0001940674 SMX:OptionsOutstandingTwoMember 2023-01-01 2023-06-30 0001940674 SMX:OptionsOutstandingThreeMember ifrs-full:BottomOfRangeMember 2023-06-30 0001940674 SMX:OptionsOutstandingThreeMember ifrs-full:TopOfRangeMember 2023-06-30 0001940674 SMX:OptionsOutstandingThreeMember 2023-06-30 0001940674 SMX:OptionsOutstandingThreeMember 2023-01-01 2023-06-30 0001940674 SMX:OptionsOutstandingFourMember ifrs-full:TopOfRangeMember 2023-06-30 0001940674 SMX:OptionsOutstandingFourMember 2023-06-30 0001940674 SMX:OptionsOutstandingFourMember 2023-01-01 2023-06-30 0001940674 SMX:OptionsOutstandingFiveMember ifrs-full:TopOfRangeMember 2023-06-30 0001940674 SMX:OptionsOutstandingFiveMember 2023-06-30 0001940674 SMX:OptionsOutstandingFiveMember 2023-01-01 2023-06-30 0001940674 SMX:GeneralAndAdministrativeExpensesMember 2023-01-01 2023-06-30 0001940674 SMX:GeneralAndAdministrativeExpensesMember 2022-01-01 2022-06-30 0001940674 SMX:ReverseStockSplitMember 2023-01-01 2023-06-30 0001940674 SMX:ReverseStockSplitMember 2022-01-01 2022-06-30 0001940674 SMX:NonadjustingEventMember 2023-07-01 2023-07-27 0001940674 SMX:NonadjustingEventMember 2023-07-31 0001940674 SMX:NonadjustingEventMember 2023-07-01 2023-07-31 0001940674 SMX:NonadjustingEventMember 2023-09-30 2023-09-30 0001940674 SMX:NonadjustingEventMember SMX:SecuritiesPurchaseAgreementMember 2023-09-01 2023-09-06 0001940674 SMX:NonadjustingEventMember SMX:SecuritiesPurchaseAgreementMember 2023-09-06 0001940674 SMX:NonadjustingEventMember 2023-09-01 2023-09-15 0001940674 SMX:NonadjustingEventMember 2023-09-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure SMX:Integer iso4217:AUD iso4217:ILS iso4217:AUD xbrli:shares iso4217:EUR iso4217:EUR xbrli:shares

 

Exhibit 99.1

 

SMX (SECURITY MATTERS)

PUBLIC LIMITED COMPANY

 

INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF JUNE 30, 2023

UNAUDITED

 

 
 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

 

INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF JUNE 30, 2023

UNAUDITED

 

TABLE OF CONTENTS

 

 

Page

   
Interim condensed consolidated statements of financial position 1
Interim condensed consolidated statements of comprehensive loss 2
Interim condensed consolidated statements of changes in shareholders’ equity (deficit) 3-4
Interim condensed consolidated statements of cash flows 5-6
Notes to the unaudited interim condensed consolidated financial statements 7-18

 

 

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

UNAUDITED INTERIM CONDENSED CONSOLIDATED

STATEMENTS OF FINANCIAL POSITION

 

               
       As of June 30,
2023
   As of December 31, 2022 
   Note   US$ in thousands 
Current assets              
Cash and cash equivalents       3,020    1,398 
Other current receivables       1,037    3,673 
Total current assets       4,057    5,071 
Non-current assets              
Property and equipment, net       820    969 
Intangible assets, net       5,269    5,027 
Investment in associated companies       112    221 
Total non-current assets       6,201    6,217 
               
Total assets       10,258    11,288 
               
Current liabilities              
Trade payables       7,281    2,972 
Lease liabilities       30    30 
Other payables       2,415    650 
Convertible notes  3    304    563 
Warrants       856    - 
Pre-paid advance  5.1    3,050    - 
Bridge loans and derivative financial liabilities  4    2,363    3,682 
Borrowings from related parties       689    710 
Total current liabilities       16,988    4,925 
Non-current liabilities              
Lease liabilities       403    440 
Bridge loans and derivative financial liabilities  4    938    - 
Long term payables       3,930    85 
Total non-current liabilities       5,271    4,207 
               
Total liabilities       22,259    9,132 
               
Shareholders’ equity (deficit)              
Issued capital and additional paid in capital  6    51,730    32,711 
Foreign currency translation reserve       (702)   (537)
Accumulated losses       (63,029)   (30,020)
Total Shareholders’ equity (deficit)       (12,001)   2,156 
Total liabilities and shareholders’ equity (deficit)       10,258    11,288 

 

/s/ Limor Moshe Lotker   /s/ Haggai Alon   /s/ Pauline Khoo    November 3, 2023

Limor Moshe Lotker

Chief Financial Officer

 

Haggai Alon

Chief Executive Officer

 

Pauline Khoo

Audit Committee Chairperson

  Date of approval of financial statements

 

The accompanying notes are an integral part of the financial statements.

 

-1-
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

UNAUDITED INTERIM CONDENSED CONSOLIDATED

STATEMENTS OF COMPREHENSIVE LOSS

 

               
       For the Six Months Ended 
       June 30, 2023   June 30, 2022 
   Note   US$ in thousands except share and per share data 
Research and development expenses, net       1,172    933 
Selling and marketing expenses       228    378 
General and administrative expenses  7    13,350    1,200 
Listing expenses       16,802    - 
Operating loss       31,552    2,511 
Finance income       1,143    105 
Finance expenses       2,496    36 
Share of net loss of associated companies       104    - 
Loss before income tax       33,009    2,442 
Income tax       -    - 
Loss after income tax for the period attributable to shareholders       33,009    2,442 
               
Other comprehensive loss:          
Items that will be reclassified to profit or loss:              
Foreign currency translation       (165)   (639)
               
Other comprehensive loss, net of tax       (165)   (639)
               
Total comprehensive loss       33,174    3,081 
               
Loss per share attributable to shareholders       -       
               
Basic and diluted loss per share attributable to shareholders (in dollars)  8    *(39.46)   **(3.36)

 

*After giving effect to the reverse stock split (see also Note 9.1)

**Restated as a result of the SPAC transaction and after giving effect to the reverse stock split (see also Note 1 and 9.1)

 

The accompanying notes are an integral part of the consolidated financial statements.

 

-2-
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

UNAUDITED INTERIM CONDENSED CONSOLIDATED CHANGES IN SHAREHOLDERS’ EQUITY

(US$ in thousands)

  

                     
  

Issued capital and

Additional paid-in capital

   Foreign currency translation reserve   Accumulated loss   Total equity 
Balance as of January 1, 2023   32,713    (537)   (30,020)   2,156 
Comprehensive loss                    
Loss after income tax for the period   -    -    (33,009)   (33,009)
Other comprehensive loss for the period   -    (165)   -    (165)
Total comprehensive loss for the period   -    (165)   (33,009)   (33,174)
                     
Issuance of shares, net   170    -    -    170 
Recapitalization due to issuance of shares following the SPAC transaction, net   11,460    -    -    11,460 
Share-based compensation   2,092    -    -    2,092 
Conversion of convertible notes to shares   175    -    -    175 
Conversion of bridge loans to shares   2,983    -    -    2,983 
Exercise of options   10    -    -    10 
Conversion of warrants A to ordinary shares, net (See note 5.2)   290              290 
Issuance of Security Bundle, net (See note 5.2)   1,837    -    -    1,837 
Balance as of June 30, 2023   51,730    (702)   (63,029)   (12,001)

 

The accompanying notes are an integral part of the consolidated financial statements.

 

(*)Represents an amount lower than US$ 1 thousand, see Note 2D.

 

-3-
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

UNAUDITED INTERIM CONDENSED CONSOLIDATED CHANGES IN SHAREHOLDERS’ EQUITY

(US$ in thousands)

 

  

Issued capital and

Additional paid-in capital

   Foreign currency translation reserve   Accumulated loss   Total equity 
     
Balance as of January 1, 2022   31,504    223    (23,836)   7,891 
Comprehensive income                    
Loss after income tax for the period   -    -    (2,442)   (2,442)
Other comprehensive loss for the period   -    (639)   -    (639)
Total comprehensive loss for the period   -    (639)   (2,442)   (3,081)
                     
Issuance of shares, net   721    -    -    721 
Share-based compensation   219    -    -    219 
Balance as of June 30, 2022   32,444    (416)   (26,278)   5,750 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

-4-
 

 

 

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(US$ in thousands)

 

           
   For the Six Months Ended 
   June 30, 2023   June 30, 2022 
   US$ in thousands 
Cash flows from operating activities:          
Net Loss   (33,009)   (2,442)
Share-based compensation   2,052    165 
Depreciation and amortization   114    176 
Increase (decrease) in other receivables   2,575    (1,727)
Increase in trade payables   2,545    831 
Increase in other payables   70    110 
Decrease in other liabilities   13    32 
Revaluation of financial liabilities at fair value   (41)   - 
Financial expenses due to bridge loans principal amounts   1,421    - 
Interest on leases   7    28 
Provision of borrowing to related parties   14    (89)
Revaluation of convertible notes   (382)   - 
Share of net loss of associated companies   104    - 
Issuance of shares for directors   40    54 
SPAC transaction - listing costs   16,802    - 
Net cash flow used in operating activities   (7,675)   (2,862)
Cash flows from investing activities:          
Purchase of property, plant and equipment   (10)   (183)
Capitalized development cost   (383)   (783)
Net cash flow used in investing activities   (393)   (966)
Cash flows from financing activities:          
Payment of lease liabilities   (21)   (39)
Proceeds from issuance of convertible notes   250    581 
Proceeds from issuance of Security Bundle, net   914    - 
Issuance of warrants   923    - 
Issuance of derivative financial liability   974    - 
Proceeds from bridge loans   550    - 
Repayment of bridge loans   (30)   - 
Advance payment for equity, net (see Note 5.1)   3,220    - 
Issuance of shares in the SPAC transaction, net   2,923    - 
Net cash flow from financing activities   9,703    542 
           
Increase (decrease) in cash and cash equivalents   1,635    (3,286)
Cash and cash equivalents at beginning of period   1,398    4,171 
Exchange rate differences on cash and cash equivalent   (13)   (26)
Cash and cash equivalents at end of period   3,020    859 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

-5-
 

 

 

UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(US$ in thousands)

 

   For the Six Months Ended 
   June 30, 2023   June 30, 2022 
   US$ in thousands 
Appendix A – Non-Cash transactions during the period:          
           
Conversion of liability to ordinary shares (see Note 5.1)   450    - 
Conversion of warrants to ordinary shares (see note 5.2)   290    - 
Conversion of bridge loans and derivative financial liability to ordinary shares   2,983    - 
Exercise of options and warrants to ordinary shares   2,229    - 
Conversion of convertible notes to ordinary shares   175    - 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

-6-
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 1 - GENERAL:

 

A.SMX (Security Matters) Public Limited Company (“Security Matters” or the “Company” and together with its subsidiaries, the “Group”) was incorporated in July 1, 2022 under the laws of Ireland with registered number 722009 and its registered office at Mespil Business Center, Mespil House, Sessex Road, Dublin 4, Ireland, D04 T4A6. The Company was incorporated in 2022 as part of the Business Combination (see Note 1.B).

 

The Group provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer. Its proprietary marker system embeds a permanent or removable (depending on the needs of the customer) mark on solid, liquid or gaseous objects or materials. Each marker is comprised of a combination of marker codes such that each marker is designed to be unique and unable to be duplicated. The marker system is coupled with an innovative patented reader that responds to signals from the marker and, together with a patented algorithm, captures the details of the product retrieved and stored on a blockchain digital ledger. Each marker can be stored, either locally on the reader and on private servers, cloud servers or on a blockchain ledger, to protect data integrity and custody.

 

B.The Business Combination - the SPAC transaction (“Business Combination”):

 

On March 7, 2023 (the “Closing Date”) the Company completed its Business Combination with Lionheart III Corp (“Lionheart”), following that Lionheart and Security Matters PTY Ltd. (formerly named Security Matters Limited, which was incorporated in May 2018 under Australian law) became the Company’s wholly-owned subsidiaries and the Company listed its ordinary shares and public warrants on the NASDAQ stock market under the tickers SMX and SMXWW, respectively. On July 26, 2022, Security Matters PTY Ltd. and Lionheart, a publicly traded special purpose acquisition company (SPAC), entered into a business combination agreement (the “BCA”) and accompanying scheme implementation deed (“SID”). Under the BCA, the existing Lionheart stockholders received the Company’s shares and warrants in exchange for their existing Lionheart shares and warrants and all shares existed in Security Matters PTY Ltd were cancelled in return for the Company’s shares and resulting in Security Matters PTY Ltd. becoming a wholly owned subsidiary of the Company. Security Matters PTY Ltd. shareholders received consideration of 1 ordinary share per 10.3624 Security Matters PTY Ltd. shares, having an implied value of $10.00 per ordinary share and the Company became the holder of all of the issued shares in Security Matters PTY Ltd. and Lionheart, with Security Matters PTY Ltd. being delisted from the Australian Stock Exchange.

 

The Business Combination resulted in 97.58% redemption by Lionheart’s public shareholders which resulted in leaving $3,061 of funds remaining in the trust account (See also Note 6 and Note 2.E as for the accounting treatment of the transaction in these financial statements).

 

-7-
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 1 – GENERAL (CONT.):

 

C.The Company operates primarily through 8 wholly owned subsidiaries, all of which have been consolidated in these consolidated financial statements.

 

Controlled entity 

Country of

Incorporation

  

Percentage Owned

June 30, 2023

  

Percentage Owned

December 31, 2022

 
Security Matters PTY Ltd.
(Formerly - Security Matters Limited)
   Australia    100%   - 
Lionheart III Corp   USA    100%   -** 
SMX Circular Economy Platform PTE, Ltd.   Singapore    100%   -* 
SMX (Security Matters) Ireland Limited   Ireland    100%   -* 
SMX (Security Matters) Israel Ltd.
(Formerly - Security Matters Ltd.)
   Israel    100%   100%***
Security Matters Canada Ltd.   Canada    100%   100%***
Security Matters France Ltd.   France    100%   100%***
SMX Beverages Pty Ltd.   Australia    100%   100%***

 

In addition, the Company’s has the following investments in associated companies:

 

Entity 

Country of

Incorporation

  

Percentage Owned

June 30, 2023

  

Percentage Owned

December 31, 2022

 
Yahaloma Technologies Inc.   Canada    50%   50%***
True Gold Consortium Pty Ltd   Australia    44.4%   44.4%***

 

The proportion of ownership interest is equal to the proportion of voting power held.

*Incorporated in 2023.
**Merger occurred in March 2023.
***Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2022.

 

D.During the six months ended June 30, 2023, the Company incurred operating losses and negative cash flows from operating activities. The Company has not yet generated revenues. As discussed in Note 4, during the period, the Company entered into binding loan agreements with existing shareholders. As discussed in Note 5.1, the Company executed an equity line agreement to raise up to $25,000 in consideration of the issuance of common stock over the course of 36 months with YA II PN, LTD (“Yorkville”). As discussed in Notes 4 and 9.4, the Company signed agreements to convert indebtedness by issuance of shares. As discussed in Note 9.3 the Company is continuing with additional capital raising, and post balance sheet date it received an additional $2,500 in funding. The Company has also the ability to decrease its expenses in order to meet its existing cash flow streams. Management believes that the proceeds from the recent funding agreements, combined with its cash on hand, equity line and the Company’s plans, are sufficient to meet the Company’s obligations as they come due in the foreseeable future. There are no assurances, however, that the Company will be able to obtain an adequate level of financial resources that are required for its long-term business plan.

 

-8-
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES:

 

A. Basis of preparation

 

These interim consolidated financial statements have been prepared in a condensed format in accordance with IAS 34 Interim Financial Reporting. They do not include all disclosures that would otherwise be required in a complete set of financial statements and should be read in conjunction with the annual consolidated financial statements as of December 31, 2022 of the Company and of Security Matters PTY Ltd. (formerly - Security Matters Limited).

 

B. Functional currency

 

The consolidated financial statements are prepared in US Dollars, which is the functional and presentation currency of the Company.

 

C. Application of accounting policies

 

The Group has applied the same accounting policies and methods of computation in its interim condensed consolidated financial statements as in its 2022 annual financial statements and as in the 2022 annual financial statements of Security Matters PTY Ltd, except as stated below in note 2D and 2E.

 

Several amendments to IFRS Standards apply for the first time in 2023, but do not have an impact on the interim condensed consolidated financial statements.

 

D. Issue of a unit of financial instruments

 

The issue of a unit of financial instruments such as a financial liability (e.g., a loan) and free-standing derivative (e.g. warrants) involves the allocation of the proceeds received (before issuance costs) to financial derivatives and other financial instruments measured at fair value in each period and to financial liabilities that are measured at amortized cost, with residual allocated to equity instruments. Issuance costs are allocated to each component pro rata to the amounts determined for each component in the unit.

 

E. Reverse acquisition transaction

 

The result of the merger between the Company and Security Matters PTY Ltd. as described in Note 1B is that legally the Company owns the entire share capital of Security Matters PTY Ltd.

 

Accordingly, for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY Ltd. and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the business combination transaction ($11,599), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $16,802, between the fair value of the shares deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date.

 

-9-
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

E. Reverse acquisition transaction (Cont.)

 

The Company is initially consolidated in the financial statements from the Closing Date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($4,921) and trade and other payables and warrants ($10,127) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:

 

1.The assets and liabilities of Security Matters PTY Ltd. have been recognized and measured in these consolidated financial statements at their pre-combination carrying amounts.

 

2.The retained earnings and other equity balances recognized in those consolidated financial statements are the retained earnings and other equity balances of Security Matters PTY Ltd. immediately before the Business Combination.

 

3.The amount recognized as issued equity instruments in these consolidated financial statements has been determined by adding to the issued equity of Security Matters PTY Ltd. immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY Ltd. (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.

 

4.The statement of comprehensive loss reflects that of Security Matters PTY Ltd. for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY Ltd. for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.

 

F. Reverse stock split

 

The presentation of loss per share amounts has been retrospectively adjusted to give effect to the reverse share split which occurred on August 8, 2023. Except otherwise specifically provided, no other adjustments have been made in these notes to reflect the reverse share split. See also Note 9.1.

 

NOTE 3 – CONVERTIBLE NOTES

 

On January 25, 2023, the Company received an amount of $250 in consideration for issuance of convertible notes (the “Convertible Notes”) and two types of warrants. The Convertible Notes principal amount is $250 and maturity date is the earlier between December 31, 2024, and the date of any change in control (excluding the Business Combination). The Convertible Notes have an interest rate of 15% per annum and shall be converted into ordinary shares: (1) at the note holder’s discretion, at a fixed conversion price of USD 10 per ordinary share, or (2) through issuance of the Company’s ordinary shares at a 20% discount.

 

As part of the Convertible Note agreements, the investor was granted two types of warrants:

 

(i)Bonus Warrants – 12,500 warrants to purchase ordinary shares of the Company at an exercise price of USD 11.50 per share. The Bonus Warrants term is five years commencing upon the Business Combination.

 

(ii)Redeemable Warrants – 12,500 warrants to purchase ordinary shares of the Company at a purchase price of USD 11.50 per share. The Redeemable Warrants term is five years commencing upon the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD 5.00 per warrant. The investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.

 

The Convertible Notes are recorded in accordance with their fair value. The Redeemable Warrants are accounted for as a derivative financial liability. Management utilized a third-party appraiser to assist them in valuing the Convertible Notes and Redeemable Warrants.

 

In order to calculate the fair value of the Convertible Notes, the Company discounted the payment schedule by a discount rate of 30.7%.

 

The fair value of the Redeemable Warrants was calculated using Monte-Carlo simulation model with expected volatility of 71.54% and the risk-free interest rate used is 4.19%. As of June 30, 2023, the fair value of the Convertible Notes was $218 and the fair value of the Redeemable Warrants was $71.

 

-10-
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 4 – BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY:

 

Between August 2022 to January 2023, Security Matters PTY Ltd. entered into bridge loan agreements (the “Bridge Loans”) with eleven lenders, which lent Security Matters PTY Ltd. an aggregate amount of $3,860. The Bridge Loans have a maturity date of up to two years and bear an interest rate of 10% per annum. The Bridge Loans were accounted for in accordance with the amortized cost method.

 

As part of the Bridge Loans agreements, the lenders were granted two types of warrants:

 

(iii)Bonus Warrants – 243,000 warrants to purchase ordinary shares of the Company at an exercise price of USD 11.50 per share. The Bonus Warrants term is five years commencing upon the Business Combination.

 

(iv)Redeemable Warrants – 572,000 warrants to purchase ordinary shares of the Company at a purchase price of USD 11.50 per share. The Redeemable Warrants term is five years commencing upon the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD 5.00 per warrant.

 

Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.

 

Management with the assistance of a third-party appraiser valued the Bonus and the Redeemable Warrants. The fair value of the Bonus Warrants was calculated using the Black-Scholes model. As of June 30, 2023, the fair value of the Bonus Warrants was less than $1 (December 31, 2022 - the fair value of the Bonus Warrants was $24).

 

The fair value of the Redeemable Warrants was calculated using Monte-Carlo simulation model. As of June 30, 2023, the fair value of the Redeemable Warrants was 2,133 (December 31, 2022, the fair value of the Redeemable Warrants was $2,669).

 

The main assumptions used in the three valuation models described above were: (1) risk free rate 3.99%; (2) volatility of assets 81.03%; and (3) excepted terms of the warrants -5.18 years. All warrants were classified as a derivative financial liability and are re-measured each reporting date, with changes in fair value recognized in finance expense (income), net.

 

During 2023, the Company entered into an additional bridge loan agreement (the “Additional Bridge Loans”), in which the Company raised an aggregate amount of $550. The Additional Bridge Loans have a maturity date of up to two years and bear interest rate of 10% per annum. In March 2023, the Company signed an addendum to the Bridge Loans agreements which convert principal amount of $1,350 and redeemable warrants at the amount of $1,000 into 872,418 ordinary shares and defer the remaining cash payments to March 31, 2024.

 

-11-
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 5 – MATERIAL EVENTS DURING THE PERIOD

 

1.The Company entered in February 2023 into a Standby Equity Purchase Agreement (“SEPA”) to raise up to $25,000 in consideration of the issuance of ordinary shares over the course of 36 months with Yorkville. According to the SEPA, the Company may issue Yorkville the ordinary shares at a purchase price as one of two options (i) equal to 96% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period (ii) equal to 97% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period.

 

Yorkville advanced to the Company an aggregate principal amount of $3,500 (the “Pre-Paid Advance”). The Pre-Paid Advance was disbursed in two separate installments evidenced as convertible loans, the first for $1,500 at the closing of the Business Combination, and the second, as subsequently amended, for $2,000 upon the effectiveness of the Initial Yorkville Registration Statement. The purchase price for the Pre-Paid Advance is 92.0% of the Pre-Paid Advance. Such Pre-Paid Advances will be offset upon the issuance of ordinary shares to Yorkville at a price per share equal to the lower of (a) 100% of the daily VWAP of the Ordinary Shares on The Nasdaq Stock Market as of the trading day immediately prior to the date of the disbursement of the Pre-Paid Advance (the “Fixed Price”) (in the case of the first Pre-Paid Advance, $3.65), or (b) 93.0% of the lowest daily VWAP of the Ordinary Shares on Nasdaq during the seven trading days immediately prior to each purchase (the “Variable Price” and the lower of the Fixed Price and the Variable Price shall be referred to as the “Purchase Price”); however, in no event shall the Purchase Price be less than $1.10 (the “Floor Price”). On July 27, 2023, the Company amended the promissory note evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $1.10 (as adjusted for reverse stock split which occurred on August 21, 2023, see also Note 9.1), after the Company was required to repay in cash $500 of principal amount as a result of the Company’s share price being below the original Floor Price. The maturity date will be 12-months after the initial closing of each Pre-Paid Advance. In July 2023, the Company repaid in full the first Pre-Paid Advance in the amount of $1,500. In the period, the Company issued ordinary shares in consideration of $450 in accordance with the terms of the SEPA.

 

2.On June 22, 2023, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with EF Hutton, LLC (the “Underwriter”) relating to the public offering of (i) 13,333,333 ordinary shares of the Company, at a subscription price per share of $0.24 (the “Firm Shares”), (ii) 13,333,333 warrants in the form of Warrant A to subscribe for 13,333,333 ordinary shares, at an exercise price of $0.24 per share (“Warrant A”), and (iii) 13,333,333 warrants in the form of Warrant B to subscribe for 13,333,333 ordinary shares, at an exercise price of $0.24 per share (“Warrant B” and together with Warrant A, the “Firm Warrants” and, collectively with the Firm Shares, the “Firm Securities”).

 

The Company also granted the Underwriter a 45-day option to subscribe for, in the aggregate, (a) up to 1,999,999 additional ordinary shares (15% of the Firm Shares) at a subscription price per share of $0.24 (100% of the public offering price allocated to each Firm Share) (the “Option Shares” and together with the Firm Shares, the “Shares”) or Pre-Funded Warrants to subscribe for up to 1,999,999 ordinary shares at a price per share of $0.2399 (100% of the public offering price allocated to each Firm Share less $0.0001) and the remaining non pre-funded exercise price of each pre-funded warrant will be $0.0001 per share, and/or (b) 1,999,999 warrants in the form of Warrant A to subscribe for an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at an exercise price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant A), and/or (c) 1,999,999 warrants in the form of Warrant B to purchase an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at a purchase price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant B) (the “Option Warrants” and together with the Firm Warrants and Pre-Funded Warrants, if any, the “Warrants”), which may be subscribed for in any combination of Option Shares and/or the Option Warrants. The Option Shares and the Option Warrants are referred to as the “Option Securities”.

 

The offering closed on June 27, 2023. The Company delivered the Firm Shares (or Firm Share equivalents in the form of Pre-Funded Warrants), the Firm Warrants and the Option Warrants to the Underwriter on the same day.

 

The Warrant A terms specify that the warrants may be exercised at any time on or before June 27, 2028. On or after the earlier of (i) the thirty day anniversary of the date of the Underwriting Agreement and (ii) the date on which the aggregate composite trading volume of the Company’s ordinary shares as reported by Bloomberg LP beginning on the date of the Underwriting Agreement exceeds 15,000,000 ordinary shares, a holder of Warrant A warrants may also provide notice and elect a “cashless exercise” pursuant to which the holder would receive an aggregate number of ordinary shares equal to the product of (x) the aggregate number of ordinary shares that would be issuable upon a cash exercise and (y) $0.50. As of the date of publication of these financial statements, an aggregate of 15,195,332 Warrant A warrants were cashless exercised into an aggregate of 7,597,665 ordinary shares.

 

-12-
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 5 – MATERIAL EVENTS DURING THE PERIOD (CONT.)

 

The Warrant B terms specify that the warrants may be exercised at any time on or before June 27, 2028. All of such Warrant B warrants remain outstanding as of the end of period.

 

Warrant A was valued at $0.0635 which is half of the share market price at the end of the period, assuming cashless exercise. Warrants A were considered to be a derivative financial liability. The terms of warrants B specify that each warrant has a cash exercise price of $0.24. Warrant B was valued at $0.0602 by using the Black-Scholes option-pricing model, with expected volatility of 70.39% and the risk-free interest rate used is 4.13%. Warrants A and B expire in June 2028.

 

The net proceeds to the Company upon the closing of this offering were approximately $2,580. The capital raise fee amounted to $660.

 

The Company also granted to the Underwriter, 666,667 warrants at an exercise price of $0.264 per share, which expires after 5 years. The Underwriter’s warrants were valued at $0.0575 per option by using the Black & Scholes option-pricing, with expected volatility of 70.39% and the risk-free interest rate used is 4.13%.

 

3.

In January 2023, the Company signed an amendment to the agreement with Isorad that determine the following:

(1) for the BCA with Lionheart, (a) Isorad was issued 864,000 options to purchase shares of the Company, which options were issued in January 2023 and valued using the Black-Scholes pricing model, with the main parameters used are: (1) risk-free rate: 3.42%; (2) expected volatility: 81.92%: (3) expected term: up to 3 years; and (4) expected dividend yield: 0%; and (b) Isorad will be entitled to 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter (to be paid after reaching an aggregated received amount of $27 million, or at the end of such 13 months, the earlier thereof). In the period, based on the funds the Company actually received, the Company recognized a technology license intellectual property at the amount of $101 against a liability that reflects the due amount; and

 

(2) Exit fee - in the occurrence of the first M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA, the Company is to pay a cash amount equal to 1.5% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.

 

4.On March 2, 2023, the Company amended its loan agreement dated September 7, 2015, between the Company, its Shareholders and Kamea Fund that postponed the repayment of the borrowings from related party (Bonus Payment) to March 31, 2024 (refer also to Note 9.4 – Subsequent Events).

 

-13-
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 6 - SHAREHOLDERS’ EQUITY

 

A. Share capital:

 

   Number of shares 
   June 30, 2023   December 31, 2022 
   Authorized   Issued and outstanding   Authorized   Issued and outstanding 
Ordinary shares
USD 0.0001 par value
   800,000,000,000    38,364,447    500,000,000    1 
Ordinary shares
USD 0.0001 par value
   800,000,000,000    38,364,447    500,000,000    1 
Preferred shares
USD 0.0001 par value
   200,000,000,000    -    -    - 
Deferred shares
Euro 1 par value
   25,000    25,000    25,000    25,000 

 

Ordinary shares

 

Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the Company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have a par value per share of $0.0001 (before the reverse split) and par value per share of $0.0022 (post reverse split) and the Company does not have a limited amount of authorised capital.

 

Preferred shares

 

preferred shares with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors.

 

Deferred shares

 

Deferred Ordinary Shares are non-voting shares and do not convey upon the holder the right to be paid a dividend or to receive notice of or to attend, vote or speak at a general meeting. The Deferred Shares confer the right on a return of capital, on a winding-up or otherwise, only to the repayment of the nominal value paid up on the Deferred Shares after repayment of the nominal value of the Ordinary Shares.

 

Changes in Share capital

 

A.On March 7, 2023 (the “Closing Date”), the Company consummated the Business Combination pursuant the BCA, dated July 26, 2022, and also consummated the SID, dated July 26, 2022.

 

Beginning on the day immediately prior to the Closing Date and ending on the day immediately after the Closing Date, the following transactions occurred:

 

1.The AUD 828,240 of the 2022 Convertible Notes have been cancelled in consideration for the issuance of 1,000,000 ordinary shares in Security Matters PTY Ltd.

 

2.Security Matters PTY Ltd. performed acceleration of vesting for all unvested warrants and options, the expense for the acceleration amounted to $186.

 

3.32,211,716 warrants have been exercised on cashless basis to 24,568,773 shares in Security Matters PTY Ltd.

 

4.18,673,253 ordinary shares of the Company have been issued to Security Matters PTY Ltd.’s shareholders in return for their 193,500,379 ordinary shares in Security Matters PTY Ltd. that were cancelled. Security Matters PTY Ltd.’s shareholders received as consideration 1 ordinary share of the Company per 10.3624 Security Matters PTY Ltd.’s ordinary shares.

 

5.The Company issued 3,525,000 ordinary shares, 2,200,000 private warrants and 6,250,000 public warrants to Lionheart’s stockholders, in exchange for their existing Lionheart shares and warrants. The warrants exercise price is $11.5 per share, expiring in March 2028. The warrants are considered to be a derivative financial liability and measured at fair value, which is the market price as of the end of the period, amounted to $0.0204 per warrant.

 

-14-
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 6 – SHAREHOLDERS’ EQUITY (CONT.)

 

6.The Company issued 303,053 ordinary shares for an aggregate of $3,110 net proceeds.

 

7.The Company issued 872,418 ordinary shares for the conversion of bridge loan at principal amount of $1,350 and 200,000 redeemable warrants ($5 per warrant, 5 years, exercise price of $11.5 per share).

 

B.In May and June 2023, the Company issued 675,168 ordinary shares to Yorkville, for an aggregate of $450 net proceeds (see also Note 5.1).

 

C.In June 2023, the Company raised capital as part of issuance of a unit of financial instruments in consideration of an aggregate of $2,580 net proceeds. As part of this issuance, the Company issued 13,333,333 shares, 15,333,332 warrants A and 15,333,332 warrants B (see also Note 5.2).

 

D.After the balance sheet date, on August 21, 2023, the Company’s ordinary shares began trading on the Nasdaq Global Market on a post-Reverse Stock Split basis, after consolidating every twenty-two ordinary shares of the Company into one ordinary share (see also Note 9.1).

 

Incentive Equity Plan

 

In April 25, 2023, the Company’s board of directors and its shareholders approved and adopted the SMX Public Limited Company 2022 Incentive Equity Plan, which was subsequently amended the Company’s board of directors, subject to applicable Nasdaq requirements, which reserved for grant a number of ordinary shares equal to 15% of the number of issued and outstanding ordinary shares on a fully diluted basis immediately after the closing of the Business Combination, or 5,082,417 authorized ordinary shares.

 

1.During the six-month period ended June 30, 2023, the Company granted 4,334,000 RSUs to employees, directors and service providers. The fair value at grant date of RSUs granted in the period were $1-$1.09. The related share-based expenses that were recognized in the period amounted to $1,738.

 

RSUs granted to employees, directors and service providers:

 

 SCHEDULE OF RESTRICTED SHARES UNITS GRANTED

  

Six months period ended

June 30, 2023 (in thousands)

  

Six months period ended

June 30, 2022
(in thousands)

 
Outstanding at beginning of period   -        - 
Granted   4,334    - 
Vested   (945)   - 
           
Outstanding at June 30, 2023   3,389    - 

 

2.During the six-month period ended June 30, 2023, the Company granted 790,408 options to employees and service providers. These grants carry an exercise price of between $1.04 - $4.0, vesting period up to 4 years from the grant date, contractual life of the options under the plan is 5 years. The fair value of the grant at grant date is $185. The related share based expenses that were recognized in the six months period ended June 30, 2023 amounted to $168.

 

-15-
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 6 - SHAREHOLDERS’ EQUITY (CONT.)

 

Options granted to employees and service providers:

 

 SCHEDULE OF SHARE OPTION GRANTED

  

Six months period ended

June 30, 2023

 
  

Number

of options

(in thousands)

  

Weighted average

exercise price per share (US$)

 
Outstanding at beginning of period   1,251    2.01 
Granted   790    3.47 
Exercised   (7)   1.39 
Expired   -    - 
           
Outstanding at June 30, 2023   2,034    2.58 
Exercisable options at June 30, 2023   1,825    2.48 

 

  

Six months period ended

June 30, 2022

 
  

Number

of options

(in thousands)

  

Weighted average

exercise price per share (US$)

 
Outstanding at beginning of period   3,346    2.02 
Granted   989    2.86 
Exercised   -    -  
Expired   (375)   2.16 
           
Outstanding at June 30, 2022   3,960    2.21 
Exercisable options at June 30, 2022   2,703    2.33 

 

The options to employees and service providers outstanding as of June 30, 2023, are comprised, as follows:

 

 SCHEDULE OF OPTIONS TO EMPLOYEES AND SERVICE PROVIDERS OUTSTANDING

Exercise price (US$)  

Outstanding as of

June 30, 2023

(in thousands)

  

Weighted average remaining

contractual term

  

Exercisable as of June 30, 2023

(in thousands)

  

Weighted average remaining

contractual term

 
        (years)       (years) 
0.84-1.39    845    1.18    845    1.18 
1.81-2.51    335    2.59    335    2.59 
3.57-4.0    707    4.89    498    4.86 
4.18    10    1.74    10    1.74 
4.87    137    3.51    137    3.51 
     2,034         1,825      

 

-16-
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 7 – GENERAL AND ADMINISTRATIVE EXPENSES

           
   Six Months Ended 
   June 30, 2023   June 30, 2022 
   US$ in thousands   US$ in thousands 
Transaction cost   7,792    - 
Advertising, Public and Investors Relations   1,526    - 
Share based compensation   1,805    82 
Professional services   718    545 
Wages and salaries related   664    429 
Travel expenses   379    4 
Insurance   329    19 
Office and maintenance   37    80 
Depreciation and amortization   15    15 
Others   86    26 
Total   13,350    1,200 

 

NOTE 8 - LOSS PER SHARE

 

           
   Six months ended 
   June 30, 2023   June 30, 2022 
Net loss attributable to the owners of the Company  $(33,009)  $(2,442)
           
Basic and diluted loss per share  $(39.46)  $*(3.36)
Weighted average number of ordinary shares          
Weighted average number of ordinary shares used in calculating basic and diluted loss per share (in thousands)   837    *727*

 

As a result of the reverse share split described in Note 9.1, the calculation of the basic and diluted loss per share for all periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.

 

*Restated as a result of the SPAC transaction

 

-17-
 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 9 – SUBSEQUENT EVENTS

 

Since the reporting date, the following significant events have occurred:

 

1.Reverse Stock Split - On August 8, 2023, at the Extraordinary General Meeting of Shareholders of the Company, the Company’s shareholders voted in favor of consolidating every twenty-two ordinary shares in the authorized but unissued and in the authorized and issued share capital of the Company into one ordinary share (the “Reverse Stock Split”).

 

On August 21, 2023, the Company’s ordinary shares began trading on the Nasdaq Global Market on a post-Reverse Stock Split basis under the current symbol “SMX”.

 

Following is a table which presents the loss per share before the change (see also Note 8).

 

Loss per share have been calculated using the weighted average number of shares in issue during the relevant financial periods, the weighted average number of equity shares in issue and loss for the period as follows:

 

           
   Six months ended 
   June 30, 2023   June 30, 2022 
Net loss attributable to the owners of the Company   (33,009)   (2,442)
           
Basic and diluted loss per share   (1.79)   (0.15)
Weighted average number of ordinary shares          
Weighted average number of ordinary shares used in calculating basic and diluted loss per share   18,404    15,984 

 

2.On July 27, 2023, the Company amended its Pre-Paid Advance agreement with Yorkville (see also Note 5.1) evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $1.10 (as adjusted for the Reverse Stock Split which occurred on August 21, 2023, see also Note 9.1), after the Company was required to repay in cash $500 of principal amount as a result of the Company’s share price being below the original Floor Price. The maturity date will be 12-months after the initial closing of the Pre-Paid Advance. In July 2023, the Company repaid in full the first Pre-Paid Advance in the amount of $1,500. In the period, the Company repaid approximately $450 principal amount by ordinary share issuance in accordance with the terms of the SEPA and subsequent to the period, the Company repaid approximately $1,350 through September 30, 2023.

 

3.On September 6, 2023, the Company consummated the transactions pursuant to a Securities Purchase Agreement dated as of September 5, 2023 and issued and sold to an institutional investor a promissory note with a fixed conversion price of $1.6378 and warrants, for gross proceeds to SMX of approximately $2,500, before deducting fees and other offering expenses payable by the Company to their service providers. The note is in the principal amount of $4,290. The actual amount loaned by the investor pursuant to the Note is $2,574 after a 40% original issue discount. The maturity date of the note is the 12-month anniversary of the Effective Date, and is the date upon which the principal amount, as well as any accrued and unpaid interest and other fees, shall be due and payable. Interest accrues in the amount of 12% per year and shall be payable on the maturity date. The investor has the right, at any time, to convert all or any portion of the then outstanding and unpaid principal amount and interest (including any costs, fees and charges) into the Company’s ordinary shares, at a fixed conversion price of $1.6378 per share. Any such conversion is subject to customary conversion limitations set forth in the Purchase Agreement so the investor beneficially owns less than 4.99% of the Company’s ordinary shares. Additionally, the Company has the right to convert in whole or in part the note into ordinary shares; provided that in no case shall the Company so convert the note if the result of the issuance of Ordinary Shares thereby would result in the beneficial ownership of the investor of ordinary shares in excess of 4.99%.

 

4.On September 15, 2023, the Company paid $250 to EF Hutton, division of Benchmark Investments, LLC, pursuant to a Satisfaction and Discharge of Indebtedness Pursuant to Promissory Note Dated March 7, 2023. Upon paying such amount, the promissory note dated March 7, 2023 in the principal sum of $900 was deemed fully paid and satisfied and the Note was thereafter canceled, discharged and no longer of any further force or effect.

 

5.On September 19, 2023, the Company amended its loan agreements dated September 7, 2015, by and between the Company, its shareholders and Kamea Fund (the “Loan Agreements”). Pursuant to the amendment to the Loan Agreements, Kamea agreed to convert $657 of indebtedness under the Loan Agreements (the “Indebtedness Amount”) into 487,281 ordinary shares (post Reverse Stock Split) of the Company, as payment in full for the Indebtedness Amount; provided however, that in the event the proceeds received from Kamea with respect to any sales of such shares are not at least equal to the Indebtedness Amount, the Company will remain liable to Kamea for the balance of the Indebtedness Amount.
  
6.

On October 3, 2023, the Company has signed an agreement with True Gold Consortium Pty Ltd (“TrueGold”) (see also Note 1C) shareholders to acquire an additional 7.5% which will increase the Company’s holdings to 51.9% in TrueGold and result in the Company’s gain control over TrueGold. As part of the agreement and in consideration for the additional 7.5%, it was agreed that the outstanding payables from TrueGold to the Company which amounted to AU$ 475 as of June 30, 2023 (approximately $307) would be forgiven in full.

 

The transaction is based on past valuation, which was prepared in October 2021, which evaluates TrueGold’s fair value in the range of $78.5 million to $90 million and at a mean of $84.3 million. This past valuation was not audited or reviewed.

 

As of the agreement’s closing date, both parties agreed to engage an independent third party appraiser to prepare an updated TrueGold valuation as of closing date by November 30, 2023. Accordingly, the Company will recognize in its financial statements the fair value of TrueGold’s assets & liabilities at closing date as will be valued by the independent third party appraiser. Once this valuation will be completed, there may be material differences between TrueGold’s past valuation from October 2021 to the updated valuation.

 

-18-

GRAPHIC 3 fin_001.jpg begin 644 fin_001.jpg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smx-20230630.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Interim Condensed Consolidated Statements of Financial Position (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Interim Condensed Consolidated Changes in Shareholders' Equity - (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Interim Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 995511 - Disclosure - GENERAL link:presentationLink link:calculationLink link:definitionLink 995512 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 995513 - Disclosure - CONVERTIBLE NOTES link:presentationLink link:calculationLink link:definitionLink 995514 - Disclosure - BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - MATERIAL EVENTS DURING THE PERIOD link:presentationLink link:calculationLink link:definitionLink 995516 - Disclosure - SHAREHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 995517 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES link:presentationLink link:calculationLink link:definitionLink 995518 - Disclosure - LOSS PER SHARE link:presentationLink link:calculationLink link:definitionLink 995519 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 995520 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 995521 - Disclosure - GENERAL (Tables) link:presentationLink link:calculationLink link:definitionLink 995522 - Disclosure - SHAREHOLDERS’ EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 995523 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 995524 - Disclosure - LOSS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - SUBSEQUENT EVENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 995526 - Disclosure - SCHEDULE OF COMPANIES SUBSIDIARIES (Details) link:presentationLink link:calculationLink link:definitionLink 995527 - Disclosure - GENERAL (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995528 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995529 - Disclosure - CONVERTIBLE NOTES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995530 - Disclosure - BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995531 - Disclosure - MATERIAL EVENTS DURING THE PERIOD (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995532 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details) link:presentationLink link:calculationLink link:definitionLink 995533 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995534 - Disclosure - SCHEDULE OF RESTRICTED SHARES UNITS GRANTED (Details) link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - SCHEDULE OF SHARE OPTION GRANTED (Details) link:presentationLink link:calculationLink link:definitionLink 995536 - Disclosure - SCHEDULE OF OPTIONS TO EMPLOYEES AND SERVICE PROVIDERS OUTSTANDING (Details) link:presentationLink link:calculationLink link:definitionLink 995537 - Disclosure - SHAREHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 995538 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 995539 - Disclosure - SCHEDULE OF LOSS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 995540 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 5 smx-20230630_cal.xml INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 6 smx-20230630_def.xml INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 7 smx-20230630_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Components of equity [axis] Issued capital [member] Foreign Currency Translation [Member] Retained earnings [member] Classes of share capital [axis] Ordinary shares [member] Business combinations [axis] Lionheart [Member] Types of contracts [axis] Business Combination Agreement [Member] Equity Line Agreement [Member] Subsidiaries [axis] Security Matters PTY Ltd [Member] Lion heart III Corp [Member] SMX Circular Economy Platform PTE Ltd [Member] SMX Ireland Limited [Member] SMX Israel Ltd [Member] Security Matters Canada Ltd [Member] Security Matters France Ltd [Member] SMX Beverages Pty Ltd [Member] Yahaloma Technologies Inc [Member] True Gold Consortium Pty Ltd [Member] Classes of financial liabilities [axis] Convertible Notes [Member] Convertiable Note Agreements [Member] Bonus Warrants [Member] Redeemable Warrants [Member] Bridge loan agreements [member] Categories of related parties [axis] Eleven Lenders [Member] Range [axis] Top of range [member] Statistical Measurement [Axis] Non-adjusting events after reporting period [axis] Non adjusting Event [Member] Equity Purchase Agreement [Axis] SEPA [Member] Bottom of range [member] Measurement [axis] First Installment [Member] Second Installment [Member] Underwriting Agreement [Member] Warrant A [Member] Warrant B [Member] Underwriter Warrant [Member] Types of antidilutive instruments [axis] Restricted share units [member] Preference shares [member] Deferred Shares [Member] 2022 Convertible Notes [Member] Private Warrants [Member] Public Warrants [Member] Ordinary Shares One [Member] Ordinary Shares Two [Member] Yorkville [Member] Characteristics of defined benefit plans [axis] 2022 Incentive Equity Plan [Member] Employees Directors And Service Providers [Member] Employees And Service Providers [Member] Ranges of exercise prices for outstanding share options [axis] Exercise price one [member] Options Outstanding Two [Member] Options Outstanding Three [Member] Options Outstanding Four [Member] Options Outstanding Five [Member] Attribution of expenses by nature to their function [axis] General And Administrative Expenses [Member] Reverse stock split [Member] Securities Purchase Agreement [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of financial position [abstract] Current assets Cash and cash equivalents Other current receivables Total current assets Non-current assets Property and equipment, net Intangible assets, net Investment in associated companies Total non-current assets Total assets Current liabilities Trade payables Lease liabilities Other payables Convertible notes Warrants Pre-paid advance Bridge loans and derivative financial liabilities Borrowings from related parties Total current liabilities Non-current liabilities Lease liabilities Bridge loans and derivative financial liabilities Long term payables Total non-current liabilities Total liabilities Shareholders’ equity (deficit) Issued capital and additional paid in capital Foreign currency translation reserve Accumulated losses Total Shareholders’ equity (deficit) Total liabilities and shareholders’ equity (deficit) Analysis of income and expense [abstract] Research and development expenses, net Selling and marketing expenses General and administrative expenses Listing expenses Operating loss Finance income Finance expenses Share of net loss of associated companies Loss before income tax Income tax Loss after income tax for the period attributable to shareholders Other comprehensive loss: Items that will be reclassified to profit or loss: Foreign currency translation Other comprehensive loss, net of tax Total comprehensive loss Loss per share attributable to shareholders Basic loss per share attributable to shareholders Diluted loss per share attributable to shareholders Statement of changes in equity [table] IfrsStatementLineItems [Line Items] Balance Loss after income tax for the period Other comprehensive loss for the period Total comprehensive loss for the period Issuance of shares, net Recapitalization due to issuance of shares following the SPAC transaction, net Share-based compensation Conversion of convertible notes to shares Conversion of bridge loans to shares Exercise of options Conversion of warrants A to ordinary shares, net (See note 5.2) Issuance of Security Bundle, net (See note 5.2) Balance Statement of cash flows [abstract] Cash flows from operating activities: Net Loss Share-based compensation Depreciation and amortization Increase (decrease) in other receivables Increase in trade payables Increase in other payables Decrease in other liabilities Revaluation of financial liabilities at fair value Financial expenses due to bridge loans principal amounts Interest on leases Provision of borrowing to related parties Revaluation of convertible notes Share of net loss of associated companies Issuance of shares for directors SPAC transaction - listing costs Net cash flow used in operating activities Cash flows from investing activities: Purchase of property, plant and equipment Capitalized development cost Net cash flow used in investing activities Cash flows from financing activities: Payment of lease liabilities Proceeds from issuance of convertible notes Proceeds from issuance of Security Bundle, net Issuance of warrants Issuance of derivative financial liability Proceeds from bridge loans Repayment of bridge loans Advance payment for equity, net (see Note 5.1) Issuance of shares in the SPAC transaction, net Net cash flow from financing activities Increase (decrease) in cash and cash equivalents Cash and cash equivalents at beginning of period Exchange rate differences on cash and cash equivalent Cash and cash equivalents at end of period Appendix A – Non-Cash transactions during the period: Conversion of liability to ordinary shares (see Note 5.1) Conversion of warrants to ordinary shares (see note 5.2) Conversion of bridge loans and derivative financial liability to ordinary shares Exercise of options and warrants to ordinary shares Conversion of convertible notes to ordinary shares Pay vs Performance Disclosure [Table] Executive Category [Axis] Individual [Axis] Adjustment to Compensation [Axis] Measure [Axis] Pay vs Performance [Table Text Block] Company Selected Measure Name Named Executive Officers, Footnote [Text Block] Peer Group Issuers, Footnote [Text Block] Changed Peer Group, Footnote [Text Block] PEO Total Compensation Amount PEO Actually Paid Compensation Amount Adjustment To PEO Compensation, Footnote [Text Block] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Compensation Actually Paid Amount Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Equity Valuation Assumption Difference, Footnote [Text Block] Compensation Actually Paid vs. Total Shareholder Return [Text Block] Compensation Actually Paid vs. Net Income [Text Block] Compensation Actually Paid vs. Company Selected Measure [Text Block] Total Shareholder Return Vs Peer Group [Text Block] Compensation Actually Paid vs. Other Measure [Text Block] Tabular List [Table Text Block] Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net Income (Loss) Attributable to Parent Company Selected Measure Amount Other Performance Measure Amount Adjustment to Compensation Amount PEO Name Measure Name Non-GAAP Measure Description [Text Block] Additional 402(v) Disclosure [Text Block] Erroneously Awarded Compensation Recovery [Table] Restatement Determination Date [Axis] Restatement Determination Date Aggregate Erroneous Compensation Amount Erroneous Compensation Analysis [Text Block] Stock Price or TSR Estimation Method [Text Block] Outstanding Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Not Yet Determined [Text Block] Forgone Recovery, Individual Name Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery, Explanation of Impracticability [Text Block] Outstanding Recovery, Individual Name Outstanding Recovery Compensation Amount Restatement Does Not Require Recovery [Text Block] Awards Close in Time to MNPI Disclosures [Table] Award Type [Axis] Award Timing MNPI Disclosure [Text Block] Award Timing Method [Text Block] Award Timing Predetermined [Flag] Award Timing MNPI Considered [Flag] Award Timing, How MNPI Considered [Text Block] MNPI Disclosure Timed for Compensation Value [Flag] Awards Close in Time to MNPI Disclosures [Table Text Block] Awards Close in Time to MNPI Disclosures, Individual Name Award Underlying Securities Amount Award Exercise Price Award Grant Date Fair Value Underlying Security Market Price Change, Percent Trading Arrangements, by Individual [Table] Trading Arrangement [Axis] Material Terms of Trading Arrangement Name Title Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted Adoption Date Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated Termination Date Arrangement Duration Aggregate Available Insider Trading Policies and Procedures [Line Items] Insider Trading Policies and Procedures Adopted [Flag] Insider Trading Policies and Procedures Not Adopted [Text Block] General GENERAL Significant Accounting Policies SIGNIFICANT ACCOUNTING POLICIES Notes and other explanatory information [abstract] CONVERTIBLE NOTES BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY Material Events During Period MATERIAL EVENTS DURING THE PERIOD Shareholders Equity SHAREHOLDERS’ EQUITY General And Administrative Expenses GENERAL AND ADMINISTRATIVE EXPENSES Loss Per Share LOSS PER SHARE Disclosure of events after reporting period [text block] SUBSEQUENT EVENTS Basis of preparation Functional currency Application of accounting policies Issue of a unit of financial instruments Reverse acquisition transaction Reverse stock split SCHEDULE OF COMPANIES SUBSIDIARIES Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [table] SCHEDULE OF SHARE CAPITAL SCHEDULE OF SHARE OPTION GRANTED SCHEDULE OF OPTIONS TO EMPLOYEES AND SERVICE PROVIDERS OUTSTANDING SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES SCHEDULE OF LOSS PER SHARE SCHEDULE OF LOSS PER SHARE Disclosure of subsidiaries [table] Country of Incorporation Percentage Owned Number of shares issued Share price Implied value Redemption percentage of business combination Remaining funds in trust account Consideration of issuance of common stock Additional capital raising Fair value based on the quoted opening share price Fair value of the shares Marketable securities held in a trust account Trade, other payables and warrants Issue of convertible instruments Principal amount Maturity date Interest rate Fixed conversion price Discount rate Warrants to purchase ordinary shares Exercise price Warrants term Share purchase price Par value per share Description of approach used to determine discount rates Volatility rate Risk-free interest rate Fair value of convertible notes Fair value of the redeemable warrants Disclosure of disaggregation of revenue from contracts with customers [table] Proceeds from loans and warrants Borrowings maturity Borrowings, interest rate Exercise price of warrants Excepted terms Par value Fair value of the bonous Warrants [custom:FairValueOfRedeemableWarrants-0] Proceeds from borrowings, classified as financing activities Aggregate amount of convertible instruments issued Redeemable warrants Number of shares Disclosure of detailed information about borrowings [table] EquityPurchaseAgreementAxis [Axis] Issued capital, ordinary shares Percentage of weighted average price of common stock Percentage of common stock Pre-paid advance Purchase price pre paid advance description Cash Issued ordinary shares value Options to purchase shares Subscription price per share Number of warrants issued Number of warrants issued Option granted description Warrant share price cash exercise Number of warrant cashless exercised Warrant share price cashless exercise Exercise price Expected volatility Risk-free rate Net proceeds Capital raise fee Number of shares issued warrants Warrants expiration date Expected term Expected dividend yield Convertible percentage Aggregated received amount Payment of cash percent Number of shares authorized Number of shares issued and outstanding Number of options outstanding, beginning balance Number of options, granted Number of options, vested Number of options outstanding, ending balance Schedule Of Share Option Granted Weighted average exercise price, outstanding beginning balance Weighted average exercise price, granted Number of options, exercised Weighted average exercise price, exercised Number of options, expired Weighted average exercise price, expired Weighted average exercise price, outstanding ending balance Number of options, Exercisable Weighted average exercise price, Exercisable Disclosure of number and weighted average remaining contractual life of outstanding share options [table] Exercise price Number of outstanding shares Weighted average remaining contractual life of outstanding share options Number of exercisable shares Weighted average remaining contractual life of exercisable share options Explanation of fact that shares have par value Convertiable notes Warrants acceleration amount Exercise of warrants Number of shares on cashless basis Proceeds from issuance of stock Principal amount Shares issued warrants Number of issued and outstanding ordinary shares percentage Options granted Related share based expenses Vesting period description Fair value Disclosure of attribution of expenses by nature to their function [table] Transaction cost Advertising, Public and Investors Relations Share based compensation Professional services Wages and salaries related Travel expenses Insurance Office and maintenance Depreciation and amortization Others Total Net loss attributable to the owners of the Company Diluted loss per share attributable to shareholdersDiluted loss per share attributable to shareholders Weighted average number of ordinary shares Weighted average number of ordinary shares used in calculating basic and diluted loss per share Disclosure of non-adjusting events after reporting period [table] Floor price Repayment of debt Pre-paid advance Debt conversion price Gross proceeds Debt principal smount Loans payable Investor owned percentage Payments for promissory notes Maturity date Number of shares converted Foreign Currency Translation [Member] Share in earnings losses of associated companies net. Redemption percentage of business combination. Lionheart [Member] Business Combination Agreement [Member] Remaining funds in trust account. Percentage of weighted average price of common stock. Percentage of common stock. Description of expected expected term options granted. Addtional equity fund of convertible percent. Payment of cash percent. Number of shares issued warrants. Convertible Notes [Member] Proceeds from loans and warrants. Bridge loan agreements [member] Eleven Lenders [Member] Number of shares issued and outstanding. Weighted average number of ordinary shares [Abstract] Exercise price one [member] Weighted average remaining contractual life of exercisable share options 2019. Warrants expiration date. Number of issued and outstanding ordinary shares percentage. Bridge loans and derivative financial liabilities non current. Convertible notes current. Warrants current. Prepaid advance current. Long term payables non current. Listing expenses. Bridge loans and derivative financial liabilities current. Issue of equity one. Stock issued during period value recapitalization due to issuance of shares following spac transaction. Stock issued during period value conversion of convertible notes to shares. Stock issued during period value conversion of bridge loans to shares. Stock issued during period value exercise of options. Stock issued during period value conversion of warrants to ordinary shares net. Adjustments for interest on leases. Provision of borrowing to related parties. Issuance of shares for directors. Capitalized development cost classified as investing activities. Adjustments for financial expenses due to bridge loans principal amounts. Adjustments forRevaluationOfConvertibleNotes Share issued price per share. Advance payment for equity net. Spac transaction listing costs. Proceeds from issuance of security bundle net. Proceeds from bridge loans. Repayment of bridge loans. Non cash transactions during period abstract. Conversion of liability to ordinary shares. Conversion of warrants to ordinary shares. Conversion of bridge loans and derivative financial liability to ordinary shares. Exercise of options and warrants to ordinary shares. Conversion of convertible notes to ordinary shares. Security Matters PTY Ltd [Member] Lion heart III Corp [Member] SMX Circular Economy Platform PTE Ltd [Member] SMX Ireland Limited [Member] SMX Israel Ltd [Member] Security Matters Canada Ltd [Member] Security Matters France Ltd [Member] SMX Beverages Pty Ltd [Member] Yahaloma Technologies Inc [Member] True Gold Consortium Pty Ltd [Member] Non adjusting Event [Member] Proceeds from issuance of derivative financial liability. Stock issued during period value consideration of issuance of common stock. Equity Line Agreement [Member] Disclosure Of Summary Of Significant Accounting Policies Explanatory. Description Of Accounting Policy For Basis Of Preparation Explanatory. Description Of Accounting Policy For Application Of Accounting Policies Explanatory. First Installment [Member] Description Of Accounting Policy For Reverse Acquisition Transaction Explanatory. Second Installment [Member] Fair value of shares. Fair value based on quoted opening share price. Purchase price pre paid advance description. Marketable securities held in trust account. Debt interest rate. Debt principal amount. Fixed conversion price. Discount rate. Warrants to purchase ordinary shares. Convertiable Note Agreements [Member] Subscription price per share. Exercise price of warrants. Warrants term. Bonus Warrants [Member] Underwriting Agreement [Member] Redeemable Warrants [Member] Description Of Accounting Policy For Reverse Stock Split Explanatory. Fair value of convertible notes. Fair value of redeemable warrants. Number of subscription shares. Number of warrants issued. Warrant A [Member] Warrant B [Member] Fair value of bonous warrants. Redeemable warrants. Number of warrant cashless exercised. Disclosure Of Detailed Information About General And Administrative Expense Explanatory. Transaction cost. Deferred Shares [Member] Options Outstanding Two [Member] Options Outstanding Three [Member] Options Outstanding Four [Member] Options Outstanding Five [Member] Disclosure Of Loss Per Share Explanatory. Reverse stock split [Member] Warrant share price cashless exercise. Warrant share price cash exercise. Prepaid advance. Debt conversion price. Underwriter Warrant [Member] Gross proceeds. Securities Purchase Agreement [Member] Employees And Service Providers [Member] Investor owned percentage. Payments for promissory notes. Debt maturity date. Number of shares converted. Employees Directors And Service Providers [Member] Disclosure Of Material Events During The Period Explanatory. Yorkville [Member] 2022 Incentive Equity Plan [Member] Ordinary Shares Two [Member] Proceeds from issuance of stock. Ordinary Shares One [Member] Convertiable notes. 2022 Convertible Notes [Member] Warrants acceleration amount. Exercise of warrants. Number of shares on cashless basis. Private warrants. Public warrants. Payments for share issued. Share purchase price. Floor price. Equity Purchase Agreement [Axis] SEPA [Member] Explanation of fact that shares have par value. Current assets [Default Label] Non-current assets [Default Label] Assets Current liabilities [Default Label] Non-current lease liabilities BridgeLoansAndDerivativeFinancialLiabilitiesNoncurrent Non-current liabilities [Default Label] Liabilities Equity Equity and liabilities Profit (loss) from operating activities Profit (loss) before tax Other comprehensive income that will be reclassified to profit or loss, net of tax AdjustmentsForInterestOnLeases ShareInEarningsLossesOfAssociatedCompaniesNet IssuanceOfSharesForDirectors SpacTransactionListingCosts Cash flows from (used in) operating activities Purchase of property, plant and equipment, classified as investing activities CapitalizedDevelopmentCostClassifiedAsInvestingActivities Cash flows from (used in) investing activities Payments of lease liabilities, classified as financing activities Repayments of borrowings, classified as financing activities Cash flows from (used in) financing activities Increase (decrease) in cash and cash equivalents after effect of exchange rate changes DisclosureOfLossPerShareExplanatory Current prepaid expenses NumberOfSubscriptionShares Exercise price, share options granted Number of share options exercised in share-based payment arrangement Weighted average exercise price of share options outstanding in share-based payment arrangement Number of share options expired in share-based payment arrangement Weighted average exercise price of share options exercisable in share-based payment arrangement Exercise price of outstanding share options Depreciation and amortisation expense PrepaidAdvance DebtMaturityDate EX-101.PRE 8 smx-20230630_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 9 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
6 Months Ended
Jun. 30, 2023
Cover [Abstract]  
Document Type 6-K
Amendment Flag false
Entity File Number 001-41639
Entity Registrant Name SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY
Entity Central Index Key 0001940674
Entity Address, Address Line One Mespil Business Centre
Entity Address, Address Line Two Mespil House
Entity Address, Address Line Three Sussex Road
Entity Address, City or Town Dublin 4
Entity Address, Country IE
City Area Code +353-1
Local Phone Number 920-1000
XML 10 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Interim Condensed Consolidated Statements of Financial Position (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 3,020 $ 1,398
Other current receivables 1,037 3,673
Total current assets 4,057 5,071
Non-current assets    
Property and equipment, net 820 969
Intangible assets, net 5,269 5,027
Investment in associated companies 112 221
Total non-current assets 6,201 6,217
Total assets 10,258 11,288
Current liabilities    
Trade payables 7,281 2,972
Lease liabilities 30 30
Other payables 2,415 650
Convertible notes 304 563
Warrants 856
Pre-paid advance 3,050
Bridge loans and derivative financial liabilities 2,363 3,682
Borrowings from related parties 689 710
Total current liabilities 16,988 4,925
Non-current liabilities    
Lease liabilities 403 440
Bridge loans and derivative financial liabilities 938
Long term payables 3,930 85
Total non-current liabilities 5,271 4,207
Total liabilities 22,259 9,132
Shareholders’ equity (deficit)    
Issued capital and additional paid in capital 51,730 32,711
Foreign currency translation reserve (702) (537)
Accumulated losses (63,029) (30,020)
Total Shareholders’ equity (deficit) (12,001) 2,156
Total liabilities and shareholders’ equity (deficit) $ 10,258 $ 11,288
XML 11 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Analysis of income and expense [abstract]    
Research and development expenses, net $ 1,172 $ 933
Selling and marketing expenses 228 378
General and administrative expenses 13,350 1,200
Listing expenses 16,802
Operating loss 31,552 2,511
Finance income 1,143 105
Finance expenses 2,496 36
Share of net loss of associated companies 104
Loss before income tax 33,009 2,442
Income tax
Loss after income tax for the period attributable to shareholders 33,009 2,442
Items that will be reclassified to profit or loss:    
Foreign currency translation (165) (639)
Other comprehensive loss, net of tax (165) (639)
Total comprehensive loss $ 33,174 $ 3,081
Loss per share attributable to shareholders    
Basic loss per share attributable to shareholders $ (39.46) [1] $ (3.36) [2],[3]
Diluted loss per share attributable to shareholders $ (39.46) [1] $ (3.36) [3]
[1] After giving effect to the reverse stock split (see also Note 9.1)
[2] Restated as a result of the SPAC transaction
[3] Restated as a result of the SPAC transaction and after giving effect to the reverse stock split (see also Note 1 and 9.1)
XML 12 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Interim Condensed Consolidated Changes in Shareholders' Equity - (Unaudited) - USD ($)
$ in Thousands
Issued capital [member]
Foreign Currency Translation [Member]
Retained earnings [member]
Total
Balance at Dec. 31, 2021 $ 31,504 $ 223 $ (23,836) $ 7,891
IfrsStatementLineItems [Line Items]        
Loss after income tax for the period (2,442) (2,442)
Other comprehensive loss for the period (639) (639)
Total comprehensive loss for the period (639) (2,442) (3,081)
Issuance of shares, net 721 721
Share-based compensation 219 219
Balance at Jun. 30, 2022 32,444 (416) (26,278) 5,750
Balance at Dec. 31, 2022 32,713 (537) (30,020) 2,156
IfrsStatementLineItems [Line Items]        
Loss after income tax for the period (33,009) (33,009)
Other comprehensive loss for the period (165) (165)
Total comprehensive loss for the period (165) (33,009) (33,174)
Issuance of shares, net 170 170
Recapitalization due to issuance of shares following the SPAC transaction, net 11,460 11,460
Share-based compensation 2,092 2,092
Conversion of convertible notes to shares 175 175
Conversion of bridge loans to shares 2,983 2,983
Exercise of options 10 10
Conversion of warrants A to ordinary shares, net (See note 5.2) 290     290
Issuance of Security Bundle, net (See note 5.2) 1,837 1,837
Balance at Jun. 30, 2023 $ 51,730 $ (702) $ (63,029) $ (12,001)
XML 13 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Interim Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net Loss $ (33,009) $ (2,442)
Share-based compensation 2,052 165
Depreciation and amortization 114 176
Increase (decrease) in other receivables 2,575 (1,727)
Increase in trade payables 2,545 831
Increase in other payables 70 110
Decrease in other liabilities 13 32
Revaluation of financial liabilities at fair value (41)
Financial expenses due to bridge loans principal amounts 1,421
Interest on leases 7 28
Provision of borrowing to related parties 14 (89)
Revaluation of convertible notes (382)
Share of net loss of associated companies 104
Issuance of shares for directors 40 54
SPAC transaction - listing costs 16,802
Net cash flow used in operating activities (7,675) (2,862)
Cash flows from investing activities:    
Purchase of property, plant and equipment (10) (183)
Capitalized development cost (383) (783)
Net cash flow used in investing activities (393) (966)
Cash flows from financing activities:    
Payment of lease liabilities (21) (39)
Proceeds from issuance of convertible notes 250 581
Proceeds from issuance of Security Bundle, net 914
Issuance of warrants 923
Issuance of derivative financial liability 974
Proceeds from bridge loans 550
Repayment of bridge loans (30)
Advance payment for equity, net (see Note 5.1) 3,220
Issuance of shares in the SPAC transaction, net 2,923
Net cash flow from financing activities 9,703 542
Increase (decrease) in cash and cash equivalents 1,635 (3,286)
Cash and cash equivalents at beginning of period 1,398 4,171
Exchange rate differences on cash and cash equivalent (13) (26)
Cash and cash equivalents at end of period 3,020 859
Appendix A – Non-Cash transactions during the period:    
Conversion of liability to ordinary shares (see Note 5.1) 450
Conversion of warrants to ordinary shares (see note 5.2) 290
Conversion of bridge loans and derivative financial liability to ordinary shares 2,983
Exercise of options and warrants to ordinary shares 2,229
Conversion of convertible notes to ordinary shares $ 175
XML 14 R6.htm IDEA: XBRL DOCUMENT v3.23.3
GENERAL
6 Months Ended
Jun. 30, 2023
General  
GENERAL

NOTE 1 - GENERAL:

 

A.SMX (Security Matters) Public Limited Company (“Security Matters” or the “Company” and together with its subsidiaries, the “Group”) was incorporated in July 1, 2022 under the laws of Ireland with registered number 722009 and its registered office at Mespil Business Center, Mespil House, Sessex Road, Dublin 4, Ireland, D04 T4A6. The Company was incorporated in 2022 as part of the Business Combination (see Note 1.B).

 

The Group provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer. Its proprietary marker system embeds a permanent or removable (depending on the needs of the customer) mark on solid, liquid or gaseous objects or materials. Each marker is comprised of a combination of marker codes such that each marker is designed to be unique and unable to be duplicated. The marker system is coupled with an innovative patented reader that responds to signals from the marker and, together with a patented algorithm, captures the details of the product retrieved and stored on a blockchain digital ledger. Each marker can be stored, either locally on the reader and on private servers, cloud servers or on a blockchain ledger, to protect data integrity and custody.

 

B.The Business Combination - the SPAC transaction (“Business Combination”):

 

On March 7, 2023 (the “Closing Date”) the Company completed its Business Combination with Lionheart III Corp (“Lionheart”), following that Lionheart and Security Matters PTY Ltd. (formerly named Security Matters Limited, which was incorporated in May 2018 under Australian law) became the Company’s wholly-owned subsidiaries and the Company listed its ordinary shares and public warrants on the NASDAQ stock market under the tickers SMX and SMXWW, respectively. On July 26, 2022, Security Matters PTY Ltd. and Lionheart, a publicly traded special purpose acquisition company (SPAC), entered into a business combination agreement (the “BCA”) and accompanying scheme implementation deed (“SID”). Under the BCA, the existing Lionheart stockholders received the Company’s shares and warrants in exchange for their existing Lionheart shares and warrants and all shares existed in Security Matters PTY Ltd were cancelled in return for the Company’s shares and resulting in Security Matters PTY Ltd. becoming a wholly owned subsidiary of the Company. Security Matters PTY Ltd. shareholders received consideration of 1 ordinary share per 10.3624 Security Matters PTY Ltd. shares, having an implied value of $10.00 per ordinary share and the Company became the holder of all of the issued shares in Security Matters PTY Ltd. and Lionheart, with Security Matters PTY Ltd. being delisted from the Australian Stock Exchange.

 

The Business Combination resulted in 97.58% redemption by Lionheart’s public shareholders which resulted in leaving $3,061 of funds remaining in the trust account (See also Note 6 and Note 2.E as for the accounting treatment of the transaction in these financial statements).

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 1 – GENERAL (CONT.):

 

C.The Company operates primarily through 8 wholly owned subsidiaries, all of which have been consolidated in these consolidated financial statements.

 

Controlled entity 

Country of

Incorporation

  

Percentage Owned

June 30, 2023

  

Percentage Owned

December 31, 2022

 
Security Matters PTY Ltd.
(Formerly - Security Matters Limited)
   Australia    100%   - 
Lionheart III Corp   USA    100%   -** 
SMX Circular Economy Platform PTE, Ltd.   Singapore    100%   -* 
SMX (Security Matters) Ireland Limited   Ireland    100%   -* 
SMX (Security Matters) Israel Ltd.
(Formerly - Security Matters Ltd.)
   Israel    100%   100%***
Security Matters Canada Ltd.   Canada    100%   100%***
Security Matters France Ltd.   France    100%   100%***
SMX Beverages Pty Ltd.   Australia    100%   100%***

 

In addition, the Company’s has the following investments in associated companies:

 

Entity 

Country of

Incorporation

  

Percentage Owned

June 30, 2023

  

Percentage Owned

December 31, 2022

 
Yahaloma Technologies Inc.   Canada    50%   50%***
True Gold Consortium Pty Ltd   Australia    44.4%   44.4%***

 

The proportion of ownership interest is equal to the proportion of voting power held.

*Incorporated in 2023.
**Merger occurred in March 2023.
***Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2022.

 

D.During the six months ended June 30, 2023, the Company incurred operating losses and negative cash flows from operating activities. The Company has not yet generated revenues. As discussed in Note 4, during the period, the Company entered into binding loan agreements with existing shareholders. As discussed in Note 5.1, the Company executed an equity line agreement to raise up to $25,000 in consideration of the issuance of common stock over the course of 36 months with YA II PN, LTD (“Yorkville”). As discussed in Notes 4 and 9.4, the Company signed agreements to convert indebtedness by issuance of shares. As discussed in Note 9.3 the Company is continuing with additional capital raising, and post balance sheet date it received an additional $2,500 in funding. The Company has also the ability to decrease its expenses in order to meet its existing cash flow streams. Management believes that the proceeds from the recent funding agreements, combined with its cash on hand, equity line and the Company’s plans, are sufficient to meet the Company’s obligations as they come due in the foreseeable future. There are no assurances, however, that the Company will be able to obtain an adequate level of financial resources that are required for its long-term business plan.

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

XML 15 R7.htm IDEA: XBRL DOCUMENT v3.23.3
SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2023
Significant Accounting Policies  
SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES:

 

A. Basis of preparation

 

These interim consolidated financial statements have been prepared in a condensed format in accordance with IAS 34 Interim Financial Reporting. They do not include all disclosures that would otherwise be required in a complete set of financial statements and should be read in conjunction with the annual consolidated financial statements as of December 31, 2022 of the Company and of Security Matters PTY Ltd. (formerly - Security Matters Limited).

 

B. Functional currency

 

The consolidated financial statements are prepared in US Dollars, which is the functional and presentation currency of the Company.

 

C. Application of accounting policies

 

The Group has applied the same accounting policies and methods of computation in its interim condensed consolidated financial statements as in its 2022 annual financial statements and as in the 2022 annual financial statements of Security Matters PTY Ltd, except as stated below in note 2D and 2E.

 

Several amendments to IFRS Standards apply for the first time in 2023, but do not have an impact on the interim condensed consolidated financial statements.

 

D. Issue of a unit of financial instruments

 

The issue of a unit of financial instruments such as a financial liability (e.g., a loan) and free-standing derivative (e.g. warrants) involves the allocation of the proceeds received (before issuance costs) to financial derivatives and other financial instruments measured at fair value in each period and to financial liabilities that are measured at amortized cost, with residual allocated to equity instruments. Issuance costs are allocated to each component pro rata to the amounts determined for each component in the unit.

 

E. Reverse acquisition transaction

 

The result of the merger between the Company and Security Matters PTY Ltd. as described in Note 1B is that legally the Company owns the entire share capital of Security Matters PTY Ltd.

 

Accordingly, for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY Ltd. and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the business combination transaction ($11,599), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $16,802, between the fair value of the shares deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date.

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

E. Reverse acquisition transaction (Cont.)

 

The Company is initially consolidated in the financial statements from the Closing Date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($4,921) and trade and other payables and warrants ($10,127) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:

 

1.The assets and liabilities of Security Matters PTY Ltd. have been recognized and measured in these consolidated financial statements at their pre-combination carrying amounts.

 

2.The retained earnings and other equity balances recognized in those consolidated financial statements are the retained earnings and other equity balances of Security Matters PTY Ltd. immediately before the Business Combination.

 

3.The amount recognized as issued equity instruments in these consolidated financial statements has been determined by adding to the issued equity of Security Matters PTY Ltd. immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY Ltd. (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.

 

4.The statement of comprehensive loss reflects that of Security Matters PTY Ltd. for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY Ltd. for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.

 

F. Reverse stock split

 

The presentation of loss per share amounts has been retrospectively adjusted to give effect to the reverse share split which occurred on August 8, 2023. Except otherwise specifically provided, no other adjustments have been made in these notes to reflect the reverse share split. See also Note 9.1.

 

XML 16 R8.htm IDEA: XBRL DOCUMENT v3.23.3
CONVERTIBLE NOTES
6 Months Ended
Jun. 30, 2023
Notes and other explanatory information [abstract]  
CONVERTIBLE NOTES

NOTE 3 – CONVERTIBLE NOTES

 

On January 25, 2023, the Company received an amount of $250 in consideration for issuance of convertible notes (the “Convertible Notes”) and two types of warrants. The Convertible Notes principal amount is $250 and maturity date is the earlier between December 31, 2024, and the date of any change in control (excluding the Business Combination). The Convertible Notes have an interest rate of 15% per annum and shall be converted into ordinary shares: (1) at the note holder’s discretion, at a fixed conversion price of USD 10 per ordinary share, or (2) through issuance of the Company’s ordinary shares at a 20% discount.

 

As part of the Convertible Note agreements, the investor was granted two types of warrants:

 

(i)Bonus Warrants – 12,500 warrants to purchase ordinary shares of the Company at an exercise price of USD 11.50 per share. The Bonus Warrants term is five years commencing upon the Business Combination.

 

(ii)Redeemable Warrants – 12,500 warrants to purchase ordinary shares of the Company at a purchase price of USD 11.50 per share. The Redeemable Warrants term is five years commencing upon the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD 5.00 per warrant. The investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.

 

The Convertible Notes are recorded in accordance with their fair value. The Redeemable Warrants are accounted for as a derivative financial liability. Management utilized a third-party appraiser to assist them in valuing the Convertible Notes and Redeemable Warrants.

 

In order to calculate the fair value of the Convertible Notes, the Company discounted the payment schedule by a discount rate of 30.7%.

 

The fair value of the Redeemable Warrants was calculated using Monte-Carlo simulation model with expected volatility of 71.54% and the risk-free interest rate used is 4.19%. As of June 30, 2023, the fair value of the Convertible Notes was $218 and the fair value of the Redeemable Warrants was $71.

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

XML 17 R9.htm IDEA: XBRL DOCUMENT v3.23.3
BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY
6 Months Ended
Jun. 30, 2023
Notes and other explanatory information [abstract]  
BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY

NOTE 4 – BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY:

 

Between August 2022 to January 2023, Security Matters PTY Ltd. entered into bridge loan agreements (the “Bridge Loans”) with eleven lenders, which lent Security Matters PTY Ltd. an aggregate amount of $3,860. The Bridge Loans have a maturity date of up to two years and bear an interest rate of 10% per annum. The Bridge Loans were accounted for in accordance with the amortized cost method.

 

As part of the Bridge Loans agreements, the lenders were granted two types of warrants:

 

(iii)Bonus Warrants – 243,000 warrants to purchase ordinary shares of the Company at an exercise price of USD 11.50 per share. The Bonus Warrants term is five years commencing upon the Business Combination.

 

(iv)Redeemable Warrants – 572,000 warrants to purchase ordinary shares of the Company at a purchase price of USD 11.50 per share. The Redeemable Warrants term is five years commencing upon the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD 5.00 per warrant.

 

Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.

 

Management with the assistance of a third-party appraiser valued the Bonus and the Redeemable Warrants. The fair value of the Bonus Warrants was calculated using the Black-Scholes model. As of June 30, 2023, the fair value of the Bonus Warrants was less than $1 (December 31, 2022 - the fair value of the Bonus Warrants was $24).

 

The fair value of the Redeemable Warrants was calculated using Monte-Carlo simulation model. As of June 30, 2023, the fair value of the Redeemable Warrants was 2,133 (December 31, 2022, the fair value of the Redeemable Warrants was $2,669).

 

The main assumptions used in the three valuation models described above were: (1) risk free rate 3.99%; (2) volatility of assets 81.03%; and (3) excepted terms of the warrants -5.18 years. All warrants were classified as a derivative financial liability and are re-measured each reporting date, with changes in fair value recognized in finance expense (income), net.

 

During 2023, the Company entered into an additional bridge loan agreement (the “Additional Bridge Loans”), in which the Company raised an aggregate amount of $550. The Additional Bridge Loans have a maturity date of up to two years and bear interest rate of 10% per annum. In March 2023, the Company signed an addendum to the Bridge Loans agreements which convert principal amount of $1,350 and redeemable warrants at the amount of $1,000 into 872,418 ordinary shares and defer the remaining cash payments to March 31, 2024.

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

XML 18 R10.htm IDEA: XBRL DOCUMENT v3.23.3
MATERIAL EVENTS DURING THE PERIOD
6 Months Ended
Jun. 30, 2023
Material Events During Period  
MATERIAL EVENTS DURING THE PERIOD

NOTE 5 – MATERIAL EVENTS DURING THE PERIOD

 

1.The Company entered in February 2023 into a Standby Equity Purchase Agreement (“SEPA”) to raise up to $25,000 in consideration of the issuance of ordinary shares over the course of 36 months with Yorkville. According to the SEPA, the Company may issue Yorkville the ordinary shares at a purchase price as one of two options (i) equal to 96% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period (ii) equal to 97% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period.

 

Yorkville advanced to the Company an aggregate principal amount of $3,500 (the “Pre-Paid Advance”). The Pre-Paid Advance was disbursed in two separate installments evidenced as convertible loans, the first for $1,500 at the closing of the Business Combination, and the second, as subsequently amended, for $2,000 upon the effectiveness of the Initial Yorkville Registration Statement. The purchase price for the Pre-Paid Advance is 92.0% of the Pre-Paid Advance. Such Pre-Paid Advances will be offset upon the issuance of ordinary shares to Yorkville at a price per share equal to the lower of (a) 100% of the daily VWAP of the Ordinary Shares on The Nasdaq Stock Market as of the trading day immediately prior to the date of the disbursement of the Pre-Paid Advance (the “Fixed Price”) (in the case of the first Pre-Paid Advance, $3.65), or (b) 93.0% of the lowest daily VWAP of the Ordinary Shares on Nasdaq during the seven trading days immediately prior to each purchase (the “Variable Price” and the lower of the Fixed Price and the Variable Price shall be referred to as the “Purchase Price”); however, in no event shall the Purchase Price be less than $1.10 (the “Floor Price”). On July 27, 2023, the Company amended the promissory note evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $1.10 (as adjusted for reverse stock split which occurred on August 21, 2023, see also Note 9.1), after the Company was required to repay in cash $500 of principal amount as a result of the Company’s share price being below the original Floor Price. The maturity date will be 12-months after the initial closing of each Pre-Paid Advance. In July 2023, the Company repaid in full the first Pre-Paid Advance in the amount of $1,500. In the period, the Company issued ordinary shares in consideration of $450 in accordance with the terms of the SEPA.

 

2.On June 22, 2023, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with EF Hutton, LLC (the “Underwriter”) relating to the public offering of (i) 13,333,333 ordinary shares of the Company, at a subscription price per share of $0.24 (the “Firm Shares”), (ii) 13,333,333 warrants in the form of Warrant A to subscribe for 13,333,333 ordinary shares, at an exercise price of $0.24 per share (“Warrant A”), and (iii) 13,333,333 warrants in the form of Warrant B to subscribe for 13,333,333 ordinary shares, at an exercise price of $0.24 per share (“Warrant B” and together with Warrant A, the “Firm Warrants” and, collectively with the Firm Shares, the “Firm Securities”).

 

The Company also granted the Underwriter a 45-day option to subscribe for, in the aggregate, (a) up to 1,999,999 additional ordinary shares (15% of the Firm Shares) at a subscription price per share of $0.24 (100% of the public offering price allocated to each Firm Share) (the “Option Shares” and together with the Firm Shares, the “Shares”) or Pre-Funded Warrants to subscribe for up to 1,999,999 ordinary shares at a price per share of $0.2399 (100% of the public offering price allocated to each Firm Share less $0.0001) and the remaining non pre-funded exercise price of each pre-funded warrant will be $0.0001 per share, and/or (b) 1,999,999 warrants in the form of Warrant A to subscribe for an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at an exercise price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant A), and/or (c) 1,999,999 warrants in the form of Warrant B to purchase an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at a purchase price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant B) (the “Option Warrants” and together with the Firm Warrants and Pre-Funded Warrants, if any, the “Warrants”), which may be subscribed for in any combination of Option Shares and/or the Option Warrants. The Option Shares and the Option Warrants are referred to as the “Option Securities”.

 

The offering closed on June 27, 2023. The Company delivered the Firm Shares (or Firm Share equivalents in the form of Pre-Funded Warrants), the Firm Warrants and the Option Warrants to the Underwriter on the same day.

 

The Warrant A terms specify that the warrants may be exercised at any time on or before June 27, 2028. On or after the earlier of (i) the thirty day anniversary of the date of the Underwriting Agreement and (ii) the date on which the aggregate composite trading volume of the Company’s ordinary shares as reported by Bloomberg LP beginning on the date of the Underwriting Agreement exceeds 15,000,000 ordinary shares, a holder of Warrant A warrants may also provide notice and elect a “cashless exercise” pursuant to which the holder would receive an aggregate number of ordinary shares equal to the product of (x) the aggregate number of ordinary shares that would be issuable upon a cash exercise and (y) $0.50. As of the date of publication of these financial statements, an aggregate of 15,195,332 Warrant A warrants were cashless exercised into an aggregate of 7,597,665 ordinary shares.

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 5 – MATERIAL EVENTS DURING THE PERIOD (CONT.)

 

The Warrant B terms specify that the warrants may be exercised at any time on or before June 27, 2028. All of such Warrant B warrants remain outstanding as of the end of period.

 

Warrant A was valued at $0.0635 which is half of the share market price at the end of the period, assuming cashless exercise. Warrants A were considered to be a derivative financial liability. The terms of warrants B specify that each warrant has a cash exercise price of $0.24. Warrant B was valued at $0.0602 by using the Black-Scholes option-pricing model, with expected volatility of 70.39% and the risk-free interest rate used is 4.13%. Warrants A and B expire in June 2028.

 

The net proceeds to the Company upon the closing of this offering were approximately $2,580. The capital raise fee amounted to $660.

 

The Company also granted to the Underwriter, 666,667 warrants at an exercise price of $0.264 per share, which expires after 5 years. The Underwriter’s warrants were valued at $0.0575 per option by using the Black & Scholes option-pricing, with expected volatility of 70.39% and the risk-free interest rate used is 4.13%.

 

3.

In January 2023, the Company signed an amendment to the agreement with Isorad that determine the following:

(1) for the BCA with Lionheart, (a) Isorad was issued 864,000 options to purchase shares of the Company, which options were issued in January 2023 and valued using the Black-Scholes pricing model, with the main parameters used are: (1) risk-free rate: 3.42%; (2) expected volatility: 81.92%: (3) expected term: up to 3 years; and (4) expected dividend yield: 0%; and (b) Isorad will be entitled to 1% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter (to be paid after reaching an aggregated received amount of $27 million, or at the end of such 13 months, the earlier thereof). In the period, based on the funds the Company actually received, the Company recognized a technology license intellectual property at the amount of $101 against a liability that reflects the due amount; and

 

(2) Exit fee - in the occurrence of the first M&A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA, the Company is to pay a cash amount equal to 1.5% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.

 

4.On March 2, 2023, the Company amended its loan agreement dated September 7, 2015, between the Company, its Shareholders and Kamea Fund that postponed the repayment of the borrowings from related party (Bonus Payment) to March 31, 2024 (refer also to Note 9.4 – Subsequent Events).

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

XML 19 R11.htm IDEA: XBRL DOCUMENT v3.23.3
SHAREHOLDERS’ EQUITY
6 Months Ended
Jun. 30, 2023
Shareholders Equity  
SHAREHOLDERS’ EQUITY

NOTE 6 - SHAREHOLDERS’ EQUITY

 

A. Share capital:

 

   Number of shares 
   June 30, 2023   December 31, 2022 
   Authorized   Issued and outstanding   Authorized   Issued and outstanding 
Ordinary shares
USD 0.0001 par value
   800,000,000,000    38,364,447    500,000,000    1 
Ordinary shares
USD 0.0001 par value
   800,000,000,000    38,364,447    500,000,000    1 
Preferred shares
USD 0.0001 par value
   200,000,000,000    -    -    - 
Deferred shares
Euro 1 par value
   25,000    25,000    25,000    25,000 

 

Ordinary shares

 

Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the Company in proportion to the number of and amounts paid on the shares held. The fully paid ordinary shares have a par value per share of $0.0001 (before the reverse split) and par value per share of $0.0022 (post reverse split) and the Company does not have a limited amount of authorised capital.

 

Preferred shares

 

preferred shares with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors.

 

Deferred shares

 

Deferred Ordinary Shares are non-voting shares and do not convey upon the holder the right to be paid a dividend or to receive notice of or to attend, vote or speak at a general meeting. The Deferred Shares confer the right on a return of capital, on a winding-up or otherwise, only to the repayment of the nominal value paid up on the Deferred Shares after repayment of the nominal value of the Ordinary Shares.

 

Changes in Share capital

 

A.On March 7, 2023 (the “Closing Date”), the Company consummated the Business Combination pursuant the BCA, dated July 26, 2022, and also consummated the SID, dated July 26, 2022.

 

Beginning on the day immediately prior to the Closing Date and ending on the day immediately after the Closing Date, the following transactions occurred:

 

1.The AUD 828,240 of the 2022 Convertible Notes have been cancelled in consideration for the issuance of 1,000,000 ordinary shares in Security Matters PTY Ltd.

 

2.Security Matters PTY Ltd. performed acceleration of vesting for all unvested warrants and options, the expense for the acceleration amounted to $186.

 

3.32,211,716 warrants have been exercised on cashless basis to 24,568,773 shares in Security Matters PTY Ltd.

 

4.18,673,253 ordinary shares of the Company have been issued to Security Matters PTY Ltd.’s shareholders in return for their 193,500,379 ordinary shares in Security Matters PTY Ltd. that were cancelled. Security Matters PTY Ltd.’s shareholders received as consideration 1 ordinary share of the Company per 10.3624 Security Matters PTY Ltd.’s ordinary shares.

 

5.The Company issued 3,525,000 ordinary shares, 2,200,000 private warrants and 6,250,000 public warrants to Lionheart’s stockholders, in exchange for their existing Lionheart shares and warrants. The warrants exercise price is $11.5 per share, expiring in March 2028. The warrants are considered to be a derivative financial liability and measured at fair value, which is the market price as of the end of the period, amounted to $0.0204 per warrant.

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 6 – SHAREHOLDERS’ EQUITY (CONT.)

 

6.The Company issued 303,053 ordinary shares for an aggregate of $3,110 net proceeds.

 

7.The Company issued 872,418 ordinary shares for the conversion of bridge loan at principal amount of $1,350 and 200,000 redeemable warrants ($5 per warrant, 5 years, exercise price of $11.5 per share).

 

B.In May and June 2023, the Company issued 675,168 ordinary shares to Yorkville, for an aggregate of $450 net proceeds (see also Note 5.1).

 

C.In June 2023, the Company raised capital as part of issuance of a unit of financial instruments in consideration of an aggregate of $2,580 net proceeds. As part of this issuance, the Company issued 13,333,333 shares, 15,333,332 warrants A and 15,333,332 warrants B (see also Note 5.2).

 

D.After the balance sheet date, on August 21, 2023, the Company’s ordinary shares began trading on the Nasdaq Global Market on a post-Reverse Stock Split basis, after consolidating every twenty-two ordinary shares of the Company into one ordinary share (see also Note 9.1).

 

Incentive Equity Plan

 

In April 25, 2023, the Company’s board of directors and its shareholders approved and adopted the SMX Public Limited Company 2022 Incentive Equity Plan, which was subsequently amended the Company’s board of directors, subject to applicable Nasdaq requirements, which reserved for grant a number of ordinary shares equal to 15% of the number of issued and outstanding ordinary shares on a fully diluted basis immediately after the closing of the Business Combination, or 5,082,417 authorized ordinary shares.

 

1.During the six-month period ended June 30, 2023, the Company granted 4,334,000 RSUs to employees, directors and service providers. The fair value at grant date of RSUs granted in the period were $1-$1.09. The related share-based expenses that were recognized in the period amounted to $1,738.

 

RSUs granted to employees, directors and service providers:

 

 SCHEDULE OF RESTRICTED SHARES UNITS GRANTED

  

Six months period ended

June 30, 2023 (in thousands)

  

Six months period ended

June 30, 2022
(in thousands)

 
Outstanding at beginning of period   -        - 
Granted   4,334    - 
Vested   (945)   - 
           
Outstanding at June 30, 2023   3,389    - 

 

2.During the six-month period ended June 30, 2023, the Company granted 790,408 options to employees and service providers. These grants carry an exercise price of between $1.04 - $4.0, vesting period up to 4 years from the grant date, contractual life of the options under the plan is 5 years. The fair value of the grant at grant date is $185. The related share based expenses that were recognized in the six months period ended June 30, 2023 amounted to $168.

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 6 - SHAREHOLDERS’ EQUITY (CONT.)

 

Options granted to employees and service providers:

 

 SCHEDULE OF SHARE OPTION GRANTED

  

Six months period ended

June 30, 2023

 
  

Number

of options

(in thousands)

  

Weighted average

exercise price per share (US$)

 
Outstanding at beginning of period   1,251    2.01 
Granted   790    3.47 
Exercised   (7)   1.39 
Expired   -    - 
           
Outstanding at June 30, 2023   2,034    2.58 
Exercisable options at June 30, 2023   1,825    2.48 

 

  

Six months period ended

June 30, 2022

 
  

Number

of options

(in thousands)

  

Weighted average

exercise price per share (US$)

 
Outstanding at beginning of period   3,346    2.02 
Granted   989    2.86 
Exercised   -    -  
Expired   (375)   2.16 
           
Outstanding at June 30, 2022   3,960    2.21 
Exercisable options at June 30, 2022   2,703    2.33 

 

The options to employees and service providers outstanding as of June 30, 2023, are comprised, as follows:

 

 SCHEDULE OF OPTIONS TO EMPLOYEES AND SERVICE PROVIDERS OUTSTANDING

Exercise price (US$)  

Outstanding as of

June 30, 2023

(in thousands)

  

Weighted average remaining

contractual term

  

Exercisable as of June 30, 2023

(in thousands)

  

Weighted average remaining

contractual term

 
        (years)       (years) 
0.84-1.39    845    1.18    845    1.18 
1.81-2.51    335    2.59    335    2.59 
3.57-4.0    707    4.89    498    4.86 
4.18    10    1.74    10    1.74 
4.87    137    3.51    137    3.51 
     2,034         1,825      

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

XML 20 R12.htm IDEA: XBRL DOCUMENT v3.23.3
GENERAL AND ADMINISTRATIVE EXPENSES
6 Months Ended
Jun. 30, 2023
General And Administrative Expenses  
GENERAL AND ADMINISTRATIVE EXPENSES

NOTE 7 – GENERAL AND ADMINISTRATIVE EXPENSES

           
   Six Months Ended 
   June 30, 2023   June 30, 2022 
   US$ in thousands   US$ in thousands 
Transaction cost   7,792    - 
Advertising, Public and Investors Relations   1,526    - 
Share based compensation   1,805    82 
Professional services   718    545 
Wages and salaries related   664    429 
Travel expenses   379    4 
Insurance   329    19 
Office and maintenance   37    80 
Depreciation and amortization   15    15 
Others   86    26 
Total   13,350    1,200 

 

XML 21 R13.htm IDEA: XBRL DOCUMENT v3.23.3
LOSS PER SHARE
6 Months Ended
Jun. 30, 2023
Loss Per Share  
LOSS PER SHARE

NOTE 8 - LOSS PER SHARE

 

           
   Six months ended 
   June 30, 2023   June 30, 2022 
Net loss attributable to the owners of the Company  $(33,009)  $(2,442)
           
Basic and diluted loss per share  $(39.46)  $*(3.36)
Weighted average number of ordinary shares          
Weighted average number of ordinary shares used in calculating basic and diluted loss per share (in thousands)   837    *727*

 

As a result of the reverse share split described in Note 9.1, the calculation of the basic and diluted loss per share for all periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.

 

*Restated as a result of the SPAC transaction

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

XML 22 R14.htm IDEA: XBRL DOCUMENT v3.23.3
SUBSEQUENT EVENTS
6 Months Ended
Jun. 30, 2023
SUBSEQUENT EVENTS

NOTE 9 – SUBSEQUENT EVENTS

 

Since the reporting date, the following significant events have occurred:

 

1.Reverse Stock Split - On August 8, 2023, at the Extraordinary General Meeting of Shareholders of the Company, the Company’s shareholders voted in favor of consolidating every twenty-two ordinary shares in the authorized but unissued and in the authorized and issued share capital of the Company into one ordinary share (the “Reverse Stock Split”).

 

On August 21, 2023, the Company’s ordinary shares began trading on the Nasdaq Global Market on a post-Reverse Stock Split basis under the current symbol “SMX”.

 

Following is a table which presents the loss per share before the change (see also Note 8).

 

Loss per share have been calculated using the weighted average number of shares in issue during the relevant financial periods, the weighted average number of equity shares in issue and loss for the period as follows:

 

           
   Six months ended 
   June 30, 2023   June 30, 2022 
Net loss attributable to the owners of the Company   (33,009)   (2,442)
           
Basic and diluted loss per share   (1.79)   (0.15)
Weighted average number of ordinary shares          
Weighted average number of ordinary shares used in calculating basic and diluted loss per share   18,404    15,984 

 

2.On July 27, 2023, the Company amended its Pre-Paid Advance agreement with Yorkville (see also Note 5.1) evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $1.10 (as adjusted for the Reverse Stock Split which occurred on August 21, 2023, see also Note 9.1), after the Company was required to repay in cash $500 of principal amount as a result of the Company’s share price being below the original Floor Price. The maturity date will be 12-months after the initial closing of the Pre-Paid Advance. In July 2023, the Company repaid in full the first Pre-Paid Advance in the amount of $1,500. In the period, the Company repaid approximately $450 principal amount by ordinary share issuance in accordance with the terms of the SEPA and subsequent to the period, the Company repaid approximately $1,350 through September 30, 2023.

 

3.On September 6, 2023, the Company consummated the transactions pursuant to a Securities Purchase Agreement dated as of September 5, 2023 and issued and sold to an institutional investor a promissory note with a fixed conversion price of $1.6378 and warrants, for gross proceeds to SMX of approximately $2,500, before deducting fees and other offering expenses payable by the Company to their service providers. The note is in the principal amount of $4,290. The actual amount loaned by the investor pursuant to the Note is $2,574 after a 40% original issue discount. The maturity date of the note is the 12-month anniversary of the Effective Date, and is the date upon which the principal amount, as well as any accrued and unpaid interest and other fees, shall be due and payable. Interest accrues in the amount of 12% per year and shall be payable on the maturity date. The investor has the right, at any time, to convert all or any portion of the then outstanding and unpaid principal amount and interest (including any costs, fees and charges) into the Company’s ordinary shares, at a fixed conversion price of $1.6378 per share. Any such conversion is subject to customary conversion limitations set forth in the Purchase Agreement so the investor beneficially owns less than 4.99% of the Company’s ordinary shares. Additionally, the Company has the right to convert in whole or in part the note into ordinary shares; provided that in no case shall the Company so convert the note if the result of the issuance of Ordinary Shares thereby would result in the beneficial ownership of the investor of ordinary shares in excess of 4.99%.

 

4.On September 15, 2023, the Company paid $250 to EF Hutton, division of Benchmark Investments, LLC, pursuant to a Satisfaction and Discharge of Indebtedness Pursuant to Promissory Note Dated March 7, 2023. Upon paying such amount, the promissory note dated March 7, 2023 in the principal sum of $900 was deemed fully paid and satisfied and the Note was thereafter canceled, discharged and no longer of any further force or effect.

 

5.On September 19, 2023, the Company amended its loan agreements dated September 7, 2015, by and between the Company, its shareholders and Kamea Fund (the “Loan Agreements”). Pursuant to the amendment to the Loan Agreements, Kamea agreed to convert $657 of indebtedness under the Loan Agreements (the “Indebtedness Amount”) into 487,281 ordinary shares (post Reverse Stock Split) of the Company, as payment in full for the Indebtedness Amount; provided however, that in the event the proceeds received from Kamea with respect to any sales of such shares are not at least equal to the Indebtedness Amount, the Company will remain liable to Kamea for the balance of the Indebtedness Amount.
  
6.

On October 3, 2023, the Company has signed an agreement with True Gold Consortium Pty Ltd (“TrueGold”) (see also Note 1C) shareholders to acquire an additional 7.5% which will increase the Company’s holdings to 51.9% in TrueGold and result in the Company’s gain control over TrueGold. As part of the agreement and in consideration for the additional 7.5%, it was agreed that the outstanding payables from TrueGold to the Company which amounted to AU$ 475 as of June 30, 2023 (approximately $307) would be forgiven in full.

 

The transaction is based on past valuation, which was prepared in October 2021, which evaluates TrueGold’s fair value in the range of $78.5 million to $90 million and at a mean of $84.3 million. This past valuation was not audited or reviewed.

 

As of the agreement’s closing date, both parties agreed to engage an independent third party appraiser to prepare an updated TrueGold valuation as of closing date by November 30, 2023. Accordingly, the Company will recognize in its financial statements the fair value of TrueGold’s assets & liabilities at closing date as will be valued by the independent third party appraiser. Once this valuation will be completed, there may be material differences between TrueGold’s past valuation from October 2021 to the updated valuation.

XML 23 R15.htm IDEA: XBRL DOCUMENT v3.23.3
SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Jun. 30, 2023
Significant Accounting Policies  
Basis of preparation

A. Basis of preparation

 

These interim consolidated financial statements have been prepared in a condensed format in accordance with IAS 34 Interim Financial Reporting. They do not include all disclosures that would otherwise be required in a complete set of financial statements and should be read in conjunction with the annual consolidated financial statements as of December 31, 2022 of the Company and of Security Matters PTY Ltd. (formerly - Security Matters Limited).

 

Functional currency

B. Functional currency

 

The consolidated financial statements are prepared in US Dollars, which is the functional and presentation currency of the Company.

 

Application of accounting policies

C. Application of accounting policies

 

The Group has applied the same accounting policies and methods of computation in its interim condensed consolidated financial statements as in its 2022 annual financial statements and as in the 2022 annual financial statements of Security Matters PTY Ltd, except as stated below in note 2D and 2E.

 

Several amendments to IFRS Standards apply for the first time in 2023, but do not have an impact on the interim condensed consolidated financial statements.

 

Issue of a unit of financial instruments

D. Issue of a unit of financial instruments

 

The issue of a unit of financial instruments such as a financial liability (e.g., a loan) and free-standing derivative (e.g. warrants) involves the allocation of the proceeds received (before issuance costs) to financial derivatives and other financial instruments measured at fair value in each period and to financial liabilities that are measured at amortized cost, with residual allocated to equity instruments. Issuance costs are allocated to each component pro rata to the amounts determined for each component in the unit.

 

Reverse acquisition transaction

E. Reverse acquisition transaction

 

The result of the merger between the Company and Security Matters PTY Ltd. as described in Note 1B is that legally the Company owns the entire share capital of Security Matters PTY Ltd.

 

Accordingly, for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY Ltd. and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the business combination transaction ($11,599), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $16,802, between the fair value of the shares deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date.

 

 

 

SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY

NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(US$ in thousands except share and per share data)

 

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (CONT.):

 

E. Reverse acquisition transaction (Cont.)

 

The Company is initially consolidated in the financial statements from the Closing Date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($4,921) and trade and other payables and warrants ($10,127) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:

 

1.The assets and liabilities of Security Matters PTY Ltd. have been recognized and measured in these consolidated financial statements at their pre-combination carrying amounts.

 

2.The retained earnings and other equity balances recognized in those consolidated financial statements are the retained earnings and other equity balances of Security Matters PTY Ltd. immediately before the Business Combination.

 

3.The amount recognized as issued equity instruments in these consolidated financial statements has been determined by adding to the issued equity of Security Matters PTY Ltd. immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY Ltd. (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.

 

4.The statement of comprehensive loss reflects that of Security Matters PTY Ltd. for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY Ltd. for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.

 

Reverse stock split

F. Reverse stock split

 

The presentation of loss per share amounts has been retrospectively adjusted to give effect to the reverse share split which occurred on August 8, 2023. Except otherwise specifically provided, no other adjustments have been made in these notes to reflect the reverse share split. See also Note 9.1.

XML 24 R16.htm IDEA: XBRL DOCUMENT v3.23.3
GENERAL (Tables)
6 Months Ended
Jun. 30, 2023
Notes and other explanatory information [abstract]  
SCHEDULE OF COMPANIES SUBSIDIARIES

 

Controlled entity 

Country of

Incorporation

  

Percentage Owned

June 30, 2023

  

Percentage Owned

December 31, 2022

 
Security Matters PTY Ltd.
(Formerly - Security Matters Limited)
   Australia    100%   - 
Lionheart III Corp   USA    100%   -** 
SMX Circular Economy Platform PTE, Ltd.   Singapore    100%   -* 
SMX (Security Matters) Ireland Limited   Ireland    100%   -* 
SMX (Security Matters) Israel Ltd.
(Formerly - Security Matters Ltd.)
   Israel    100%   100%***
Security Matters Canada Ltd.   Canada    100%   100%***
Security Matters France Ltd.   France    100%   100%***
SMX Beverages Pty Ltd.   Australia    100%   100%***

 

In addition, the Company’s has the following investments in associated companies:

 

Entity 

Country of

Incorporation

  

Percentage Owned

June 30, 2023

  

Percentage Owned

December 31, 2022

 
Yahaloma Technologies Inc.   Canada    50%   50%***
True Gold Consortium Pty Ltd   Australia    44.4%   44.4%***

 

The proportion of ownership interest is equal to the proportion of voting power held.

*Incorporated in 2023.
**Merger occurred in March 2023.
***Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2022.
XML 25 R17.htm IDEA: XBRL DOCUMENT v3.23.3
SHAREHOLDERS’ EQUITY (Tables)
6 Months Ended
Jun. 30, 2023
IfrsStatementLineItems [Line Items]  
SCHEDULE OF SHARE CAPITAL

 

   Number of shares 
   June 30, 2023   December 31, 2022 
   Authorized   Issued and outstanding   Authorized   Issued and outstanding 
Ordinary shares
USD 0.0001 par value
   800,000,000,000    38,364,447    500,000,000    1 
Ordinary shares
USD 0.0001 par value
   800,000,000,000    38,364,447    500,000,000    1 
Preferred shares
USD 0.0001 par value
   200,000,000,000    -    -    - 
Deferred shares
Euro 1 par value
   25,000    25,000    25,000    25,000 
SCHEDULE OF SHARE OPTION GRANTED

 SCHEDULE OF SHARE OPTION GRANTED

  

Six months period ended

June 30, 2023

 
  

Number

of options

(in thousands)

  

Weighted average

exercise price per share (US$)

 
Outstanding at beginning of period   1,251    2.01 
Granted   790    3.47 
Exercised   (7)   1.39 
Expired   -    - 
           
Outstanding at June 30, 2023   2,034    2.58 
Exercisable options at June 30, 2023   1,825    2.48 

 

  

Six months period ended

June 30, 2022

 
  

Number

of options

(in thousands)

  

Weighted average

exercise price per share (US$)

 
Outstanding at beginning of period   3,346    2.02 
Granted   989    2.86 
Exercised   -    -  
Expired   (375)   2.16 
           
Outstanding at June 30, 2022   3,960    2.21 
Exercisable options at June 30, 2022   2,703    2.33 
SCHEDULE OF OPTIONS TO EMPLOYEES AND SERVICE PROVIDERS OUTSTANDING

The options to employees and service providers outstanding as of June 30, 2023, are comprised, as follows:

 

 SCHEDULE OF OPTIONS TO EMPLOYEES AND SERVICE PROVIDERS OUTSTANDING

Exercise price (US$)  

Outstanding as of

June 30, 2023

(in thousands)

  

Weighted average remaining

contractual term

  

Exercisable as of June 30, 2023

(in thousands)

  

Weighted average remaining

contractual term

 
        (years)       (years) 
0.84-1.39    845    1.18    845    1.18 
1.81-2.51    335    2.59    335    2.59 
3.57-4.0    707    4.89    498    4.86 
4.18    10    1.74    10    1.74 
4.87    137    3.51    137    3.51 
     2,034         1,825      
Restricted share units [member]  
IfrsStatementLineItems [Line Items]  
SCHEDULE OF SHARE OPTION GRANTED

 SCHEDULE OF RESTRICTED SHARES UNITS GRANTED

  

Six months period ended

June 30, 2023 (in thousands)

  

Six months period ended

June 30, 2022
(in thousands)

 
Outstanding at beginning of period   -        - 
Granted   4,334    - 
Vested   (945)   - 
           
Outstanding at June 30, 2023   3,389    - 
XML 26 R18.htm IDEA: XBRL DOCUMENT v3.23.3
GENERAL AND ADMINISTRATIVE EXPENSES (Tables)
6 Months Ended
Jun. 30, 2023
General And Administrative Expenses  
SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES

           
   Six Months Ended 
   June 30, 2023   June 30, 2022 
   US$ in thousands   US$ in thousands 
Transaction cost   7,792    - 
Advertising, Public and Investors Relations   1,526    - 
Share based compensation   1,805    82 
Professional services   718    545 
Wages and salaries related   664    429 
Travel expenses   379    4 
Insurance   329    19 
Office and maintenance   37    80 
Depreciation and amortization   15    15 
Others   86    26 
Total   13,350    1,200 
XML 27 R19.htm IDEA: XBRL DOCUMENT v3.23.3
LOSS PER SHARE (Tables)
6 Months Ended
Jun. 30, 2023
Loss Per Share  
SCHEDULE OF LOSS PER SHARE

 

           
   Six months ended 
   June 30, 2023   June 30, 2022 
Net loss attributable to the owners of the Company  $(33,009)  $(2,442)
           
Basic and diluted loss per share  $(39.46)  $*(3.36)
Weighted average number of ordinary shares          
Weighted average number of ordinary shares used in calculating basic and diluted loss per share (in thousands)   837    *727*

 

As a result of the reverse share split described in Note 9.1, the calculation of the basic and diluted loss per share for all periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.

 

*Restated as a result of the SPAC transaction
XML 28 R20.htm IDEA: XBRL DOCUMENT v3.23.3
SUBSEQUENT EVENTS (Tables)
6 Months Ended
Jun. 30, 2023
SCHEDULE OF LOSS PER SHARE

Loss per share have been calculated using the weighted average number of shares in issue during the relevant financial periods, the weighted average number of equity shares in issue and loss for the period as follows:

 

           
   Six months ended 
   June 30, 2023   June 30, 2022 
Net loss attributable to the owners of the Company   (33,009)   (2,442)
           
Basic and diluted loss per share   (1.79)   (0.15)
Weighted average number of ordinary shares          
Weighted average number of ordinary shares used in calculating basic and diluted loss per share   18,404    15,984 
XML 29 R21.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF COMPANIES SUBSIDIARIES (Details)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Security Matters PTY Ltd [Member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation Australia  
Percentage Owned 100.00%
Lion heart III Corp [Member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation USA  
Percentage Owned 100.00% [1]
SMX Circular Economy Platform PTE Ltd [Member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation Singapore  
Percentage Owned 100.00% [2]
SMX Ireland Limited [Member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation Ireland  
Percentage Owned 100.00% [2]
SMX Israel Ltd [Member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation Israel  
Percentage Owned 100.00% 100.00% [3]
Security Matters Canada Ltd [Member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation Canada  
Percentage Owned 100.00% 100.00% [3]
Security Matters France Ltd [Member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation France  
Percentage Owned 100.00% 100.00% [3]
SMX Beverages Pty Ltd [Member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation Australia  
Percentage Owned 100.00% 100.00% [3]
Yahaloma Technologies Inc [Member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation Canada  
Percentage Owned 50.00% 50.00% [3]
True Gold Consortium Pty Ltd [Member]    
IfrsStatementLineItems [Line Items]    
Country of Incorporation Australia  
Percentage Owned 44.40% 44.40% [3]
[1] Merger occurred in March 2023.
[2] Incorporated in 2023.
[3] Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2022.
XML 30 R22.htm IDEA: XBRL DOCUMENT v3.23.3
GENERAL (Details Narrative)
$ / shares in Units, $ in Thousands
6 Months Ended
Jul. 26, 2022
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
$ / shares
shares
Jun. 30, 2023
€ / shares
Mar. 07, 2023
shares
Jan. 31, 2023
shares
Dec. 31, 2022
$ / shares
Dec. 31, 2022
€ / shares
IfrsStatementLineItems [Line Items]              
Number of shares issued | shares   13,333,333     864,000    
Share price | $ / shares $ 10.3624            
Implied value | € / shares     € 1       € 1
Equity Line Agreement [Member]              
IfrsStatementLineItems [Line Items]              
Consideration of issuance of common stock   $ 25,000          
Additional capital raising   $ 2,500          
Lionheart [Member] | Business Combination Agreement [Member]              
IfrsStatementLineItems [Line Items]              
Redemption percentage of business combination 97.58%            
Remaining funds in trust account $ 3,061            
Ordinary shares [member]              
IfrsStatementLineItems [Line Items]              
Number of shares issued | shares 1     1      
Implied value | $ / shares $ 10.00 $ 0.0001       $ 0.0001  
XML 31 R23.htm IDEA: XBRL DOCUMENT v3.23.3
SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
$ in Thousands
6 Months Ended
Jun. 30, 2023
USD ($)
Significant Accounting Policies  
Fair value based on the quoted opening share price $ 11,599
Fair value of the shares 16,802
Marketable securities held in a trust account 4,921
Trade, other payables and warrants $ 10,127
XML 32 R24.htm IDEA: XBRL DOCUMENT v3.23.3
CONVERTIBLE NOTES (Details Narrative)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended
Jan. 25, 2023
USD ($)
$ / shares
shares
Jan. 31, 2023
Jun. 30, 2023
USD ($)
$ / shares
Jun. 30, 2023
€ / shares
Feb. 28, 2023
USD ($)
Dec. 31, 2022
$ / shares
Dec. 31, 2022
€ / shares
Jul. 26, 2022
$ / shares
IfrsStatementLineItems [Line Items]                
Principal amount | $         $ 3,500      
Par value per share | € / shares       € 1     € 1  
Volatility rate   81.92%            
Risk-free interest rate   3.42%            
Fair value of convertible notes | $     $ 218          
Fair value of the redeemable warrants | $     $ 71          
Redeemable Warrants [Member]                
IfrsStatementLineItems [Line Items]                
Volatility rate     71.54%          
Risk-free interest rate     4.19%          
Convertiable Note Agreements [Member] | Bonus Warrants [Member]                
IfrsStatementLineItems [Line Items]                
Warrants to purchase ordinary shares | shares 12,500,000              
Exercise price | $ / shares $ 11.50              
Warrants term 5 years              
Convertiable Note Agreements [Member] | Redeemable Warrants [Member]                
IfrsStatementLineItems [Line Items]                
Discount rate 20.00%              
Warrants to purchase ordinary shares | shares 12,500              
Warrants term 5 years              
Share purchase price | $ / shares $ 11.50              
Par value per share | $ / shares $ 5.00              
Description of approach used to determine discount rates The investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.              
Ordinary shares [member]                
IfrsStatementLineItems [Line Items]                
Fixed conversion price | $ / shares               $ 10
Par value per share | $ / shares     $ 0.0001     $ 0.0001   $ 10.00
Convertible Notes [Member]                
IfrsStatementLineItems [Line Items]                
Issue of convertible instruments | $ $ 250              
Principal amount | $ $ 250              
Maturity date December 31, 2024              
Interest rate 15.00%              
Discount rate 20.00%   30.70%          
XML 33 R25.htm IDEA: XBRL DOCUMENT v3.23.3
BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY (Details Narrative)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended 12 Months Ended
Mar. 31, 2023
USD ($)
shares
Jan. 31, 2023
$ / shares
shares
Jun. 30, 2023
USD ($)
shares
Jan. 31, 2023
USD ($)
$ / shares
shares
Jun. 30, 2022
USD ($)
Dec. 31, 2023
USD ($)
Sep. 19, 2023
shares
Jun. 30, 2023
€ / shares
Dec. 31, 2022
USD ($)
Dec. 31, 2022
€ / shares
IfrsStatementLineItems [Line Items]                    
Par value | € / shares               € 1   € 1
[custom:FairValueOfRedeemableWarrants-0]     $ 71              
Risk-free interest rate   3.42%                
Volatility rate   81.92%                
Proceeds from borrowings, classified as financing activities     $ 550            
Number of shares | shares   864,000 13,333,333 864,000            
Non adjusting Event [Member]                    
IfrsStatementLineItems [Line Items]                    
Number of shares | shares             487,281      
Redeemable Warrants [Member]                    
IfrsStatementLineItems [Line Items]                    
Risk-free interest rate     4.19%              
Volatility rate     71.54%              
Bridge loan agreements [member]                    
IfrsStatementLineItems [Line Items]                    
Borrowings, interest rate   10.00%   10.00%            
Excepted terms     5 years 2 months 4 days              
Description of approach used to determine discount rates       Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.            
Fair value of the bonous Warrants                 $ 24  
[custom:FairValueOfRedeemableWarrants-0]     $ 2,133           $ 2,669  
Risk-free interest rate     3.99%              
Volatility rate     81.03%              
Aggregate amount of convertible instruments issued $ 1,350                  
Redeemable warrants $ 1,000                  
Number of shares | shares 872,418                  
Bridge loan agreements [member] | Non adjusting Event [Member]                    
IfrsStatementLineItems [Line Items]                    
Borrowings, interest rate           10.00%        
Proceeds from borrowings, classified as financing activities           $ 550        
Bridge loan agreements [member] | Top of range [member]                    
IfrsStatementLineItems [Line Items]                    
Fair value of the bonous Warrants     $ 1              
Bridge loan agreements [member] | Bonus Warrants [Member]                    
IfrsStatementLineItems [Line Items]                    
Warrants to purchase ordinary shares | shares       243,000            
Exercise price of warrants | $ / shares       $ 11.50            
Excepted terms       5 years            
Bridge loan agreements [member] | Redeemable Warrants [Member]                    
IfrsStatementLineItems [Line Items]                    
Warrants to purchase ordinary shares | shares       572,000            
Exercise price of warrants | $ / shares       $ 11.50            
Excepted terms       5 years            
Par value | $ / shares   $ 5.00   $ 5.00            
Bridge loan agreements [member] | Top of range [member]                    
IfrsStatementLineItems [Line Items]                    
Borrowings maturity       two years            
Bridge loan agreements [member] | Top of range [member] | Non adjusting Event [Member]                    
IfrsStatementLineItems [Line Items]                    
Borrowings maturity           two years        
Bridge loan agreements [member] | Eleven Lenders [Member]                    
IfrsStatementLineItems [Line Items]                    
Proceeds from loans and warrants       $ 3,860            
XML 34 R26.htm IDEA: XBRL DOCUMENT v3.23.3
MATERIAL EVENTS DURING THE PERIOD (Details Narrative)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended
Jun. 22, 2023
$ / shares
shares
Feb. 28, 2023
USD ($)
Jan. 31, 2023
USD ($)
shares
Jun. 30, 2023
USD ($)
$ / shares
shares
Sep. 19, 2023
shares
Jul. 31, 2023
USD ($)
Jul. 27, 2023
USD ($)
Jun. 30, 2023
€ / shares
Dec. 31, 2022
USD ($)
Dec. 31, 2022
€ / shares
IfrsStatementLineItems [Line Items]                    
Principal amount | $   $ 3,500                
Purchase price pre paid advance description   The purchase price for the Pre-Paid Advance is 92.0% of the Pre-Paid Advance. Such Pre-Paid Advances will be offset upon the issuance of ordinary shares to Yorkville at a price per share equal to the lower of (a) 100% of the daily VWAP of the Ordinary Shares on The Nasdaq Stock Market as of the trading day immediately prior to the date of the disbursement of the Pre-Paid Advance (the “Fixed Price”) (in the case of the first Pre-Paid Advance, $3.65), or (b) 93.0% of the lowest daily VWAP of the Ordinary Shares on Nasdaq during the seven trading days immediately prior to each purchase (the “Variable Price” and the lower of the Fixed Price and the Variable Price shall be referred to as the “Purchase Price”); however, in no event shall the Purchase Price be less than $1.10 (the “Floor Price”). On July 27, 2023, the Company amended the promissory note evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $1.10 (as adjusted for reverse stock split which occurred on August 21, 2023, see also Note 9.1), after the Company was required to repay in cash $500 of principal amount as a result of the Company’s share price being below the original Floor Price.                
Issued ordinary shares value | $       $ 51,730         $ 32,711  
Options to purchase shares     864,000 13,333,333            
Option granted description The Company also granted the Underwriter a 45-day option to subscribe for, in the aggregate, (a) up to 1,999,999 additional ordinary shares (15% of the Firm Shares) at a subscription price per share of $0.24 (100% of the public offering price allocated to each Firm Share) (the “Option Shares” and together with the Firm Shares, the “Shares”) or Pre-Funded Warrants to subscribe for up to 1,999,999 ordinary shares at a price per share of $0.2399 (100% of the public offering price allocated to each Firm Share less $0.0001) and the remaining non pre-funded exercise price of each pre-funded warrant will be $0.0001 per share, and/or (b) 1,999,999 warrants in the form of Warrant A to subscribe for an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at an exercise price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant A), and/or (c) 1,999,999 warrants in the form of Warrant B to purchase an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at a purchase price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant B) (the “Option Warrants” and together with the Firm Warrants and Pre-Funded Warrants, if any, the “Warrants”), which may be subscribed for in any combination of Option Shares and/or the Option Warrants. The Option Shares and the Option Warrants are referred to as the “Option Securities”.                  
Expected volatility     81.92%              
Risk-free rate     3.42%              
Net proceeds | $       $ 2,580            
Capital raise fee | $       $ 660            
Par value per share | € / shares               € 1   € 1
Expected term     3 years              
Expected dividend yield     0.00%              
Convertible percentage     1.00%              
Aggregated received amount | $     $ 27,000              
Payment of cash percent     1.50%              
Warrant A [Member]                    
IfrsStatementLineItems [Line Items]                    
Warrant share price cashless exercise | $ / shares $ 0.0635                  
Number of shares issued warrants       15,333,332            
Warrant B [Member]                    
IfrsStatementLineItems [Line Items]                    
Warrant share price cash exercise | $ / shares 0.24                  
Exercise price | $ / shares $ 0.0602                  
Expected volatility 70.39%                  
Risk-free rate 4.13%                  
Number of shares issued warrants       15,333,332            
Underwriter Warrant [Member]                    
IfrsStatementLineItems [Line Items]                    
Exercise price | $ / shares $ 0.264                  
Expected volatility 70.39%                  
Risk-free rate 4.13%                  
Number of shares issued warrants 666,667                  
Warrants expiration date 5 years                  
Par value per share | $ / shares $ 0.0575                  
Underwriting Agreement [Member]                    
IfrsStatementLineItems [Line Items]                    
Options to purchase shares 13,333,333                  
Subscription price per share | $ / shares $ 0.24                  
Number of warrants issued 13,333,333                  
Underwriting Agreement [Member] | Warrant A [Member]                    
IfrsStatementLineItems [Line Items]                    
Options to purchase shares 15,000,000                  
Subscription price per share | $ / shares $ 0.24                  
Number of warrants issued 15,195,332                  
Number of warrants issued 13,333,333                  
Warrant share price cash exercise | $ / shares $ 0.50                  
Number of warrant cashless exercised 7,597,665                  
Underwriting Agreement [Member] | Warrant B [Member]                    
IfrsStatementLineItems [Line Items]                    
Subscription price per share | $ / shares $ 0.24                  
Number of warrants issued 13,333,333                  
Non adjusting Event [Member]                    
IfrsStatementLineItems [Line Items]                    
Cash | $             $ 500      
Options to purchase shares         487,281          
First Installment [Member]                    
IfrsStatementLineItems [Line Items]                    
Pre-paid advance | $   $ 1,500                
First Installment [Member] | Non adjusting Event [Member]                    
IfrsStatementLineItems [Line Items]                    
Pre-paid advance | $           $ 1,500        
Second Installment [Member]                    
IfrsStatementLineItems [Line Items]                    
Pre-paid advance | $   2,000                
Bottom of range [member]                    
IfrsStatementLineItems [Line Items]                    
Exercise price | $ / shares       $ 1.04            
SEPA [Member]                    
IfrsStatementLineItems [Line Items]                    
Issued capital, ordinary shares | $   $ 25,000                
Percentage of weighted average price of common stock   96.00%                
SEPA [Member] | Non adjusting Event [Member]                    
IfrsStatementLineItems [Line Items]                    
Issued ordinary shares value | $           $ 450        
SEPA [Member] | Bottom of range [member]                    
IfrsStatementLineItems [Line Items]                    
Percentage of common stock   97.00%                
XML 35 R27.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF SHARE CAPITAL (Details) - shares
Jun. 30, 2023
Dec. 31, 2022
Deferred Shares [Member]    
IfrsStatementLineItems [Line Items]    
Number of shares authorized 25,000 25,000
Number of shares issued and outstanding 25,000 25,000
Ordinary shares [member]    
IfrsStatementLineItems [Line Items]    
Number of shares authorized 800,000,000,000 500,000,000
Number of shares issued and outstanding 38,364,447 1
Preference shares [member]    
IfrsStatementLineItems [Line Items]    
Number of shares authorized 200,000,000,000
Number of shares issued and outstanding
XML 36 R28.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical)
Jun. 30, 2023
$ / shares
Jun. 30, 2023
€ / shares
Dec. 31, 2022
$ / shares
Dec. 31, 2022
€ / shares
Jul. 26, 2022
$ / shares
IfrsStatementLineItems [Line Items]          
Par value per share | € / shares   € 1   € 1  
Ordinary shares [member]          
IfrsStatementLineItems [Line Items]          
Par value per share $ 0.0001   $ 0.0001   $ 10.00
Preference shares [member]          
IfrsStatementLineItems [Line Items]          
Par value per share $ 0.0001   $ 0.0001    
XML 37 R29.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF RESTRICTED SHARES UNITS GRANTED (Details) - shares
shares in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
IfrsStatementLineItems [Line Items]    
Number of options outstanding, beginning balance 1,251 3,346
Number of options, granted 790 989
Number of options, vested (7)
Number of options outstanding, ending balance 2,034 3,960
Restricted share units [member]    
IfrsStatementLineItems [Line Items]    
Number of options outstanding, beginning balance
Number of options, granted 4,334
Number of options, vested (945)
Number of options outstanding, ending balance 3,389
XML 38 R30.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF SHARE OPTION GRANTED (Details)
shares in Thousands
6 Months Ended
Jun. 30, 2023
shares
$ / shares
Jun. 30, 2022
shares
$ / shares
Shareholders Equity    
Number of options outstanding, beginning balance | shares 1,251 3,346
Weighted average exercise price, outstanding beginning balance | $ / shares $ 2.01 $ 2.02
Number of options, granted | shares 790 989
Weighted average exercise price, granted | $ / shares $ 3.47 $ 2.86
Number of options, exercised | shares (7)
Weighted average exercise price, exercised | $ / shares $ 1.39
Number of options, expired | shares (375)
Weighted average exercise price, expired | $ / shares $ 2.16
Number of options outstanding, ending balance | shares 2,034 3,960
Weighted average exercise price, outstanding ending balance | $ / shares $ 2.58 $ 2.21
Number of options, Exercisable | shares 1,825 2,703
Weighted average exercise price, Exercisable | $ / shares $ 2.48 $ 2.33
XML 39 R31.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF OPTIONS TO EMPLOYEES AND SERVICE PROVIDERS OUTSTANDING (Details)
shares in Thousands
6 Months Ended
Jun. 30, 2023
shares
$ / shares
Dec. 31, 2022
shares
Jun. 30, 2022
shares
Dec. 31, 2021
shares
IfrsStatementLineItems [Line Items]        
Number of outstanding shares 2,034 1,251 3,960 3,346
Number of exercisable shares 1,825   2,703  
Exercise price one [member]        
IfrsStatementLineItems [Line Items]        
Number of outstanding shares 845      
Weighted average remaining contractual life of outstanding share options 1 year 2 months 4 days      
Number of exercisable shares 845      
Weighted average remaining contractual life of exercisable share options 1 year 2 months 4 days      
Exercise price one [member] | Bottom of range [member]        
IfrsStatementLineItems [Line Items]        
Exercise price | $ / shares $ 0.84      
Exercise price one [member] | Top of range [member]        
IfrsStatementLineItems [Line Items]        
Exercise price | $ / shares $ 1.39      
Options Outstanding Two [Member]        
IfrsStatementLineItems [Line Items]        
Number of outstanding shares 335      
Weighted average remaining contractual life of outstanding share options 2 years 7 months 2 days      
Number of exercisable shares 335      
Weighted average remaining contractual life of exercisable share options 2 years 7 months 2 days      
Options Outstanding Two [Member] | Bottom of range [member]        
IfrsStatementLineItems [Line Items]        
Exercise price | $ / shares $ 1.81      
Options Outstanding Two [Member] | Top of range [member]        
IfrsStatementLineItems [Line Items]        
Exercise price | $ / shares $ 2.51      
Options Outstanding Three [Member]        
IfrsStatementLineItems [Line Items]        
Number of outstanding shares 707      
Weighted average remaining contractual life of outstanding share options 4 years 10 months 20 days      
Number of exercisable shares 498      
Weighted average remaining contractual life of exercisable share options 4 years 10 months 9 days      
Options Outstanding Three [Member] | Bottom of range [member]        
IfrsStatementLineItems [Line Items]        
Exercise price | $ / shares $ 3.57      
Options Outstanding Three [Member] | Top of range [member]        
IfrsStatementLineItems [Line Items]        
Exercise price | $ / shares $ 4.0      
Options Outstanding Four [Member]        
IfrsStatementLineItems [Line Items]        
Number of outstanding shares 10      
Weighted average remaining contractual life of outstanding share options 1 year 8 months 26 days      
Number of exercisable shares 10      
Weighted average remaining contractual life of exercisable share options 1 year 8 months 26 days      
Options Outstanding Four [Member] | Top of range [member]        
IfrsStatementLineItems [Line Items]        
Exercise price | $ / shares $ 4.18      
Options Outstanding Five [Member]        
IfrsStatementLineItems [Line Items]        
Number of outstanding shares 137      
Weighted average remaining contractual life of outstanding share options 3 years 6 months 3 days      
Number of exercisable shares 137      
Weighted average remaining contractual life of exercisable share options 3 years 6 months 3 days      
Options Outstanding Five [Member] | Top of range [member]        
IfrsStatementLineItems [Line Items]        
Exercise price | $ / shares $ 4.87      
XML 40 R32.htm IDEA: XBRL DOCUMENT v3.23.3
SHAREHOLDERS’ EQUITY (Details Narrative)
$ / shares in Units, $ in Thousands, $ in Thousands
1 Months Ended 6 Months Ended
Jun. 22, 2023
$ / shares
Apr. 25, 2023
shares
Mar. 07, 2023
USD ($)
$ / shares
shares
Mar. 07, 2023
AUD ($)
shares
Jun. 30, 2023
USD ($)
$ / shares
shares
May 31, 2023
USD ($)
shares
Jun. 30, 2023
USD ($)
shares
$ / shares
Jun. 30, 2023
€ / shares
Jan. 31, 2023
shares
Dec. 31, 2022
$ / shares
shares
Dec. 31, 2022
€ / shares
shares
Jul. 26, 2022
$ / shares
shares
IfrsStatementLineItems [Line Items]                        
Explanation of fact that shares have par value             The fully paid ordinary shares have a par value per share of $0.0001 (before the reverse split) and par value per share of $0.0022 (post reverse split) and the Company does not have a limited amount of authorised capital.          
Number of shares issued         13,333,333   13,333,333   864,000      
Warrants acceleration amount | $     $ 186                  
Exercise of warrants     32,211,716 32,211,716                
Number of shares on cashless basis     24,568,773 24,568,773                
Share price | $ / shares                       $ 10.3624
Implied value | € / shares               € 1     € 1  
Net proceeds | $             $ 2,580          
Related share based expenses | $             $ 168          
Vesting period description             vesting period up to 4 years from the grant date, contractual life of the options under the plan is 5 years.          
Fair value | $         $ 185   $ 185          
Bottom of range [member]                        
IfrsStatementLineItems [Line Items]                        
Exercise price | $ / shares             $ 1.04          
Top of range [member]                        
IfrsStatementLineItems [Line Items]                        
Exercise price | $ / shares             $ 4.0          
Restricted share units [member]                        
IfrsStatementLineItems [Line Items]                        
Related share based expenses | $             $ 1,738          
Restricted share units [member] | Bottom of range [member]                        
IfrsStatementLineItems [Line Items]                        
Exercise price | $ / shares             $ 1          
Restricted share units [member] | Top of range [member]                        
IfrsStatementLineItems [Line Items]                        
Exercise price | $ / shares             $ 1.09          
2022 Incentive Equity Plan [Member]                        
IfrsStatementLineItems [Line Items]                        
Number of issued and outstanding ordinary shares percentage   15.00%                    
Number of shares authorized   5,082,417                    
Yorkville [Member]                        
IfrsStatementLineItems [Line Items]                        
Number of shares issued         675,168 675,168 675,168          
Net proceeds | $         $ 450 $ 450            
Employees Directors And Service Providers [Member] | Restricted share units [member]                        
IfrsStatementLineItems [Line Items]                        
Options granted             4,334,000          
Employees And Service Providers [Member]                        
IfrsStatementLineItems [Line Items]                        
Options granted             790,408          
Warrant A [Member]                        
IfrsStatementLineItems [Line Items]                        
Shares issued warrants         15,333,332   15,333,332          
Warrant B [Member]                        
IfrsStatementLineItems [Line Items]                        
Shares issued warrants         15,333,332   15,333,332          
Exercise price | $ / shares $ 0.0602                      
Ordinary shares [member]                        
IfrsStatementLineItems [Line Items]                        
Number of shares issued     1                 1
Implied value | $ / shares         $ 0.0001   $ 0.0001     $ 0.0001   $ 10.00
Number of shares authorized         800,000,000,000   800,000,000,000     500,000,000 500,000,000  
Ordinary Shares One [Member]                        
IfrsStatementLineItems [Line Items]                        
Number of shares issued     303,053                  
Proceeds from issuance of stock | $     $ 3,110                  
Ordinary Shares Two [Member]                        
IfrsStatementLineItems [Line Items]                        
Number of shares issued     872,418                  
Exercise price | $ / shares     $ 11.5                  
Implied value | $ / shares     $ 5                  
Principal amount | $     $ 1,350                  
Redeemable warrants | $     $ 200,000                  
Warrants term     5 years 5 years                
Security Matters PTY Ltd [Member]                        
IfrsStatementLineItems [Line Items]                        
Number of shares issued     18,673,253                  
Share price | $ / shares     $ 10.3624                  
Security Matters PTY Ltd [Member] | Ordinary shares [member]                        
IfrsStatementLineItems [Line Items]                        
Number of shares issued     193,500,379                  
Lion heart III Corp [Member]                        
IfrsStatementLineItems [Line Items]                        
Number of shares issued     3,525,000                  
Exercise price | $ / shares     $ 11.5                  
Implied value | $ / shares     $ 0.0204                  
Lion heart III Corp [Member] | Private Warrants [Member]                        
IfrsStatementLineItems [Line Items]                        
Number of shares issued     2,200,000                  
Lion heart III Corp [Member] | Public Warrants [Member]                        
IfrsStatementLineItems [Line Items]                        
Number of shares issued     6,250,000                  
2022 Convertible Notes [Member]                        
IfrsStatementLineItems [Line Items]                        
Convertiable notes | $       $ 828,240                
Number of shares issued     1,000,000                  
XML 41 R33.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
IfrsStatementLineItems [Line Items]    
Share based compensation $ 2,052 $ 165
Total 13,350 1,200
General And Administrative Expenses [Member]    
IfrsStatementLineItems [Line Items]    
Transaction cost 7,792
Advertising, Public and Investors Relations 1,526
Share based compensation 1,805 82
Professional services 718 545
Wages and salaries related 664 429
Travel expenses 379 4
Insurance 329 19
Office and maintenance 37 80
Depreciation and amortization 15 15
Others $ 86 $ 26
XML 42 R34.htm IDEA: XBRL DOCUMENT v3.23.3
SCHEDULE OF LOSS PER SHARE (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
IfrsStatementLineItems [Line Items]    
Net loss attributable to the owners of the Company $ (33,009) $ (2,442)
Basic loss per share attributable to shareholders $ (39.46) [1] $ (3.36) [2],[3]
Diluted loss per share attributable to shareholdersDiluted loss per share attributable to shareholders $ (39.46) [1] $ (3.36) [3]
Weighted average number of ordinary shares    
Weighted average number of ordinary shares used in calculating basic and diluted loss per share 837 727 [2]
Reverse stock split [Member]    
IfrsStatementLineItems [Line Items]    
Net loss attributable to the owners of the Company $ (33,009) $ (2,442)
Basic loss per share attributable to shareholders $ (1.79) $ (0.15)
Diluted loss per share attributable to shareholdersDiluted loss per share attributable to shareholders $ (1.79) $ (0.15)
Weighted average number of ordinary shares    
Weighted average number of ordinary shares used in calculating basic and diluted loss per share 18,404 15,984
[1] After giving effect to the reverse stock split (see also Note 9.1)
[2] Restated as a result of the SPAC transaction
[3] Restated as a result of the SPAC transaction and after giving effect to the reverse stock split (see also Note 1 and 9.1)
XML 43 R35.htm IDEA: XBRL DOCUMENT v3.23.3
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended
Sep. 30, 2023
Sep. 06, 2023
Sep. 15, 2023
Jul. 31, 2023
Jul. 27, 2023
Sep. 19, 2023
Jun. 30, 2023
Jan. 31, 2023
IfrsStatementLineItems [Line Items]                
Number of shares             13,333,333 864,000
Non adjusting Event [Member]                
IfrsStatementLineItems [Line Items]                
Floor price         $ 1.10      
Repayment of debt $ 1,350     $ 450 $ 500      
Pre-paid advance       $ 1,500        
Debt principal smount     $ 900          
Payments for promissory notes     $ 250          
Maturity date     Mar. 07, 2023          
Number of shares converted           657    
Number of shares           487,281    
Non adjusting Event [Member] | Securities Purchase Agreement [Member]                
IfrsStatementLineItems [Line Items]                
Debt conversion price   $ 1.6378            
Gross proceeds   $ 2,500            
Debt principal smount   4,290            
Loans payable   $ 2,574            
Discount rate   40.00%            
Investor owned percentage   4.99%            
XML 44 form6-k_htm.xml IDEA: XBRL DOCUMENT 0001940674 2023-01-01 2023-06-30 0001940674 2023-06-30 0001940674 2022-12-31 0001940674 2022-01-01 2022-06-30 0001940674 ifrs-full:IssuedCapitalMember 2022-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2022-12-31 0001940674 ifrs-full:RetainedEarningsMember 2022-12-31 0001940674 ifrs-full:IssuedCapitalMember 2021-12-31 0001940674 SMX:ForeignCurrencyTranslationMember 2021-12-31 0001940674 ifrs-full:RetainedEarningsMember 2021-12-31 0001940674 2021-12-31 0001940674 ifrs-full:IssuedCapitalMember 2023-01-01 2023-06-30 0001940674 SMX:ForeignCurrencyTranslationMember 2023-01-01 2023-06-30 0001940674 ifrs-full:RetainedEarningsMember 2023-01-01 2023-06-30 0001940674 ifrs-full:IssuedCapitalMember 2022-01-01 2022-06-30 0001940674 SMX:ForeignCurrencyTranslationMember 2022-01-01 2022-06-30 0001940674 ifrs-full:RetainedEarningsMember 2022-01-01 2022-06-30 0001940674 ifrs-full:IssuedCapitalMember 2023-06-30 0001940674 SMX:ForeignCurrencyTranslationMember 2023-06-30 0001940674 ifrs-full:RetainedEarningsMember 2023-06-30 0001940674 ifrs-full:IssuedCapitalMember 2022-06-30 0001940674 SMX:ForeignCurrencyTranslationMember 2022-06-30 0001940674 ifrs-full:RetainedEarningsMember 2022-06-30 0001940674 2022-06-30 0001940674 ifrs-full:OrdinarySharesMember 2022-07-26 0001940674 2022-07-26 0001940674 SMX:LionheartMember SMX:BusinessCombinationAgreementMember 2022-07-26 2022-07-26 0001940674 SMX:EquityLineAgreementMember 2023-01-01 2023-06-30 0001940674 SMX:EquityLineAgreementMember 2023-06-30 0001940674 SMX:SecurityMattersPTYLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SecurityMattersPTYLtdMember 2022-01-01 2022-12-31 0001940674 SMX:LionheartIIICorpMember 2023-01-01 2023-06-30 0001940674 SMX:LionheartIIICorpMember 2022-01-01 2022-12-31 0001940674 SMX:SMXCircularEconomyPlatformPTELtdMember 2023-01-01 2023-06-30 0001940674 SMX:SMXCircularEconomyPlatformPTELtdMember 2022-01-01 2022-12-31 0001940674 SMX:SMXIrelandLimitedMember 2023-01-01 2023-06-30 0001940674 SMX:SMXIrelandLimitedMember 2022-01-01 2022-12-31 0001940674 SMX:SMXIsraelLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SMXIsraelLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersCanadaLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SecurityMattersCanadaLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SecurityMattersFranceLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SecurityMattersFranceLtdMember 2022-01-01 2022-12-31 0001940674 SMX:SMXBeveragesPtyLtdMember 2023-01-01 2023-06-30 0001940674 SMX:SMXBeveragesPtyLtdMember 2022-01-01 2022-12-31 0001940674 SMX:YahalomaTechnologiesIncMember 2023-01-01 2023-06-30 0001940674 SMX:YahalomaTechnologiesIncMember 2022-01-01 2022-12-31 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2023-01-01 2023-06-30 0001940674 SMX:TrueGoldConsortiumPtyLtdMember 2022-01-01 2022-12-31 0001940674 SMX:ConvertibleNotesMember 2023-01-24 2023-01-25 0001940674 SMX:ConvertibleNotesMember 2023-01-25 0001940674 SMX:BonusWarrantsMember SMX:ConvertiableNoteAgreementsMember 2023-01-24 2023-01-25 0001940674 SMX:RedeemableWarrantsMember SMX:ConvertiableNoteAgreementsMember 2023-01-24 2023-01-25 0001940674 SMX:RedeemableWarrantsMember SMX:ConvertiableNoteAgreementsMember 2023-01-25 0001940674 SMX:ConvertibleNotesMember 2023-01-01 2023-06-30 0001940674 SMX:RedeemableWarrantsMember 2023-01-01 2023-06-30 0001940674 SMX:ElevenLendersMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 ifrs-full:TopOfRangeMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-01-31 0001940674 SMX:BonusWarrantsMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:RedeemableWarrantsMember SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 SMX:RedeemableWarrantsMember SMX:BridgeLoanAgreementsMember 2023-01-31 0001940674 SMX:BridgeLoanAgreementsMember 2022-08-01 2023-01-31 0001940674 ifrs-full:TopOfRangeMember SMX:BridgeLoanAgreementsMember 2023-06-30 0001940674 SMX:BridgeLoanAgreementsMember 2022-12-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-06-30 0001940674 SMX:BridgeLoanAgreementsMember 2023-01-01 2023-06-30 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 SMX:NonadjustingEventMember ifrs-full:TopOfRangeMember SMX:BridgeLoanAgreementsMember 2023-01-01 2023-12-31 0001940674 SMX:NonadjustingEventMember SMX:BridgeLoanAgreementsMember 2023-12-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-03-01 2023-03-31 0001940674 SMX:BridgeLoanAgreementsMember 2023-03-31 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-02-28 0001940674 SMX:StandbyEquityPurchaseAgreementMember 2023-02-01 2023-02-28 0001940674 SMX:StandbyEquityPurchaseAgreementMember ifrs-full:BottomOfRangeMember 2023-02-01 2023-02-28 0001940674 2023-02-28 0001940674 SMX:FirstInstallmentMember 2023-02-28 0001940674 SMX:SecondInstallmentMember 2023-02-28 0001940674 2023-02-01 2023-02-28 0001940674 SMX:NonadjustingEventMember 2023-07-27 0001940674 SMX:FirstInstallmentMember SMX:NonadjustingEventMember 2023-07-31 0001940674 SMX:StandbyEquityPurchaseAgreementMember SMX:NonadjustingEventMember 2023-07-31 0001940674 SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:WarrantAMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 SMX:WarrantBMember SMX:UnderwritingAgreementMember 2023-06-22 0001940674 2023-06-22 2023-06-22 0001940674 SMX:WarrantAMember 2023-06-22 0001940674 SMX:WarrantBMember 2023-06-22 0001940674 SMX:WarrantBMember 2023-06-22 2023-06-22 0001940674 SMX:UnderwriterWarrantMember 2023-06-22 0001940674 SMX:UnderwriterWarrantMember 2023-06-22 2023-06-22 0001940674 2023-01-31 0001940674 2023-01-01 2023-01-31 0001940674 ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-06-30 0001940674 ifrs-full:OrdinarySharesMember 2023-06-30 0001940674 ifrs-full:OrdinarySharesMember 2022-12-31 0001940674 ifrs-full:PreferenceSharesMember 2023-06-30 0001940674 ifrs-full:PreferenceSharesMember 2022-12-31 0001940674 SMX:DeferredSharesMember 2023-06-30 0001940674 SMX:DeferredSharesMember 2022-12-31 0001940674 SMX:TwentyTwentyTwoConvertibleNotesMember 2023-03-01 2023-03-07 0001940674 SMX:TwentyTwentyTwoConvertibleNotesMember 2023-03-07 0001940674 2023-03-01 2023-03-07 0001940674 SMX:SecurityMattersPTYLtdMember 2023-03-07 0001940674 ifrs-full:OrdinarySharesMember SMX:SecurityMattersPTYLtdMember 2023-03-07 0001940674 ifrs-full:OrdinarySharesMember 2023-03-07 0001940674 SMX:LionheartIIICorpMember 2023-03-07 0001940674 SMX:PrivateWarrantsMember SMX:LionheartIIICorpMember 2023-03-07 0001940674 SMX:PublicWarrantsMember SMX:LionheartIIICorpMember 2023-03-07 0001940674 SMX:LionheartIIICorpMember 2023-03-01 2023-03-07 0001940674 SMX:OrdinarySharesOneMember 2023-03-07 0001940674 SMX:OrdinarySharesOneMember 2023-03-01 2023-03-07 0001940674 SMX:OrdinarySharesTwoMember 2023-03-07 0001940674 SMX:OrdinarySharesTwoMember 2023-03-01 2023-03-07 0001940674 SMX:YorkvilleMember 2023-06-30 0001940674 SMX:YorkvilleMember 2023-05-31 0001940674 SMX:YorkvilleMember 2023-06-01 2023-06-30 0001940674 SMX:YorkvilleMember 2023-05-01 2023-05-31 0001940674 SMX:WarrantAMember 2023-06-30 0001940674 SMX:WarrantBMember 2023-06-30 0001940674 SMX:TwentyTwentyTwoIncentiveEquityPlanMember 2023-04-25 2023-04-25 0001940674 SMX:TwentyTwentyTwoIncentiveEquityPlanMember 2023-04-25 0001940674 SMX:EmployeesDirectorsAndServiceProvidersMember ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-06-30 0001940674 ifrs-full:BottomOfRangeMember ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-06-30 0001940674 ifrs-full:TopOfRangeMember ifrs-full:RestrictedShareUnitsMember 2023-01-01 2023-06-30 0001940674 SMX:EmployeesAndServiceProvidersMember 2023-01-01 2023-06-30 0001940674 ifrs-full:BottomOfRangeMember 2023-01-01 2023-06-30 0001940674 ifrs-full:TopOfRangeMember 2023-01-01 2023-06-30 0001940674 ifrs-full:RestrictedShareUnitsMember 2022-12-31 0001940674 ifrs-full:RestrictedShareUnitsMember 2021-12-31 0001940674 ifrs-full:RestrictedShareUnitsMember 2022-01-01 2022-06-30 0001940674 ifrs-full:RestrictedShareUnitsMember 2023-06-30 0001940674 ifrs-full:RestrictedShareUnitsMember 2022-06-30 0001940674 ifrs-full:BottomOfRangeMember SMX:OptionsOutstandingOneMember 2023-06-30 0001940674 ifrs-full:TopOfRangeMember SMX:OptionsOutstandingOneMember 2023-06-30 0001940674 SMX:OptionsOutstandingOneMember 2023-06-30 0001940674 SMX:OptionsOutstandingOneMember 2023-01-01 2023-06-30 0001940674 ifrs-full:BottomOfRangeMember SMX:OptionsOutstandingTwoMember 2023-06-30 0001940674 ifrs-full:TopOfRangeMember SMX:OptionsOutstandingTwoMember 2023-06-30 0001940674 SMX:OptionsOutstandingTwoMember 2023-06-30 0001940674 SMX:OptionsOutstandingTwoMember 2023-01-01 2023-06-30 0001940674 ifrs-full:BottomOfRangeMember SMX:OptionsOutstandingThreeMember 2023-06-30 0001940674 ifrs-full:TopOfRangeMember SMX:OptionsOutstandingThreeMember 2023-06-30 0001940674 SMX:OptionsOutstandingThreeMember 2023-06-30 0001940674 SMX:OptionsOutstandingThreeMember 2023-01-01 2023-06-30 0001940674 ifrs-full:TopOfRangeMember SMX:OptionsOutstandingFourMember 2023-06-30 0001940674 SMX:OptionsOutstandingFourMember 2023-06-30 0001940674 SMX:OptionsOutstandingFourMember 2023-01-01 2023-06-30 0001940674 ifrs-full:TopOfRangeMember SMX:OptionsOutstandingFiveMember 2023-06-30 0001940674 SMX:OptionsOutstandingFiveMember 2023-06-30 0001940674 SMX:OptionsOutstandingFiveMember 2023-01-01 2023-06-30 0001940674 SMX:GeneralAndAdministrativeExpensesMember 2023-01-01 2023-06-30 0001940674 SMX:GeneralAndAdministrativeExpensesMember 2022-01-01 2022-06-30 0001940674 SMX:ReverseStockSplitMember 2023-01-01 2023-06-30 0001940674 SMX:ReverseStockSplitMember 2022-01-01 2022-06-30 0001940674 SMX:NonadjustingEventMember 2023-07-01 2023-07-27 0001940674 SMX:NonadjustingEventMember 2023-07-31 0001940674 SMX:NonadjustingEventMember 2023-07-01 2023-07-31 0001940674 SMX:NonadjustingEventMember 2023-09-30 2023-09-30 0001940674 SMX:NonadjustingEventMember SMX:SecuritiesPurchaseAgreementMember 2023-09-01 2023-09-06 0001940674 SMX:NonadjustingEventMember SMX:SecuritiesPurchaseAgreementMember 2023-09-06 0001940674 SMX:NonadjustingEventMember 2023-09-01 2023-09-15 0001940674 SMX:NonadjustingEventMember 2023-09-19 iso4217:USD shares iso4217:USD shares pure SMX:Integer iso4217:AUD iso4217:ILS iso4217:AUD shares iso4217:EUR iso4217:EUR shares 6-K 001-41639 SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY Mespil Business Centre Mespil House Sussex Road Dublin 4 IE +353-1 920-1000 false 0001940674 185000 3020000 1398000 1037000 3673000 4057000 5071000 820000 969000 5269000 5027000 112000 221000 6201000 6217000 10258000 11288000 7281000 2972000 30000 30000 2415000 650000 304000 563000 856000 3050000 2363000 3682000 689000 710000 16988000 4925000 403000 440000 938000 3930000 85000 5271000 4207000 22259000 9132000 51730000 32711000 -702000 -537000 -63029000 -30020000 -12001000 2156000 10258000 11288000 1172000 933000 228000 378000 13350000 1200000 16802000 -31552000 -2511000 1143000 105000 2496000 36000 104000 -33009000 -2442000 -33009000 -2442000 -165000 -639000 -165000 -639000 -33174000 -3081000 -39.46 -39.46 -3.36 -3.36 32713000 -537000 -30020000 2156000 -33009000 -33009000 -165000 -165000 -165000 -33009000 -33174000 170000 170000 11460000 11460000 2092000 2092000 175000 175000 2983000 2983000 10000 10000 290000 290000 1837000 1837000 51730000 -702000 -63029000 -12001000 31504000 223000 -23836000 7891000 31504000 223000 -23836000 7891000 -2442000 -2442000 -639000 -639000 -639000 -2442000 -3081000 721000 721000 219000 219000 32444000 -416000 -26278000 5750000 32444000 -416000 -26278000 5750000 -33009000 -2442000 2052000 165000 114000 176000 2575000 -1727000 2545000 831000 70000 110000 13000 32000 -41000 1421000 -7000 -28000 14000 -89000 -382000 104000 -40000 -54000 -16802000 -7675000 -2862000 10000 183000 383000 783000 -393000 -966000 21000 39000 250000 581000 914000 923000 974000 550000 30000 3220000 2923000 9703000 542000 1635000 -3286000 1398000 4171000 -13000 -26000 3020000 859000 450000 290000 2983000 2229000 175000 <p id="xdx_806_eifrs-full--DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_zOH1QvAhTAEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="V_00001"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 - <span id="xdx_824_zWtCDRS7MRe9">GENERAL</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SMX (Security Matters) Public Limited Company (“Security Matters” or the “Company” and together with its subsidiaries, the “Group”) was incorporated in July 1, 2022 under the laws of Ireland with registered number 722009 and its registered office at Mespil Business Center, Mespil House, Sessex Road, Dublin 4, Ireland, D04 T4A6. The Company was incorporated in 2022 as part of the Business Combination (see Note 1.B).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer. Its proprietary marker system embeds a permanent or removable (depending on the needs of the customer) mark on solid, liquid or gaseous objects or materials. Each marker is comprised of a combination of marker codes such that each marker is designed to be unique and unable to be duplicated. The marker system is coupled with an innovative patented reader that responds to signals from the marker and, together with a patented algorithm, captures the details of the product retrieved and stored on a blockchain digital ledger. Each marker can be stored, either locally on the reader and on private servers, cloud servers or on a blockchain ledger, to protect data integrity and custody.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Business Combination - the SPAC transaction (“Business Combination”):</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 7, 2023 (the “Closing Date”) the Company completed its Business Combination with Lionheart III Corp (“Lionheart”), following that Lionheart and Security Matters PTY Ltd. (formerly named Security Matters Limited, which was incorporated in May 2018 under Australian law) became the Company’s wholly-owned subsidiaries and the Company listed its ordinary shares and public warrants on the NASDAQ stock market under the tickers SMX and SMXWW, respectively. On July 26, 2022, Security Matters PTY Ltd. and Lionheart, a publicly traded special purpose acquisition company (SPAC), entered into a business combination agreement (the “BCA”) and accompanying scheme implementation deed (“SID”). Under the BCA, the existing Lionheart stockholders received the Company’s shares and warrants in exchange for their existing Lionheart shares and warrants and all shares existed in Security Matters PTY Ltd were cancelled in return for the Company’s shares and resulting in Security Matters PTY Ltd. becoming a wholly owned subsidiary of the Company. Security Matters PTY Ltd. shareholders received consideration of <span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_c20220726__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zxW8gXd8Ngli">1</span> ordinary share per <span id="xdx_90C_ecustom--ShareIssuedPricePerShare_iI_pid_c20220726_zfk3zbmRixeh" title="Share price">10.3624</span> Security Matters PTY Ltd. shares, having an implied value of $<span id="xdx_903_eifrs-full--ParValuePerShare_iI_pid_c20220726__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zEM0R6LEE8vb" title="Implied value">10.00</span> per ordinary share and the Company became the holder of all of the issued shares in Security Matters PTY Ltd. and Lionheart, with Security Matters PTY Ltd. being delisted from the Australian Stock Exchange.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Business Combination resulted in <span id="xdx_90B_ecustom--RedemptionPercentageOfBusinessCombination_pid_dp_uPure_c20220726__20220726__ifrs-full--BusinessCombinationsAxis__custom--LionheartMember__ifrs-full--TypesOfContractsAxis__custom--BusinessCombinationAgreementMember_zzyceaVNLv2f" title="Redemption percentage of business combination">97.58%</span> redemption by Lionheart’s public shareholders which resulted in leaving $<span id="xdx_90F_ecustom--RemainingFundsInTrustAccount_pn3n3_c20220726__20220726__ifrs-full--BusinessCombinationsAxis__custom--LionheartMember__ifrs-full--TypesOfContractsAxis__custom--BusinessCombinationAgreementMember_zfWidj2qFUmg" title="Remaining funds in trust account">3,061</span> of funds remaining in the trust account (See also Note 6 and Note 2.E as for the accounting treatment of the transaction in these financial statements).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img alt="" src="fin_001.jpg"/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – GENERAL (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates primarily through 8 wholly owned subsidiaries, all of which have been consolidated in these consolidated financial statements.</span></td></tr></table> <p id="xdx_899_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_z5C4s3gbzFs" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_ziEsNQF5NmRc" style="display: none">SCHEDULE OF COMPANIES SUBSIDIARIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Controlled entity</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Security Matters PTY Ltd.<br/>(Formerly - Security Matters Limited)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zoF7QkveyGQ9" title="Country of Incorporation">Australia</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zKG04IkhyvJ2" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zuEYL4iMduu3" title="Proportion of ownership interest in subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl0439">-</span></span></span></td><td style="width: 5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lionheart III Corp</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_zCJP6zuUge2e" title="Country of Incorporation">USA</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_zakYkFviovkf" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_fKio___zTq7W0Ye4o4g" title="Proportion of ownership interest in subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl0445">-</span></span></span>**</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX Circular Economy Platform PTE, Ltd.</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_zv4dZRW4OU8f" title="Country of Incorporation">Singapore</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_zEBfcYxCulIe" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_fKg_____zNllVekcEFLg" title="Proportion of ownership interest in subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl0451">-</span></span></span>*</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX (Security Matters) Ireland Limited</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_zkuOcZ907Fie" title="Country of Incorporation">Ireland</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_zPMjkkaMF7r9" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_fKg_____zT32VHezJVWa" title="Proportion of ownership interest in subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl0457">-</span></span></span>*</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX (Security Matters) Israel Ltd.<br/>(Formerly - Security Matters Ltd.)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_zEcqxo6h3Org" title="Country of Incorporation">Israel</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_zcUiu6thOZfb" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_fKioq_zxOa6vihSNC" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Security Matters Canada Ltd.</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_z0nHDF2UXMRd" title="Country of Incorporation">Canada</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_zFSf3bA7w1l8" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_fKioq_z5Tp9J2QHM97" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Security Matters France Ltd.</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersFranceLtdMember_z0xeG20s13uf" title="Country of Incorporation">France</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersFranceLtdMember_z0FE9hRwCuF4" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersFranceLtdMember_fKioq_znwHGhuNPqyi" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX Beverages Pty Ltd.</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_zyTc9IRvpG1a" title="Country of Incorporation">Australia</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_zaNuWmt9VU6b" title="Percentage Owned">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_fKioq_zHXDRkCQfg32" title="Percentage Owned">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, the Company’s has the following investments in associated companies:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Entity</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Yahaloma Technologies Inc.</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_zGClbW5Jmmri" title="Country of Incorporation">Canada</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_zkNHpkUv99Uk" title="Proportion of ownership interest in subsidiary">50</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_fKioq_zS20jPsv777h" title="Proportion of ownership interest in subsidiary">50</span></span></td><td style="width: 5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">True Gold Consortium Pty Ltd</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_zvDIRVv7uri" title="Country of Incorporation">Australia</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_zZrWeVUhncXa" title="Percentage Owned">44.4</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_fKioq_zuzkeH5RsZW8" title="Percentage Owned">44.4</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The proportion of ownership interest is equal to the proportion of voting power held.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F02_zgyvU6HoFvve" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F15_z1guaolQhe9i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated in 2023.</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F08_zivIiiVGygT" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: justify"><span id="xdx_F1A_zmGoJo6nnbr7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger occurred in March 2023.</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F04_zXICV7FOGsx4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">***</span></td><td style="text-align: justify"><span id="xdx_F1A_zrE6HTvu0lSe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2022.</span></td> </tr></table> <p id="xdx_8A5_z8mHgwwQ9Q11" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 14.2pt"></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six months ended June 30, 2023, the Company incurred operating losses and negative cash flows from operating activities. The Company has not yet generated revenues. As discussed in Note 4, during the period, the Company entered into binding loan agreements with existing shareholders. As discussed in Note 5.1, the Company executed an equity line agreement to raise up to $<span id="xdx_905_ecustom--StockIssuedDuringPeriodValueConsiderationOfIssuanceOfCommonStock_pn3n3_c20230101__20230630__ifrs-full--TypesOfContractsAxis__custom--EquityLineAgreementMember_z69hQAv9mVy2" title="Consideration of issuance of common stock">25,000</span> in consideration of the issuance of common stock over the course of 36 months with YA II PN, LTD (“Yorkville”). As discussed in Notes 4 and 9.4, the Company signed agreements to convert indebtedness by issuance of shares. As discussed in Note 9.3 the Company is continuing with additional capital raising, and post balance sheet date it received an additional $<span id="xdx_909_eus-gaap--AdditionalPaidInCapital_iI_pn3n3_c20230630__ifrs-full--TypesOfContractsAxis__custom--EquityLineAgreementMember_zYjNqjPfGx93" title="Additional capital raising">2,500</span> in funding. The Company has also the ability to decrease its expenses in order to meet its existing cash flow streams. Management believes that the proceeds from the recent funding agreements, combined with its cash on hand, equity line and the Company’s plans, are sufficient to meet the Company’s obligations as they come due in the foreseeable future. There are no assurances, however, that the Company will be able to obtain an adequate level of financial resources that are required for its long-term business plan.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img alt="" src="fin_001.jpg"/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 1 10.3624 10.00 0.9758 3061000 <p id="xdx_899_eifrs-full--DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory_z5C4s3gbzFs" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_ziEsNQF5NmRc" style="display: none">SCHEDULE OF COMPANIES SUBSIDIARIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Controlled entity</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Security Matters PTY Ltd.<br/>(Formerly - Security Matters Limited)</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zoF7QkveyGQ9" title="Country of Incorporation">Australia</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zKG04IkhyvJ2" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zuEYL4iMduu3" title="Proportion of ownership interest in subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl0439">-</span></span></span></td><td style="width: 5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Lionheart III Corp</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_zCJP6zuUge2e" title="Country of Incorporation">USA</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_zakYkFviovkf" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_fKio___zTq7W0Ye4o4g" title="Proportion of ownership interest in subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl0445">-</span></span></span>**</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX Circular Economy Platform PTE, Ltd.</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_zv4dZRW4OU8f" title="Country of Incorporation">Singapore</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_zEBfcYxCulIe" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXCircularEconomyPlatformPTELtdMember_fKg_____zNllVekcEFLg" title="Proportion of ownership interest in subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl0451">-</span></span></span>*</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX (Security Matters) Ireland Limited</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_zkuOcZ907Fie" title="Country of Incorporation">Ireland</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_zPMjkkaMF7r9" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIrelandLimitedMember_fKg_____zT32VHezJVWa" title="Proportion of ownership interest in subsidiary"><span style="-sec-ix-hidden: xdx2ixbrl0457">-</span></span></span>*</td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX (Security Matters) Israel Ltd.<br/>(Formerly - Security Matters Ltd.)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_zEcqxo6h3Org" title="Country of Incorporation">Israel</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_zcUiu6thOZfb" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXIsraelLtdMember_fKioq_zxOa6vihSNC" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Security Matters Canada Ltd.</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_z0nHDF2UXMRd" title="Country of Incorporation">Canada</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_zFSf3bA7w1l8" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersCanadaLtdMember_fKioq_z5Tp9J2QHM97" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Security Matters France Ltd.</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersFranceLtdMember_z0xeG20s13uf" title="Country of Incorporation">France</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersFranceLtdMember_z0FE9hRwCuF4" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersFranceLtdMember_fKioq_znwHGhuNPqyi" title="Proportion of ownership interest in subsidiary">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">SMX Beverages Pty Ltd.</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_zyTc9IRvpG1a" title="Country of Incorporation">Australia</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_zaNuWmt9VU6b" title="Percentage Owned">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SMXBeveragesPtyLtdMember_fKioq_zHXDRkCQfg32" title="Percentage Owned">100</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In addition, the Company’s has the following investments in associated companies:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Entity</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Country of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Incorporation</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Percentage Owned</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31, 2022</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 48%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Yahaloma Technologies Inc.</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_zGClbW5Jmmri" title="Country of Incorporation">Canada</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_zkNHpkUv99Uk" title="Proportion of ownership interest in subsidiary">50</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--YahalomaTechnologiesIncMember_fKioq_zS20jPsv777h" title="Proportion of ownership interest in subsidiary">50</span></span></td><td style="width: 5%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">True Gold Consortium Pty Ltd</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eifrs-full--CountryOfIncorporationOrResidenceOfSubsidiary_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_zvDIRVv7uri" title="Country of Incorporation">Australia</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20230101__20230630__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_zZrWeVUhncXa" title="Percentage Owned">44.4</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20220101__20221231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--TrueGoldConsortiumPtyLtdMember_fKioq_zuzkeH5RsZW8" title="Percentage Owned">44.4</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">%***</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The proportion of ownership interest is equal to the proportion of voting power held.</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F02_zgyvU6HoFvve" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F15_z1guaolQhe9i" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporated in 2023.</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F08_zivIiiVGygT" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: justify"><span id="xdx_F1A_zmGoJo6nnbr7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Merger occurred in March 2023.</span></td> </tr></table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F04_zXICV7FOGsx4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">***</span></td><td style="text-align: justify"><span id="xdx_F1A_zrE6HTvu0lSe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned by Security Matters PTY Ltd. (formerly - Security Matters Limited) as of December 31, 2022.</span></td> </tr></table> Australia 1 USA 1 Singapore 1 Ireland 1 Israel 1 1 Canada 1 1 France 1 1 Australia 1 1 Canada 0.50 0.50 Australia 0.444 0.444 25000000 2500000 <p id="xdx_802_ecustom--DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_zxn5nFtPJUme" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - <span id="xdx_824_zAv0LNOHbUs6">SIGNIFICANT ACCOUNTING POLICIES</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_848_ecustom--DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_zP8piNvJ5Urk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zZMMdT4GNkx6">Basis of preparation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These interim consolidated financial statements have been prepared in a condensed format in accordance with IAS 34 Interim Financial Reporting. They do not include all disclosures that would otherwise be required in a complete set of financial statements and should be read in conjunction with the annual consolidated financial statements as of December 31, 2022 of the Company and of Security Matters PTY Ltd. (formerly - Security Matters Limited).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_zNxP8632gBK6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zvuy0uLPpE0c">Functional currency</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements are prepared in US Dollars, which is the functional and presentation currency of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_ecustom--DescriptionOfAccountingPolicyForApplicationOfAccountingPoliciesExplanatory_zIescIK9pQsh" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zPmPH5b4W6N3">Application of accounting policies</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group has applied the same accounting policies and methods of computation in its interim condensed consolidated financial statements as in its 2022 annual financial statements and as in the 2022 annual financial statements of Security Matters PTY Ltd, except as stated below in note 2D and 2E.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Several amendments to IFRS Standards apply for the first time in 2023, but do not have an impact on the interim condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_zrSDUEY8xEub" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zJ0NDQAYsgM5">Issue of a unit of financial instruments</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The issue of a unit of financial instruments such as a financial liability (e.g., a loan) and free-standing derivative (e.g. warrants) involves the allocation of the proceeds received (before issuance costs) to financial derivatives and other financial instruments measured at fair value in each period and to financial liabilities that are measured at amortized cost, with residual allocated to equity instruments. Issuance costs are allocated to each component pro rata to the amounts determined for each component in the unit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_ecustom--DescriptionOfAccountingPolicyForReverseAcquisitionTransactionExplanatory_zkm75ne7Zs2a" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zZCAWMM95tcb">Reverse acquisition transaction</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The result of the merger between the Company and Security Matters PTY Ltd. as described in Note 1B is that legally the Company owns the entire share capital of Security Matters PTY Ltd.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly, for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY Ltd. and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the business combination transaction ($<span id="xdx_901_ecustom--FairValueBasedOnQuotedOpeningSharePrice_pn3n3_c20230101__20230630_zWamHQUy2jYb" title="Fair value based on the quoted opening share price">11,599</span>), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $<span id="xdx_90F_ecustom--FairValueOfShares_pn3n3_c20230101__20230630_zquPSmySNqe8" title="Fair value of the shares">16,802</span>, between the fair value of the shares deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img alt="" src="fin_001.jpg"/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reverse acquisition transaction (Cont.)</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is initially consolidated in the financial statements from the Closing Date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($<span id="xdx_903_ecustom--MarketableSecuritiesHeldInTrustAccount_iI_pn3n3_c20230630_zA0JylOBtRF1" title="Marketable securities held in a trust account">4,921</span>) and trade and other payables and warrants ($<span id="xdx_900_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20230630_zErrY0Xx5tN8" title="Trade, other payables and warrants">10,127</span>) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The assets and liabilities of Security Matters PTY Ltd. have been recognized and measured in these consolidated financial statements at their pre-combination carrying amounts.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The retained earnings and other equity balances recognized in those consolidated financial statements are the retained earnings and other equity balances of Security Matters PTY Ltd. immediately before the Business Combination.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount recognized as issued equity instruments in these consolidated financial statements has been determined by adding to the issued equity of Security Matters PTY Ltd. immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY Ltd. (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The statement of comprehensive loss reflects that of Security Matters PTY Ltd. for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY Ltd. for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--DescriptionOfAccountingPolicyForReverseStockSplitExplanatory_zKAjJb8wqbb2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_z48VN1KHwPBd">Reverse stock split</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The presentation of loss per share amounts has been retrospectively adjusted to give effect to the reverse share split which occurred on August 8, 2023. Except otherwise specifically provided, no other adjustments have been made in these notes to reflect the reverse share split. See also Note 9.1.</span></p> <p id="xdx_858_z9N8ocSxhjT4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_ecustom--DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory_zP8piNvJ5Urk" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zZMMdT4GNkx6">Basis of preparation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These interim consolidated financial statements have been prepared in a condensed format in accordance with IAS 34 Interim Financial Reporting. They do not include all disclosures that would otherwise be required in a complete set of financial statements and should be read in conjunction with the annual consolidated financial statements as of December 31, 2022 of the Company and of Security Matters PTY Ltd. (formerly - Security Matters Limited).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory_zNxP8632gBK6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>B.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zvuy0uLPpE0c">Functional currency</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements are prepared in US Dollars, which is the functional and presentation currency of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_ecustom--DescriptionOfAccountingPolicyForApplicationOfAccountingPoliciesExplanatory_zIescIK9pQsh" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>C.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zPmPH5b4W6N3">Application of accounting policies</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Group has applied the same accounting policies and methods of computation in its interim condensed consolidated financial statements as in its 2022 annual financial statements and as in the 2022 annual financial statements of Security Matters PTY Ltd, except as stated below in note 2D and 2E.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Several amendments to IFRS Standards apply for the first time in 2023, but do not have an impact on the interim condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_84D_eifrs-full--DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_zrSDUEY8xEub" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>D.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zJ0NDQAYsgM5">Issue of a unit of financial instruments</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The issue of a unit of financial instruments such as a financial liability (e.g., a loan) and free-standing derivative (e.g. warrants) involves the allocation of the proceeds received (before issuance costs) to financial derivatives and other financial instruments measured at fair value in each period and to financial liabilities that are measured at amortized cost, with residual allocated to equity instruments. Issuance costs are allocated to each component pro rata to the amounts determined for each component in the unit.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_843_ecustom--DescriptionOfAccountingPolicyForReverseAcquisitionTransactionExplanatory_zkm75ne7Zs2a" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zZCAWMM95tcb">Reverse acquisition transaction</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The result of the merger between the Company and Security Matters PTY Ltd. as described in Note 1B is that legally the Company owns the entire share capital of Security Matters PTY Ltd.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly, for financial reporting purposes, Security Matters PTY Ltd. (the legal subsidiary) is the accounting acquirer, and the Company (the legal parent) is the accounting acquiree. The consolidated financial statements prepared following the reverse acquisition are issued under the name of the Company, but they are a continuance of the financial statements of Security Matters PTY Ltd. and reflect the fair values of the assets and liabilities of the Company (the acquiree for accounting purposes), together with a deemed issuance of shares by Security Matters PTY Ltd. at fair value based on the quoted opening share price of the Company in its first trading day following the closing of the business combination transaction ($<span id="xdx_901_ecustom--FairValueBasedOnQuotedOpeningSharePrice_pn3n3_c20230101__20230630_zWamHQUy2jYb" title="Fair value based on the quoted opening share price">11,599</span>), and a recapitalization of its equity. This deemed issuance of shares is in fact both an equity transaction under IAS 32 (receiving the net assets of the Company) and an equity-settled share-based payment transaction under IFRS 2 (receiving the listing status of the Company). The difference, in the amount of $<span id="xdx_90F_ecustom--FairValueOfShares_pn3n3_c20230101__20230630_zquPSmySNqe8" title="Fair value of the shares">16,802</span>, between the fair value of the shares deemed to have been issued by Security Matters PTY Ltd. and the fair value of the Company’s identifiable net assets represent a payment for the service of obtaining a stock exchange listing for its shares and it is therefore expensed immediately to profit or loss at the closing date. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img alt="" src="fin_001.jpg"/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES (CONT.):</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"> <tr style="vertical-align: top"> <td style="text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>E.</b></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reverse acquisition transaction (Cont.)</b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is initially consolidated in the financial statements from the Closing Date of the Business Combination. Substantially all of the assets and liabilities of the Company were comprised of marketable securities held in a trust account ($<span id="xdx_903_ecustom--MarketableSecuritiesHeldInTrustAccount_iI_pn3n3_c20230630_zA0JylOBtRF1" title="Marketable securities held in a trust account">4,921</span>) and trade and other payables and warrants ($<span id="xdx_900_eifrs-full--TradeAndOtherPayables_iI_pn3n3_c20230630_zErrY0Xx5tN8" title="Trade, other payables and warrants">10,127</span>) respectively, with fair values that were equivalent to their carrying amounts. Below are the implications of the accounting treatment on the financial statements:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The assets and liabilities of Security Matters PTY Ltd. have been recognized and measured in these consolidated financial statements at their pre-combination carrying amounts.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The retained earnings and other equity balances recognized in those consolidated financial statements are the retained earnings and other equity balances of Security Matters PTY Ltd. immediately before the Business Combination.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount recognized as issued equity instruments in these consolidated financial statements has been determined by adding to the issued equity of Security Matters PTY Ltd. immediately before the Business Combination the fair value of the deemed issuance of shares, as described above. However, the equity structure (the number and type of shares issued) reflects the equity structure of the Company, including the shares issued by the Company through recapitalization. Accordingly, the equity structure of Security Matters PTY Ltd. (issued capital and addition paid in capital) in comparative periods is restated using the exchange ratio established in the Business Combination to reflect the number and par value of shares of the Company issued in the reverse acquisition transaction.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The statement of comprehensive loss reflects that of Security Matters PTY Ltd. for the full period together with the post-acquisition results of the Company from the Closing Date. Loss per share of Security Matters PTY Ltd. for periods prior to the acquisition date is restated such the denominator of the historical loss per share calculation is adjusted by multiplying the weighted-average shares used in each historically reported loss per share calculation by the exchange ratio established in the Business Combination.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 11599000 16802000 4921000 10127000 <p id="xdx_840_ecustom--DescriptionOfAccountingPolicyForReverseStockSplitExplanatory_zKAjJb8wqbb2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>F.</b></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_z48VN1KHwPBd">Reverse stock split</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The presentation of loss per share amounts has been retrospectively adjusted to give effect to the reverse share split which occurred on August 8, 2023. Except otherwise specifically provided, no other adjustments have been made in these notes to reflect the reverse share split. See also Note 9.1.</span></p> <p id="xdx_800_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_zIX2gv9ibmrf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span style="text-transform: uppercase"><span id="xdx_82F_zVoZ1cwTeH2j">CONVERTIBLE NOTES</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 25, 2023, the Company received an amount of $<span id="xdx_90A_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20230124__20230125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_ziMgtK44gsk6">250</span> in consideration for issuance of convertible notes (the “Convertible Notes”) and two types of warrants. The Convertible Notes principal amount is $<span id="xdx_903_eifrs-full--NotionalAmount_iI_pn3n3_c20230125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zoPNVGAdMUEk" title="Principal amount">250</span> and maturity date is the earlier between <span id="xdx_900_eifrs-full--BorrowingsMaturity_c20230124__20230125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zQTRQ5x52O8f" title="Maturity date">December 31, 2024</span>, and the date of any change in control (excluding the Business Combination). The Convertible Notes have an interest rate of <span id="xdx_90E_eifrs-full--BorrowingsInterestRate_iI_pid_uPure_c20230125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zfpfsMT32p76" title="Interest rate">15%</span> per annum and shall be converted into ordinary shares: (1) at the note holder’s discretion, at a fixed conversion price of USD <span id="xdx_905_ecustom--FixedConversionPrice_iI_pid_c20220726__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zzezanaWrYal" title="Fixed conversion price">10</span> per ordinary share, or (2) through issuance of the Company’s ordinary shares at a <span id="xdx_90C_ecustom--DiscountRate_pid_dp_uPure_c20230124__20230125__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zICNv23WhZNd" title="Discount rate">20%</span> discount.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the Convertible Note agreements, the investor was granted two types of warrants:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bonus Warrants – <span id="xdx_906_ecustom--WarrantsToPurchaseOrdinaryShares_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertiableNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember_zyE0JF34rq7i" title="Warrants to purchase ordinary shares">12,500</span> warrants to purchase ordinary shares of the Company at an exercise price of USD <span id="xdx_90A_ecustom--ExercisePriceOfWarrants_pid_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertiableNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember_zhNv9OM8zjqf" title="Exercise price">11.50</span> per share. The Bonus Warrants term is <span id="xdx_907_ecustom--WarrantsTerm_dc_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertiableNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember_zBz1hSJQHUYk" title="Warrants term">five years</span> commencing upon the Business Combination.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable Warrants – <span id="xdx_90D_ecustom--WarrantsToPurchaseOrdinaryShares_pid_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertiableNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zKEiVLroDy4e" title="Warrants to purchase ordinary shares">12,500</span> warrants to purchase ordinary shares of the Company at a purchase price of USD <span id="xdx_905_ecustom--SharePurchasePrice_pid_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertiableNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zjC017LN0wn3" title="Share purchase price">11.50</span> per share. The Redeemable Warrants term is <span id="xdx_905_ecustom--WarrantsTerm_dc_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertiableNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zPKhyYp14UWk" title="Warrants term">five years</span> commencing upon the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD <span id="xdx_903_eifrs-full--ParValuePerShare_iI_pid_c20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertiableNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zuvv9DS7MVH2">5.00</span> per warrant. <span id="xdx_903_eifrs-full--DescriptionOfApproachUsedToDetermineDiscountRates_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertiableNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zz86Ct4WQKp4" title="Description of approach used to determine discount rates">The investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a <span id="xdx_900_ecustom--DiscountRate_pid_dp_uPure_c20230124__20230125__ifrs-full--TypesOfContractsAxis__custom--ConvertiableNoteAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zaYj5ogZmwse" title="Discount rate">20</span>% discount to the 20-trading day VWAP preceding each such anniversary.</span></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Convertible Notes are recorded in accordance with their fair value. The Redeemable Warrants are accounted for as a derivative financial liability. Management utilized a third-party appraiser to assist them in valuing the Convertible Notes and Redeemable Warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to calculate the fair value of the Convertible Notes, the Company discounted the payment schedule by a discount rate of <span id="xdx_900_ecustom--DiscountRate_pid_dp_uPure_c20230101__20230630__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--ConvertibleNotesMember_zJklEslY03Rh" title="Discount rate">30.7%</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Redeemable Warrants was calculated using Monte-Carlo simulation model with expected volatility of <span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_uPure_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_z9kZNJKOnxyf" title="Volatility rate">71.54%</span> and the risk-free interest rate used is <span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zlAl0KNmwmKi" title="Risk-free interest rate">4.19%</span>. As of June 30, 2023, the fair value of the Convertible Notes was $<span id="xdx_907_ecustom--FairValueOfConvertibleNotes_iI_pn3n3_c20230630_zzvLZDuIZDK2" title="Fair value of convertible notes">218</span> and the fair value of the Redeemable Warrants was $<span id="xdx_902_ecustom--FairValueOfRedeemableWarrants_iI_pn3n3_c20230630_zWQATOyfIx73" title="Fair value of the redeemable warrants">71</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img alt="" src="fin_001.jpg"/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 250000 250000 December 31, 2024 0.15 10 0.20 12500000 11.50 P5Y 12500 11.50 P5Y 5.00 The investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary. 0.20 0.307 0.7154 0.0419 218000 71000 <p id="xdx_809_eifrs-full--DisclosureOfDerivativeFinancialInstrumentsExplanatory_zUIChB0zT4ih" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span id="xdx_823_zOXCbAGm0kq9">BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Between August 2022 to January 2023, Security Matters PTY Ltd. entered into bridge loan agreements (the “Bridge Loans”) with eleven lenders, which lent Security Matters PTY Ltd. an aggregate amount of $<span id="xdx_900_ecustom--ProceedsFromLoansAndWarrants_pn3n3_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ElevenLendersMember_z4SXVNgkVo24" title="Proceeds from loans and warrants">3,860</span>. The Bridge Loans have a maturity date of up to <span id="xdx_905_eifrs-full--BorrowingsMaturity_c20220801__20230131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_z9cVhEyWNiq6" title="Borrowings maturity">two years</span> and bear an interest rate of <span id="xdx_901_eifrs-full--BorrowingsInterestRate_iI_pid_uPure_c20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zVZ5YSqr6JKl" title="Interest rate">10%</span> per annum. The Bridge Loans were accounted for in accordance with the amortized cost method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the Bridge Loans agreements, the lenders were granted two types of warrants:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bonus Warrants – <span id="xdx_905_ecustom--WarrantsToPurchaseOrdinaryShares_pid_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember_zjpHNBToL8c" title="Warrants to purchase ordinary shares">243,000</span> warrants to purchase ordinary shares of the Company at an exercise price of USD <span id="xdx_902_ecustom--SharePurchasePrice_pid_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember_zQG0D3LF7fCj">11.50</span> per share. The Bonus Warrants term is <span id="xdx_909_ecustom--WarrantsTerm_dc_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--BonusWarrantsMember_zEYY1UllvWmc" title="Warrants term">five years</span> commencing upon the Business Combination.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Redeemable Warrants – <span id="xdx_909_ecustom--WarrantsToPurchaseOrdinaryShares_pid_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zCFsN9LHUXml" title="Warrants to purchase ordinary shares">572,000</span> warrants to purchase ordinary shares of the Company at a purchase price of USD <span id="xdx_908_ecustom--SharePurchasePrice_pid_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zpK2yy67zsal" title="Exercise price of warrants">11.50</span> per share. The Redeemable Warrants term is <span id="xdx_90B_ecustom--WarrantsTerm_dc_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zRf8RcijkHd7" title="Warrants term">five years</span> commencing upon the Business Combination. The Redeemable Warrants shall be redeemable on a non-cumulative basis at the option of the holder, according to a schedule for USD <span id="xdx_901_eifrs-full--ParValuePerShare_iI_pid_c20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--ComponentsOfEquityAxis__custom--RedeemableWarrantsMember_zQveNNdsesW6" title="Par value">5.00</span> per warrant.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eifrs-full--DescriptionOfApproachUsedToDetermineDiscountRates_c20220801__20230131__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_z51IwbLhA4C8">Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management with the assistance of a third-party appraiser valued the Bonus and the Redeemable Warrants. The fair value of the Bonus Warrants was calculated using the Black-Scholes model. As of June 30, 2023, the fair value of the Bonus Warrants was less than $<span id="xdx_90E_ecustom--FairValueOfBonousWarrants_iI_pn3n3_c20230630__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__srt--RangeAxis__ifrs-full--TopOfRangeMember_zbbwCUSNgz75" title="Fair value of the bonous Warrants">1</span> (December 31, 2022 - the fair value of the Bonus Warrants was $<span id="xdx_908_ecustom--FairValueOfBonousWarrants_iI_pn3n3_c20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_z3IG0Lxgvqt5" title="Fair value of the bonous Warrants">24</span>).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The fair value of the Redeemable Warrants was calculated using Monte-Carlo simulation model. As of June 30, 2023, the fair value of the Redeemable Warrants was <span id="xdx_902_ecustom--FairValueOfRedeemableWarrants_iI_pn3n3_c20230630__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zDbkLXeVaOe6">2,133 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(December 31, 2022, the fair value of the Redeemable Warrants was $<span id="xdx_903_ecustom--FairValueOfRedeemableWarrants_iI_pn3n3_c20221231__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_z4dX0zWT84Q7">2,669</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The main assumptions used in the three valuation models described above were: (1) risk free rate <span id="xdx_903_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230101__20230630__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zLDpMQpZ2fgg" title="Risk-free interest rate">3.99%</span>; (2) volatility of assets <span id="xdx_90B_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230101__20230630__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zbMu1JagW1Kc" title="Volatility rate">81.03%</span>; and (3) excepted terms of the warrants -<span id="xdx_908_ecustom--WarrantsTerm_dtY_c20230101__20230630__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zkg8Oyx7iDHi" title="Excepted terms">5.18</span> years. All warrants were classified as a derivative financial liability and are re-measured each reporting date, with changes in fair value recognized in finance expense (income), net.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2023, the Company entered into an additional bridge loan agreement (the “Additional Bridge Loans”), in which the Company raised an aggregate amount of $<span id="xdx_90A_eifrs-full--ProceedsFromBorrowingsClassifiedAsFinancingActivities_pn3n3_c20230101__20231231__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zxG2JUkUjIl7" title="Proceeds from borrowings, classified as financing activities">550</span>. The Additional Bridge Loans have a maturity date of up to <span id="xdx_90E_eifrs-full--BorrowingsMaturity_c20230101__20231231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_ztdQofQUzZmi" title="Borrowings maturity">two years</span> and bear interest rate of <span id="xdx_90A_eifrs-full--BorrowingsInterestRate_iI_pid_dp_uPure_c20231231__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zBIvq3i7K4e6" title="Borrowings, interest rate">10%</span> per annum. In March 2023, the Company signed an addendum to the Bridge Loans agreements which convert principal amount of $<span id="xdx_900_eifrs-full--IssueOfConvertibleInstruments_pn3n3_c20230301__20230331__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zbzBOitYKUHd" title="Aggregate amount of convertible instruments issued">1,350</span> and redeemable warrants at the amount of $<span id="xdx_909_ecustom--RedeemableWarrants_iI_pn3n3_c20230331__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zkWWo1avX494" title="Redeemable warrants">1,000</span> into <span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_c20230331__ifrs-full--TypesOfContractsAxis__custom--BridgeLoanAgreementsMember_zWvWzMOGX9u2" title="Number of shares">872,418</span> ordinary shares and defer the remaining cash payments to March 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img alt="" src="fin_001.jpg"/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 3860000 two years 0.10 243000 11.50 P5Y 572000 11.50 P5Y 5.00 Each investor has the option to decide that the Company will satisfy any or each redemption through the issuance of ordinary shares of the Company based upon a 20% discount to the 20-trading day VWAP preceding each such anniversary. 1000 24000 2133000 2669000 0.0399 0.8103 P5Y2M4D 550000 two years 0.10 1350000 1000000 872418 <p id="xdx_800_ecustom--DisclosureOfMaterialEventsDuringThePeriodExplanatory_zXYsHeFGxYH7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – <span id="xdx_826_zwbF9YaL0b9d">MATERIAL EVENTS DURING THE PERIOD</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered in February 2023 into a Standby Equity Purchase Agreement (“SEPA”) to raise up to $<span id="xdx_903_eifrs-full--IssuedCapitalOrdinaryShares_iI_pn3n3_c20230228__custom--EquityPurchaseAgreementAxis__custom--StandbyEquityPurchaseAgreementMember_zHCSNEumytV2" title="Issued capital, ordinary shares">25,000</span> in consideration of the issuance of ordinary shares over the course of 36 months with Yorkville. According to the SEPA, the Company may issue Yorkville the ordinary shares at a purchase price as one of two options (i) equal to <span id="xdx_901_ecustom--PercentageOfWeightedAveragePriceOfCommonStock_pid_dp_uPure_c20230201__20230228__custom--EquityPurchaseAgreementAxis__custom--StandbyEquityPurchaseAgreementMember_zaGueVD9XIJe" title="Percentage of weighted average price of common stock">96</span>% of the weighted average price (“VWAP”) of the common stock during the applicable pricing period (ii) equal to <span id="xdx_90D_ecustom--PercentageOfCommonStock_pid_dp_uPure_c20230201__20230228__custom--EquityPurchaseAgreementAxis__custom--StandbyEquityPurchaseAgreementMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zx6Ef3Uu5Hy9" title="Percentage of common stock">97</span>% of the lowest VWAP of the common stock during a pricing period of 3 consecutive trading days commencing on the relevant period.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yorkville advanced to the Company an aggregate principal amount of $<span id="xdx_90D_eifrs-full--NotionalAmount_iI_pn3n3_c20230228_zd3I2I3GZqm2" title="Principal amount">3,500</span> (the “Pre-Paid Advance”). The Pre-Paid Advance was disbursed in two separate installments evidenced as convertible loans, the first for $<span id="xdx_90D_eifrs-full--CurrentPrepaidExpenses_iI_pn3n3_c20230228__ifrs-full--MeasurementAxis__custom--FirstInstallmentMember_zzpJ8HjGC6s3" title="Pre-paid advance">1,500</span> at the closing of the Business Combination, and the second, as subsequently amended, for $<span id="xdx_902_eifrs-full--CurrentPrepaidExpenses_iI_pn3n3_c20230228__ifrs-full--MeasurementAxis__custom--SecondInstallmentMember_ztJgrpxcLXB7" title="Pre-paid advance">2,000</span> upon the effectiveness of the Initial Yorkville Registration Statement. <span id="xdx_905_ecustom--PurchasePricePrePaidAdvanceDescription_c20230201__20230228_zavE7Nmms465" title="Purchase price pre paid advance description">The purchase price for the Pre-Paid Advance is 92.0% of the Pre-Paid Advance. Such Pre-Paid Advances will be offset upon the issuance of ordinary shares to Yorkville at a price per share equal to the lower of (a) 100% of the daily VWAP of the Ordinary Shares on The Nasdaq Stock Market as of the trading day immediately prior to the date of the disbursement of the Pre-Paid Advance (the “Fixed Price”) (in the case of the first Pre-Paid Advance, $3.65), or (b) 93.0% of the lowest daily VWAP of the Ordinary Shares on Nasdaq during the seven trading days immediately prior to each purchase (the “Variable Price” and the lower of the Fixed Price and the Variable Price shall be referred to as the “Purchase Price”); however, in no event shall the Purchase Price be less than $1.10 (the “Floor Price”). On July 27, 2023, the Company amended the promissory note evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $1.10 (as adjusted for reverse stock split which occurred on August 21, 2023, see also Note 9.1), after the Company was required to repay in cash $<span id="xdx_905_eifrs-full--CashOnHand_iI_pn3n3_c20230727__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zrWiWGI95p77" title="Cash">500</span> of principal amount as a result of the Company’s share price being below the original Floor Price.</span> The maturity date will be 12-months after the initial closing of <span style="background-color: white">each </span> Pre-Paid Advance. In July 2023, the Company repaid in full the first Pre-Paid Advance in the amount of $<span id="xdx_905_eifrs-full--CurrentPrepaidExpenses_iI_pn3n3_c20230731__ifrs-full--MeasurementAxis__custom--FirstInstallmentMember__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zkmwOQPC0a42" title="Pre-paid advance">1,500</span>. In the period, the Company issued ordinary shares in consideration of $<span id="xdx_906_eifrs-full--IssuedCapital_iI_pn3n3_c20230731__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__custom--EquityPurchaseAgreementAxis__custom--StandbyEquityPurchaseAgreementMember_zFMgcDQIxBw9" title="Issued ordinary shares value">450</span> in accordance with the terms of the SEPA.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 22, 2023, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with EF Hutton, LLC (the “Underwriter”) relating to the public offering of (i) <span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember_z8u3aFcougnh" title="Ordinary shares">13,333,333</span> ordinary shares of the Company, at a subscription price per share of $<span id="xdx_90D_ecustom--SubscriptionPricePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember_zyxZ2GX6VlXb" title="Subscription price per share">0.24</span> (the “Firm Shares”), (ii) <span id="xdx_902_ecustom--NumberOfWarrantsIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember_zazNswzyRxcg" title="Number of warrants issued">13,333,333</span> warrants in the form of Warrant A to subscribe for <span id="xdx_906_ecustom--NumberOfSubscriptionShares_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember_zgRq0Ps9kruk" title="Number of warrants issued">13,333,333</span> ordinary shares, at an exercise price of $<span id="xdx_90C_ecustom--SubscriptionPricePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember_zXUMyle7Ox0g" title="Subscription price per share">0.24</span> per share (“Warrant A”), and (iii) <span id="xdx_90B_ecustom--NumberOfWarrantsIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember_zL3XSnsRV77i" title="Ordinary shares">13,333,333 </span>warrants in the form of Warrant B to subscribe for <span id="xdx_90B_ecustom--NumberOfSubscriptionShares_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_zuajAqGl4Kt2" title="Number of warrants issued">13,333,333</span> ordinary shares, at an exercise price of $<span id="xdx_90D_ecustom--SubscriptionPricePerShare_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_zNnE4FKQzwRe" title="Subscription price per share">0.24</span> per share (“Warrant B” and together with Warrant A, the “Firm Warrants” and, collectively with the Firm Shares, the “Firm Securities”).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--DescriptionOfInputsToOptionPricingModelShareOptionsGranted_c20230622__20230622_zUbapdXlxmD6" title="Option granted description">The Company also granted the Underwriter a 45-day option to subscribe for, in the aggregate, (a) up to 1,999,999 additional ordinary shares (15% of the Firm Shares) at a subscription price per share of $0.24 (100% of the public offering price allocated to each Firm Share) (the “Option Shares” and together with the Firm Shares, the “Shares”) or Pre-Funded Warrants to subscribe for up to 1,999,999 ordinary shares at a price per share of $0.2399 (100% of the public offering price allocated to each Firm Share less $0.0001) and the remaining non pre-funded exercise price of each pre-funded warrant will be $0.0001 per share, and/or (b) 1,999,999 warrants in the form of Warrant A to subscribe for an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at an exercise price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant A), and/or (c) 1,999,999 warrants in the form of Warrant B to purchase an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at a purchase price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant B) (the “Option Warrants” and together with the Firm Warrants and Pre-Funded Warrants, if any, the “Warrants”), which may be subscribed for in any combination of Option Shares and/or the Option Warrants. The Option Shares and the Option Warrants are referred to as the “Option Securities”.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The offering closed on June 27, 2023. The Company delivered the Firm Shares (or Firm Share equivalents in the form of Pre-Funded Warrants), the Firm Warrants and the Option Warrants to the Underwriter on the same day.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Warrant A terms specify that the warrants may be exercised at any time on or before June 27, 2028. On or after the earlier of (i) the thirty day anniversary of the date of the Underwriting Agreement and (ii) the date on which the aggregate composite trading volume of the Company’s ordinary shares as reported by Bloomberg LP beginning on the date of the Underwriting Agreement exceeds <span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember_zz4TeEmrqNZj" title="Ordinary shares">15,000,000</span> ordinary shares, a holder of Warrant A warrants may also provide notice and elect a “cashless exercise” pursuant to which the holder would receive an aggregate number <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of ordinary shares equal to the product of (x) the aggregate number of ordinary shares that would be issuable upon a cash exercise and (y) $<span id="xdx_90F_ecustom--WarrantSharePriceCashExercise_iI_pid_c20230622__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember_zOgY9idnvif1" title="Warrant share price cash exercise">0.50</span>. As of the date of publication of these financial statements, an aggregate of <span id="xdx_90C_ecustom--NumberOfWarrantsIssued_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember_zlpwCwNu1AX7" title="Number of warrants issued">15,195,332</span> Warrant A warrants were cashless exercised into an aggregate of <span id="xdx_90F_ecustom--NumberOfWarrantCashlessExercised_iI_pid_c20230622__ifrs-full--TypesOfContractsAxis__custom--UnderwritingAgreementMember__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember_z8NNY6M3RK6g" title="Number of warrant cashless exercised">7,597,665</span> ordinary shares.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img alt="" src="fin_001.jpg"/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – MATERIAL EVENTS DURING THE PERIOD (CONT.)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Warrant B terms specify that the warrants may be exercised at any time on or before June 27, 2028. All of such Warrant B warrants remain outstanding as of the end of period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant A was valued at $<span id="xdx_904_ecustom--WarrantSharePriceCashlessExercise_iI_c20230622__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember_z75rIF9tFWhj" title="Warrant share price cashless exercise">0.0635</span> which is half of the share market price at the end of the period, assuming cashless exercise. Warrants A were considered to be a derivative financial liability. The terms of warrants B specify that each warrant has a cash exercise price of $<span id="xdx_903_ecustom--WarrantSharePriceCashExercise_iI_c20230622__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_zav4fTwInIxe" title="Warrant share price cash exercise">0.24</span>. Warrant B was valued at $<span id="xdx_902_eifrs-full--ExercisePriceShareOptionsGranted2019_c20230622__20230622__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_zTPEf0z5lYw4">0.0602</span> by using the Black-Scholes option-pricing model, with expected volatility of <span id="xdx_90C_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230622__20230622__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_zIar7uDiOC7f" title="Expected volatility">70.39</span>% and the risk-free interest rate used is <span id="xdx_908_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230622__20230622__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_zkvX6AzuzNS9" title="Risk-free rate">4.13</span>%. Warrants A and B expire in June 2028.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The net proceeds to the Company upon the closing of this offering were approximately $<span id="xdx_90D_eifrs-full--ProceedsFromIssuingOtherEquityInstruments_pn3n3_c20230101__20230630_zeNWLZ921oOj" title="Net proceeds">2,580</span>. The capital raise fee amounted to $<span id="xdx_900_ecustom--PaymentsForShareIssued_pn3n3_c20230101__20230630_zaAJUbyWTBQe" title="Capital raise fee">660</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also granted to the Underwriter, <span id="xdx_907_ecustom--NumberOfSharesIssuedWarrants_iI_pid_c20230622__ifrs-full--ComponentsOfEquityAxis__custom--UnderwriterWarrantMember_zrBbXOggGHAk" title="Number of shares issued warrants">666,667</span> warrants at an exercise price of $<span id="xdx_905_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230622__20230622__ifrs-full--ComponentsOfEquityAxis__custom--UnderwriterWarrantMember_zmDIe8jU8DM" title="Exercise price">0.264</span> per share, which expires after <span id="xdx_90C_ecustom--WarrantsExpirationDate_dtY_c20230622__20230622__ifrs-full--ComponentsOfEquityAxis__custom--UnderwriterWarrantMember_ztrl20ugHBnd" title="Warrants expiration date">5</span> years. The Underwriter’s warrants were valued at $<span id="xdx_901_eifrs-full--ParValuePerShare_iI_c20230622__ifrs-full--ComponentsOfEquityAxis__custom--UnderwriterWarrantMember_zNYTdXoGfPJ8">0.0575</span> per option by using the Black &amp; Scholes option-pricing, with expected volatility of <span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230622__20230622__ifrs-full--ComponentsOfEquityAxis__custom--UnderwriterWarrantMember_zcREhRfaN0Xf" title="Expected volatility">70.39</span>% and the risk-free interest rate used is <span id="xdx_905_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230622__20230622__ifrs-full--ComponentsOfEquityAxis__custom--UnderwriterWarrantMember_zMuxaBif491j" title="Risk-free rate">4.13</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">3.</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2023, the Company signed an amendment to the agreement with Isorad that determine the following:</span></p> <p style="margin-top: 0; margin-bottom: 0"></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1) for the BCA with Lionheart, (a) Isorad was issued <span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pid_c20230131_zwHUjDzZDPQ2" title="Options to purchase shares">864,000</span> options to purchase shares of the Company, which options were issued in January 2023 and valued using the Black-Scholes pricing model, with the main parameters used are: (1) risk-free rate: <span id="xdx_904_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_uPure_c20230101__20230131_zDtoVj4G6bG" title="Risk-free rate">3.42</span>%; (2) expected volatility: <span id="xdx_90D_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_uPure_c20230101__20230131_z4tdQBfTpXs8" title="Expected volatility">81.92</span>%: (3) expected term: up to <span id="xdx_907_ecustom--DescriptionOfExpectedExpectedTermOptionsGranted_dtY_c20230101__20230131_zPCocoyGXj1e" title="Expected term">3</span> years; and (4) expected dividend yield: <span id="xdx_907_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_uPure_c20230101__20230131_zENQF1XHwOVa" title="Expected dividend yield">0</span>%; and (b) Isorad will be entitled to <span id="xdx_90B_ecustom--AddtionalEquityFundOfConvertiblePercent_iI_pid_dp_uPure_c20230131_z0MswvGJeyCe" title="Convertible percentage">1</span>% of any amount actually received against equity or other funding convertible into equity at the closing of the transaction and until 13 months thereafter (to be paid after reaching an aggregated received amount of $<span id="xdx_907_eifrs-full--ConsiderationPaidReceived_pn6n6_c20230101__20230131_zJxR0PoVinma" title="Aggregated received amount">27</span> million, or at the end of such 13 months, the earlier thereof). In the period, based on the funds the Company actually received, the Company recognized a technology license intellectual property at the amount of $101 against a liability that reflects the due amount; and</span></p></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2) Exit fee - in the occurrence of the first M&amp;A event (as such event is defined in such agreement to include mergers, sale of all or substantially all the assets of the Company and similar event) after the closing of the BCA, the Company is to pay a cash amount equal to <span id="xdx_90F_ecustom--PaymentOfCashPercent_iI_pid_dp_c20230131_z9axhEsyTECa" title="Payment of cash percent">1.5</span>% of the amount received or transferred. This will not apply to any future offer of shares, merger or sale of assets thereafter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.7pt"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 18pt">4<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 2, 2023, the Company amended its loan agreement dated September 7, 2015, between the Company, its Shareholders and Kamea Fund that postponed the repayment of the borrowings from related party (Bonus Payment) to March 31, 2024 (refer also to Note 9.4 – Subsequent Events).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img alt="" src="fin_001.jpg"/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands except share and per share data)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 25000000 0.96 0.97 3500000 1500000 2000000 The purchase price for the Pre-Paid Advance is 92.0% of the Pre-Paid Advance. Such Pre-Paid Advances will be offset upon the issuance of ordinary shares to Yorkville at a price per share equal to the lower of (a) 100% of the daily VWAP of the Ordinary Shares on The Nasdaq Stock Market as of the trading day immediately prior to the date of the disbursement of the Pre-Paid Advance (the “Fixed Price”) (in the case of the first Pre-Paid Advance, $3.65), or (b) 93.0% of the lowest daily VWAP of the Ordinary Shares on Nasdaq during the seven trading days immediately prior to each purchase (the “Variable Price” and the lower of the Fixed Price and the Variable Price shall be referred to as the “Purchase Price”); however, in no event shall the Purchase Price be less than $1.10 (the “Floor Price”). On July 27, 2023, the Company amended the promissory note evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $1.10 (as adjusted for reverse stock split which occurred on August 21, 2023, see also Note 9.1), after the Company was required to repay in cash $500 of principal amount as a result of the Company’s share price being below the original Floor Price. 500000 1500000 450000 13333333 0.24 13333333 13333333 0.24 13333333 13333333 0.24 The Company also granted the Underwriter a 45-day option to subscribe for, in the aggregate, (a) up to 1,999,999 additional ordinary shares (15% of the Firm Shares) at a subscription price per share of $0.24 (100% of the public offering price allocated to each Firm Share) (the “Option Shares” and together with the Firm Shares, the “Shares”) or Pre-Funded Warrants to subscribe for up to 1,999,999 ordinary shares at a price per share of $0.2399 (100% of the public offering price allocated to each Firm Share less $0.0001) and the remaining non pre-funded exercise price of each pre-funded warrant will be $0.0001 per share, and/or (b) 1,999,999 warrants in the form of Warrant A to subscribe for an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at an exercise price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant A), and/or (c) 1,999,999 warrants in the form of Warrant B to purchase an aggregate of 1,999,999 ordinary shares (15% of the Firm Warrants) at a purchase price of $0.24 per warrant (100% of the public offering price allocated to each set of warrants in the form of Warrant B) (the “Option Warrants” and together with the Firm Warrants and Pre-Funded Warrants, if any, the “Warrants”), which may be subscribed for in any combination of Option Shares and/or the Option Warrants. The Option Shares and the Option Warrants are referred to as the “Option Securities”. 15000000 0.50 15195332 7597665 0.0635 0.24 0.0602 0.7039 0.0413 2580000 660000 666667 0.264 P5Y 0.0575 0.7039 0.0413 864000 0.0342 0.8192 P3Y 0 0.01 27000000 0.015 <p id="xdx_807_eifrs-full--DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_zz6j439Xxn0f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 - <span id="xdx_827_zqepZNA4cBOh">SHAREHOLDERS’ EQUITY </span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>A. Share capital:</b></span></p> <p id="xdx_89E_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_zY25N94f9kKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B7_zb0npF8F9BWe" style="display: none">SCHEDULE OF SHARE CAPITAL</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Authorized</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued and outstanding</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Authorized</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued and outstanding</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 36%">Ordinary shares <br/> USD 0.0001 par value</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zEq30svhFuOb" style="width: 12%; text-align: right" title="Number of shares authorized">800,000,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zF6WdmxtwREc" style="width: 12%; text-align: right" title="Number of shares issued and outstanding">38,364,447</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zH1eyFMojDv4" style="width: 12%; text-align: right" title="Number of shares authorized">500,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_ziQbsG9qcxsb" style="width: 12%; text-align: right" title="Number of shares issued and outstanding">1</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Ordinary shares <br/> USD <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eifrs-full--ParValuePerShare_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zVMMJnJafmgc"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eifrs-full--ParValuePerShare_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zJJkTHKODSZg">0.0001</span></span> par value</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zx5yUkcmOYLk" style="text-align: right" title="Number of shares authorized">800,000,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z9Izaj4gdsFi" style="text-align: right" title="Number of shares issued and outstanding">38,364,447</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zTjP3HMNCNp8" style="text-align: right" title="Number of shares authorized">500,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zx26Xr8Sw3Zj" style="text-align: right" title="Number of shares issued and outstanding">1</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Preferred shares <br/>USD <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eifrs-full--ParValuePerShare_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zZvcRR3emln4"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eifrs-full--ParValuePerShare_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zYsTlYZqpNoi">0.0001</span></span> par value</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zGvL3jsDDw8k" style="text-align: right" title="Number of shares authorized">200,000,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zWPad88e31Ba" style="text-align: right" title="Number of shares issued and outstanding"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zBSYiM2KZpx8" style="text-align: right" title="Number of shares authorized"><span style="-sec-ix-hidden: xdx2ixbrl0726">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zaXsbWafCsa" style="text-align: right" title="Number of shares issued and outstanding"><span style="-sec-ix-hidden: xdx2ixbrl0728">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred shares <br/> Euro <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eifrs-full--ParValuePerShare_iI_pid_uEuroPerShare_c20230630_zvItZ4KtoHCi"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eifrs-full--ParValuePerShare_iI_pid_uEuroPerShare_c20221231_zm9AUi9ABEnb">1</span></span> par value</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--DeferredSharesMember_zzlarAy0gIgi" style="text-align: right" title="Number of shares authorized">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--DeferredSharesMember_z9bvcSOENwwh" style="text-align: right" title="Number of shares issued and outstanding">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ComponentsOfEquityAxis__custom--DeferredSharesMember_zK7HnQHWMOB8" style="text-align: right" title="Number of shares authorized">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ComponentsOfEquityAxis__custom--DeferredSharesMember_zzfmkxTQ8ytc" style="text-align: right" title="Number of shares issued and outstanding">25,000</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A1_zRghuPS7WDLh" style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ordinary shares entitle the holder to participate in dividends and the proceeds on the winding up of the Company in proportion to the number of and amounts paid on the shares held. <span id="xdx_905_ecustom--ExplanationOfFactThatSharesHaveParValue_c20230101__20230630_zaiZVnfxeXK" title="Explanation of fact that shares have par value">The fully paid ordinary shares have a par value per share of $0.0001 (before the reverse split) and par value per share of $0.0022 (post reverse split) and the Company does not have a limited amount of authorised capital.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred shares</span></p> <p style="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">preferred shares with such designation, rights and preferences as may be determined from time to time by the Company’s Board of Directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Deferred shares</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred Ordinary Shares are non-voting shares and do not convey upon the holder the right to be paid a dividend or to receive notice of or to attend, vote or speak at a general meeting. The Deferred Shares confer the right on a return of capital, on a winding-up or otherwise, only to the repayment of the nominal value paid up on the Deferred Shares after repayment of the nominal value of the Ordinary Shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Changes in Share capital </span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 7, 2023 (the “Closing Date”), the Company consummated the Business Combination pursuant the BCA, dated July 26, 2022, and also consummated the SID, dated July 26, 2022.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning on the day immediately prior to the Closing Date and ending on the day immediately after the Closing Date, the following transactions occurred:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The AUD <span id="xdx_901_ecustom--ConvertiableNotes_uAUD_c20230301__20230307__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TwentyTwentyTwoConvertibleNotesMember_zyWq912O3eba" title="Convertiable notes">828,240</span> of the 2022 Convertible Notes have been cancelled in consideration for the issuance of <span id="xdx_90E_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--TwentyTwentyTwoConvertibleNotesMember_zqCDZGeP2H2l" title="Number of shares">1,000,000</span> ordinary shares in Security Matters PTY Ltd.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Security Matters PTY Ltd. performed acceleration of vesting for all unvested warrants and options, the expense for the acceleration amounted to $<span id="xdx_904_ecustom--WarrantsAccelerationAmount_pn3n3_c20230301__20230307_zP5HsNa8rP79" title="Warrants acceleration amount">186</span>.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--ExerciseOfWarrants_pid_c20230301__20230307_zYkqXe5E1AQi" title="Exercise of warrants">32,211,716</span> warrants have been exercised on cashless basis to <span id="xdx_908_ecustom--NumberOfSharesOnCashlessBasis_pid_c20230301__20230307_zbf1XBzLq02j" title="Number of shares on cashless basis">24,568,773</span> shares in Security Matters PTY Ltd.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zg9UDYKnp6Q7" title="Number of shares">18,673,253</span> ordinary shares of the Company have been issued to Security Matters PTY Ltd.’s shareholders in return for their <span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z6jdZkdpCBn6" title="Number of shares">193,500,379</span> ordinary shares in Security Matters PTY Ltd. that were cancelled. Security Matters PTY Ltd.’s shareholders received as consideration <span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zDDibTQ8fNXh">1</span> ordinary share of the Company per <span id="xdx_90E_ecustom--ShareIssuedPricePerShare_iI_pid_c20230307__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SecurityMattersPTYLtdMember_zEYtcKXKHek2" title="Share price">10.3624</span> Security Matters PTY Ltd.’s ordinary shares.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_zcPC21FeqCz3">3,525,000</span> ordinary shares, <span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember__ifrs-full--ComponentsOfEquityAxis__custom--PrivateWarrantsMember_zFwKzxQTnBde" title="Private warrants">2,200,000</span> private warrants and <span id="xdx_900_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember__ifrs-full--ComponentsOfEquityAxis__custom--PublicWarrantsMember_ziXWgFKZnlx8" title="Public warrants">6,250,000</span> public warrants to Lionheart’s stockholders, in exchange for their existing Lionheart shares and warrants. The warrants exercise price is $<span id="xdx_900_ecustom--ExercisePriceOfWarrants_pid_c20230301__20230307__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_zFSxHTKqJrNh" title="Warrants exercise price">11.5</span> per share, expiring in March 2028. The warrants are considered to be a derivative financial liability and measured at fair value, which is the market price as of the end of the period, amounted to $<span id="xdx_90E_eifrs-full--ParValuePerShare_iI_pid_c20230307__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--LionheartIIICorpMember_zHgf7tnYCNO1" title="Market price">0.0204</span> per warrant.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img alt="" src="fin_001.jpg"/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(US$ in thousands except share and per share data)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 – SHAREHOLDERS’ EQUITY (CONT.)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90F_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--ClassesOfShareCapitalAxis__custom--OrdinarySharesOneMember_zF3D6mYli4Ml">303,053</span> ordinary shares for an aggregate of $<span id="xdx_906_ecustom--ProceedsFromIssuanceOfStock_pn3n3_c20230301__20230307__ifrs-full--ClassesOfShareCapitalAxis__custom--OrdinarySharesOneMember_zQzt4jjElsE8" title="Proceeds from issuance of stock">3,110</span> net proceeds.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"></td><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pid_c20230307__ifrs-full--ClassesOfShareCapitalAxis__custom--OrdinarySharesTwoMember_zM7KP6Tf5Af7">872,418</span> ordinary shares for the conversion of bridge loan at principal amount of $<span id="xdx_90A_ecustom--DebtPrincipalAmount_pn3n3_c20230301__20230307__ifrs-full--ClassesOfShareCapitalAxis__custom--OrdinarySharesTwoMember_zl3yHFzIUwnj" title="Principal amount">1,350</span> and <span id="xdx_902_ecustom--RedeemableWarrants_iI_pn3n3_c20230307__ifrs-full--ClassesOfShareCapitalAxis__custom--OrdinarySharesTwoMember_zt8o26dTJCM5" title="Redeemable warrants">200,000</span> redeemable warrants ($<span id="xdx_904_eifrs-full--ParValuePerShare_iI_pid_c20230307__ifrs-full--ClassesOfShareCapitalAxis__custom--OrdinarySharesTwoMember_zQcF5Uf8EuBk">5</span> per warrant, <span id="xdx_905_ecustom--WarrantsTerm_c20230301__20230307__ifrs-full--ClassesOfShareCapitalAxis__custom--OrdinarySharesTwoMember_zA5TWpu3Wea2" title="Warrants term">5 years</span>, exercise price of $<span id="xdx_90E_ecustom--ExercisePriceOfWarrants_pid_c20230301__20230307__ifrs-full--ClassesOfShareCapitalAxis__custom--OrdinarySharesTwoMember_zUTdCAxJ2PU5" title="Exercise price">11.5</span> per share).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May and June 2023, the Company issued <span id="xdx_904_eifrs-full--NumberOfSharesIssued_iI_pid_c20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--YorkvilleMember_zIGOK6QjraV1" title="Shares issued"><span id="xdx_903_eifrs-full--NumberOfSharesIssued_iI_pid_c20230531__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--YorkvilleMember_zfAzVVjFZe0e" title="Shares issued">675,168</span></span> ordinary shares to Yorkville, for an aggregate of $<span id="xdx_900_eifrs-full--ProceedsFromIssuingOtherEquityInstruments_pn3n3_c20230601__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--YorkvilleMember_zSxEpZzLZb9" title="Net proceeds"><span id="xdx_903_eifrs-full--ProceedsFromIssuingOtherEquityInstruments_pn3n3_c20230501__20230531__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--YorkvilleMember_z79lUom6FgO8" title="Net proceeds">450</span></span> net proceeds (see also Note 5.1).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2023, the Company raised capital as part of issuance of a unit of financial instruments in consideration of an aggregate of $<span id="xdx_904_eifrs-full--ProceedsFromIssuingOtherEquityInstruments_pn3n3_c20230101__20230630_zfj8BZwythzg" title="Net proceeds">2,580</span> net proceeds. As part of this issuance, the Company issued <span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pid_c20230630_zMIQ4hR1d4Nb" title="Shares issued">13,333,333</span> shares, <span id="xdx_903_ecustom--NumberOfSharesIssuedWarrants_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantAMember_z16cNcSqMrbl" title="Shares issued warrants">15,333,332</span> warrants A and <span id="xdx_90A_ecustom--NumberOfSharesIssuedWarrants_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--WarrantBMember_zLuZBx5DGntl" title="Shares issued warrants">15,333,332</span> warrants B (see also Note 5.2).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">After the balance sheet date, on August 21, 2023, the Company’s ordinary shares began trading on the Nasdaq Global Market on a post-Reverse Stock Split basis, after consolidating every twenty-two ordinary shares of the Company into one ordinary share (see also Note 9.1).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Incentive Equity Plan</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 25, 2023, the Company’s board of directors and its shareholders approved and adopted the SMX Public Limited Company 2022 Incentive Equity Plan, which was subsequently amended the Company’s board of directors, subject to applicable Nasdaq requirements, which reserved for grant a number of ordinary shares equal to <span id="xdx_901_ecustom--NumberOfIssuedAndOutstandingOrdinarySharesPercentage_pid_dp_c20230425__20230425__ifrs-full--CharacteristicsOfDefinedBenefitPlansAxis__custom--TwentyTwentyTwoIncentiveEquityPlanMember_z85RMggrBVQj" title="Number of issued and outstanding ordinary shares percentage">15</span>% of the number of issued and outstanding ordinary shares on a fully diluted basis immediately after the closing of the Business Combination, or <span id="xdx_90C_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230425__ifrs-full--CharacteristicsOfDefinedBenefitPlansAxis__custom--TwentyTwentyTwoIncentiveEquityPlanMember_zTU1B0qbKETd" title="Number of shares authorized">5,082,417</span> authorized ordinary shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six-month period ended June 30, 2023, the Company granted <span id="xdx_90A_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20230101__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesDirectorsAndServiceProvidersMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zysmxjXXkOn3" title="RSUs granted">4,334,000</span> RSUs to employees, directors and service providers. The fair value at grant date of RSUs granted in the period were $<span id="xdx_90E_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230101__20230630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_z4stL4iW8mK1" title="RSUs granted">1</span>-$<span id="xdx_906_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230101__20230630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zTsI3l9GxHH" title="RSUs granted">1.09</span>. The related share-based expenses that were recognized in the period amounted to $<span id="xdx_90F_eifrs-full--EmployeeBenefitsExpense_pn3n3_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_z5nhrVmWwD7a" title="Related share based expenses">1,738</span>.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RSUs granted to employees, directors and service providers:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89B_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_hifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zRg1B1uotnMd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_z0YNFflG5Tna">SCHEDULE OF RESTRICTED SHARES UNITS GRANTED</span></span></b></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months period ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023 (in thousands)</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months period ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2022 <br/> (in thousands)</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding at beginning of period</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zdUuFEdKwkQ9" style="text-align: right" title="Number of options outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0811">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20220101__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zWgke93XOxg4" style="text-align: right" title="Number of options outstanding, beginning balance">    <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0813">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_z0Jwszuc7wCb" style="width: 16%; text-align: right" title="Number of options, granted"><span style="font-family: Times New Roman, Times, Serif">4,334</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20220101__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zRmaPiC1OG46" style="width: 16%; text-align: right" title="Number of options, granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0817">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_z2Joya5zT9Bg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options, vested"><span style="font-family: Times New Roman, Times, Serif">(945</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zQmX4fwDBVnd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options, vested"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0821">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zCFN3vDTclEe" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif">3,389</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20220101__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zfNwZSGam2T9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0825">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AE_zE8uHS5KfC4h" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the six-month period ended June 30, 2023, the Company granted <span id="xdx_90B_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_pid_uShares_c20230101__20230630__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--EmployeesAndServiceProvidersMember_zgJrOKI6G0Zi" title="Options granted">790,408</span> options to employees and service providers. These grants carry an exercise price of between $<span id="xdx_905_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230101__20230630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zhbA1sqx5yi3" title="Exercise price">1.04</span> - $<span id="xdx_90D_eifrs-full--ExercisePriceShareOptionsGranted2019_pid_c20230101__20230630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zgWUptxWc7zh" title="Exercise price">4.0</span>, <span id="xdx_909_eifrs-full--DescriptionOfVestingRequirementsForSharebasedPaymentArrangement_c20230101__20230630_zJDLLjBvI2yj" title="Vesting period description">vesting period up to 4 years from the grant date, contractual life of the options under the plan is 5 years.</span> The fair value of the grant at grant date is $<span id="xdx_903_eifrs-full--WeightedAverageFairValueAtMeasurementDateShareOptionsGranted_iI_pn3n3_c20230630_zu6SptSstOl6" title="Fair value"><span style="-sec-ix-hidden: xdx2ixbrl0835">185.</span></span> The related share based expenses that were recognized in the six months period ended June 30, 2023 amounted to $<span id="xdx_904_eifrs-full--EmployeeBenefitsExpense_pn3n3_c20230101__20230630_zX1tXAJfz9o6" title="Related share based expenses">168</span>.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img alt="" src="fin_001.jpg"/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 - SHAREHOLDERS’ EQUITY (CONT.)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options granted to employees and service providers:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_893_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_ziuluaIhx73l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zgbSKN7rfZQ4">SCHEDULE OF SHARE OPTION GRANTED</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months period ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exercise price per share (US$)</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding at beginning of period</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20230101__20230630_zWydLFQt0Wmg" style="width: 16%; text-align: right" title="Number of options outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,251</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20230101__20230630_zoO1MQiiuzKf" style="width: 16%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif">2.01</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20230101__20230630_zi9HijHJCqo4" style="text-align: right" title="Number of options, granted"><span style="font-family: Times New Roman, Times, Serif">790</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_c20230101__20230630_zDkUDjjj4Dh2" style="text-align: right" title="Weighted average exercise price, granted"><span style="font-family: Times New Roman, Times, Serif">3.47</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20230630_zPJ0395NtZAc" style="text-align: right" title="Number of options, exercised"><span style="font-family: Times New Roman, Times, Serif">(7</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20230630_zegjR82N9Xbi" style="text-align: right" title="Weighted average exercise price, exercised"><span style="font-family: Times New Roman, Times, Serif">1.39</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20230630_zXRB1vJmUB2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options, expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0853">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_c20230101__20230630_zAxtItihRO8j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0855">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20230101__20230630_zLDdvPjdWCAg" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif">2,034</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20230630_zlYnGDKX4127" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif">2.58</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable options at June 30, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20230101__20230630_zlp7FXVmZHXg" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options, Exercisable"><span style="font-family: Times New Roman, Times, Serif">1,825</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_c20230101__20230630_zOsdN34Nm4p5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-family: Times New Roman, Times, Serif">2.48</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months period ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2022 </b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exercise price per share (US$)</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding at beginning of period</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20220101__20220630_z2zijKXRvqZf" style="width: 16%; text-align: right" title="Number of options outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif">3,346</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20220101__20220630_zQpDi5Q8WUJc" style="width: 16%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif">2.02</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20220101__20220630_z6kIS5shyZX4" style="text-align: right" title="Number of options, granted"><span style="font-family: Times New Roman, Times, Serif">989</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_c20220101__20220630_zIR7kCdP08I4" style="text-align: right" title="Weighted average exercise price, granted"><span style="font-family: Times New Roman, Times, Serif">2.86</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20220630_zTDO8FWJAsXi" style="text-align: right" title="Number of options, exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0873">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20220101__20220630_zwd7PtOfy1Tk" style="text-align: right" title="Weighted average exercise price, exercised"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0875">-</span></span><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20220630_zFm8rp9inglg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options, expired"><span style="font-family: Times New Roman, Times, Serif">(375</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_c20220101__20220630_z464REOXrcHi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, expired"><span style="font-family: Times New Roman, Times, Serif">2.16</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2022</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20220101__20220630_zdIKKmEPfAmc" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif">3,960</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20220101__20220630_zPBk8SHBaO0h" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif">2.21</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable options at June 30, 2022</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20220101__20220630_zOZtU4XrvWk" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options, Exercisable"><span style="font-family: Times New Roman, Times, Serif">2,703</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_c20220101__20220630_zIbXkBwhAfB7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-family: Times New Roman, Times, Serif">2.33</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AA_zpRXQIY26ami" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eifrs-full--DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_zMAN4uluRsgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 23.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The options to employees and service providers outstanding as of June 30, 2023, are comprised, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 23.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zq1cSnmIHwxc">SCHEDULE OF OPTIONS TO EMPLOYEES AND SERVICE PROVIDERS OUTSTANDING</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercise price (US$)</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding as of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual term</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercisable as of June 30, 2023 </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual term</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(years)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(years)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 17%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zPzbl0nEZJM7" title="Exercise price">0.84</span>-<span id="xdx_90C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zQbeNxr9wCq6" title="Exercise price">1.39</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zf9jy1XUTCtd" style="width: 16%; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif">845</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zvfUWF7dprO1" style="width: 16%; text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif">1.18</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zvdB76Q3QqCe" style="width: 15%; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif">845</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_z23Baqv60fWc" style="width: 15%; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif">1.18</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zsU7bkhAEBn6" title="Exercise price">1.81</span>-<span id="xdx_909_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zAitavhITd3f" title="Exercise price">2.51</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zVjlpxepx51k" style="text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif">335</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zfqXm0c1nBGb" style="text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif">2.59</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zCyKJTdoHhw1" style="text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif">335</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zbUmj3FKYP17" style="text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif">2.59</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z8CMJtwbckyk" title="Exercise price">3.57</span>-<span id="xdx_902_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z45TfdCBG4Di" title="Exercise price">4.0</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_z7IipnlFRQbe" style="text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif">707</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_z8Gw9Pu1aXka" style="text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif">4.89</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zYlhmrA97mo6" style="text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif">498</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zoe1CVEi1yTe" style="text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif">4.86</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zBckb092CZac" title="Exercise price">4.18</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_ztnxpe7vKwh4" style="text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zsL2M5Y70EU9" style="text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif">1.74</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zA44AI4WvYq8" style="text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zPq30lI76SJj" style="text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif">1.74</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTRgjQz9xxIa" title="Exercise price">4.87</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_znEsJIlFljT3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif">137</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zKswVouhCH78" style="padding-bottom: 1.5pt; text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif">3.51</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zzywW0LoalEl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif">137</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zlalEnEYusZk" style="padding-bottom: 1.5pt; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif">3.51</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630_z3YVGDXSyDQ9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif">2,034</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630_zhgEN8O6uHw5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif">1,825</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A3_zTjGsLpcRBYl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 23.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img alt="" src="fin_001.jpg"/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89E_eifrs-full--DisclosureOfClassesOfShareCapitalExplanatory_zY25N94f9kKh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B7_zb0npF8F9BWe" style="display: none">SCHEDULE OF SHARE CAPITAL</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Number of shares</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2023</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Authorized</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued and outstanding</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Authorized</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Issued and outstanding</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 36%">Ordinary shares <br/> USD 0.0001 par value</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zEq30svhFuOb" style="width: 12%; text-align: right" title="Number of shares authorized">800,000,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zF6WdmxtwREc" style="width: 12%; text-align: right" title="Number of shares issued and outstanding">38,364,447</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zH1eyFMojDv4" style="width: 12%; text-align: right" title="Number of shares authorized">500,000,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_980_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_ziQbsG9qcxsb" style="width: 12%; text-align: right" title="Number of shares issued and outstanding">1</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Ordinary shares <br/> USD <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eifrs-full--ParValuePerShare_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zVMMJnJafmgc"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eifrs-full--ParValuePerShare_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zJJkTHKODSZg">0.0001</span></span> par value</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zx5yUkcmOYLk" style="text-align: right" title="Number of shares authorized">800,000,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z9Izaj4gdsFi" style="text-align: right" title="Number of shares issued and outstanding">38,364,447</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zTjP3HMNCNp8" style="text-align: right" title="Number of shares authorized">500,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zx26Xr8Sw3Zj" style="text-align: right" title="Number of shares issued and outstanding">1</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Preferred shares <br/>USD <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_904_eifrs-full--ParValuePerShare_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zZvcRR3emln4"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_908_eifrs-full--ParValuePerShare_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zYsTlYZqpNoi">0.0001</span></span> par value</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zGvL3jsDDw8k" style="text-align: right" title="Number of shares authorized">200,000,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20230630__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zWPad88e31Ba" style="text-align: right" title="Number of shares issued and outstanding"><span style="-sec-ix-hidden: xdx2ixbrl0724">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zBSYiM2KZpx8" style="text-align: right" title="Number of shares authorized"><span style="-sec-ix-hidden: xdx2ixbrl0726">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--PreferenceSharesMember_zaXsbWafCsa" style="text-align: right" title="Number of shares issued and outstanding"><span style="-sec-ix-hidden: xdx2ixbrl0728">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred shares <br/> Euro <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90B_eifrs-full--ParValuePerShare_iI_pid_uEuroPerShare_c20230630_zvItZ4KtoHCi"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNIQVJFIENBUElUQUwgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_902_eifrs-full--ParValuePerShare_iI_pid_uEuroPerShare_c20221231_zm9AUi9ABEnb">1</span></span> par value</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--DeferredSharesMember_zzlarAy0gIgi" style="text-align: right" title="Number of shares authorized">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20230630__ifrs-full--ComponentsOfEquityAxis__custom--DeferredSharesMember_z9bvcSOENwwh" style="text-align: right" title="Number of shares issued and outstanding">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eifrs-full--NumberOfSharesAuthorised_iI_pid_c20221231__ifrs-full--ComponentsOfEquityAxis__custom--DeferredSharesMember_zK7HnQHWMOB8" style="text-align: right" title="Number of shares authorized">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--NumberOfSharesIssuedAndOutstanding_iI_pid_c20221231__ifrs-full--ComponentsOfEquityAxis__custom--DeferredSharesMember_zzfmkxTQ8ytc" style="text-align: right" title="Number of shares issued and outstanding">25,000</td><td style="text-align: left"> </td></tr> </table> 800000000000 38364447 500000000 1 0.0001 0.0001 800000000000 38364447 500000000 1 0.0001 0.0001 200000000000 1 1 25000 25000 25000 25000 The fully paid ordinary shares have a par value per share of $0.0001 (before the reverse split) and par value per share of $0.0022 (post reverse split) and the Company does not have a limited amount of authorised capital. 828240000 1000000 186000 32211716 24568773 18673253 193500379 1 10.3624 3525000 2200000 6250000 11.5 0.0204 303053 3110000 872418 1350000 200000000 5 P5Y 11.5 675168 675168 450000 450000 2580000 13333333 15333332 15333332 0.15 5082417 4334000 1 1.09 1738000 <p id="xdx_89B_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_hifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zRg1B1uotnMd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_z0YNFflG5Tna">SCHEDULE OF RESTRICTED SHARES UNITS GRANTED</span></span></b></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months period ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023 (in thousands)</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months period ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2022 <br/> (in thousands)</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding at beginning of period</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zdUuFEdKwkQ9" style="text-align: right" title="Number of options outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0811">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20220101__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zWgke93XOxg4" style="text-align: right" title="Number of options outstanding, beginning balance">    <span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0813">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_z0Jwszuc7wCb" style="width: 16%; text-align: right" title="Number of options, granted"><span style="font-family: Times New Roman, Times, Serif">4,334</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20220101__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zRmaPiC1OG46" style="width: 16%; text-align: right" title="Number of options, granted"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0817">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Vested</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_z2Joya5zT9Bg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options, vested"><span style="font-family: Times New Roman, Times, Serif">(945</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zQmX4fwDBVnd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options, vested"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0821">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20230101__20230630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zCFN3vDTclEe" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif">3,389</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20220101__20220630__ifrs-full--TypesOfAntidilutiveInstrumentsAxis__ifrs-full--RestrictedShareUnitsMember_zfNwZSGam2T9" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0825">-</span></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 4334000 945000 3389000 790408 1.04 4.0 vesting period up to 4 years from the grant date, contractual life of the options under the plan is 5 years. 168000 <p id="xdx_893_eifrs-full--DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory_ziuluaIhx73l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zgbSKN7rfZQ4">SCHEDULE OF SHARE OPTION GRANTED</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months period ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exercise price per share (US$)</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding at beginning of period</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20230101__20230630_zWydLFQt0Wmg" style="width: 16%; text-align: right" title="Number of options outstanding, beginning balance"><span style="font-family: Times New Roman, Times, Serif">1,251</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20230101__20230630_zoO1MQiiuzKf" style="width: 16%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif">2.01</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20230101__20230630_zi9HijHJCqo4" style="text-align: right" title="Number of options, granted"><span style="font-family: Times New Roman, Times, Serif">790</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_c20230101__20230630_zDkUDjjj4Dh2" style="text-align: right" title="Weighted average exercise price, granted"><span style="font-family: Times New Roman, Times, Serif">3.47</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20230630_zPJ0395NtZAc" style="text-align: right" title="Number of options, exercised"><span style="font-family: Times New Roman, Times, Serif">(7</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20230101__20230630_zegjR82N9Xbi" style="text-align: right" title="Weighted average exercise price, exercised"><span style="font-family: Times New Roman, Times, Serif">1.39</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20230101__20230630_zXRB1vJmUB2" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options, expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0853">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_c20230101__20230630_zAxtItihRO8j" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, expired"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0855">-</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20230101__20230630_zLDdvPjdWCAg" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options outstanding, ending balance"><span style="font-family: Times New Roman, Times, Serif">2,034</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20230101__20230630_zlYnGDKX4127" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif">2.58</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable options at June 30, 2023</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20230101__20230630_zlp7FXVmZHXg" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options, Exercisable"><span style="font-family: Times New Roman, Times, Serif">1,825</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_c20230101__20230630_zOsdN34Nm4p5" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-family: Times New Roman, Times, Serif">2.48</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Six months period ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2022 </b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>exercise price per share (US$)</b></span></p></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Outstanding at beginning of period</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eifrs-full--NumberOfOutstandingShareOptions_iS_pn3n3_uShares_c20220101__20220630_z2zijKXRvqZf" style="width: 16%; text-align: right" title="Number of options outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif">3,346</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pid_c20220101__20220630_zQpDi5Q8WUJc" style="width: 16%; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="font-family: Times New Roman, Times, Serif">2.02</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Granted</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_pn3n3_uShares_c20220101__20220630_z6kIS5shyZX4" style="text-align: right" title="Number of options, granted"><span style="font-family: Times New Roman, Times, Serif">989</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pid_c20220101__20220630_zIR7kCdP08I4" style="text-align: right" title="Weighted average exercise price, granted"><span style="font-family: Times New Roman, Times, Serif">2.86</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Exercised</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20220630_zTDO8FWJAsXi" style="text-align: right" title="Number of options, exercised"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0873">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pid_c20220101__20220630_zwd7PtOfy1Tk" style="text-align: right" title="Weighted average exercise price, exercised"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0875">-</span></span><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Expired</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_iN_pn3n3_di_uShares_c20220101__20220630_zFm8rp9inglg" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of options, expired"><span style="font-family: Times New Roman, Times, Serif">(375</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pid_c20220101__20220630_z464REOXrcHi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted average exercise price, expired"><span style="font-family: Times New Roman, Times, Serif">2.16</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Outstanding at June 30, 2022</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--NumberOfOutstandingShareOptions_iE_pn3n3_uShares_c20220101__20220630_zdIKKmEPfAmc" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif">3,960</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_982_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pid_c20220101__20220630_zPBk8SHBaO0h" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, outstanding ending balance"><span style="font-family: Times New Roman, Times, Serif">2.21</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Exercisable options at June 30, 2022</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iE_pn3n3_uShares_c20220101__20220630_zOZtU4XrvWk" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of options, Exercisable"><span style="font-family: Times New Roman, Times, Serif">2,703</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_iE_pid_c20220101__20220630_zIbXkBwhAfB7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, Exercisable"><span style="font-family: Times New Roman, Times, Serif">2.33</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 1251000 2.01 790000 3.47 7000 1.39 2034000 2.58 1825000 2.48 3346000 2.02 989000 2.86 375000 2.16 3960000 2.21 2703000 2.33 <p id="xdx_89D_eifrs-full--DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory_zMAN4uluRsgi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 23.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The options to employees and service providers outstanding as of June 30, 2023, are comprised, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 23.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zq1cSnmIHwxc">SCHEDULE OF OPTIONS TO EMPLOYEES AND SERVICE PROVIDERS OUTSTANDING</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Exercise price (US$)</span></td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding as of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>June 30, 2023</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual term</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercisable as of June 30, 2023 </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in thousands)</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted average remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>contractual term</b></span></p></td><td style="text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(years)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">(years)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 17%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zPzbl0nEZJM7" title="Exercise price">0.84</span>-<span id="xdx_90C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zQbeNxr9wCq6" title="Exercise price">1.39</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zf9jy1XUTCtd" style="width: 16%; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif">845</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_987_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zvfUWF7dprO1" style="width: 16%; text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif">1.18</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_zvdB76Q3QqCe" style="width: 15%; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif">845</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_981_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingOneMember_z23Baqv60fWc" style="width: 15%; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif">1.18</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zsU7bkhAEBn6" title="Exercise price">1.81</span>-<span id="xdx_909_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zAitavhITd3f" title="Exercise price">2.51</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zVjlpxepx51k" style="text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif">335</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zfqXm0c1nBGb" style="text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif">2.59</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zCyKJTdoHhw1" style="text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif">335</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingTwoMember_zbUmj3FKYP17" style="text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif">2.59</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z8CMJtwbckyk" title="Exercise price">3.57</span>-<span id="xdx_902_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z45TfdCBG4Di" title="Exercise price">4.0</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_z7IipnlFRQbe" style="text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif">707</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_z8Gw9Pu1aXka" style="text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif">4.89</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zYlhmrA97mo6" style="text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif">498</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingThreeMember_zoe1CVEi1yTe" style="text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif">4.86</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90E_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zBckb092CZac" title="Exercise price">4.18</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_985_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_ztnxpe7vKwh4" style="text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zsL2M5Y70EU9" style="text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif">1.74</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98C_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zA44AI4WvYq8" style="text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif">10</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_988_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFourMember_zPq30lI76SJj" style="text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif">1.74</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_900_eifrs-full--ExercisePriceOfOutstandingShareOptions2019_iI_pid_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTRgjQz9xxIa" title="Exercise price">4.87</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_znEsJIlFljT3" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif">137</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98B_eifrs-full--WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zKswVouhCH78" style="padding-bottom: 1.5pt; text-align: right" title="Weighted average remaining contractual life of outstanding share options"><span style="font-family: Times New Roman, Times, Serif">3.51</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zzywW0LoalEl" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif">137</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98A_ecustom--WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019_dtY_c20230101__20230630__ifrs-full--RangesOfExercisePricesForOutstandingShareOptionsAxis__custom--OptionsOutstandingFiveMember_zlalEnEYusZk" style="padding-bottom: 1.5pt; text-align: right" title="Weighted average remaining contractual life of exercisable share options"><span style="font-family: Times New Roman, Times, Serif">3.51</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eifrs-full--NumberOfOutstandingShareOptions_iI_pn3n3_uShares_c20230630_z3YVGDXSyDQ9" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of outstanding shares"><span style="font-family: Times New Roman, Times, Serif">2,034</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_iI_pn3n3_uShares_c20230630_zhgEN8O6uHw5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number of exercisable shares"><span style="font-family: Times New Roman, Times, Serif">1,825</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 0.84 1.39 845000 P1Y2M4D 845000 P1Y2M4D 1.81 2.51 335000 P2Y7M2D 335000 P2Y7M2D 3.57 4.0 707000 P4Y10M20D 498000 P4Y10M9D 4.18 10000 P1Y8M26D 10000 P1Y8M26D 4.87 137000 P3Y6M3D 137000 P3Y6M3D 2034000 1825000 <p id="xdx_800_eifrs-full--DisclosureOfGeneralAndAdministrativeExpenseExplanatory_zU5fQYiLfVU1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – <span id="xdx_82B_zh8KZnsyyHR3">GENERAL AND ADMINISTRATIVE EXPENSES</span></b></span></p> <p id="xdx_893_ecustom--DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_zdo4UnfpmLyl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span id="xdx_8BF_zAkq56APyIf" style="display: none">SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td id="xdx_49B_20230101__20230630_zrjLNVmqJuJ9" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td id="xdx_495_20220101__20220630_zDXLePFwUTmk" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$ in thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$ in thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_ecustom--TransactionCost_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zQfdFXzZcLlc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Transaction cost</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,792</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0956">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--AdvertisingExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zsrBy0ab4RUl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advertising, Public and Investors Relations</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,526</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0959">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eifrs-full--AdjustmentsForSharebasedPayments_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zwqWcY9COwTk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share based compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,805</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">82</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--ProfessionalFeesExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zsDjrDpKiny9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional services</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">718</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">545</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--WagesAndSalaries_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zZKfPg0ypHI5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Wages and salaries related</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">664</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">429</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_z50MaUf3flZ9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Travel expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">379</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--InsuranceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_z0m3ePgzFQAf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Insurance</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">329</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">19</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--RepairsAndMaintenanceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zhmrOm3fDsBh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office and maintenance</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">37</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">80</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zZmU6e66Uf4d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Depreciation and amortization</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zLkoFEj0R3Zf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Others</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">26</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eifrs-full--GeneralAndAdministrativeExpense_iT_pn3n3_mtGAAEz4rn_zvFnIbtYaUe3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,350</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,200</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8AB_z76sMwblslpb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_ecustom--DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory_zdo4UnfpmLyl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span id="xdx_8BF_zAkq56APyIf" style="display: none">SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td id="xdx_49B_20230101__20230630_zrjLNVmqJuJ9" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td id="xdx_495_20220101__20220630_zDXLePFwUTmk" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$ in thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">US$ in thousands</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_ecustom--TransactionCost_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zQfdFXzZcLlc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Transaction cost</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif">7,792</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="width: 16%; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0956">-</span></span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40B_eus-gaap--AdvertisingExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zsrBy0ab4RUl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Advertising, Public and Investors Relations</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,526</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span style="-sec-ix-hidden: xdx2ixbrl0959">-</span></span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eifrs-full--AdjustmentsForSharebasedPayments_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zwqWcY9COwTk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Share based compensation</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,805</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">82</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--ProfessionalFeesExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zsDjrDpKiny9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Professional services</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">718</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">545</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--WagesAndSalaries_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zZKfPg0ypHI5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Wages and salaries related</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">664</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">429</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_403_eifrs-full--TravelExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_z50MaUf3flZ9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Travel expenses</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">379</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">4</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_401_eifrs-full--InsuranceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_z0m3ePgzFQAf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Insurance</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">329</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">19</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--RepairsAndMaintenanceExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zhmrOm3fDsBh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Office and maintenance</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">37</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">80</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--DepreciationAndAmortisationExpense_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zZmU6e66Uf4d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">Depreciation and amortization</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif">15</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40F_eifrs-full--OtherExpenseByNature_pn3n3_hifrs-full--AttributionOfExpensesByNatureToTheirFunctionAxis__custom--GeneralAndAdministrativeExpensesMember_maGAAEz4rn_zLkoFEj0R3Zf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Others</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">86</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif">26</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_400_eifrs-full--GeneralAndAdministrativeExpense_iT_pn3n3_mtGAAEz4rn_zvFnIbtYaUe3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Total</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">13,350</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">1,200</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> 7792000 1526000 1805000 82000 718000 545000 664000 429000 379000 4000 329000 19000 37000 80000 15000 15000 86000 26000 13350000 1200000 <p id="xdx_800_eifrs-full--EarningsPerShareExplanatory_zV48zfMF5BGb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 - <span id="xdx_820_zsF5qYlpPqT5">LOSS PER SHARE</span></b></span></p> <p id="xdx_891_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zSV3yUf0Nrj2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span id="xdx_8BF_zAaVOdHaTZTa" style="display: none">SCHEDULE OF LOSS PER SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_491_20230101__20230630_zg9atNlEdxG9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_491_20220101__20220630_zTElYtkcaRN6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Six months ended</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eifrs-full--ProfitLoss_pn3n3_z8C0V1Hx0sr7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss attributable to the owners of the Company</span></td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$<span style="font-family: Times New Roman, Times, Serif"></span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(33,009</span></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,442</span></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted loss per share</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_eifrs-full--BasicEarningsLossPerShare_pid_c20230101__20230630_z3R8EEJG2nt5" title="Basic loss per share attributable to shareholders"><span id="xdx_90F_eifrs-full--DilutedEarningsLossPerShare_pid_c20230101__20230630_zhssqd3YA6l4" title="Diluted loss per share attributable to shareholders">(39.46</span></span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">*<span id="xdx_901_eifrs-full--BasicEarningsLossPerShare_pid_c20220101__20220630_fKg_____zCWKDucqMAjh" title="Basic loss per share attributable to shareholders"><span class="xdx_phnt_U3RhdGVtZW50IC0gSW50ZXJpbSBDb25kZW5zZWQgQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgQ29tcHJlaGVuc2l2ZSBMb3NzIChVbmF1ZGl0ZWQpAA__" id="xdx_906_eifrs-full--DilutedEarningsLossPerShare_pid_c20220101__20220630_zKiwk8uQ88dh" title="Diluted loss per share attributable to shareholders">(3.36</span></span>)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup></sup></span></td></tr> <tr id="xdx_404_ecustom--WeightedAverageNumberOfOrdinarySharesAbstract_iB_zIVyqslm1Mh3" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average number of ordinary shares</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eifrs-full--WeightedAverageShares_pn3n3_zROmFbUdvLt2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average number of ordinary shares used in calculating basic and diluted loss per share (in thousands)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">837</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">*727</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F25_zDn6gnEZjqZ">*</sup></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the reverse share split described in Note 9.1, the calculation of the basic and diluted loss per share for all periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F0C_z1p43QNgUyC8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F1C_zHeTEubYU4Ed" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restated as a result of the SPAC transaction</span></td> </tr></table> <p id="xdx_8AF_z0onbtPV8qc4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="fin_001.jpg"/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SMX (SECURITY MATTERS) PUBLIC LIMITED COMPANY</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(US$ in thousands except share and per share data)</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zSV3yUf0Nrj2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span id="xdx_8BF_zAaVOdHaTZTa" style="display: none">SCHEDULE OF LOSS PER SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_491_20230101__20230630_zg9atNlEdxG9" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_491_20220101__20220630_zTElYtkcaRN6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Six months ended</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40C_eifrs-full--ProfitLoss_pn3n3_z8C0V1Hx0sr7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss attributable to the owners of the Company</span></td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$<span style="font-family: Times New Roman, Times, Serif"></span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(33,009</span></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,442</span></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted loss per share</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_901_eifrs-full--BasicEarningsLossPerShare_pid_c20230101__20230630_z3R8EEJG2nt5" title="Basic loss per share attributable to shareholders"><span id="xdx_90F_eifrs-full--DilutedEarningsLossPerShare_pid_c20230101__20230630_zhssqd3YA6l4" title="Diluted loss per share attributable to shareholders">(39.46</span></span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">*<span id="xdx_901_eifrs-full--BasicEarningsLossPerShare_pid_c20220101__20220630_fKg_____zCWKDucqMAjh" title="Basic loss per share attributable to shareholders"><span class="xdx_phnt_U3RhdGVtZW50IC0gSW50ZXJpbSBDb25kZW5zZWQgQ29uc29saWRhdGVkIFN0YXRlbWVudHMgb2YgQ29tcHJlaGVuc2l2ZSBMb3NzIChVbmF1ZGl0ZWQpAA__" id="xdx_906_eifrs-full--DilutedEarningsLossPerShare_pid_c20220101__20220630_zKiwk8uQ88dh" title="Diluted loss per share attributable to shareholders">(3.36</span></span>)</span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup></sup></span></td></tr> <tr id="xdx_404_ecustom--WeightedAverageNumberOfOrdinarySharesAbstract_iB_zIVyqslm1Mh3" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average number of ordinary shares</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_408_eifrs-full--WeightedAverageShares_pn3n3_zROmFbUdvLt2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average number of ordinary shares used in calculating basic and diluted loss per share (in thousands)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">837</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">*727</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><sup id="xdx_F25_zDn6gnEZjqZ">*</sup></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the reverse share split described in Note 9.1, the calculation of the basic and diluted loss per share for all periods presented have been adjusted retrospectively based on the new number of shares as derived from the conversion ratio.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F0C_z1p43QNgUyC8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F1C_zHeTEubYU4Ed" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restated as a result of the SPAC transaction</span></td> </tr></table> -33009000 -2442000 -39.46 -39.46 -3.36 -3.36 837000 727000 <p id="xdx_80B_eifrs-full--DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory_zVYCl0snBrf3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 – <span id="xdx_82F_zN10RKysQOQ7">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since the reporting date, the following significant events have occurred:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reverse Stock Split - On August 8, 2023, at the Extraordinary General Meeting of Shareholders of the Company, the Company’s shareholders voted in favor of consolidating every twenty-two ordinary shares in the authorized but unissued and in the authorized and issued share capital of the Company into one ordinary share (the “Reverse Stock Split”).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 21, 2023, the Company’s ordinary shares began trading on the Nasdaq Global Market on a post-Reverse Stock Split basis under the current symbol “SMX”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following is a table which presents the loss per share before the change (see also Note 8).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89F_ecustom--DisclosureOfLossPerShareExplanatory_zJzbzOqq8H8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss per share have been calculated using the weighted average number of shares in issue during the relevant financial periods, the weighted average number of equity shares in issue and loss for the period as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B3_z9aLmrmmiB0d" style="display: none">SCHEDULE OF LOSS PER SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_492_20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--ReverseStockSplitMember_z0BswyTMptE7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_49F_20220101__20220630__ifrs-full--ComponentsOfEquityAxis__custom--ReverseStockSplitMember_z9acmGUA8Ez6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Six months ended</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--ProfitLoss_pn3n3_zDhKWbAQjXz2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss attributable to the owners of the Company</span></td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(33,009</span></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,442</span></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted loss per share</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_eifrs-full--BasicEarningsLossPerShare_pid_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--ReverseStockSplitMember_zRsv4klBJUWl" title="Basic loss per share attributable to shareholders"><span id="xdx_90F_eifrs-full--DilutedEarningsLossPerShare_pid_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--ReverseStockSplitMember_zSK5puTv51Si" title="Diluted loss per share attributable to shareholders">(1.79</span></span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eifrs-full--BasicEarningsLossPerShare_pid_c20220101__20220630__ifrs-full--ComponentsOfEquityAxis__custom--ReverseStockSplitMember_zuANCstzv3N8" title="Basic loss per share attributable to shareholders"><span id="xdx_901_eifrs-full--DilutedEarningsLossPerShare_pid_c20220101__20220630__ifrs-full--ComponentsOfEquityAxis__custom--ReverseStockSplitMember_zFC76OSCNjX4" title="Diluted loss per share attributable to shareholdersDiluted loss per share attributable to shareholders">(0.15</span></span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40F_ecustom--WeightedAverageNumberOfOrdinarySharesAbstract_iB_zxuPYtGHLVfd" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average number of ordinary shares</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--WeightedAverageShares_pn3n3_zwjRTbN8WoIj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average number of ordinary shares used in calculating basic and diluted loss per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,404</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,984</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p id="xdx_8A6_zHnAWVj1YF38" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 27, 2023, the Company amended <span style="background-color: white">its </span> Pre-Paid Advance agreement with Yorkville (see also Note 5.1) evidencing the remaining Pre-Paid Advance to decrease the Floor Price to $<span id="xdx_90B_ecustom--FloorPrice_pid_c20230701__20230727__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zo9fr2Kl0hl9" title="Floor price">1.10</span> (as adjusted for the Reverse <span style="background-color: white">S</span>tock <span style="background-color: white">S</span>plit which occurred on August 21, 2023, see also Note 9.1), after the Company was required to repay in cash $<span id="xdx_904_eifrs-full--PaymentsForDebtIssueCosts_pn3n3_c20230701__20230727__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zYZhYvTnIvA1" title="Repayment of debt">500</span> of principal amount as a result of the Company’s share price being below the original Floor Price. The maturity date will be 12-months after the initial closing of the Pre-Paid Advance. In July 2023, the Company repaid in full the first Pre-Paid Advance in the amount of $<span id="xdx_905_ecustom--PrepaidAdvance_iI_pn3n3_c20230731__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zSysZ8x4wQv4" title="Pre-paid advance">1,500</span>. In the period, the Company repaid approximately $<span id="xdx_908_eifrs-full--PaymentsForDebtIssueCosts_pn3n3_c20230701__20230731__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zF506FoBoE0e" title="Repayment of debt">450</span> principal amount by ordinary share issuance in accordance with the terms of the SEPA and subsequent to the period, the Company repaid approximately $<span id="xdx_905_eifrs-full--PaymentsForDebtIssueCosts_pn3n3_c20230930__20230930__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zJKwIXTAHAX2" title="Repayment of debt">1,350</span> through September 30, 2023.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 6, 2023, the Company consummated the transactions pursuant to a Securities Purchase Agreement dated as of September 5, 2023 and issued and sold to an institutional investor a promissory note with a fixed conversion price of $<span id="xdx_902_ecustom--DebtConversionPrice_pid_c20230901__20230906__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zniVJn9nkmtb" title="Debt conversion price">1.6378</span> and warrants, for gross proceeds to SMX of approximately <span id="xdx_90A_ecustom--GrossProceeds_c20230901__20230906__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zadkxbe7o7za" title="Gross proceeds">$2,500</span>, before deducting fees and other offering expenses payable by the Company to their service providers. The note is in the principal amount of $<span id="xdx_90B_ecustom--DebtPrincipalAmount_c20230901__20230906__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zQbztEjZQMw9" title="Debt principal amount">4,290</span>. The actual amount loaned by the investor pursuant to the Note is $<span id="xdx_901_eus-gaap--LoansPayable_iI_c20230906__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zBLsG3HSc1T2" title="Loans payable">2,574</span> after a <span id="xdx_904_ecustom--DiscountRate_pid_uPure_c20230901__20230906__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_z89pOnlBx3p6" title="Discount rate">40%</span> original issue discount. The maturity date of the note is the 12-month anniversary of the Effective Date, and is the date upon which the principal amount, as well as any accrued and unpaid interest and other fees, shall be due and payable. Interest accrues in the amount of 12% per year and shall be payable on the maturity date. The investor has the right, at any time, to convert all or any portion of the then outstanding and unpaid principal amount and interest (including any costs, fees and charges) into the Company’s ordinary shares, at a fixed conversion price of $<span id="xdx_901_ecustom--DebtConversionPrice_pid_c20230901__20230906__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zR4GUPdVGl1h" title="Debt conversion price">1.6378</span> per share. Any such conversion is subject to customary conversion limitations set forth in the Purchase Agreement so the investor beneficially owns less than <span id="xdx_90A_ecustom--InvestorOwnedPercentage_pid_uPure_c20230901__20230906__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zl9xo0h0rvZ7" title="Investor owned percentage">4.99%</span> of the Company’s ordinary shares. Additionally, the Company has the right to convert in whole or in part the note into ordinary shares; provided that in no case shall the Company so convert the note if the result of the issuance of Ordinary Shares thereby would result in the beneficial ownership of the investor of ordinary shares in excess of <span id="xdx_906_ecustom--InvestorOwnedPercentage_pid_uPure_c20230901__20230906__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember__ifrs-full--TypesOfContractsAxis__custom--SecuritiesPurchaseAgreementMember_zVeXZ1XmqBOl" title="Investor owned percentage">4.99%</span>.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 15, 2023, the Company paid $<span id="xdx_90C_ecustom--PaymentsForPromissoryNotes_pn3n3_c20230901__20230915__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zGSxgCTXjZba" title="Payments for promissory notes">250</span> to EF Hutton, division of Benchmark Investments, LLC, pursuant to a Satisfaction and Discharge of Indebtedness Pursuant to Promissory Note Dated March 7, 2023. Upon paying such amount, the promissory note dated <span id="xdx_90C_ecustom--DebtMaturityDate_c20230901__20230915__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zyyk0xBaOGsl" title="Maturity date">March 7, 2023</span> in the principal sum of $<span id="xdx_90F_ecustom--DebtPrincipalAmount_pn3n3_c20230901__20230915__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zCUnCodSMvei" title="Debt principal smount">900</span> was deemed fully paid and satisfied and the Note was thereafter canceled, discharged and no longer of any further force or effect.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 19, 2023, the Company amended its loan agreements dated September 7, 2015, by and between the Company, its shareholders and Kamea Fund (the “Loan Agreements”). Pursuant to the amendment to the Loan Agreements, Kamea agreed to convert $<span id="xdx_901_ecustom--NumberOfSharesConverted_iI_pid_c20230919__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_znFq3EhEv2cb" title="Number of shares converted">657</span> of indebtedness under the Loan Agreements (the “Indebtedness Amount”) into <span id="xdx_905_eifrs-full--NumberOfSharesIssued_iI_pid_c20230919__ifrs-full--NonadjustingEventsAfterReportingPeriodAxis__custom--NonadjustingEventMember_zKO6cmfyRFdb" title="Number of shares">487,281</span> ordinary shares (post Reverse Stock Split) of the Company, as payment in full for the Indebtedness Amount; provided however, that in the event the proceeds received from Kamea with respect to any sales of such shares are not at least equal to the Indebtedness Amount, the Company will remain liable to Kamea for the balance of the Indebtedness Amount.</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif">6.</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On October 3, 2023, the Company has signed an agreement with True Gold Consortium Pty Ltd (“TrueGold”) (see also Note 1C) shareholders to acquire an additional 7.5% which will increase the Company’s holdings to 51.9% in TrueGold and result in the Company’s gain control over TrueGold. As part of the agreement and in consideration for the additional 7.5%, it was agreed that the outstanding payables from TrueGold to the Company which amounted to AU$ 475 as of June 30, 2023 (approximately $307) would be forgiven in full.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The transaction is based on past valuation, which was prepared in October 2021, which evaluates TrueGold’s fair value in the range of $78.5 million to $90 million and at a mean of $84.3 million. This past valuation was not audited or reviewed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">As of the agreement’s closing date, both parties agreed to engage an independent third party appraiser to prepare an updated TrueGold valuation as of closing date by November 30, 2023. Accordingly, the Company will recognize in its financial statements the fair value of TrueGold’s assets &amp; liabilities at closing date as will be valued by the independent third party appraiser. Once this valuation will be completed, there may be material differences between TrueGold’s past valuation from October 2021 to the updated valuation.</p></td></tr> </table> <p id="xdx_89F_ecustom--DisclosureOfLossPerShareExplanatory_zJzbzOqq8H8b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss per share have been calculated using the weighted average number of shares in issue during the relevant financial periods, the weighted average number of equity shares in issue and loss for the period as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span id="xdx_8B3_z9aLmrmmiB0d" style="display: none">SCHEDULE OF LOSS PER SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 96%; margin-left: 0.25in"> <tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: center; padding-bottom: 1.5pt"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_492_20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--ReverseStockSplitMember_z0BswyTMptE7" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td id="xdx_49F_20220101__20220630__ifrs-full--ComponentsOfEquityAxis__custom--ReverseStockSplitMember_z9acmGUA8Ez6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Six months ended</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2023</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif">June 30, 2022</span></td><td style="padding-bottom: 1.5pt; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_409_eifrs-full--ProfitLoss_pn3n3_zDhKWbAQjXz2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Net loss attributable to the owners of the Company</span></td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(33,009</span></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; width: 16%; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif">(2,442</span></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif">Basic and diluted loss per share</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_903_eifrs-full--BasicEarningsLossPerShare_pid_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--ReverseStockSplitMember_zRsv4klBJUWl" title="Basic loss per share attributable to shareholders"><span id="xdx_90F_eifrs-full--DilutedEarningsLossPerShare_pid_c20230101__20230630__ifrs-full--ComponentsOfEquityAxis__custom--ReverseStockSplitMember_zSK5puTv51Si" title="Diluted loss per share attributable to shareholders">(1.79</span></span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td><td style="font-weight: bold; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90B_eifrs-full--BasicEarningsLossPerShare_pid_c20220101__20220630__ifrs-full--ComponentsOfEquityAxis__custom--ReverseStockSplitMember_zuANCstzv3N8" title="Basic loss per share attributable to shareholders"><span id="xdx_901_eifrs-full--DilutedEarningsLossPerShare_pid_c20220101__20220630__ifrs-full--ComponentsOfEquityAxis__custom--ReverseStockSplitMember_zFC76OSCNjX4" title="Diluted loss per share attributable to shareholdersDiluted loss per share attributable to shareholders">(0.15</span></span></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif">)</span></td></tr> <tr id="xdx_40F_ecustom--WeightedAverageNumberOfOrdinarySharesAbstract_iB_zxuPYtGHLVfd" style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left"><span style="font-family: Times New Roman, Times, Serif">Weighted average number of ordinary shares</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr id="xdx_40A_eifrs-full--WeightedAverageShares_pn3n3_zwjRTbN8WoIj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif">Weighted average number of ordinary shares used in calculating basic and diluted loss per share</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">18,404</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif">15,984</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> -33009000 -2442000 -1.79 -1.79 -0.15 -0.15 18404000 15984000 1.10 500000 1500000 450000 1350000 1.6378 2500000 4290000 2574000 0.40 1.6378 0.0499 0.0499 250000 2023-03-07 900000 657 487281 EXCEL 45 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

1GT Y.(0S"-CS- MK^#XZ.2 ;KM.3MOIMC]+#EUSNJ()X1J&22)*KBE?PTPPFE!LC+P2[#0+V@J[ M5 5)<."9$E(H-^C%7[^THN#; =Q.C=LYI![?$"IA0UB)[J*F8&Z]SA!>2J'M MS!2RQ5<9D0B%I DV15#YZ#H?MJ0W<:O5O;CH^YL&M&Z-UOU?-+%R4(ZB,865 M4K0/$)T'83- 5 -$!P'NB7PV-WG)C&=,2DFU.4#(D*7V,A/0TM2:Z1'ND)NH MH@]4G8NPU0S5JZ%Z!Z$6DJ1X"L+D0T)!WBR> E-4L+75QG5C?GH?#RAHA;U_ M4/R]GI"C7+O.I\#%5[6'>K5NKL.JI_S97G5FD[LUY0H8KHQI<-8SOF75[:J) M%H7K,$NA3;]RP\S\(%#:#>;[2I@+N)M8!_4O)_X-4$L#!!0 ( ^(8U

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�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

.)&8D/,LOPC+_/@&.N<\2R.(J3(8)&*?&1=:;=UFZKO;N_W]H0 MZ\;\#:V8 &=C_-X0%Y*<0_9ED$6T4[3N%V.BQ"8TM6%9NP[]+ QP&(7:0 M)]I'K&C(CR'S!<$-F[=+!"HWR'XGG^T*;8GJJI&QH'@*U\_CD66EHJO@@43] M!3L!0B;(FZTZ.TLR!? ,GW74"7=#N7MO8G#E7+\ZJS5](@U23>"O@&R* ME8$9(T:.F01_\_F1X2!&,RXFVEC<2QPS+H=G]#B4&VII?X4GC!S;'!@@U)X] M+Q-,_/.7W^EL$%,X1&*!^<"?OAN[YWQO;0&&RZ\?'GW<$'OM/=$Z:(N#@^?E MB38]>4Y/ENA)"&3D?;0=VSI%QOE9=N8X_PO'?\E_?8"V43A M7C_,3+@X!A!.WEXX\3XZ__MPRF W8A!U-^.+B+7U5 =:HDGUQ>22N??>!K.F M=S+M6W/'^_PRAQ.W_HY,$QOLZ<"'WB"\E\2:*Y^A-6ZEF.P&75$4EM!782!V MFT^1+_TN^Z"]#Z3XXAKV3R(?-TPF 6G.]^BH#A MH1"U;T*V7&'@*(S)CO@6I#6'%SJATABAE0\&+ H3C*HZ1R2[X;;P"#M=V;)N[GVK!=W?\U55^)X?,"[BT22#W.(^K5)L3X$ M^:Z0!ZF1@OF@4'1D$/Q.E?5EX" X2IB#&ZQ"$XJ4BU;J:(H\I@<4W=I1I-2A MU!6&_&:BL'H J:VDPZ?(\'PEJA&9A5YM2V1RH@KUV"B#0BV/YGZP+3*S*A[; MU*'A0HX+Q,6/W$&Q(NL4WNG,VTV7J3;94<#YV2'%@JL8$UQ'8S/4B/H>J8UVH0&8HRT.9=A+CGB$'I0UIJ(DN$5@IEKF3?#,,D=+(I> M8 1B*6T6!:J!^36:"EL<8MDR]- ;X %SIT&0 MY\B::(W1X0K=G]*N%7K-7)>_ZS;+8O];X3&KC_5"'NOZ^JCIK+X^;CF=0QI\ MI"["T28FQF,\S'37_;@%U$9!F"!>$PXQSG&+S]!0FL9KVWG,[Q)8=IT1PY<.T#99IT MF^/GN;[,Q*\79+K*C*S-YA6.X<+FS*\IYJ#%B)G"Z0LRP+6Q:2!^#/*Z,1E1 M. !Y"3&EDW)()P<.KTK*0AD?9(T4NK 'KV;P-9W5#/X.F;XX_*N"(BQ+)+NW ML3[$D?AX>/;V\#^.;0:F@3EE&/%JS26?\TZH??&K9=!N$]->_/77+5[)A\#O M7(PXPD5%R9F78I=Z+L 6DL.T8,-JL"2H7ZG)8H >-)C MJ >[#54/T?,*]6\#LT4)DX*3T,G& MZ/^5P]B2"=.ATP*AV&13WO;,VXHS4[\/WS>$"4A,CBD!&CEUD^#1>3 6R28I MS)/E$8SD8#PXJN%U\HR1/\@"2D!S.JK$44T=RQ7K;R &NR%Y\O!E";(;V5X+ M+Q@"/QKHF5!S*C_F%8UI].N\6+Q"M)'.NMO]VRC3;"W>3X!9-4$E&,R(G9W1 M%4/.G%$:%#WCO?LKCXD1#A6#]; -.M$3068H:&I"2$[2#%/%* 4ID*.QO?)- MC/"UIP#1$/"\&%IW4M6P"P5+DHTLGN65L]4DER,FD8%NB,R;C"$C?V:NQ>#.+B\ -;L(C! I(/6_R @[EB%S04SI[=WHF)CJS M:2)(8OE$AUL>GA"+F>"KHJ)*E<3L:V8)S.(@&I)$! M\P1R**VG!G./)-L"(-4#F"FF"886%:.K*<<_1"PA [1CB0]9S):8Y>VS.$D? MCR,'^Q@I0949T1/DZ)0=*S)])L%2#:$L1W' 1&NL\"RX(F&I',G&?&DSAB7(!&#L] M+;R["X($IK3< ERXSI%=#6Y0:9>&%"C?A+B]8+$#: ,&<%0D=GM%_G5:K,DJ M+LUC9I0/ +_HXGEZ=X!?- G_=P5?%-/ %[W[!%\45X$O>O,!7WPT=/WH#O); M4,8-!@AIL40@%T"5>D!G)Y48^:NZ72I-!+_!2>LI+L_ )P#HE5!8LLV!)"P6 M.(9PW@>*H)<;12N"B,J4J) (_04G);7"2L;8[1@<0#TD3O%0R4 <2,$-$>1T M9@?X30*47V#NH]&@HT8Q%U$@$TL2AVSMOHT3$I5RW#6ZKPD1,;4FEF#8.."$)WIE7$ M;LRN7/!BRD)0:=$)U[F MSB/ A$3R^X,K"DZ\X&ER"2P]=:(W_00.3XDM%6= M&C,1?F4,CD:11!"O =;IB!"A/92C(I.CE( LTKJIB0+R "%!"F/[_X[MTV Y6<4Q'2]G-UFEQ#-Y+:_T:[-F> MBFCYR<@>Y:J6..8PX;F:RHX*>%VDRH)JJW[*W+5?HD] M9"<-U&_)5PG< PYU5L@?0<4X;X21,CV(M$A3L\^U*:&@2,)=I02RFRYPN!B+JNLPL#[:+JZ(M&4!T$P5E1B45I1CM'Z4?(<) M^GV-1R(K"O*-."HC1V$/714RS3RN^L,.X]B!W[3F.>,XO2>GY6+0Q.KSLD(8 M\X[9CYW6;&VE2'B:+=Z6IHP+2=P$,7!U5U1";=Q1$3E3ELAX<36.L6VF89@F MLQ<9#'2$!=;(KN<5?1'*-"B<%KJ9%5)W.)5R:*3<)@,,7K;5G4N MF6":=\C18,(K&-8\0A$0@[0;*'(E"F2LHI"3'&!P;&EOP^"^(0.4%X.LLD\G MW \Y-/S"+T_GH%R+V E:2=R#,77J9*$$%1J]*L16]G5%7R M1-IRUWZ2ZZRHQBGF0 =?$YB5&'Z@*) M1;Z"B:Q__G2T(601*4(AR%S:VJ+J8DBF,?JGH-1@82 GZ!P>_.X!]TB+ Z*E M-#6L.V3++=$!PA@J;A?=B(G2@TZ>I&8\V%7E3!:AH?1TW.UBK6K9P]+AF0D6 M9T9Q^@\Y&+Y\6XY"1V-1H_4A6"4IY&>6B8G7'E9D8E$K7RM)T^Z.5[6@[\@6 MR 84Q4>6EA=@-0J[1KDC_8[@<858T/"ZTB>U:=.^Y,=I1B&C;J5'QB>_6H=S MQ(L3X_?3EV( B]%/C0W\WSDH8=M-6QOA1OH@AK4::[VQ\J>9$[]AAVPB4J8E M;M0,4HI:]BQ&2U<&5%&)C&' MX[8H\:[ M*%2XTB>,;W4@!1B(Q\Y*?U1[9U9_PF@7OD%H'P% &!P.'8FO9^(M,C@LDFX, MPJDIWTX!ABP#6#H:RW+=F@I"4$ ,=$WH(>:GV0:@=0<+V'3-CI9ICR-,1UE< M5_/JV+J]9WWU386U0K+*$_Y2XF^DI-YV9(AB+*.#,)NSY$)":4(!KG@#VZJR M)8E3N2YR@9"UKHB(!=DWPM@'>!_]#9BOU$>(C9-*!'6%)N)AV 07BE=.4 MJ0DV21>QSN%]GH5;B7HW7Y2*Y%?)OIK,DJI(@C?O8BHXG#>#^HG/7L^@D?N$ MJ;O3<.\7Z)F@I*W[C('DJ,?Z'EBV :WT/5 S]YJYWZ_EQ/?S04ZAB+9CS/['V/N5]C_7XHK(RIJ?K_R_-XZNVY%ZI3NPQ;S M.,7XU0(G0J+'K^2W[ %+;<$((W;_[2!J6=L,@4N@)G [Q2(>#!/55U&*[6-!]@^.S?T#J"V/1UFL4)WE)B.GZ7E5-9 M&"6<9G@:Q.(7*W:N%B+8;J[! 4:-Q9A.I$TFS>]&D3['2,^[UXO:RG&&74E=J;I9_ :A%7>Z7V9@Y7 MP32I-.EUUMO-G49[^WFCO;N[\2-RFY$F]] "-\^+X?0JT"$MYP0*M[O722DVG*TRG M!]O7BT,+M+8;#W S_&B M728UX2THX6WO+Q/A+9_F,L^U^?EJQ+09ZBOUT5W0H]O:;FSO7F^E?NAUK*^- M5:6]1KNY3*2W)(K%5&O@?-?I/5P:F.P_4PO70UJ<[\/*//,#=>VAGY=;;0YL M8:_QO/GC%K('. 8_;BVK:?YQTOSFK8(M-\0RGHZ%=R+=B:)GO4IEI2P&8'T(&7HCEG)=;? Y&E%9C=W<.3N+[O>1J>EP5>FPW=ENM92/')5'1 MYKD@!KRXMMRMN/6DW=@YV%LBZTE->BM#>MO+1'>+I6,\]-K8VX'AXNL#NI(' MM-5H[?QX\,["KV)-?@M*?LW=92.^)=4;[L%@3!A3F,:")5 PR=RB/4A'S$.$.L 5 M2*/F*D*V[E8F+V=C*ZT9R4,PDL68ROKV=J/9/)@C(2V!:Z@^ H_Z"+0;.SLS M\H(^^ E8$JWR =:):ZC2D+]W<]8<8U$YQ@+,XGF[U?YQ:]ABR. UX=>$_R@) M?T64S_8]*I]53+SYB$OM!>$E- X1Q'DG5,O.3!9W+G/5/>_A:,Q)]ZP/P:,Z M!'/4/N_]#"R ]KG(JOH;F6J?/9F(TZ3#'%V9Y.$L$?MDEB6ZDS,<:A;SMWV8 ME4IF$I=?2_"/V=CUS_7M@ZV=ZX/I%OD(U?;>^@C\Z!& ,[#UG7C2Y3D"]LI] MP.H&#PH;_J/=\K\9%WQJ\0U+^3/IS?[_FO[F!?7^3^^PFX&4T=/GA,S5[2H_ ML_62$H6E.K D1PQ'-QV&.ILM*/Q#3OR?WJFB6B,!5@Z4!O/?EIYZDZHK2>'6QI7J2S&("5I=3985H3IG M3SAYLL#?YHC$!)X%&GE"F6SE;S=JM]WP8(XZ\A,E4XI_?-(^:#1WRG8: MII M-5J[>T^WQ!SABNL\&-]X=,5UL*H.E5^*1N0) MVG^94B'?::C3)>.X&3]MC+$61"LN.4NBAMA1E#&ZJ%=ED-L'5>[8WGO:J++B M@^WMVS)BE[ERA30JM>#.UYLZ7ZY8/,;$6WOE&+$9#F_G.IDX4GC5<%\)JUB^ MN-W>K[R7RE F6G'M-<='^:< (N.$]N,F5+1#MT7 M-(^XVTT5W!U4\"TS='*0?&C:5/AM*'7@#7489]SB,(FQEE(7R[]1.0KX MXD\0G4S+=H TH"=[^ZU[O0L6Y31-81_>J__:W!3OM J#%^*S[*F7T-9?N8)% M?"&>B\U-8T (]/G-U>Y*25\6I_0!N_5MDP-/7\!FX[C<5O>F MM$I:ZI2(=["KO&N!&XM[X_J54Y0G[>\?E$>**]0CZ[0-B@]S7$]J-G:'K_L"=_Q5K=\ M<56C4C=,--8)#$?C7AAO3'&ARDMCZDYC\N9O[+;W*N\W]W?'!P_R2[%M4UYH M-2LO@ R0)Y3'37JEQTK?F+JZ7>WD0O:,9%+(+E8++>@E4=T0Q ,6[AQ5EDO$ M1OF@HQ)L7 V&83Q2ICV2QE@"HJ9'18./7(Q8&8;+]XZI*D#4]J&H*E!?.2M) MSM.NG/3:LA+ F3,9 CMYTFX_KUXSW[UBJKI2Y7KQX/V=YOC=LKW__-86/1IW M]68Q%CJG?V!F@>[I#&_6\G[PD,_6W&PUSC)S,X.$XG$J M%&S((8L61@2?%P^;V\ZJ,?/#\X&G#JTK(S=V[F<-<+\,$-TO4N0QS M]IW!6'BJ&AA:J&5'ASH#V:_AL3_ !^$6% =\[D(F(%-FUGIU%$?$_E#FCN), MP1PST94Z$=BZJIGA"D^8RK97<01O?T0(H.Z:(P*_[XVID7N-Y]O;XX=D>^_' MSXCC;Y-W/1^=1 <])<)8DCY8'X;5NQJ-GH.*/)HZ/JI,?$[BKLZ>O6?D&W%8 MHMX3QC!T.?J*[* ;+>L1D&N?;@W1Z06D;7-AK)HLB*1 M;P9TBFEH2D033+G*AS5;&:%)UQP'0=H:SK9F#N) M'E!_Y3H;\?/D G3>^#/60'SG,*T[4CL$5X^I\TYDT M_"^8@E_?82M$NE/O,#ST1@\6<#6!UDA\!:\O9 J@_P6(QD#,!.,G,+!N=Z_1 M:CH"^'I%T'X!S.&@<>#$1FR8.+.!'(F.\K!QK8*B>6QB/)1!7I)?Q]'$25,( M% CFL$@FQ]4Z(;HY>D!2U29T0'P MG@8EH#II,V';0Z$/4)PJWN IS,67.>@2\ (_7D&:L+?K$'8MV(,WU T%1XC M7N\XJF$2=_#K^V&=JWRV'HA+@AK@D?Q_?398S4!7BX&.QZ;#">_%Y"N.\Z24 MTFYJ%^$X94JR=HP>8X'*.SOMBK'#NYE;8\Q;W&SL[NV+,0=]>[?]])%+;]>& M=1W485UU6-=#7C,DS20ZC2//<)S?E4Q2<4QG?L+X,-4DT7JX\._V#F?;7;EZ M,\S=NAGC>4#;>1R&\07)FB0KI/D 731_0[-X=_0UAA=A?KVY8DB5CSG]!93[ M,7@7E$P#>!JD]1>K>0"FB1>\VLWO^A_:+;N'OG GU0RRZGB14&3H[OB52=Y]KIR- MTF3R%,X2!.[^SNG7K;,MFDF K"LQQ@Q6 %*QKBXI_0-NF1+;))"9G!&"PP*> M[/9JG&R4]%;E]-;DM8CD-:,:GP]/7O=Q.=R\QI=&A]YI/[U,B+N 2"HB_*4GB/[SQ9F[MIP]RI.XZW-:] M[L2,SI@=^]ZU@Y]#,6QMN-YO;UT,_+M/ + 'R[6,:A MLS)OCX8[F;NW1 +0,BSX'*3*.7. W;T?/_]+O;XUT2X?T>[L_GB5\T=P4\U2 ME[M^N>[!.&O!;ZQ6=P7TR8SI8HD@JA>>Z.][2G.0EO?;/\YX;F P7T)^7Q^4 M^J X!V7G^?7>RV4]*$NB8M9.J%HBO]<3/_<1+\$2UW1;T^WJWDDS+Z-Y?VM6 MUA? $6-&U^S#DQ[B\"_@4L\O^FN^]?]V&ZV#YKR'O:!EN&HR7ADRWFD<[.\L M-QDOB89U?\OSKHK'5;OL'KO,NMYJM-H_'IFR*/=43;*/@62;UX>;+]8"/\2- M='_.NGE<3@SB4I_S1W[.E^I:JDV R[&H\Z;9[?WE)MJ5T)CNP8/,0(LX?@.V M."2(5[&.<#X;%=3%$G2Q=I,O+-TOO9N\U;R^_OFR.LGK8U(?DT53'A_\G"R[ M3EF'E-1R>>V:K^EV^1>UIMME4"EGY*B\!UD2 TIH#HSD:0&M,P17G[TG=HE$ MXP7T-<]$/EY(U_]>H_5\1J[_!9.5ZX-3'YSYQLQ\)P=^60].K636POKB,(E: M6%_0 ==T6]/M(U4RET*_-,6Z< +?TRE76BI>>()>>D\+57 YN'9* MUD>E/BJ+?3'7>F,M?]?R]Q(O<4VW-=VN[O7T,,[)]MRJ4!@5J53=51F6:([.5=WSF+^M@]S M5$GZSW_>6_S5 HC52Q(8M[H1?\^W=JY/^5Z>HS'\BDIV&H^&B3_KUMIN5.Y,\\S71W-+NYC!_3,?(; MSF(V]O];NSJZY^G\\Y_>J4HSB2*%3(44B4KSD$J:HSG[39[J2(&D<10/.CJ2 MF8XCK@_2S4#VZ.ES*G?5[2H_0[$#WTD4B&BI@L'&!Q(#*8QEB3T.\3 M N?TBA>^TPO\&YK1D9\H";2*#;1;>T5_,/!$[&QM/]UZ1#MYCZ1[[W-[U7G] M2I?%:Y%"WCJ%:X\-^F<#D6M>/=,P?7BAWOJ5G?"7OO*."(5H1+%F^R]39&)$ M'5>6-:YX>:]B7\!8!C"1C'G5$ZISZ_"51 VQGXB8EX1NF -YR(%:.ZTJ!]I_ MVJAPOB=44514F-QWQM/:$C!7V)D_X5F_+Z,>S$-'5T[6*R9[H="N,,8DM_?+ M(6(SJ0QEHN%I_)RHD 2)HHFL+S-N)^YV4Y4)V9,Z2C,C)^A!)P=)@=:XF\0# MD%MU((8ZC+.4CN@PB:%3^)\?1[X:$J;4GR!JF);MR&@D3[:W=\NAX?_/\@Z\ MER72S^*$1PB?\:*249::;1\;K-T/;K*]NU_<*/=S$ZSRR7\@IF]+V^'^'U;+ MVAT7H,_WR/%7>8L7E[GWF JN*VX('#:3(1S])U2*[E9L%MD^H=Y51=Z^!2.O](&2\C#1L#.P:A,V8(=W\_7R?+O"NR]DSS#N@HM/IE@T;MS0ZQ9UQ$>)DU4MM0+:VO!L=BQFWJ:Q/C_E#4UJYY]DJ2\S2> MG98%UJ<45R_9]>[>[63B]J3RWW*5?P^::.^-<^J=W=M="61B",9X=)"/LV9D M;('NZ0POIX"\FRE.TX_3S"L@4Z$=G?7)G.*L1!>&D=5<;T7./',]@_GN<5XJ MD="#L+Q'M]^+,>%I?+!;*0-P0PY7"K.N^4%6):QV\Z!J<7C^W&%['@FHV_MW M,3A<-8=)[DWU5J[KPKL)_VXTV\XX4=1N-%L3]I-6LW7+R3PBTEM]WLH8Y4 O M'T';^$SXY,_>&P?"87G5'I7PY+6,N4($3MN?>E5\>A>8/BB1ZML9-\@4Z7SSI^QCC)Q#G/+T6(*VO(Y/CV%O8"J:CF,5[B[))M#V6K,S*RY M5[5D-UTU.QTNV[,W@W'7'#%J6,N.>L6'";\TB<>IID6XJ7 G@#J-;$#Y!_( .[D$F 4#[$^!2S MRB&P[DMZ$'3P)^V=1H7%KD^PI!? /_8;>[NE=+SAP73]/JS?2'286VD5%/V1 MT#GFXY*79(EUI':26@,%LC"L'$;OZCBPMM1NCJRX(CQ3JQJ8>9IW4AUHLM%Z M@0Y$%&? TORX%\'R@4C?50F)N#!K8)$J,Y9<-!* V%M=&K,LMEN2R[4,!44! M(:--88*^S$&RA@=T(O),A_IOMK3:MV+T'RJV*'70X2-G9 M\+7;H3/W9SAYFNZ=B&#:_MZ ,.9]Z=AIK_*%PS,%3FZ#(/57HC'>/-. M">ES(OH*->0FIBB.YZ,T=4<@KYK6,1%WPC#CW2Y^K]5H[^Q6K5GMW3J ;T4. M(7"C]QH4V@#45/(('LDA^4Q.50HDZ:.QIF9 RS&IO@]U""R/HR@UQ?_SB,EMIO$S;=)TP&6#]P<$PNJ.EX?[H]N3M< M*D,F]CN.R*\*NLM0AJ#5V7;):)2F.7D;X%[XE 2@XB0CCZU_#;B.D@0# /$. MBLC?BA(-Z"[X8QC+R%C+V/)D(P=M9 Q<6ED9[S@9P9C$9&A"A13V A2_A&_) MJ:&-F_"_\=!&:SRKK,_X@@3BR7:CV78"Y$$Q\V7*X9ST!UK_SF6(^MR6.(D$ MI@3AJC7PT3/HD% ,>XLJL= -*X#?RA')$UV1IXS@ :O)'Z3POBIY\I6P2@&L,,QZ+2X:\;+ MSIM:.-?A'&0YSA>N"+N3M2RPPA-&QRDK)QT5QA?"A%FG)+#2B>C"UZ7(RM87 MM(,$VL>C_>(>%NM^]YN7PU=A:!("?UIKKM%G>,JWG^]JF,&<06>_V7@!@PKE M,(5!VK]>B@L=9/T7XGGSZ=J,L_[G!SQ^SX@-2UAT!T:"W_ZTME>0T#UFW[(M M:)93?1MLRV:4(#W:6+\-BQSIRM[FMNK<9I1 MN5J5DUJ3UR*25[LFKYJ\:O*JR6LIR>O^X(Z63HR=-]ZN,IS2+T00X M9++'Y2;-O@1S,7&H%'E]#6'<8G[CTUM4Q%,SW-:][L:,H$3MV*\?_,SQTO8; M>_N[,QO\$B]\3>,K2^/MQO.]ZV6P1[+P-8W?'XTW[Y?&=QOM[UA)'LG"US2^ MLC2^W3AH/E\9&E\ ^/;%,M)C.BFJ-#16J]9PU,F,U9IEX ]+QQ3NDQ$<_/A5 MM]3K6Q/M\A'MP=Y>3;0UT2X7T2*LR/5U*%9^A6NR74:RW=_[<:OF(U /9ND, MN7ZY[L'M5_&+#)/X7&.V0V=DT[/GIT0\K$_SEG[,A2?]^Y[2[$6]QG[SQS64 M!Z\_,Q>^7Q^4^J"45NN='_?+U,>D/B8K?DRV&\]W?MQX4!^4^J"L^$'9:[1: M/^XA6L2#4GN+IGB+BL(,.-YUB\F[<6T:=VT;6GR>/F?;T-[VDMN&:K)=P$6= M=V';[4;[^3)YD*XO^UR3[",@600WV:E)MB;9I2'9G9TE%PUF7R5\ 2!85@6Z MC&':5AN>S4#1V6PD[]#QN#U4X9WV#FOP-7[4O">,+MCOIJ4QEBEE'I70:T%. ML&8$6*8OQ2 FX!C&+1U#<7-13R,3-#K9H>=T2%5Z, OD]OVU&4S\BFJ1U"N! M824R2K''.!)8=(PQVX9R1%C@'I7%Q?(3%@$/AHY=O\E3':DT1=BVCHXDOO\ M &OU 5G T(I'5,)]OJ:57<['A16C<['.888#_32ET7U;(;XS5-&U=6 MV&X@G+]3F)IP*&U5:E/K,(,=D>$X<&/F#MA:"G&HWE6[$4 [YSB5!,N_% U7 M6ADFBL IG9JOWSWHXK"7*,6S"6@AI &MA,5K[]G][' ) PDLJB&=YIP%KYF]A MI;.W,(\+Y%Q^G QCQ@SE\<"[,6*&QA<1S+.HKC"R:-<6"G,=/V )LW9QTM\< M'=(7K9<;*UH1',0@R]M66]([L0D:"R'IU4BA#W:13 M&Z[$A16TNB17T7\9M!R&5KD2BFO$UE=Q"FMMNU6[N;*5 _M;7E0Y7#62*L<. M$[P+,N"RPQ#N%'H)W4C4U9;X.'ZQ%M/WQJ=_L+=W![&S<:NYB[&YF_I??+7O M3T[>^:8AN";/A0(F?]U*C"W!(Z+U^G!??;@I0^#64NI,#_>!JT^V[^MT M4ZCYK>7FQJT7P#WA7KD J:G:L;/W?&P-V@?[]1E?R#/^H#6Q'U!2>Z!Y/T"9 MJ<4@Z8*+?R\7PL@I&+5^1X.T BK7,CBG>A+6'( \B,NK M-M \=^!:._ W4U^62R=P-0FG) 65SBJN@VGZ-54WDCU0LGN@7<,['AH!6TZ- MT\D>Q@M?=&"[L,!VRJJVQM5_LKM;K1E1;:*3Z*"G3!$,9L75Y[WKNZS6:<#B M#'49P&O* +;J,H W)(*%*P/X>.7JFW'DW9V[."RNX,>[SUL5;GP]$YI2U<>( MD&CBQ?(]DFQ_7*T59N'8>)^,EZ$+R4H::MG1(4UO18U^-3U?3\^4QW GC\94 M^6*[U;R&HB>NX:*Z$=W)[G&P1>&O%C8FCH.UH[0KPH0W*:#'[0OEH2\G!-IXALDYNQ?;#[ MGV0F>?X93GH5Q_&VU->1'=V-A@3.W)**._)RJOAM[7*:C7%$!//K%U'EO3/[<4Q&Z MBN$Z0.U2GZM*>31D64Z)Q10K-SKE&T$';#=;NUN":CNZWE)TB[;V7Z;EPPVA M,QHJ%H:WO8)""JNKN]I'ZV6BSA6,:[+D'_!0K"-X3_+68NSPHR/IP]0;KW1) MY#I%D/I>_4L6:AK;SDU)(1A8C!-(/!PU)G*KO$J)S"].!VBP]K&8),8^8,<$X)# +.,9YZ']J:#&BIL+0XS](,1D[B7W4!6VUW_8K],"5$ MW3JCKE3DA+(43@@3XV'-;E[%[(;R&4EE8]T_=_&@=Y>%F7$ C>H9J43C>0V".M&YK=S MJ4/:%Z1./C._Q\FWI43$?E]&H.[ _DNOK#H_P(Z['"+% M!Y&>91$'A@$TFT??(J1]O/(R)GES+B+%,P0Z_5;0&XP65Q+NM#B.Z+ 4\-A M1(K7WAL?K2'O8JYXWA,*>P*=! ].H("HZ.BZPW5XP7T4%5T4;GZ/)4@+&%_$ M\:T8 B?-@->MQ"QRDJ'?M=?>CP#Z\HZM/?LA5R!QW]V!O_^#'4V+N-24# M+QAQBW^ Y_<2],6PT)RRDQHK"%\5S>F8*2;36>:=RU*?_&M/?GW ZP,^]D]Q MIKL@(D:]!IYX=)!F]$%%(-RR\9%.>5>Q+#H$*1".NA]*/7!%31V!=!B"F);+ M\+9\AH-6* WP 3A'S0MJ7O#8><$PQE.-Z1 %5[!I&=KJVUE?)Z7Y'#0*XZM M^OJFLH)5@#J::%"#43],57*N?97>:C"H7>4O- _X!30B- MCI-$Z"EXB1W7?*/F&S7?N&>^,9"]2&=YH*QNP*;MD&UUP4!'R W8LFZM3ENU M;O!8S"!?X4X)/==\YD,_A=.EZOU >Q;R>>,',;FW2=Q%@U8VW1R8 FFEW1'9 M9PL+5=HGHU=:6"2-T->0#R3?/A,$ZRJAD2QHG> MFPZRX223%+.()MZJ38WO2[8DEU9(LGSBJ%30\##WSD?'$/T$M]@ [61=LA>' M8:73TEKHV(-+MSM:3S7)W\;NB>LTB",UPNNS+\\QT %.H0Q+O_LPP1OYI0=# MB!-L#QT"[OH&L6(_%2\T.<_1+B_PQR)O,^(^)(^[#6 MF[@.6^*D:YK#N>$@BC6L#A)-FQUE[9!DX21+>VEG9T,TFMIQ((71 GYW;19D M>ZT]:RL\X5^51UQ'TV$0,DWS!&-9C"G]0I7'E8YCS&'"RJ7P%.XVGYT!3)WX M%/,(NO8=I-F2TDM. 2WGF$.-8V//AG/0BHB@Z;ZJ M@5(\'N)_=)A@>N;P%LUXW&UG1&$]V!K';^,HW1"I0'6R2LATZ=8;Y@D&!&4V M,9H=*CJ#]_,0O6WDNH!S'NB0-0%X$ =6>*O2+/:_&?[KQ4F1AAW )"]54/IW M.D!4O+1C'C-TDN!X^7.ID!"''V=.9E7-'<&)0.A-(<^A&J"+U.-\>@PZTB8ZV!C[!2]51?CS ?>S\ MR;S6\V.X_XA/,GW:%06MRI^@-G9'&>4MA!T%[J@3>@H1!$ M0]F+^V1J2D6H M!W =%M2*S[*;<%1$3'C.P''8C>^\)'UBP] '*"1(1R'<,1$EU9=FH7%3CV,] M*GUA=J+8$0-N\#K) .@R56:*9B&<$2 AY.;KCO%G;HG#8AIXR9%?RD@)<0C' M+;;+"-M!H=0XWGB*NNLA75A]U_K 3-)"A"%W>,[)]TLN-Y82D"CQ^(L"-Z0K MSZ'+XI3#^*(BT1Y]R>1\-!-VA*,07<+)P'/GUG"DE?(0L*L;#Q];ZPM"L62) MH\@C.X1QSN!.S>$LA6\5-BKR>$XNC^.S=:&F7CSLE8'B$/F8\,T[B(>,CDMU)5XWN&L9U('( K(;Y .R/* M3? $/\5OH.DL) MV6 ;%/]G47"LA=7\5-Z%&C@CW_ZD[9#\ M"4J:GV=%R&0^Q/PX<_&A) Q""'!4:%MW,&*IE']##?& M>1VG"OA#$H,BX)VA7;$S$L=LO/C,.!BJQ&-[A& !C^[2..YV.:K=^T#6W7T; M+&XU>D)^<:Q4+*(4H<"8>08/ 1G!"V0OQP?)/M$@?1[%.?RJM$,UV$0(UQ+\ MMXPISH=HO'G2WMUJ%N'1YG[YA&9V%,_.3.I<9N+H0-5*&031&'^H*VLT@''I M:$O\:@;&(>PHL:4F'_)SHC8/&8[!P#^6H=D-KXS?+H*8 T900-M&*DX5FR\C M\2Y.!F)O\Y<)J 7QI+7UW TV'R9P_<(%'?*0.DI%UF1H%WK*A#VRR1.RHDD\ MH%FAP,Y. ]AQFCS^-X8=3=A%0[:D*>LW'N#/T]1I)9)\7"J5D3=AT*W(L[43 M8(4G_"E/O #NCM28B@>H&Z(]T)R?,9H:#VF7XAP!3S.RUA61^)@V _A>=41 MITWGZ21).QIBPV, 4-;=X!A&O93]6B"HL&4=O7-7,@X*Q>/^V&C&79*PS&TZ MFIHUYAFK'%G".J!UHEE/ABSB5EI+37,RM:R(4C]@2.2MK?I <+ 8G^,:)5DO M+8V.CXC 'MV) G4MB(VIFRT,1(7L ,8DVB&5I6GR6P<,WL$R>Y'\VS8/56"XB8X*!&[QU4HP'OU [G@8 MBE%.A,>AZN]06+& >A2@;6$&#!26<1PB]PQHB@(GBI7+2"AE$ MK1?#-1'A9S25YS#FQ-P/@SB [4=V6#1,C9K)V]O JRA5AG?3CM32R6JP&F:J M;^(DB2]0GJX9ZTJ1[J?(*[$ 6@?6OE/)R39,$Z- "?BGX+6I8;9E"V0@:NT6 M!1DZ*KM *T:E) ,VY :(XI/>+]"-%.]@YEMH;*S(FC0"BS1$'*8ZC(;@M^F; MP$B :#417\^>[.TZT,O H=Q((4C.2T!WAD&C$$;Z9D^G&9C%E[+QGR92%(/49&C7UQV8 M@4FOT@3=6W"3H%JXY7NPI'FJ!6:VDZ>4]N)SKA[575(=*50 MG#'ORW;C^9X#[$2WZ##1YQR'8"U+5H0IA9RB.,,[U4E0R_2,4XS8E@'3A/L5 M]:XH%J"FA=JBP#@:W@Y&$H5%< Z_9RQXG'X)(V"+&3S3:CXE#5)&43[8$L<2 M7N'W%,DPZ\981T;C2-FOS9@HSC1R"T*T&LVF,_G"R4.9*5&FL[ LS)6H ,0B MSK0Q628;&.U-\#NE&-)N/O6<1WLZ72&+CU/=-:*;5:@ZGU&2)0V6X% 9:$X\$ LX==KT>!,J6,6%=@ MD-GZC-@U#[2@WTXD\JP-;9(P"YY:A>TWQ?_&>:C+&2GZ$/CB./ > M,,,SRP4)H0VTL4D>N.OP0 /#E5:2:@@3CK\@7V3A[WO2:FXU*PS%WA.LA$YR M,^BK9&;>0S,S;-N[0=OUF5Q^L:9BD]F;9I*A.IZ# =N=^V,>-==3)^TEA9 . MDS%QP8:9]"ME9:YHOU&G>J?C2=X9SV=QQUMXON5"EV0 @$\:2'*<>$HZXX3R>/ M3#(UK F+)&4L4CD%_+O5WB3U&'FHQLUPBI$6T5[B+;Q=\-5VX.Y@L+ODE$N\'"27A<8]0?G( MOD+-32ENUFK3M> 1+S79Y]R8W=B87QE;G81GA+E6H0FJP"\1$;W$-D=Q&L=Y MH5-E*_F:W<-KRHEGP[LG&GD/-6JR761',#RAOH2!T..9)3Z4;+.]-N39NIVYDG0^< M$EA=@J$'R#599"2L^#*UT4/ >3B<6;_([HLS-X"'SCV&OTCCDW(9VT2^(:/9 M%XM9/DIQ"89Q91=QF1K/Q\P[*0038&7&W6>+[8I?S37,6H'Y]/0@DHDXYH\+TU;0@GD=:V&!CBX\"H''$A M.&8?#[,Y%A/'O1C]EH>3>5.93+NQUSIH;._MWVPR4^GF=I/Q?F@R;\J= 84* MM&X?+SIF!&,W)QW*@B]B?2T[%:2-8E4H%J32=(J9/:PA6>S8;*PDS/AB93;\ M=2QQF^SC1; 8E8=.TKX>FC:]@L=@J-J8\X%0B3'+!W_#KF="AUT/+N M=KG,V"!7--+EP0K;/=!,?RY\^=[/1*VK/>E'IY#?&<+> #F@*(P"C44MY_(T MK9V60;3?=KPI53A[$L9+ZB+T!O3.E/Y'PRGSM H&+P0$!#9K9-W ]=R@E(<>=.J0<'2)Y,>UD?M!X;-8-# MVRD8Y_17K4F@"+3!F\B1#)E5H[$T,9@6M?:]&LR%.>H)J+$R\-X;L(V'R7Q: MY7U=#$*N6#HQ=J6"AC:>Y<1$(2:(@BT=]E#+;.<,Y9.: M_D:;75CX+?%U:'3[V.>*#:8^;"0^_$,.AB\/3>#,NDQ9@^6/7%F#TDJL.:'8 M2,Z"#A%V$5:]!X)YP[/%@HPNCV;93%I4(*MCR!3T6XOCSO-)0?D-L68<]KK1 ML)WQA509897L=&KC2641S4XWI%?$Z;2*V\L8"(KK&&\]5(:-3\>4GT-H4J**AH. Q'-OK(D DGGCDE_WAM:37MXO+ZDMRP[:.]ZBQO#S?VZ$P"P[;9YYNG3!E M'$$E7I3O9?O"A4H*2R;P<'?2%#5[+D/\*4]M#A7MV>:9#P('.C8234@Q@SA0 M8:,$H*&XS:%,8($H<"''B[NCBIDF.OU&%RRY7E^([:V=]M.78KV]428!G\H2+[PGK>V#MI/X=UMYP',"7C!B=MBFR]T@A(7ZSO.4W#@-<8VB!&?=43* MIH37NGZC4F\,P^: M-#L_C&E5)\W+QDR/VF!KVQ29]LI;2ZQSZBJ9\?D;^,7OL[&^C$$*G*$6OHP[ M'N*UUT_,,6WO>S9'W22S4?0PQSZ3!%2,F8]-&9X$$XB[&V;Y8:N/+T')[P(1 M;%KYH2ID72')7"]K,4SB%&'+L\*6N*6P-2Y65F4NLP-3=A2.\;C0Y95"%X%3 M\;:4(M?6[@V%KA^0B+QK)2*T;E?B7*>5-P>&6,CBM$D,TNFNT_AIJ:X$?!OW M(K@1T 52:A7>];B3AM;<(+.F4T#:GD?IF*"([R:J&YHJB,;_1RULT8VSP!?C MBEM _H.>:7+=G2L*!8 O0O-9O-4I'J><_(D=A,?^0"AJXA2NCMHXLC+&D2]. MX4R& (E3OH$9-8]$A<(G7[BJ?-2 B865:+$?RA?0BHI6XBBS'G3X#M%"T%Y0 ME&!TH&@+8$#/ @,668TFTYUK.])(2A1!,T;&9&?X5L(E%9^@36<"/"_"+B:A M"7[2>-AN H(@W2)KV=OZ:J! M6Z*(,DXX)A&?+@L+.]$Q7684YD=_1+=2 4[F$1*8I/ \=B XMQW=G]:5\/ZL M;(*<#TF9Q>'<8!0\1081>"%0MC: E=#'GJ9D7C?FTMM[2A-K;3\M+,O7ZB-N MXMT<\^Z6@:[J@P0':1B#)CFRZ4:3>$$%#?=5T"/3EA,'R(<*@6>Y8A"5'%%B M%.>B FMKZ@04I0V\R@&R/70=]EW(9?E]@<\NRB:M]&5-HM@1<$*=>;7B*F"4Q/$ZV&&94;441;[2*K:L$>\:(*&WU-AH&_H'V[G,9)?LAJ*A(P2'EBU/Y _AF;= D1F=!G.05 M8ODF ,?/."2C3;LE/ N,@KV<%:9R$F)D##'C$B M8D#&ZUAE==7(5@S2I42W@ SJ> OI2 \XVDL:'MH9%954N&!S44&J8.O<55_W M^L G&7K9,_JF]241*A/V>$[^R*(P'B69HZX1)IQB$8%#GXX<4MIG5/FL%'0,@T-30ETL8BGG9HM%D&(-FPPGV3AEOCA1 M$G6!B-6?\&'JR;%TN#<6K1PNMXZ!/J]*ZO%%E)JH%$J=8!06BT-]!; *QU0? MNE65*0BYD.H3*KA@RJ>BEY(F<55#A/0:JAY5H^ZDS,I M 2/L-)PFT,Z*L2::0Y8G7S>IPQAGBU&8LEKL+,50<,Z8IRL\XKQ,M&>.LMGMW(#,ZI[BL0; RF T!PJJ&1? MFI Z$&_&Q^V5X\ZN#B'SUI^T6HW=@Q+2;L,@%*/BS2?!J=R)G7%TF@DLNGKR#%6 111$)V;\ M8!/7YD:P$<%X)X=G8KLMUEG7MZ/&XE]3HZLV>(2VP4TK^%+/F[R4-CEJHC-Q M\N[T3$QT%G*17P_)+I_HD$]-H#%2"J/.B@!Z-\9HK_&\V18N_D.).>IL=17_ MTBP@R*AEJ14^3-X4\JF2_?2&)Y)OD37K+H-C.FM:&E)DL5H%>B&#(N(!CCM6 MT)>"*B"7$09FS>BM DLU-2D5AH49AY/Q4\$/ YBN9L0,+M_2U01N0*8QK -L M:!5YTR./N[]?$)D;A/KOUJ'^=:C_8F$4C<6% :?]]%8;P+:9+_+367*//0ZR\8#[?>NX7.LCZ M^"AF-!A>C9X:.4QAF#G, M>E?67K=*$2,+9COJ60X3N1R.[6K^,E52+$5*-Y >D6Z41.]8P1B_KP\:D $< MA&5C$U#7B+BCXV!Z(@ 'Y6LLPZN _@IN.H6#N%L"_TH6F#3+DSQ[\G%:7OA5 MF!VIMY?K1";H#* MZ:61C)U@=,K2)5ZM0YTU/S MPLL<\&(4TUP"CM6UO@0>]26PLUR70,&W3= )*"M]%2'\D8G=G O7'^/X1K L MF)W,KN0P!4($UO,R358=5/@K5@G;=,\G>THG1SEF"J.!H#EL2[PG#.RB5,5U MX[&,BTI8%*73G-X)]=AE:Y2+SS>+R6!AQ%'\JJ\1?Y2B.' T874<\+6?A\S7 M,.:6(%V9P0]@AGH8CNP-<*$0TTH%F]+ VAL&EYN42(1&<'JCG'3TY,*OU4YI M'&['YC:Y&SN^@C\^(VO08@.R/#8CUO<=';>>4'-K?ZYVQE>=U\>7?=W1&4WF M8[Q5B83Y(99L-K18#UH)9V:M>S2@3IG(['9KKMOSEL1E@MD9WYK%$1,>@X.MEK+MB^+-\974O1!W/QI35T>'&RVMOK9 *'-0*C3 RP5%G#H MQI$K]+XKA-ZS4NCE^BT58?;5,SF5IWF+0)8S4/9FWPBOT!V6YT>TP#F)(VNO M6\W6ULG'LW_.1N28CVPQRU-:U51#U9UA3,?:Z]_>G+ZGD9U$&(#@*_$V]G/& M@IX)YU\$)K^83'-^1#('<\9,I8'%H ED)&='_YH)(WFD5%%PCR_R,H[B <( M96C=BB-QYO?50-;L9!E'5;.3N[&3H\/W-3N9#SLYRH\*:K2SU MJ&JVV\OGTN&8K\V$KGSG5ME:(EG]4-7>Y"W?9J3G+W8=ZA$5O:724E4RN M64)Y5!B=)\4['2JQCM5W@\ AIF(LY,HU)$2R)I$8+C-QM94VK(19W-)=YY, M=G9SL+^7=[Y7YYW7>>=7)?#R-.<:HW5V\O/'PR]?3X_/9H(C]0@WZ:HLZ[D& M/W[.$\Q0R3P3@YPH O>I!&B?E>GV14V,0Y\"KEL'VSNAKQ6*.,DG&" M'/$%) 4.9WT*9,9 8<'EUDS9OYBA>3JJ+\.NZ(P('X 0:,P#!(Z2(](XM2>Y MXOC?*OAQU)-'06#S&RU&O+_P/L*ER_7L;2338]B558[?OG\I\Q;1@/ @?OO3 M6OO6RSO?N^_#;S3&];/CHZ^G)U]^%Q\.OWPY/CW;$)^_OGE_GWPX^7+\ M5AQ]^O#Y\./O=13SXN_K(D<+%\QBM_ET&>)RR_'.<;AO1B^N&^L<,E-VYCF= M5_KUL_09S>)?LM>36AR&F/^@:\ZQ@&/\* ?J6O)[^"$R%=&XF))J*EJT,7Y! MW/4%)Z.COE9=&M;Q)2B&9&'[A/#V*IFYS>R>E!D0X2QUC)DNKK>Y[;\4G[CX M^POQ7J;9_9K@9F<1N[]EGK0-/>O$P0BHXUD_&X2O_W]02P,$% @ #XAC M5S ,",3H$@ I,D ! !S;7@M,C R,S V,S N>'-D[5WK<]LXDO]^5?L_ M\'Q5MW,?Y.=D)O8DNR7KD7!/EC22[$GVRQ1$0A8V%*$!2#_VK[\&WR3X &5Y MC>PI54DD= /HQ@]H-!H/??CKT\8Q'C#CA+H?C\Z.3X\,[%K4)N[]QZ/;>:<[ M[YGFD?'7O_SI/PSX\^$_.QUC2+!C7QE]:G5,=T5_,<9H@Z^,3]C%#'F4_6+< M(<<7*71(',R,'MUL'>QA((0U71GOCL]/ET:GHU#N'79MRFYG9E+NVO.V_.KD MY/'Q\=BE#^B1LF_\V*(;M0+G'O)\GI1V^G0:_5'+?D.XE62^_.EFRW]^FI$O M]]A][_>1^\A_0V346TXO__GN[^^?\;?UPV_7[Y?(^=^3Y_LM,^^'OSY[S/_R M]_/'Q>,PK/(#M]9X@PP P^4?CX1^D7J/%\>4W9^G7RY&K) M(>ZW,O:SR\O+DX :LTJ<3TOFQ$5?G CR$G&M/(2N)66U"+/*<"\DNSN*<\YLO21Z^>3KVL+4.BC[]Z4*,4P=OL.L-*=OT M\0KY#K3_'SYRR(I@^\CP$+O'GNBR?(LL7%-2W.>1ZU(8&C ^HQ21MMT2Z/M) M B2)OG+%J(,7(+8A/L#8E(L7A),>!=MR9!!HJ_!CIJ"X*!NOB$N":J-Q>&9T MQ*CSA7KP,J#."A"A_Q%*?UT*.Y3L[94WE MJ\L9I<>-N&OKFJZ'&=GTJ&MC%^J #YPZQ$8>MH61"_H'GZR&Q(7!2I SI3R0 M+41D]^Q**)X#=$DQ\#FJSDCJ,[(5IJS0I=UR(X&D3U+ IXG!?QF)N? MQN;0['7'"Z/;ZTUNQPMS_,F83D9FSQS,#SB5+4)<6$!X9.G@,?5B:*14!30N MBFCT)N.[P6QA7H\&QGBR.+1_6?M?,V+?@Z^(7-YU[3Z8^P<0^@$G/OZ(H"5Q M8#(/D6G!KX#9CT7,KF=F_]/ &$VZX[G1'?>-_F!FWG47YMW &)KC[KAG=D?& MR.Q>FR-S\?6 J(SH#1*3-G(&#V)F[OM,6#5(H7:(8 U= ;%W1<1NN@N "$ 9 MW W&B[G1!\G YBT^#XPI$";] T8ELY/DGT=3DIRN@,E/TCSTN3L;?)Z,8/#, M__N_WI^?_?R+,?CU]C!@ZMPQ,&==>P/5#+=#">'R:M,L1$E %,5C!:0G1R*0I(O"\B,9K,Y\)@ MA6/GT.@E-LM?8/Z)9Y-#^+5F99R$K2%>"1P@-Y+^V 1 MW M+6?PRFD*B$C+?\EU.X!2!XJUQK;OX'"K%KG@* DLB$T0@\]]["'BQ""I\2J M)L<'>I\'_=O1P)@,C=[D9MH="]]-0&GVS>XL<.2B\@\P5D]641.-$0OGG]SL M)!$5@*J,#\1H&$EQ!US:+I'*T6J710%#*;+0N&0Z8+O+1E$YG(U<"@A*X0EI M(^F V;XWE\K1?$'^9IPOI.!&R\VG0R]XZ894.>HM^!50EN(EC1M6!US;.K/! MLJZ'ML1+_)ZB#UO&HH">'%[)N*[A(K#7G9J+C(]TP*HM5E-(<;TU]L -8>(Y8X_B?PXK<@ __$P*O%=L6(5,FB@*T4 MH\EB.QO,%S.SMQCT0YCGQNW8!)O[:0;>\*!_&+,MQNQD*^JMQ[2:40%).;8C MC=+)=&%.Q@?XVL$7 L(7=+#9.O098^'-SC%[(!:>,OI Q,;#Q/?$M2UQN:\" MW%V+48"^-D(4@CXW%A-C<#,=3;X.!J%[/!_,[LP>N$VSR9TI]CN,R>UBO@"2 M<*@.G:/5AE1%>**93P%>*:Y4MTEU<'[;C>ZFW:B*T:R:30%>.>24&;U*.UJ' MH:J"='83JP+5,A8%!.43,1D$BYM>![#4=[TJK&H35S-D/\I'8^2=L/_GIE3\ M(RZNS_#*""Z\7XG+U!^/.!%/#AQ%:6N&5Y"V>>K$EYY_!ZV/GS9.S"$JJ+GO M'@!?;*BHWK@(Q"RI%.D^/A1"MR)ZC/E)+'M<@$<\D7V:J<80]8 %.-F?X@Y: MME4B?)?057HG6U5+73H5U*XE];R"FK#R&JK=GXPOI+6_:026>D/ M)_F7!N![\36"#Z W99[A2D\:U+U/$;ZL,:)64%1-%O&M$^?KB*3.V7GGXNSX MB=NII&V$2)NAG1!QOAV$*']X0['Z.(.H]UVK&N5W.=J]VAZ\F55_:[Z$VSQAVK><%0RX/Y]T; MO%F*IVF$M!^/%/B(XXA#9Q^//.:+F4V\D'2U#?8,%\&\;/LLR'%DA/-T\O#/ ME4TWB+BFAS>"$]2&M0',B7X80Z7^]N-16!P!EAIM1L"_QHAY>>'E9 UDO?8Y M<3'G/;I9$C>HK'O/<,"4%U^)4P.-PM@8>"ZX0I$Z!@WDGV/+9R#@#?(\S/AT M\77DV7D-ZEDTT"'IZJ9I]BC;5@R$(E4#R>%OCS#A];.!%3@:4S P*\HVT\5 M!D*56P_-3(8=Y-HCLA$/;2 M3Y,A$PNO)DUD+ATTN?ERC1\P0_>83V$&*.E+570-I/^*ULB!LA;86KO4H?=$ M/.]DY55H8M) CP74_(DZX4-%S"/^I@R+1BX--"F>,,UK4$G52'(4"989M:$DA1;G@-70-I$]/XU;UG%H.#308.&#I MW1%VQ79Z87U02M) YC$%]^ ?/A?W$H+=JKS*8+3CR'I44C60'/PUZMJ5HE>3-9#]5HS,1_ VH:-7=*%Z M%@UTB*QZ-R^VE*J/I->EDE[K)&D".F:1>!6=0J9K('T?KS!C\1'S0K>MDSY(UD/TK9=\>0(Y">\O)&LA:,!ZF:\$G<4HR=!,=Y-8: MFSI^#;1+#G+W"<.61UG9B>[".J55%IUT5%=-CIQ9@=QNUR/)HH$73J?R\/LK<&F@V$YL< M',\]:GV;;QU26"95DS60/=IG$H\7-@21%!@UT*>X!@J/MGA5FP@IN5'V\(RD M%Y.6R!%;FR.76M#5&%!P?S#93]!R\S@8R%\"OY=!5 M*Q+N>R0/=<='C8K)+6Q^00$;+U]/_O"Z=G!I;++J'?#Z M#+Z'#U-A>TC9+1>:!:O9&^RMQ:/^T=2WG[(T;2ESQ7CR2G#O][$?!MZ5R;F/[>RS-L'/E!;OWC-E:T,%BDU6H26 F MX<>'FX:RC9R>/!&?-=LM,FNHN.RDLV?W( MVNH:'ET';L'-BE8N/DD!NC8*F%X+8YL/&=UD.FQTBO[:=VVP0^GP56?7=."6*U#_ M(X-UJC?DU+05HLCA%#V+9#!,H4.9 ;J60U.M1-0+\77&,N6>:NU&2^_,.54U M=MW6[-GE3=+9BNN;?.2^F5E7 Z6REBO3M8;W>U!5_9UIE<9X46FZ-M?@"3.+ M\/090E"MJ8>TS*.KZEELBPL&E?Z@D$=7U>,-[H(QEY)U,]JUO^I0U$:163<= MT\?'P"?T-QL '#[4Z3)XVD*O0; D2ORLEQ;R@LUT#S]YUXZ(*^ZQ*:K?CB^B MWBZ/SN"7R;]8XU"%!LQ;Y-4#:OE!5&DXUW#H!F/3 :(JP]O,KYNFV8+WT4C1B;NN!3:*!R_O91;'.S11B_*^JP9*CR3NWBA596C2$)D).7PR M%MNF*QZ4"1]<6E+?:[#\#=/\7DK5K[&R$T=#"U2SZJ%6N%43[+!/F;CYD/R\ M?78KIY2N?CBK*/\V*F0?IXMMO F&(0@F[MR@>VCTDM?#TO/&ZAE>@- V+'P? M"HJCO^+$NN_:W 3;ZO-X=93J5,NCZR*_X7 '%Q=PHIDW#<4#0B!!D%7QD(A* M.;HVT1 1%N@!_IEX!/M7GWKP/QA)<51*#*%@4,8MH9BV8_O&J7MRY6+X<^.PE*)%NV;,>M4QJGH638UB*K/\ME:)8J5,FEY^ MR!Z1B#<;BZHU\&AZM" #R#5U:?J66PEB$H.F:%5WO^^ISU6\SM5](ND$4L?R M+X[IVMZ53:!V'MGU]IKU@QN?#;K%3"_7[A6>ALFLKG_#Y'X-"Y%N^-QI-,67 MK.3:9M+!0\O*W*"2AL)G?8(I^ CIA=-,A#/1197[K7?A(5\L37E0JX9!A\7) MV!=WQE,O. QN)$?:JJAM1=^O@Q^+E6W<_"*EEN-MA8_:,HV1]!!?QVN2@L-? MR:1AUQ$2.ICS6,JJ3E3&IR$B61%K42DPZH!,=,I6W!#(!-43VUI%U37(E0SF M$.] W**+V<"C10<3>[@D;,%^)A9427WS97YNZU%LF(F?4H__%[&(Z-!C]$/< MI3N62MG>7-.N;8LLR G]7[&[D8L!1+Y5>II=E?U%YF!/GEF5N(@;3B1!B#[]H7M^ M?GIVF9B+_93UYD,NWJ(.K,00!%^L43BU\L_H 3S^,/Z11FU5V;6X39'^MD#A MP'2>H&EX*IZ2NI8%I%""\ )T<=(JY=#5D4A/ZU?M";QL.^"55CG1Z["QLQD< MH"LW?C+3&^M0<;\O%[:H9=&U*_7QTBN\#9"Z/V4D34=ZW'_*ILW\OEX:7BKV MO99Y=8A&96XG"<%4&"'U M7[>8_W#"K37>(/CX?U!+ P04 " /B&-7?^G2?U\0 "PQ0 % '-M M>"TR,#(S,#8S,%]C86PN>&ULW5W=<^(X$G^_JOL??-FJK;T'0CYF=C>9F=LB MX&1\13 ')+O[-*78(NC66*QDD^3^^I-D0PS^DK"-[9V'20)2N[M_K>Z66I(_ M__*Z=+0U)!1A]\O)^>G9B09="]O(??YR\C#M]*9]PSC1J =<&SC8A5].7'SR MR[_^_C>-_?O\CTY'NT70L:^U ;8ZACO'G[016,)K[0ZZD /DT_:(W!\_@F^ M10XD6A\O5P[T(/LB>/"U]O'TXNQ)ZW0DZ#Y"U\;D86)LZ2X\;T6ON]V7EY=3 M%Z_!"R9_T%,++^4(3CW@^71+[>SU+/P7=/_L(/>/:_[?$Z!08_IRZ?4K15]. M^'/#Q[YIW?G5UU17?;IK& M6KX^$6?SC,ONAITM9?8MRF@?X82B:RK8&V(+> +VW,=HJ2WX7YU-LP[_J'-^ MT;D\/WVE]LE&^4*#!#MP N<:_\G0VSZ5+E]//6@MNOR+;A\S8V1$3- %[<.?BD-JWUZQ44) M0H"3P^!>J^*/G:)G%\V1!5RO9UG8=ST6S<9,9@O!/&U)]2W.(@.!^3 //3EP MA+U:P^8I:Q94%C#K5,:(O"$'&;B.2RJ$RK._#W@ MI@T. 3CA7[!-LYS.9W+,$*8TXBS_12.Y0V$ADR/7N)7$0](M#17U?< M*>39GVSWXHSR(,&0$+K(82JI:0FP^4\4_NDSNPB,(P^TE.85>[$RO%GY7BTT MDQE@?DK2I';;5C'JI+C)ZU;]"%11FB21C%(/I'.*/1#8"A/T^@!Y 3BZ32D1*L\60[@B0P(KDC"^M5\4>3Y'9@VB5 MG]-#F0\ MET*9[ ;/H3.L,VKX#4+N(Z:0K)$%QP2O$<^_3-\3R\ULK*D*4Y!^%>FG:MR2 M)E F+GEYI2H.BO3*%"6:@:JRG=&W_/15U3 DNV999H_>0QQN&)9-SK,W6TW]GM( M7MO2UZ(/>&]*-3S7ML_0-@_1?GAP@6\CUO:?FSK(1@$.MG:$=G@A!N]5/39% M+5%N07-"1-SMEEY^*R._<=YQMO\?Y;Q\+DVWL384#B<]&B M[Q,>67N4PO<%"P<\04?P\FW;%DL;-&E_G(IR'28)2PW_><$+[-5':H52_(? M18$]^D1[@>AYX0F6FX::R5(Z$HH[@19D4D2GY$FPI7:1P^VB=MQR9&X'<"/L M6K*>(]ZV:=*P='#%IMIO8XZ$OIO MC%SOD7WN$S&U8])BEG9YV>'C(')RZ%\V _V#U=4.>\B/-VE1YOA>."^#2T14 M"H7C^Y\<65(-M!5&%2*Q68Y&V3XDJ773))H18$,VS*/9YAB\B51SAL6W4W^U MQ1G*Z_5BW;E.$JUJG8P)7 -D]>\TW]6=J-J6IG'Y_K%N_F8)6K67IK0PH MQX,<1$@.H9_J1JB DMH1FJ<+3#P/DN4-)@2_(/UKW_J)8M)OM3M\/*2[J]A_DYE1>-0[W9\?Z#H MN]NZ2K-[*BO)VC8MFL:Y0:D/[7!_;6:M;+=A_0-F[R1M/+')12Q:O'> $PK'D5#*=2&[?%#>9+$<,LA9E%DIR)9V:3A/IQL5+XLLE%YYQD:?TB3-RJ/"9XCCW-YRRS#7/'[A)B+Z5EL M#ID[4B4Z-\T9\0#(['4AYLIKZ&"Q*R\\-)&7!61TK-\]22.9F!3DZB1AJ'<: M&&RFP!'[L.X!^0-R^26@3>]3OW,^'-4\3;0$T)QS3EFXYG:M/_$['%Y)O92) M-N?O6^Q9\-O=?Q]<0P+M6TP>*/?48K9Z#[W%^[5CNY&I',I- M"F>I$)8F;4NCGERP:U:,DPAM<;Q;X2L#_\[8#K.I/N;W!_G,V,(XC=V<$T1U?"0B$7P/L5.!5*0J=>2TH(0D=2OY3@7I@UH%*7R AEPM^HCO MP0K33UKP)$8E6D>J]\:?^$WF.^)_+%1 8[0U0;S)A;.M!OC2T@,3R7 5JV>R M%)KFQ=LXHU)#JS0W7C=4/?N_?GAM 4L=A&OA+Q&QQ^!MF7>14W[?!@2M8K#* MJJ>-8 \@B\Y\>8>CX=J])28>HN)/B=*9.JWZ5S%+-09Y];73."S"3W>PM"W\ M*5*ZK;HD+PTK0+3^%=.2S459H6VTFXUX[^+NW/8@;^W"&(V=?QP2Q[U? 89FZGSRS950+$Y4# M_ZIQX)QVXBX5#2#W3%:?1I6"-]Y% M$J"JH,*0,NNX5F ME=5!$H[FK4/E"58^&L>MO087=!>IO292:)KD8Y]8"Y;XF?/4-PSTMQLO>E11 M*V50;V2M-T,/\5IO:2JNW+>%=W*@_\'HP4T^HM6-@-]B>CBY1I:")5 O)G7; MG6:X"%# :292:)KDFW*^.=^_TBZ*L*(R"A!MI(O,$#_N(HLJM"5#A@4 "T); M:$G<@L0G^*Y-Q:10G)9_"D_,Y.R$DJ;22#^J9!K**JO^(N==CL(9";1\@KRW M&]^U'9@ZG9;NW,CM+Q+ JX['!-ZMG(G2N'#M%T MU=0S++->9JXR0K/I-'(S29'!*J.V]HW;]\NQB^1IAQ%LY Z20T>YLB+;82L3 MN-HFHJ78RH$$&[F51,56"BFR\E6.\,T4X:3C%I/@/$QJSI;5OI&;-^0\?[X: MVC%J$V8()K&9"LA;4"90G$OM=V[D%HV"4ZAD!;4#[_@&(_67BLO3J']M157> MQ#>0*Q1X&GJ>M HUJ"W"2JNAREEY%6HX.'$[WFG:\':Z+5O!Z="KJX\?S\^U MCC9 U'(P]0ED?]SI(WW2&U9THG6*GEV6Q%B\A!-<:\,W3&,'65&U1?B[V.=O M:MR-C%NCWQO-M%Z_;SZ,9L;H3AN;0Z-OZ-.*^$[=@Q)A]7*?U;XY>M0G,^-F MJ&LC::KW10!OH$^.Q-S,>=>W6&/5& M?:,WU(9&[\88&K/?*Q+J'O!#RL#1UWQ #GS"#85]$KGR*"+$QWTA[GLSQC7C M4W_41[.I-GB8<#.9?=6U,?O"'%1EX+$SZ4GL_ABSZJ^]B?[5'#)53[__[N>+ M\Y\^:?I_'JI3;\Z%E8D&_E.*KQ!&TAO<&R-C.IL$AJ+_-M9'T\I,GF\O8M8@ MM)W$ZL_[K [-Z90C'VBZ*O#])PK_]/EUO>N=,!+A["H&_8383EM*BF_1#TJ8JQ^.A/YS$>V5)]0-5L MYSF#="%B,4_")50M3=0WI',>"WN['J)R2]ES%>F,QD);S&%4SJNU@+;OP.#& M?K&'D[./; 0(^WW WX?A)/(>CW/]K_K@@>5#YBU+C^['O1%W&%PB8V#T)L)[ MA/0J-O;P*2->:.&VGL1^:L#;\*AMNU>F^RRO+2-#+!+F>N^CR;:?5,N($PN? ML23[B +()]X2HEW&XJQB(GY$P=.3 MQR,^+H@E_=[8F$7<1BV\CP%_%=T">LR9)"T%7,9BN80@+->+DJU>L EDR0FR M^ 588O7UP44>O>.U62(F9E#! ).M9FIZ??CH?F[K@>NM8V< M-.%[J9-+M;%&]9=O9-^K@M.%J+8Z-P?T2'3SB0!# !%^ MP$OH/.VEF>]#"ALGM:V_G*0(2X8L;:J=-N'^OBJK8XJH*LC6)I3Y[9*0\@/D MP+EEB8N$(T_M4O_NU$,QS=%".Z#\%3P'B2=PQ$I5%H;QMO7O2ST4O#2YVX$: MB^!KZ$@,N[V&]6\2/12O1(G; 9;ALH2>[X23P"O>MOZ]FH="EB9W.U#C6TP1 M"=Y'B5PV%91$,+M?_=LY#T531A_M0+;811L!?I O"]WD]@VXCNM00+,4T)2]=^_+9]&Z=,9267R#2&2I;+](7?4ZYEZ5 M6F(5\T-\NTB\7IVV>!G"PO_C,TCVR?\!4$L#!!0 ( ^(8U?*9_$;G2D M .BN @ 4 N:$E.6"5+6DE.=CZI:!*2N$,16I!T[/OU!Y"23$EX(P6*0)9; MM9G$!L#N?@!TH]'=^-O_/JU"ZQ&@.(#1[Z^N7K]Y98'(@WX0+7Y_=3^YL"<= MQWEEQ8D;^6X((_#[JPB^^M__^<__L/#__O9?%Q?6;0!"_U>K"[T+)YK#WZR! MNP*_6E] !)";0/2;]!N$ %D=N%J'( 'X%_F'?[7>O[Y^\V!=7$B, M^PU$/D3W8V7%W^XZX_ M\99@Y5X$$9&;!UYM>Y%1:/VN/G_^?)G]=MOTJ.73 PJWWWA[N25G-S+^K9_L M.A0;O[_,?UEL&G"&+A =![_&&2=]Z+E)-D.$%%G,%N1?%]MF%^1'%U?7%V^O M7C_%_JLM3IFP$0S!&,PM\E\,].ZK\>KI=0*\Y27YQ64'XGF+J\FP"?3"*Q E,3#^6T081$&;CB"<4 $)R#SY''/QQI9O @L<9O@$?1A'"MB MC3ENO:QUEFZT +$3398N_CP,?;PE]?Z5!LGSQ0F'D;PA_*L#H< M[W16=&B>UY,(T2K/A&F&]B M*G8S];O:9II,7;Q/24ZI_;9UK#HI:D3=ZE^!980F.8C:U2A%(+N#^I4I!RRW MDP*B\%'*3T.0V[INA-<3^63@!R["?^^"Q U"(9&E!E$V%S?C#ER4SR*YR[V CY? \W."1X_K;A![(8Q3!+X'R=+V_P)>2N9E!YM0"XB>*W,A.6XMC)P\SSEC*9T\*A9DK00> MXH9/8<,HK#XKQ$/6M3A/)9LQE#IR'6S:8$LG=+_"D>Z20* MJ:,HW B02XQ$&VO8: %.!W]OO!HGP"U$"QCA#AZY*#_R$I>@F#F2.F(+UK@" M@KFCJ2,ZFWAQ!YLO8 KOHG5 C)G3IC%K-)7[0DS./Y19??.,U_H)^P1]W#C9 M&U<=(UTP=]/P\&JF!,6' _!(\S[Z_Q$,@+WT M%WY !)798YL/';%/1@FBY!(WO=RTN:0.4#_=NX]=^'#E!B6)/NY]!HJS+UVL MP.J!A R5(G>_:_VTNF%8CL*L0_UT13"QRY*V[7/6.9FOZLJ3^R_*\?^Y@-6$%G%3_S57A*%AT/F3-'\8Y4+$'@X+_N4 W=!Q!FP\UP8U;;RRK4[-DD M 1XYVX,2]PE&8/MDGH;AC+1X^=N%!]'LI4G&3?;SK,6.1CQ? MM]@5(A\OHR_6RTY7JS@4IJJ7S7_M6#>)(\);TP^SQ&"V3GH"VQ MO)!'3'#_]U<)2BE2:!IQLF7@PUBV M1>6XED:ID-X^8T;;MQA&3(9JI MAS1$:S_DGZV!9N_/C$9Y6[Q J$'VV0C!>9 4S_LT$%Y:&0#$ ;',Y: ?&,-D M"=">D\2)/+CBGFM9?0P BDLZTQ[3#[:2B)D)5EFCQ+/J V/@Y>9[\'^9-=E-P122MB0A?Q. &]_" M,(0_<,?)VO4RT]/UBJ[W?1N[ML_IBW#M7+/FR0<-5V_D(>#&H OR_TZ7"*:+ M9<8DJTAI M9SCXUAM/G9M^SQH,IW715J%.4H'J=X=4WXR=[I>>U1_:@XEE#[I6MS=VOME3 MYUO/NG4&]J#CV'VK[]@W3M^9_E$/3Q+EE H\O#_DX8J(QF;UOO<%T8G7O MQV2.3+_VK!'^Q;!;T^1FUULJ4/OA:$9_M<>]K\,^%O3DKW_Y='WU\3>K]_?[ MVH0K77NI0/1'QBZ1S1"[>^<,G,ETG,^2WC]&O<&DKNE.+=)4H/33(:7]X61" M8,_E7!/RK*)-!<(^'^%^?S/!..,9NIFG#6RYG*WW^DW)K=?Z93M:O5KLH.). M@6*6+K-^R?O41)>PUE.!Q&-]QES]+U2W<:N<@^R+-(?S@G>%Y("/L*[&T]T- M;],$_[X;A%EZ9V\^!UZ"%3D^](4IQMB).F[HI7ELQG">M7NY_M\K/\4[#I^; M$A.C:IM!R^ @79*-BD\B-I:,OY%(06ZB@%V9W@T&[S8T&PXGI;R,C8@[8? A MCM82=&PJE#5._"X+N2-BTH^J :6%0.3B;YD]6HN9E9N M11Z'9'(Y4>ZI/9.]V@G=."8SO%BM#I_#0SHM\C9(B<3LR/\.@L423VC[$1]J%V![TS3"TWS'^N;2J<*,./$SADT8%=P: M9.#)L#X&1-[8!NY@K8M<+TF))WA.;C)?2IK4-,E.^?9/,O-.%@'3-#W_;5G) M(N$%;]?1G8B$V[AF9QVGH'B!\*-KD7TOYLUXK4M46C\4W/].] @V MA>*1ODQ-/$YE@?XJ$I$2;$985_V\!D] M>8ZG$!^[;B$J\B*1UB[NW)0CL3181WF(LH(QPZ58+\YZNQ;KGPOU.!GIH:+ M2Q%);':3!*!X-/VCG_B\G'I.A^;*%T@O+BC+A^H]ERK\/A;+$K@H<1RG ]&: M)W=ZVP;SX2O(G,,#<_-3*G#\_TZ R)T?ZGG9+C@*W60.T6HT[8DFOE3?V3N3 M "G!$PN@=ZH! M,H(A7 2D *+'$S^WR^S**+TKP0L3"+7Z=XI2\ 6&>2H12H)T)5X(_#ZS*Z,4 MLPPS3"PJJ^E:2\^D48*>260B;K>&* \Q1&- GB?(JT!L!<.],BTUT.SZW*$Y M5>K5E&:(A;R&7K$1@FLR@4DXZ?!'A%7K,EAGJ7T@3@H.(B[FTH.8@'=)9B2\ M+F>^NF:^;5>XCV2F.&TO':U=]_;ZL:TDWE82+ZI*6L">L)@XNY.)]<1%(C#B MYH_*A?@NB-NML8+C0D2D,#3Q8D\]C'I?YBF%VKCD@/WJ)6*8:>T;N_6367-' MQ4T9#!BTT=ZD,;8;XK@#5P^8ERP$5*0PV7T,U)0$7)8]R($NZ'#(AW2%:/AA/0Z1"(\#)1SZF"3&\-I@#6,ZHJ MRFYO+Q#(N.5I+W&_YA2:8*W LDPPUUC5LP,5B7S7)GY?*0"8S<^>ZEA>[GS: MF1-?0_LA3]3<%N[/J\/R-C1:^[/')):_:V"2K?H"EAX'1+Z:?S1+N3XLU'<0 M!\1HK:^8140;Y( :N2@KB,R!Z.7^]Z"MO@#Q25;M6:*N@3'PP2K+Z<;?]C"Q M[@(,YQ0%1E\4TMWU!:$T%ZH/,PQ<-AGYMVGDX[/7%*7QMB(F"PIV#\VE+R"< M)?"J#TM5J5]/0H4V@4/SEW=U\-18P2CKRE :)XZJ-7!*F&.!6_5]JCTE-'?C MATP*:7RQ<-UUIH,N09C$VY]D$R&;!)L?S&S?SV3KXETYR KV99<\%'PW/1@= M](5.@FX6*H77H,X5%,6M""P3*G548UE8&9@20G660NTRW!P59CXJW-Z&@+4A M8&T(F&3(R=&[ Q*%(R0Z&^BYEQ:)$0=&&A-BOS"O5^.!84)<#A$5R\ ,_[YJ M+/7V\]>!]QD=_XUJ_##8QG:UL5V-QW9MCS[NYNRS"[:1.NRQ M>AD07R3% A,##549J8(-(Y"]'IQK .'AC]'#0'7&9U[==7.=&1X9V1))''OM M&CO8\05^E(%!8@IT$:5A<^J'.L^AD%:F M2)7'AX$5V4=EY,IJW6"%4KYPN00S%8&&#L L#">S8;9>Z<)S9;P]B-OQ_/4> MRU]62S# E)#U8'-RBPDQUXQ(OU>8J?W6IJ %(UB@RY+;B!"\ =YI_7.3;): MECQXCEN; !&+:H.N0EY8V-;\&F/VY: J]C +KF/*5?OEJ.;!;? $_'SK)99F MEF- -PUH+346,9=BU2=$JFA)D!_9)QFS%S4LD18->R7*L*M33>% MHQ1Y2S<&^Q<0=+&*>NDM:CGJ6>+_H%+\>^]9#N=;RNA29S366]ATCRFE"7"3\K3 +>+A:/!CMOI+4X6O2RA?M;/ECLI[4]?< 0T M,\]$&IY7NR#V4+#.LWSL]1I!UUO>Q\"?PB[ )ND*RZ"H_;F^B-*#F8!Q1::8 MDT##D_$>B^2=72\!_C<8N@F)HGPN/AS\A>SP_%SV\J,9-PU*<,6O?=X M' ?QG[<(@.+)])29(#F><7.A%%_,V:#V5.\&N5[:FN_VQLZW_)7Y6V=@#SJ.W;?ZCGWC M])WI'VUV9VFM5'A"&?_=72P06&SRTL?@$40IN,7S>!?^\SU(EITT3N *H'*/ MC5<=W<0<4752-3B-U/A08(4HGA8MK.&IIHT6-B[PJHT6UB]:^,5\DHL39K=O M+#%4OO CEW:#]KX.M@,6D+R@1_1 B/_ECUPD51Q!T//G5'9R\C(B?N*@;/<^ M-Z7KQ=.[-Q:!+ >3H!8\3R1FZ,GZ,=9;@]8W#\ZH6#&_>,_J$S<&XFI42L/& M5&F9I01%'!BTJXY)8HI(=Q8:_9QJ\D@*1J2-9E1+;(O[[9K2<<FJ@<6L:5.)C"-=XT" <21_&#MC4 )ZFDJ ODZ&!-(]>D6_N?(OFSSC-= MFQ_:YH=J XO>:JS-#VWS0]O\4*7YH;O:Y3%*"G7+\;]>:I;C?W!/EOCW/^N9 M[CF3=[QO06 M'N@^\I)X-/0Q#F#D^O_$NV80+7J/Q!BSYPE 8["&*-D]SR$ZY)49Y:?2*)4D MP)H?51/ISCH]Q&N7W:>I0V(%<,3XFGB(5 FGENKS')"?\?!Y1 +OH,1H/+MJ MS"7DPY2^@: M;FNG5UG1%BHAUPT(\>E2.TQ5L!7\RSI88^ M@.;KR1@V$TIPQ?:_Z3;&@S1PO:2X#%[L9%KOU89 MT(39< )CS FAX0UG757.]0=8@@$FD$J=(;*FE6GV5%DCJG(!H#JO!%,BA\V+ M?'$V9;B:D=9>8Y0DZ&:BU4#=H#O,#PK<,+\MZZ9H=U4I4R?HZK!.T)T][8U) M*:#>M]Y@.K&Z]V-G\,6:?NU9(_R+8;>M#%3:SBS&D&2R [X3S2%:98$D]@-, MDQ=M6JX4D.QPQM?^*2>WNHO]T#-ELR#?K:=[5YJ!$0E%\DUY'70)>BHI>"C' MG>H[R#* =/>"?Z0@V78Y:]QN32DO%@Z'>$GP;(9&4P^>WOI. R]&<+FD<^2]GL-3['_OHFE M)YH;*C))=;QG;#-)VTS2-I/4Z$S2<]_RRZ\9<2(I-WA;0_W)*]AOWC,A)^I$ M[NL%)B3,J'IDHGT7Q#C(]-9N"F ]HQ:[)\6\?Z" ;.Y2MYR<#N=_[TYV>4!Y M\IG7FF\T5&D_7_'8$]5:V6JQ&B8:MM5BM51>;;789JK%;N+ ;9Y.VF_38'D> M01U3&IU,?5,Y\X,GQAL),=YLR6OL+EA.C'MT,L58^0J8;RX!M*%"RE8Z:#V[ M^J2I:/D4,X7\24/;*$](Z+CK('%#8:6673].M]GUN:M/5\Q0XI'/PE#IICW" MYA\FUUU@D^X["!;+!/CV(T#X!UF%$V*IKU8PFB30^Y.^=DH-H3$RU5AAKK2Z M4"J%AY&2EY:QAC%# TADZ8;VBA3/X-\(%%MJC Z78J9IJ1\TG10AS.<(@;4; M^"0%/(KY&H;>PP2H>)2KOCBE[UC%,EF8C!$FP_8?W<@#A4Q\Q@8FU5=C&$KR M8) OO^/&RV'TU8VX>;(OK30&B4FM01ZH/1M2VE8V 10*PZ8Z)%Q$FU>MEMW>#$FSZ&9[6?7;YO=J2CG1.B7E=X>[A1I$ MBSOH@_"4^ENE1M48>67* M76FQI(-MF) 1@CC>DB*G<(YZZ2U\.>J9\J^CR/3^1"A24V+J%[OIC8 D^4P( M-#RG;RG/V*'LI==OKCYS[\8E^FL,:@4^F.AJ>.QOO-ZG 0^ M9]^\A;D7A^=*H;?56/0"FID7N?6X4@I>27[Q55X/O:4MIIPIKU&7X0$-#,14NJ]H)JI>0@&F-2E1DF6!IF=F]YZ0:/@0\BWXY? IE*&M\EA](8^--88L)?U)M&_EZU^ VA]#4JV5ECB,HRP01%0^\(YB'&TRW7TB3N9@P\ M$#SR5Q^SD\8@RA+/!$_IPUT;NQ_/(3=>=KKWO?[UG#6VORU1[WK(X]4AYU5[FO4]N0-X-(1G-QS0ES M>]F=&DSOE07K2/V(1&!$Z6DJ%^(L4FZWQG)]A8A(86AB]J]Z/#58)M7%U ME/?SYL0PT]J?N])_J35W"!Z+ 8,VVA'^ $ @VES(2Z!&[]%PJP'%X4.ZA M;^N8U&3HE*Q9HJ'_OZU9HJ75TM8L::9F29=LR@CX DV4764L/EL2E9TF2X@80<"[3JP^9R_?>6HNU0'I+-QJCYNP(W^8)C%Y:2J( M%O+1$_O]]!6_//D2%K86CMZ12S*_ER )O)>X]0*W M7N#6"]QZ@5LOL);GJ=8+W'J!6R^PSAMMZP4VV M\4A2QMF=!/LD21_#SG__& M($Y00&(L\_ETCP??AE-R G_>\8Z X]YD.G8ZTUXW/PU.K/N!,YU87\;V@/RP M#0622\XK%$LOI!I]#Y+E"&*HD\ -;],$_[X;A&D2/(+>? Z\9 3)_+"U">U MU3MNZ*6AFP=09^V WW-11.JK;V>G\$QY;DI,/*(V@Y;!)][-.PXVEHR_D4A! M;I(O]G![:_+0P1EG ^/-$0D9&V'R,?@06WZ"C@T_"R0#S]$SKC*B,..H70^J M>A^WZT+>N)/W@?V9F9]BY-F]&CN%RRW(0S#YC!BT-6_OP J77L4$+9DK5T97 M XY[,ARHOH ]U[WY?H:=DY?:>W"Q8;G):;%)7O,"%#<\X<5ZF4$-PK\:;P:N M\B*CNSIC:N>&Y+"&SHXRW#%MN<;C!G)FQ-ZB]^* @>%HZ@P'%!?1"X^U\+'! M8PI[JW4(GP&([G>C_O"/7F]B MV8.N->F-OSF=GC4:#[\YW=YX8@WOIY,I_I4S^-*ZRLJ[RO+EAE$\>']E#,BZ MQA!N7XY,W; ?S %3;9=RBZG^JNDNL'I0,-C=-2B>>DQNWK_,T)SP!\3FO>Z'D*DCJO_MF=0X[*\\[DN:_MK M<0B4,,'-/:^50\* LY4T6L9%--S )(&KX3QC0HP;I7G#1RA!R *#8(,VMRE< M2\-SV+:&I:42'"JY;$-//VSVC"NFRBWU^A!W%$R)]A?(9;DQ,-2DAK A X"5 M8L&@ZXA3+6G1LE8QO@GS0AV?!FEE3I@,.6#5$ETD'MB$Z:* 0::!K?2)%]EI M72!>8GL@CZLH&%ECI)5RR/25-Q!.1@AN R , I)HK/)E6A$(C'"*J H3 M-R3OTQ9XD:B]+.[W/7N& MYTE2Y_# $OA'#:V;MAQME7*T5;WE1M4QU>#XWY:C;>'9U M[A>?E0C\@'ZFP-_J:!:VC[?)/][V3C_\VL?;M+3NVL?;FGF\;82"1[P7?">Q M(;R*D[@MM6ES"9R"Y]O8U+($^TFI/35*'\+ DY(KI>7LLZYB91'+DNIGI5+= M?-CFR7._S?ECVF1%2:.3O64KM3TWG[Z1$./-EKS&3'LY,>[1R12CCM>H';Q- M+2!QJ9*W"$+\+W_D(JG0(T%/$RU,*6%0#L/ZX7K@.]_GIO05&KU[8W:I'$R" M:S&>2 PQ6VO'6',CM[9Y<$8;^ ^(_GP,PI#K\CIHU& 1AC*+"/+I9WI>*A=9 MH IX5UBT&R#@X3ZT"J,\X9<88':MRQ6U)#"E>6/NCVJOK7G58*6PXK#1W*'Q M-(@$+#&1J5SIITZS<^F2K!F @C@)/+Q_=PD P+\!$?Y+,@I=<05.^3%,-$5+ M"N@8]P]FHBYQJ5IBE,9,U++P5<'?1)OUW%- 5CJ6H3ZKL>?U!:X3H]#+A^:#V/N1I';K1 MYBGR6]=+IDLWR>.9O[J/8.2B;VZ8TLH#D1L$N@G@XWY+#VNH/V^DM M7!:]+*%6S>F@"G5_ 0VCCALO0Q#'-VY,/3WC/MPN>HM:@G26U*O&-](K0I#O MY[M55E![!%#V([K 6:WUEC6?:I:8J][8,3=%RN6WCH+'>0N82;="-RM9T MY2R$7>/#MAHC)*!9M>..D6 $/0#\^!:33Y:C&Y&9,DF@]R=](7 Z:"QJ&<)9 M\OZL4MY=\)#@Y1AYP=H-><8@I:'>\F42S#P8*3UKCH$/P(J(I0"O^H86TT%N2QY0R9:CAI=7A]D4>?4V6 .6W086;/*YRE!U$ M8R2K,L,$6^DQE.9RX&](O!X:PR!%.5/FM9Q2)3?2&L8:';ST=>L&N?O23NZ 2UZ\(FQUL?Q*:O%3 MQC5AHIS.'W.6%)P^9WL:S5L"/PW!&1\\,X>,MOLA_'F MA;,=^867TCX=O936^=KKWO=[UO#6^M(;],9VW[('7VC:?P=?B?CX=Q.$A0\I/E^M<7HYGG@)OC74SA=@@#=II%' M&@B?5#MQ8*4+]DP/KBF1)=T=;L1S;&5X%D79EQ^KP6!\-< ?9_G\,M<.-%I9DE2RO8487 \#C4PT- .:87A8J M&H8C.%&<(A)?*@',85L#L*&2S()'PYB#,5B[05;'\PX+)@&1)%2\?@; )B2? M!:&&801=L$; "_)4,WR(6T%BZ6;_E !2W-L ."698(&J8?1 'KV9T[[UK_!@ MI+4W #@FV2RH-(P8$/A/>*@)NAH H P'O%N>YFYJ^S".MTE&G%O9S[Q;V?YP M,K%&O;$U^6J/>^T%K-R"D2SD1%LPPJXF7J+*%K8R]YJT?8FPQ$N$&CH?VY<( MM;QY;%\B;.8EPC%X!"@&6;[L9!T&">^FD-%XUE@]:L$C93QZF8M#PSV+.)V# MA%AY(J=ZWLH 8_N V%HO$=6"0#T714&TB(N6-P\;9B<#H.+3;I#J[Y+Z MN, OBQVGFP'HB:A7?=%(SS??#Y'>YKGM9RK:#^3$[;&J:)490E]<*G%BTL7B M/G,Y,]S;15H'??&3H%OBGO%L+J+T(0;_2C%#O4=BB6Z<.@.2S4U<6Q0OT;LW M1UZB^YM)[^_WO<'4ZGW#?[Y$YUN[@5HWD72<_@!&;A8!0@)X,E3L>0+0&*R) MIS]:X-TY@'ZI"/U20YKH5CI1?@:[F^2X%;F@RHRB221^%9B/\NE+"\\(._:8 M+;'?A-VG*==6!7#$^)KH^E()I]XNL1HA/Z/+[(@$GLN,T;BQ:'KADH$RI!NT M66X>.^K@R4K.4[*/L1VT_XF4(D\@1L0;'S(@\>("HT?#3Z_1(1#A9:**4P69 MWNI- :QG5&,3X*4H("]PCU+D+=T8V L$,F9Y"DW8;=;8&VB"E0)+\L#TXRAU MC=Z&$**L7!!=WB^_GWW6U2EV3*9!]SG;M)M;B$BMVZRB'DENX]^UL3KI"Y(D M[:I-.T9Y:A*T[-O^(PE6ID_\_3;ZRI5.ZEFN50A\^;,U1(-Q-A%*0ZT%RJ)7 M]44(/9<:D3NR315:NCSWFF@MR6-*):XG&JZ'KK,\6?2RI*HDC:E*%G0?NE&, MMWK&/<*F6;&5OG)G$ MQV/<=/@C KZH5#.CL=9BY=',DK#:USY>+#J\U:^".(;HF?,R'[N]UG(6D,T2 MM?*'/NY(;D^0/'?9.\)!*ZW%2B66>0Q0ZTK?*WB]>8&16DWRJ"[]KK'6LN71 MS!2QAEYT)4]+:@N4F&PF5H7S7'U!/9D 8N"]7L#'2^#Y>7#/Z''=>P)>2N)O M.IC%!22E#H91^%R@J9[O%DJ8U/\])_*#Q\!/W;#>C]D_7.03'V+]+$V12UYJ M*)0++K"VF4?D#U(7!O_D_P%02P,$% @ #XAC5WN$_0:+9P $:\% !0 M !S;7@M,C R,S V,S!?;&%B+GAM;.6]ZX[D.)(N^'^!?0=N#3#H!C+JDC4S M9[I[YAQXW+)\3V1X3(175O<6%@FZ1/=0EUSRHN21&?WT2U)W\2J_D!:S#715 M5LK,_*/XR6@DC<;_^%]?MREZ(;1(\NP_O_GAV^^_022+\CC)-O_YS<]/%[.G MJ_G\&U24.(MQFF?D/[_)\F_^U__\/_\/Q/[W'__7Q06Z34@:_QE=Y]'%/%OG M?T'W>$O^C#Z0C%!GFN_?? M?__#=W_]>/<4/9,MOD@R_MXB\DVCQ:VH]'[XTY_^])UXVHA*DE]7-&U^X\?O M&CBM9?8T,:P>" MS[X=6A[1@+Z^]R8L\Q*G!X'O:WJ'?4\.>^.=GO\WS?P\.>Q-]S3/ KN4(4]^ MO>KWFO*_O&-_&D D7TLV@)&X 4[GM?&04 M-I,U+83A$G_-LWS[RG[A_8\7S&.___&[]3Y-/W.)[D\744X_=R+BY8B_%Q)\ M$&?A0%86B_7-[_ND?)U]38KFYT7;__,;N_AWXV9QQ1EMVH9I9'E!M<1W4W9A5E22**E'TZU8('\VH8OOU@G/B^W_[ M\7O!B*>/?_U\FU.2;+*K/:5LAO*ZI#@K4A' *HGAIN*#'U/ N@^59' :.<$;,TJ(\O@G:H3/Z3,4/FVVH81L2:9W M(RY*OCR+>P,:9V/7"$Z<23"UXTY/$[6J)_-32CI5BZEW[/?M+#+(^B*/%6[# M&:T@"*K8T(T94LDCKG &8IQQ 'M*-EFR3B*GTBTI^Q;^8C+DM#B8?FWNS+6 M>C2CM"^?Y@"Y\6H&T>!4<<,G\:+60+4*8CJ(*9UWU&LG ?/Y_"JG._O\:R3H M?1JF!"K-Q@92(!AAA*::FZ%JOCVAU'1%$I9)"H,A4 UP3G(ZD8=##!:(U1*W4 MO//FEO*L]@F\D10"\48#7,.;D31$WJ@A6GE3J7F)-2[)"Z%X0XJ'\M4RR&A$ M/0XU1K"] 451P]\9>_9IO$E+,LTA+ M#(N\+W8XP6XH8A0&P1,7A&.R-#JHKX28UGD)LZ1[\B%/XZL\*W):)ONMQ978 M%'Q1Q@UXPQFS- C2.$&4-B69$N):J%,[N:?QD11XFV1LU$QP>I?@59(FI6W' MP$$S4)*@K2F:9$&=6G!R3L=J2!Y<-YHH[53/N5/ O@LV I?)*B7W>:E) #0) M^G)H9J"-(U-+!>>(%9I\>*<51D+ZO,-<\W.X!M?NKMKYH%?QS0P;^#%'=/*@ MV&(!J>,-;HC3;92?F4*7>;8O?L&4S>X,K%%*>Y"B$ DJ9!L*]00+^T8(K7))-SG-H%NM'DHK: M$IC:IT06-<_S(:=&C"9#1IW@-)P(5(I=6B4^$Z*5&MI5>N>< ]VDY(5D=[Q( M ]5[*Z64MXQ//<0VUU,6"A*>C_^.H8U. M_#:/@W-$CTF*9OAS^"3V.U7*:4A;T?$Q% W1T1&4D!8@P&FC2*G"^ M$R-*19]SQ#=K7*P$\H*6@CO?D;0L^'^)T480A/V'UE^,GOF@@1(.[_G!@^"= MK4(C;226N$R*,HEPBCX27.QI?3)@!MQ3W.<9CO^^9]"SS_C=-P#:^TS+KJ5:(5? MLDK[/2%GA#P\(Z<4!4$..S[-.;E&I7]6[B0CHCK=BM<+7KUJT.I3KYS4O*5A M36A$FY+EH ."2!. 2A'6SGN.29)V.GI51O0F$,Q"4YOU32P!S2:"0$B$)J9&/Z#"9WYPM^;Q-:E'-> M/SU-C8.73M!;C4DCT+:RI%(J>.=;H4E5)+DPZDF?_=Q!GL4N--!*>CQI8(+: M.V*@$@/!!#,VQ:$")NV/"S_S'8DO-.$S+GM,:Y3VQ0D'R TO#*(@N&''-^9' M7\-7#9DZP6*FI<58P!<3U,":SA\^!='?2DCC+JZ%T.GF):9>O;3UZF6@7KTT M]NHEO%Z]=.K52T_^G-#Z%^W.7!+U[LDU8"4W/I(#T?L6<%H'3FB3N?86UA_J M>GFSK$SB)-V7R0OA,0K=B]PJE[J%1M4@50P=&J.L:6C0"\[( \!JZQWBGBI* M.EWXB0J/A(%-HI+$H@3QSUFB2=9T4_%=WMX&?ESB7B MM_/74YK1'L-V40+!GBE(QW1B7?X>>3[@^$"3%US:CREIY'RQQ@BS88E2" 0K M3,CD 47(>CJ7]+!?I4ED[WZEF+?>-X!L.U\A Z/O]<"DKA>BGGI^>,O*(E.G M!1@E??6_!6I# 8T8"!:8L6FOM:D#"R;ODPQLX'(D0T\R#!DDJ&HRM&( R3#& M9B,#DS]S,:B<_O:2I*G>(T@2W@H^J:&U)9Z&CT%TMAJ35,:ID7H+J[E7C(@X M*@D5APN*Q9I-A/B]@I3!DZ63J M4)VO^L:5 ;2J+* =-W'.I*31C&O.NCGC2\YU.B?[>=>IL4$UT.S8VAC-!%FK M%YQZ!X!53I-;)=0D=3.9,V?[;W=I_DI(<9U0$C&=8I;%3X2^)!%YH/E+8CXE M/47;VVF Z4UJ3P>XJX(@W72\TNF!Q@)J32!F ]5&4&O%$PT/8A\DTDWGVANA MV.',.B^?SGW@G\4/-U\)C9*"-9PUH;C-Z6)?%OQ\19)MQ/QEL;/?>'J8L0!E M! YLL*+BP$1+P?E^$OC*.@8BBB2U,;03UM ZIRCO[-5[NOGN['>PUJ![;3&N ME)FDO2V0V"&WBR1ZT> ,<\,GN=(!<5">G>XLC2,_C(MG)NEP_- OHNE%@?+# MNIA6NXR>ROD7U!0PF?04-S*0#T@4&;:!*ITP5+)(")WHPK5\$^:6O88)?.F+ MAZ.+#%K/EDX6*%DD@"YJ9*\3'$M??& 5)% &ZC2RD*ERAB@$U7X8M8; MF.G-RI(FJSUO _Z=R0K2''Y>H_+/27+?/E,$GJ[SR)QP;5IEC?=D-\9WJ$- M'<[NIEH)3NFCH8_)WC-33>TJ0VCUBC)A"I4Y*KDQM*ZMG7-&]X%DA.)TEL6S M>)MD25%2+%:?:UQ:U^FJZ,N)3FM(XT[=M(*S<#+4,>MJ9;&B-E1'C?ZY:X"_ M$%J0IS*/?GO:I8G^))56TE\%<"/4K@"X4@P$5\S8Y-,!0AH57!P57-[+77T) M*294 ++K>+ZQSPY_=&F?7@$$:5Q1:J[NX]675;6DSA'#%23Z=I._?!>3I*JC MR?[0E=!D__'Y*F> M*."/GOOJ8B6LIH\'#T%TL@J1-#5I9! 7"M7-UZ2(:"*6!$SM&(AY[W0%2*GO M>S*P*" #TS.A)QO(L3^233U9R3->PEF$%08WII'W[?J-L,=C@5(8!&E<$&I' MB[X2:K4"\6B697N<5B66#0T=BOEFC0KDF"Q]&5 <40#34J.2195P($;\UQ[3 MDM#TU4H*2=(W+S10Q]08B8%BAQJ;EB"M>%B.+"G.BH0[,"M)9%'OTPT-6&GJ M,9(#Q1,-./V4I)4/RY2G9Y*F5_EVAS.[0U$)^V:+'O"8+[(D*,9HX6DY(S10 MK0*'-J)(_S4+DQP;VY,/21X)MHD_K3!8"HT1.K*HNF&!ZP5B4G5I" NSJ8U# MDJ1O]FB@CGDS$@/%V+5$2E#"_(U@ MZD:7GF08LDA0U51IQ0 298S-1A,N'X0D5WM*!ZCU(XY>U-NFK 5LNS^KD0-! M% LX:=>V$A\0)= (=).52?EZFZ3D?J](_E"+^.*&#ES#B?%S$%S0@)).!PDQ MQ.50)1BDYYM=@JR\QUN5AU"+^66 &N20!4,90$Q0 M.PH9-%7#@((ZZ89Z(X MG6:6H)+(, M%;*@7VKH@ ZY,98"1 X-- T[:FGT-+\*.9(L\==YS(B:K)-(;#I;6**5]TL6 M"^PA9S3"@*AC1JAA$%-"0ZV01)IG44YW>2_=X2K?,P?X>I7'^@C%HN675$Y- M&%++J *(8"XX-30;J+ZK-+\Z$J:'T&3YL>#2,.K+82DS17[XX(N\R^JY&RM9!#*R%"5 MA.G$X-%%PF8C"U?@\0Q7"4D3$5@MJ"C:ED7ZD%DG'H0P&M!*UHQDX5%'#=#& MGS8@;O2"^IHJ*+=^)(U8&"\S!*EV,94,/)(,@5F=2R4=DA(/.;_*^?])=L:) MN%HX"#V4@)4D&4C"HXH*GHTPE0YB2B$FUC5=^8:&\BC9Z+F_(\ *6-T1X-Y# M$"10(9*/ %>K)Y60[V[F'*4$:SS"\+&W3E: :ONX]PQ&%\N I!X6WS63"?$A MW^4\1^HYS_0) K*(KY[6@6MZ>_P<1(]K0(U[78@A(1=H-?YK2;)"[;Y[S[R- M[&,X[4#>/ #1NV,TKEXTPFQY7 M"H'H?1.R,1-J6304]DR+ISQ-HJ1,LLU'S"]/P:I6J81\$4(/L&&#+ &""EI8 M4@F?5A UDIY)\$ ))R&_.5@< B193.ABO5:.]B9A7Z2P V[(H9<$01(K/,4= MSQ=13P-5*DCHA*7-O"CVA$XBCT(E$(6TX#5$DN0ATDD'TDJJ2C$DM^JZ9J\_ MO%\MDS)532YE$6]CD@9<.R*-GH/@A@;4F OB&2^.^L/[/ZS^B!HMS]U_GR\I M%M=UO&Y7>:JI/J64\D4" \2&!PH1$%30XQJSX3Y'M2BJ9$-4IQJ 531G]-P7 M 92PFJX?/ 31Z2I$TL<_Z.M +O_F:_3,;]_1'$A0B_EV_2J08_??EP%! 0,P M35W15]3(ACB0T U9&WL0L D6!&PL0< &8A"P<0T"-L&"@.9GJQ(A_,:E59IL ML*8XH5':-RD,D,?\4(B"HHH>G]9GM"JHT_%=T5*4.)MGZYQNQ>_?LC\H6JF1 M\U;3T@2S+6JI$@+!$1,RJ:QE572N)XRXM&]>[..D)'$%YC;)!H?<0$ITJM2:6H:M8E?JTO=2>I6 \0M)T_^=Y5^R)X*+ M/"-QM9:BVBDRR_O-F+' 'B;-:(1!T,D%H29UABM=_,:U4*-6KX0%8=*G/-UG M):;B+#E5>2:-G%_F:& .&3,2 L04-3(-0UIA5$F'.:!=58]H@RSN\)0E8,SB MGH]K&T&/3FTK90%QQ@A0=X:[KOG1Q<:55J CEB7A]T4D+^0:E[C&IFVO3MSW MH4H3Z/%I2I4L( H9 6K/3[8ZO%0,;C@5K&0,O6*AUB8W9(F/I/P7CI$@RK5C M6A% ]%#A,E20H:B1#<*%IRU.T\M]D62DT ]$(RF_7%!"'')A( *("RI<&BX( M4=3(!N'"S9;0#1O>/M#\2_EZWY71ZP/-(T)XEE71 M>BO;^INCME_.3&K2D$U.JH!X-@6OAH&="=2S\:XW8H5O3DW9SR9LRJ"(.%4M+JI7H'Z M!M"*YXC5)M"OW @25DY[?WFRIH5H9XF_YEF^?174O/C^QPM&T/4^33]SB>Y/ M%PSAYTY$4%?\O9!H\TH6ZS;9Y"&OECPT=]U/5?9!WL,:Q-D[33,X?0^"*Z4T M-JH\&7;=YACM:FWT*Z[U(3.WCBQF14'*PDI5C;1?;AHA#\FH% 7$/A,^W<4@ M6 A#IA0NGF=9S/]U\_L^><&I(GG2+NZ95$;0(U8I92'1R@10XA630BSL0Q'_ M ^GD 5-,K.BUF38189!7*=%S3"OOEV06V$.6:80!TC';R@'DV M\,]N7CSH:.@P"GKE3YF7.+US'P)U1XZXF98ZX ? >]9OD\(JO8)?+MF #VFE MDP;DH2P0Y1/-V<6;8=D#S7>$EJ\/K DE&^WY2+_;RDO%3AI^>6:%/B2:5AP0 MTVP8Y;(:E;R(O$@C_ YEY+2KO*?EW#PK62,2-FI7WY,8TY?/./N0Y_&7)-6_ M'P=-OQQT;LJ0BU8U0)QTQ3KF9J=7>T'XM'PA15FO13[M5T42)Y@FI/B_\R0K M/[&_W[.WR[Y*]A[R*,&E8:IPD"W?U#VXN6,R3S8$BMZ'HI<)WUA"2<8Y7XFS M*;%("TA SU'&,8YS,!0ZNG2+*J'-5S3XU%.6["T%E!;ZA"&-B2HP">) "_!4 MJ"?E=PE>)6E2,@?HNC6@5 FR(F( KUP>4<@#&NRL('7;!6FG 9APO+@484-U M?TGQ ;^*]<&EJ$A&GO:[79K(AYT/->*7E($G5-^2T.],)A]OP M&@/6[W8UDH X98"GWNG18Q ]K,8DW$DGL4OF+U=?;=JY'QUKA%FT\5*(1 =;4*F M*GS.A1&NI,_2[9)7.?MY5_H%6FT\>E;1->'( +9O".+<0F[H(=.+S@H4-A[=@N!S M#26'[_)LLV3A:K/:RF#K)\ F85]A]$4 ,4N&2[3M9U-99BD8E*KJGJFK6#+/AEX.2F M#=GIK Z(N5,QCUE]FU.2;+)ZS39Z166G@FAE'#292YQD)+[!-#/N,\F"OJFI M!CIFX% *%-&4T*2;N:)HO]U7^TEI7A1O(#2SQ!5A0C%3" 8M7A^@4H?J;SSZ MJB/,+':9]:F%@\3S2L#*J'X@"9-@2HS6F:$(U(JW3;\9BS!?BZ18K'DAO2W/ MMK_YNB-90:S32A=5SP>^G!LS.@QFU0,T6CJ#E2]*K11YR;E$J%8%!"KEMU%R MCL>D[,T_BYV*%Y+FHO1!W7YC)&O0\C^3L#9!GCUH50!1TP7GF)6-3KU;U&HU MO 1?0. )I^*D^$=,?R.\XK*-C7H%S\EI%N"C##6--"#Z62#*UXJG*2^0S8FW M;51:V@%FW >2$8I37IT@WB99PMTVWV&U$<^JYY=_CLT8TM"B!(B-;DC'I*RU MZC7 OM[)F*G>,F>_TWTQXQF(4L+;YK@:6KLC/GP=R7U%ES. \W7 M27F7%\4MZY?%CG!.9IL9OS34/&5UT/1>0,RM*5(A,;.:'^+]J2)>1C9\'6QI MG^"ZXI:.(C:28JT-,#6K/"5238:TKV$DY9=R2HA#>@U$@OLP,RYIH;^2J2>5 M\*ERE1>&6C5#H2!$&0!4\D1(P*-)'Y:.)6<-8\1B\&+-W=UBW=7N8D'8L+!7 M=4$@B6]S^G/!1VJQ8O>1E,_2U:"G,^LK8#KE2VBBK%/8#,[7$S=$F0?"5]"Y"3BOS\#)B5O99[Q\L>+M:[9RV=<_I*DZ7U>7I)'$J4LE$W6"?_BJP]Z M0?EW>T_*Q9J-#/8JG^?\3<_G[\__^D8'^<_W@X ^P/.W4@I.2K(MV""#2\2+ MVK-HFM\NU-KDP\Q.6$5L+(+^4>M>6?,N;'F\;8W__M^MZS1>APC=V^_#&/?. M]%K=AL\3_S@@)^"WQ5.2UM_@I]]X2Q=7.;E'IAF'\=$>\D+JMKDU=XB*)FI;S)C6M MU[XF@X9? EJA#QFH%0=$01M&J=@.EZ\V&M\\$Z^3=%]V1P"=N&C4\.]7P=6CST(ILY3F#'K[\W=)1L0R MI")912?H*Y/(#+3)#5)+!2>(%9JT&*P41K_R/R+Q9R,=SAMOVX]NO_?ZQJM- M6?:Z:&F>OXW0R4%,:JN0#V5SW>\+-OL\!:Q#-M4!C[VZ-:G)BUA0EAZG+2<" MXIH%HNN*WP3JP5TC@^0#3/ACC\01;(6:TMAE9%4@#)E8XB*,F6-"" N MJ7"IRI2)%'X6,(L)W&G.9JL3^[X7495"2_XA M]N6N]V29-^ 6:S$]+6[S-!4W43SM<"2V G&D*#UVYM_REO)_[M?5G@,XUP\% M_Q9\M$XN?C"TB>*]6!Y)I"^-^>G:LO#63P^SJVIKNK(/O4@"&YTH+U]_3:I_ M+Y]IOM\\BY>V8O\=/^!7/NOJO3)C)O@!QKQGAA_<8"E3?+*EX!_32> KS]=< M""41R; P!GI>AJ;UU46/A+(+X ]Z8[?09V<_"_ M!>VB[T'ZFLY:&P;+?I-X%$\N\&B8G#KU6:Q#"+,"D M/ACRF,>-'&=Q7DD&];_-WP52_;# 9 MG,JG;8?93W^I]=&,>^F\MM%?'T)_>")51(+^]=OW1Q=#5>^H]I>O%MEXDT M MXFT750.NW3\=/0?!'PTHTYK@$XD8T\I7=+G/XI1,[?S0^Z<_!M@_O;,6"/XMST)ICEGABFA-==Z&[6# MVT;R0F@_%R2>9XIR:/9CK!/->#X <% C1_N>DVP 8O1!P*7PIJ.UN,(\;POA MX=:$\10HE'05O^.9TYVW"G32#XVI])*MGZ&;U?T M7"_?L2&C:OD6+7BT)M3LND:H.M5O1T0R&I MZ]Y0$Y7M5@"-=0="E_+U>XI5T6FA^H^W1O1JI:Y9N9M7I\#;P?^11"1Y$=<+ M.[_0"1;#4G]RT\W?@+,YP!_#U#8H:I8)37Z%3_6G/_*C ;G(;*2=^IOY0,9+ MVG->'2'F=\>(5]-9@_4!F!L][0M0VWI#GX"Q :9OH!H%_KM\ R[7#DXW!)#WUNL* MIUIY:URWWW#8*'0L[]UV^(:)?DTH"]CX)3I5$?H$IZ>@O^AVUK\3>7#XD\ M]5X6U@--V/,=3F=;7N%>E8MWM$5?.^LG:GJS$7^DN>!\/UT;U)=W<&XWUW7J[QAI?1N+F/!!^GI6$OZ6:*7.IFGT%,&K@Q_J10.#-/Y[GHIO_6@LVF$\ ME%.3U.[*J J"=M/Q6N(_Z?S%^6ZXFF?]DDRD?Y-1?-7<,J3)[YVF[_7.JJG- M&EQ.Y:H,97OZ4.#!;IW2)MX.#\#2ZX22B&DK"QH9Q7TFY-I ]Y-S=;*08C ' MG/;S_*(:1-RHG<=_#0]&UW?@JJYDM$I[\TUVR*TGTHM"(HL=IN1E1@?.T05* MZ^N+(ZX&>'70+2OPR*1"F'F>Q^1W0JM1/@FU*JNPS5=&>Y[1Q=>X%:F=;XO( MV0R.M!#?8"#X;.1*X+8$Y:2RX)C"'OHN/O=-GS,]9LND] M^T++UP?6OG*6Q?PPS([/V*[:NPAFA>(%:=_O*4Q[OOOO9"]CE"=^M%TH\:"\JTV_0SMN7.1,DL;\62+FJZ9$$(FOR0M)\ZHE+.J:]AD<:B#^X.M^@Y8C^VZ:- _5!S4**8TS5%"LLK>SPJ%PD$;R1;D4U. M(D)BX1_J*AN7>1878JN135:NR8JU:B^723O,A/>[ZBRLZ3%59DI3>MDR+FK!23<=JSO7 M5/5[WH@?[6JS-?6LG#Y6E5HX?ZEOA-Y'RCK!*3H1J&E7NBDNYM'I&3+!Q[<. M'&HDK"MT::#9*YHL!&??4;!-7(Q;=46F_^L;\9-M@N7A\[##K(7SJI.;K'>V MSJ:"?P6GP6\.'?J9_X#I_TAV[;SS>/H?:,TO_8]J\I#^!YF"M_1P3#/DM-]= MM_!PRH] DV3^PD>@>JWC-J=514CU;,PD["^%W :XRQC720;WGT[PQL2H%5!# M#YY,6=TF6I="+0A!]U4IU!^.KH/K=X5J6!QXRDK(6#/X>I2Z*=9EJ*%:<(9. MQ^J0_LLK?+S!VX77&U!J]RS5W4-KP&Q(ILDXX>\1 XA]+M6;]9K$I6+]XJ@6W&-,QRJME.QVC%#)5S1#__Q/__[^AQ_^@IC!"\' WKR3%YFAS96W M%?6.3GI3I]CW+D1J]X3&-R(IWH*CGK?4^2G-:-/D791 <&X*4O.E5>VVG>+. MJA,OTUGYIKN R_("]&HAV&9KA(IL.AUP7+, =;P?3<>T\UZ,IKF*4R2EZ;?# M)W+Q&,,AV'K\BU#Q^7"KX!A_=%,FW.W*(TYS;H7BTSG+MR)=\,G:/L$[3U/W MQ?M#&M6P>XHN" X? -CA]E9!48,?/[OC'M>CFNB>[>HAG+!KHU2NUJ8+@HP' M #[@@O<3 AB*Y6(9)3R9KBI'R,O^I=/ABFYS\2S <@3;\/GOKJ=06DIL][CT#T MN(QGW-^U1)C.;4*2)?E:7C*#OQG"EIZ,[[!.@C>.[UH!$)VN0^40\55A'N*: M2*CZ9L15_D12$I4DKHEYC[>J&%\CYXL91I@-.Y1"(!AB0B;/!'D5WU?4:*#& M8W =S^S@/QFW(>ABO4XB-DF]S4S^PT''%VNBMV)7\-YH@="Z >:[W-9DP# M"154Z\#@497'%+<-,O/(*.UM=+-#;L-=I8$Z/L'@T0/)ESSW M5\S?MN-L)*6$/[^CA-;YFL%C$+Q08Y)\RLT"";'A1+BZL=2&CD0 M'+* DV9.>7;!J7//G<\+H7A#P(Q3_::(5O1GFO YX-]F#8TPF#X)<+0O,64Y]K XY!& FKP@N? MFLOV9D6QWXK4K.OV9)&9=5,->$M9.*AA;2[#)&T01#T(LI3]((R@U@KJS*#. M#HP@;NSM/Q4B0A!97\]Y&A/Z6)J7HB8:\+?WU<&S5-T+/45D'*#.U0"?RD1?5 MJ S!8J"T/#IZ+= S%1UEG3 M%ULG-J4AJJ,:"(Y.PSJFIW;D_E3T]K!@>=%%^4SH00Y4HQG.=QJ;HG>;2C40 M;)R&=:*S%*9 >$B\VJ>8\ON'K1F(!EEO7M &M_5[.D$0W+*ADWQ;)8^X0OC< M1(6?5B]HZP0#CIF*Y6NU% R>F* Y#X"!MNF;<=N5+58-[^EC;ORQB(,@DAM& M0RJ93W*M<;$2[=H7%QN,=S7#TK)H_J:C6OT7G]OY]EU>C ](:&1\T,D(CQ-( M*1"<,B94JK*?]0K%'[C8']&L+&FRVI=BF"IS%O70$]S,>VP"O=KIJ,6"I<\K MW(M*)CA!+,"<<^>##$TB^.:G/8S,4$KY(H8!8L,+A0@(6NAQC5E138+ZQVZ" MTJ([%:CDP_"Q_Y.5,@/ZST!TO0+0A&.5H;))-2>KVB<>\T55IZ?JOP;1P4,L MJA30 (>AS ?D@AR+,QR&@W8$SG[P+>0YMSS[P.+0&L$U*2*:B"P#XT$W!R6/ MF72.#>@ETUDT0-#&&:8JI>[#;/;0CO4]W9 +H;,X3C@&G/[+]^]?NHHOYE0Z MJXZ_.,$1?A<\6!1 T,P5I1QF-'J(*?[AY8_#&C[A\N@HY3'/(XGR%T)?=96; MU&+>- M449DJ=5#QK)/Y6\/-%K094%OBC+9"F0?2?FN:GYXM241C3\\>RK9,_1 $WX[)47+IT?4F4"5C9#D6^Q+-I9F,;^8T#:0&62][>?8X+:[ M.CI!$(2RH9-V>#IY!', [#7C/B__1MI8CAB=F)M:@(C)V@A%'*75 <&Y"4 G MQUS,(&(64699K-G3T GZXIL9:,,PM10(3AFAC5E4"[>K M0>]0KPIP@$V1$?CK/5GF-U\YJ\-CZB>"_2K&HK_)Z"GIUW8<9553,_)7DJ_.YB_5.^)5<<%GV]PU_?K).H;OD2?[TD M&5DG9>%.9+N9D&1V;:2)T#8;8$GM"-R5V&-SG-_,(&HLPN V&SQ8:^KVSK<[ M?G4H UQ?,6:8"1UH)Q"[IS530V\W(Q#Y/0FY/0[NF>.L'AL$LCYDGT^9A .L M$%GF57I)$)2SPC,M$D&98RD:X;2^* D'I(]]A7$D"94^[FN,[=@;?F&QOSV< MD^(^+Q_YA>ZT]<6F076*[<&J;;RS9H@&#@9KG&;GUD0RXRUC7Y.4;A< M1Y[L5%RE><'"W8_9+N')<;I<-).PMP5N*^!V65LK"8);5GC2$K900$(#)1E: M)ELQJ_AX_S#OY3069TE1.^0@I@"\9#^@2%?3R/@\B*F$US^(.1 (SAD3*B55 M$!<*=#>=P+C=M+0V[9_I9;WZ%!/<@4M1"09GAPLZ#4N2+8^71EXD^)C$VV%- M(-%*>F>..4U$(P:+-4[)($/.!,_]:, _4!*7=)O%MRG>&!HYDO--$R7,,4D& M0J HHD)F) A7Z.VG<[600]%55L341I&Q8(A!2 :J&H$Z*5 L44*SCSU7>58D M,:&AB?)3_J5K@+; M7&0P?<*IQA,9I;V=6[9#;L\QZT5!\,F.3SKG/ J&A29:YW2XFLB+GI. WDJY M>F!U63:M\"LY9N=E5@'!.'><1R[R!"S]IVRC?F/-+!Z42+1GB9E0C0Y-099K[0RP1UP2B4(AU &=.J8BRD0IL$# M^4XI4 H_!W3SE4;BM(JNA3T!KP21@ U8T3Z%0X4Q)'7_WWPE-$J8/Q&B(7K\ M \75R>U;G% 1E.E:I)+TR@$]U $99#$XK-!B4]-#B%?'X[E"%31[9LG0I[U^ M_*T47+UZSC8/D6I,L2GXXHP;\(8Z9FD0#'*".":2/,*\HH^8_D;*^EAB=4'U M.UY ,/)?7W1)L3@&1^DESV_2[9ZKQ;P5P#: ;,M?*V1 L,8 3"I]78DB)LLY MP3,O6#2[>NT'M&%JN'2-T)1O&0OXIX:J:,OP*3 Z&/; %40(LQG^L:3IDM!M ML5@O:EOZL@-N5/ZTD")Y8X4GK?BQ*H0GS$$)+I.?++/+N-CAR M_<+*Z+D_IZ& U?F,WD,05% ADNH1^E_G:&$MDU(3- P%O'?O )C4O^(IK [N M0Y+&!/[,=_;O/B4_?+_ZUQ_XLU0VR1>M1@(&IBQ2>FY M3!IQ\8L?!G%"K>F_Q*T[64S"'DO:.E)&+PF"-59XJM*UL,A3^3_QV_K:?RHA MOR.*"N!P5.E+@""'%I9<:3;?A2KAUZ?ODFZSTF60Z0N&&&-DH*HAII,"00])Q (QJD MQWNI 9O-[ 4GJ>;.3Y.T7RX8(0^)H10%Q!(3/GW5.R'(=ST\,V9>I=_6RZ@/ M>9I$#/D#S:.[)"/SDFQ5.R%.6KX8-*$)#9,<5$ PRAWGF%FU9KL^WN@BG,6( M&R!QE:;(#2%AR?>^2]NXN-\P\ZJ*@XYWVMG@2Z33*<"BG 7EH82K+87)RE8W M[CXO:U2FG;\)NF$I:&B.F8H*1<"4U*,]E)J\]D-+SQ,F;A?;KX*&W__;C]\+ M*CY]_.OG#R0C%*>S55'R2DRC9BLE?-#* (V31_$X.$7TF,9$J*5.ZG22-2T$ MR!)_S;-\^RII^EG+M']Z2+*Z>=.1/!!_+V0Z%*\%^L:[3P3 M=Z[RV<1LE>_+6S:CS*($IT]-Y9*B*>Z5T]?1NSFI91_\.\.KX+P]H=G@?#]] M6Z3OY.;^YG%V=Q:_]Y1L,E%@,2MG4<1ST'N1K<$;.NKY\I&3FM%X3B>EX/R: MBE2ZCZ+319UR.^J>A57]+^%IO]UB^LK^8&J$WF>>P)XO%IZDV0T[CS(&@K6G M:('$YOF'^_GM_&IVOT2SJZO%S_?+^?T']+"XFU_-;YX QQ(LG&7?:A:+N]M[ M#1T,$4I_>Z -O_'! +^T\WC\OYY=T- MNE\L03OJ?FNO"4U>V/?W0D[!Y@G6PO%Z?7<[OYLN_G3D4;[+U;UXX M^NL]Y8$7^YL\-LSSIJG[#[3=&R7'U7;=X+P\$+#VH$:EB2I55.F>?0:H@KU\ M)M6ONT_\W,V$F.]-;:1JFN=J Q@M)P.7Z#E;,L?(7.'-IYO[Y1.Z_OF13^J6 M/]V@!_9@<7V>I:]G3,ESGL:$%C>_[Y/RU;3>91#VMLAE!=RN;&DE05#'"D^: M]?<44*7Q1@)(@?P*[Y(2IX^D(/2E-UT4#9EG[-LA13DUF#S0/-3XL[%G,^_?,__?O['_['7]#-?_U\KCBSV?++XEF\ M3;*$?\\\"_6IA> U>S>(J:/A@::^Q2/WEOP MN[.K>Q$';NFH)0(MWAZXC-D)&(]P(3K^]IJ MC6"V9G'L(]GEM&P7L:8.M(Z6PHVQDYJJ'UZ=S B\J'8Q_3N593.UXA42Y>8 MFT*TL85VPACZM>0)HJO35_8]WX=PGVS^MM3B]QD12+]0/[ M;G%U%,^R[G^.@9+3CC ;_>D[=$NDH9E'LQ>0:HWV6E/Q/Z\802CI+00:41S;CIP69 M1;_ODR+A8DN*LP)'QT\?W$U#&4RFO@S7H<35;O!/X0R-D6^?%^IL_&CU4=D9 M"/D1/)5Y]-L3&^4,:2+'FP-&=F.C)Q)<:>LMD=K4 !V1"ZZ#"JX$.0#J)\!T MI\/FV0LI2C'\S+.G_:I(X@13XTSB1#8#ID@=UGQ#LC^RB.UV M7[+GUTFZ%[D+ZS6)RON"KE)<%*089JQ.'9CM1L)]_JX-U'^\ M-@M /SU'V*;!562CH*O9PWQY?-427YOQ^^V*T%D6_T*2S3/[1FI>LF<9B7Q8ESGC5N'-\A\?],+R/\Q0O M\ROOK'/^ 1--7W;U5?]A)8+=//QX6[QMYN;ZACYT\WCI_G5#7IX7'R: M\_,]:/'S\FG)'LWO/YS]..\U*7&2\FA[6-OLX&,4Y_B!$$> 3_=B5(>#C[<> M_.LZ6Y-,7Y&'HQF^,J\*'-ND7ZF&"B M%;^T/ZB)0[I/,@&(YH?@E@KM538XMP=6 )/Z@>;B3 O?LEE\89%_\9SLFCH7 MO0];3^@)%OR2>7+3AD1V5@=$XJF8QP1F@4S$/#K>$,353WMKWVF)6RT+U:NW MAQU]3(*>AS<-T-$H M-I(*3APK-"E-?KM+$Q*C%RY[%L_Q2&*R%7L$W?BW6%_NBR0C17&5;U?UQ:6* M;V""KB_?,KDYC;-Q5@Q.HD/0RGFZC3Y/!&K"'C94K6H3*.ILG(EW]0[6[3Z+ MV2QZ2?=% M2UZ-M/W"P\)]7N75E6YUWAV7PF*ZRCZ!;9X)5=7@?;1);['2B1K?QE1'V@/! MW!,U0E[!Z*F*+,Q:F?\Y$NK5P8:31G!K7*Q$N_?%Q0;C77UC95H6S=]T5U?6 M?_%Y%L=)=?+Z 2E57:!XD=(7-^6D2#4\\-GW1$N)5&426(*$[8 M*+LYB[>\Q4D565[B@L2+[+_V>WE*+!R>>&;\PX(?NNOHAN5\N*N^F^8$KQ"2I!G)%F8BK"9QC9"Z%E MPJ#WCI%I7X]%RR_MG)HPI)]1!1 -77!JRY-$G=8IRY*<][9/,=N8;15#L5[, M^YV="I#2M9P]&4"$4@*3=I-IDD7)CLWV\!;X*'F94YI_X9FA'W')!WM]OH-* MU"]S]&"'[)'E #%("TYQ?9IXC&)<0MXX[!K4)%P\,L .[1^*AZ*2"K2.3GU9 MD)12 )2&MUH$T1/02KTFD'PE<37D%GR72K?FI!3SMC)@ -DN#BAD@G>[!9BT M1,!%ZU"F$'M^9UL+XDFN?+A3?/[R8Y])^6-0_>S[YAF(?E4 4F42[6P-)FC MC>^V?K)GG3(=F'?Y'LH!1@>,TD(.;K;7VI)9@"?BPYJ>NQW-T)3396Z'7]3?# ML_P$X[^-(_R8"MGR7!##^I%%/@!/]+ 53)&%H7%%B]">BDA;U;>0QS.H$)84 M>+.A9%,?). W&V1[YEZ$O"'&8W M^/=QAL:8B\7$ ]/\;VAE'/%>XWZY,E_5"H^:'SA571FEFWZ@>41(7/#VW>4X M*WB52KV7-HO[@ N+AI02K?, MMJ)H6\L"Z(2#$V) =X82J;Y#WKE/B"#M;H#I @L^\ZXD'^0">:5)6X6@WK82 MF?R>>274T"_A7-T)%RY .4,WJ.,>^K6:/?W9J'WQO7%. M=5Z_V8OZNUA%7)Z3K!,2SXKZ1MYL,XO*Y$6GD4S7$/$E:]>+! MJ+6(<-%<6)QM$&Z-!J/%R0]P >QF-\!2 89ZY834)W$,Q[K.6:+/:2T[Y *V MW?D#7:IV7I]^G+8:?=;O]^\'-SI%Q0=W3I7GRXQUU:9']A#-]5G]?Q+._DL"-?%3[/#B=#*"D(M%,(.PB?ZPHG:P1@3,- MMP'4S'Q&$Q[[_CGD-5MPJ0M&E.,>J<^2# I)G'$:RJ_K:CRP]4HCO:RW<^@V MN&W"EDXPN!-T02<=3N_)-T/IJ4Y)*VG14+;9Z5'>?682]$4(,]"HI$%0P M0M-OYS0;:^?<2FW]5H]]VKI$)F'?9- #'A-"EH0RDCNA],8/7X=KY]ENSXLO M+5K7F&2;CWE,TH./V$XT&?"@[4&--QRWG60ON#,\82/4,17:5$*GG'2:BC)U M]TKPR4R3=JWXS"WRGLLVF6&/DK/5PL&YY(I04^FI?Y4'BI@:(K6>CV"+XTQ) M4318'<(NA4J@ $P+7A.*2?(@N.,(TCK\"O)PS99 YXG4E%SO(W;]/H8Z03V/ M"K[1^_050+#(%:6K%QH0"7!$-ZB2J!BEWW__PY^T@[^;LM\H;4J#AO&8BR:4 M&<=!J ^O>>DOKO9;J0G@6O 1K9#[M])&+ZTZC$[V7Z4(>D=/;8>^8!'P\ES] M8RE\^8Q-$,5=2%5NH+Z ?6K3]">/C.K!XZ7#,4M!."G9X%/9.$_J M GX5OW^;5VOVVK5QG:"WU 0CT#8502D5G!!6:/*.<7?K*T%KG\OSW#0 MR"SN?5W< %I:&5?(@B"% T#;*9AZ4?QDM;*,I=E9Q)14=UU?JR_KT GZ+M>N M!CJNQC"4 L$((S1M,7?22I_DUB?U-2VJP+OY-Z\>8=S0.,B"M\M>#FM:>Q_, M-'40/#L,LW8&=8K;!,ZZBE/AO$Y>DIAD\:SH>@9HZ7>289 M"<[F8Y%K.1W79M!K0M+SK'7/XKBZ%[*:$-SNLWAP5KW&K_A^G35]^=")36E\ MIZ-:<)9-QRK%]+WZ ;N6EX"=)@-<0VZ*.T M8IUX<-JY8]26L(@1K25/=*VL:2&!?0^X>-:[+;68YT4$)/=^A%=DD6<9KNZUP>HK#IK[&V^&T>%ZE9:\P<_IU(#'CRXP;4-?G*;^R3:),D3_A1.-L,_UE,;+[]PW T MZ.?3^%/U:635+-EMP#B\,0[?R LI+)_(VQO^_28650' 3>;8FS;0$P, (O[M M,OJ?:6XA&O&T]RG:8Z[9^QCSD\_V>WZ'KC._MJ'#.]./P9PGG;>Q4CK# MN%P8&21@O^M[VS7GZ:P%/^WN )DUG M;Z3YDL&L&HUYTK5T;1-M?I9?@MO\+DK9#XO1NQ?WB@SN-CO&X4K"X >#!\Y2 M\Q;=B[Q93 0L]>;4.$/!-Z,^E)2A([ #+?YVEJ0\O[=*N.4>V[ :9@]C_P/Y M9N!C'?J4B<*!QH/."HYZ(<8IP$&6 7TH)VR.-:8_<, /[B7!+.'X73&=?KIC M>DOT_I=TMLYYNX\S_WMMLWC.TYGU5M_JA"^AK89U IO!Z7[BAASI(:5/PL5# M'OQEW'S=,;"XJN5TRZ LGW%5J;OXB>%]P/03OP--\<:<-7WQ>V)3VFOEW=1 ML'0:5D5UHD:;$VW-]%')##1GIY^9";3#U'[MW<%T:PK9<';?YZ7R!B6%C"\* M:>$U9)$$0-!"ATI71DCXEHP+GK7BXRR*2%I7G9F)\C$JQVL0]EWY40]X7/U1 ME@1!!"L\;15(W-,X9ZV?9FFDN^A-Z>9D(7^CB Y@-V",)4#TO1:6=G6J=SV: MAWHKBZRY]N,2%XF]2+ D'Z;*B@:VNL#*2!@$+UP06LNJ,*?0WKRRXHKG*00V M*GG.\U\8\#*/?E,TS"CMK2R8'7);'4PO"H(H=GQ2K;!: _'W(4KOB,O,.6VX MUIE*":_*!YID4;+#J3:J4$KY*PFLA=B5_95$H.R#F.')%*BE'((&+_[ZB*KN MH$ZO.R&5SJ]7WMI'6?<&GZI8UZ*^1KV"TQ72-31SFAG?H< AC1Q3;HH-$./! M$<#U\82Z/AO*:WM-O/$FBMP.ZJ!7ZX!\C5!Q.E:?N#'!1, ;>9T:9[A*RJ@? MG.Q'@%;?L%N\@9)5-]M=FK\2PN"K^D2*DGG\1_+[/J%D<*W1U),"1]L- MZ%$/?PT&-SO=**!/X30M&7\RM2%4Y4.?\LIS?XD^MSBI]G5FY4>">=(E;_"U M^6)'6P[(1*-!$WL.>@'&A)Y)%@%])"=HQO@+X39.L^/G*>5^5I8T6>TK1U$/ MF,7EZSTNV>-EOGPF";W=9Q$7<,^J/\!JN,3Y@U^!/C=^LDE 7\4IVF'.<,>= MU2I'H[*+5J\H$Y91F:.2VT;KVOBI,MB5JR]+]DD76/S.55ZH5D E"5]K)AIH MS7+(Z'%P%NDQC1G1DT(1$SNINUSC8B70[HN+#<8[X2V_(VE9-'\C2" (4/_% MYUDL=O,+%M^H9V\F01]TL /EK-!+!2>'%9IT64?YEG*#YFA1% MPB\7NR7$NI"CE?=^H[<)MG1_MTH8$./,"!4;IZTT*@A]22+0*SB_L+E&,R9!SQ-'#=#19' D!8A'&FARWM:&WY?$1I:B%D2T6AP$S"(60+V0 MU.:?1E)^^:.$."3/0 00#:)C2ZRH%_&Z( .23.6 M L0;#;0Q=5HQP*1Y)#N<4.X^/^(D*TGF0B"SDE\RN31@2"R3!B"2.<"4ME+7 M:Q85B3%NV^D 9M\UV5$2)572=1;/MCF?"8K_M''01=7W9I5K8\;[438]*$E6 M!V"6U@A[BH*H6*C^ _J4<5$^$UHWK5D:U;X=M;!?-IH #_FGD@3D!PWP)/_' M1<.M$GT@&:$XY=]#O$VRA-^<4R8OYM'(HN1YC:C,2YR:/WU7P%(@S4T'ZQN^ M?)"4=WFAF=]VSS__B]\W;K\I0(%-RA8D)4J90+OK(LZK51LL*/_">JS@FS#\ MOZ[R[0YGK\%ZXCI)]VS2?8,I/\];\&8]D&K!4;?EIE6 DW\\#:Z\]%Z&TD3]0.=_'=KEN:(OUDY^%![ M*&+KH?VLJQDTS%4&'.>-7D35<-?[R6*6M%%O=$8*STI8(X.2A?F&18[=WR?]85OU,W6+*1X)#L^KP5UL,O5-?9Q_GDCE$^?+&K-+A/B9G&F8[ \Y7R>!:_ M\-5NQ;^*$;")12 M/D^N:R#V3ZZ/1()_U&9<\JK]JN25UVK1TPP;RA[_0/EZ25TD08%Y]-Q7+RMA M-?T[> BB9U6(QGTJ9%A/5D(!BA <6/,A?-*D#9GRZ]FU51^*DY2*.CH5^B[' M6<%&=,744"WB,_U9!:Z?^-Q_'IP/!E!C*@@1M*MDSN) F[3IQ9>,Q,8Z$EI) M7T[5 K5Q AJQX-UNQR8G!%728D"."8B;CH91@7<=4.NQLE Q3/E""JJY$U8J!^.3-V*S% M J-&(4 =>#J(^$PI95.B_SG.(^\]0?[K3UWG>+W M5>N@;F"EU=%*#35ZJ*>(?JU4C4O>9^HK0:]YUD\N(,5B/6/#!4^J(W&5W9&0 MXIY(LZE)RJ!Z\1#DZG-J289(;45L^!&1%X-;0^((F["$,E)^&Z"+'TE,MJ(* M01=/+M:7^R+)2,$\RW:59(/WU'2OLR*HKIV*6EYC;O1[\33OTU5M@O=H8R-$ M?]ZQWWUFG"O5WG3T&%3?J+%)<]I&*J1C5!!FMJ%$%/=0OWB[!JB^<(8[[IY& M$?4T4:L:LL_:&T-N]UEXI]D[XDTA8 MJNH^A^YBQ\Y\"]TVM8-"=\.@B!M/HH]X]G#][R6A6WVMK@/4077;8=CE[976 M2E-HB.MW?RB9I?:2W+K,:(B>GL5Q*>H7W/R^3\I7/D!PNE87S*Q24O-RW,.. M:J!Z=AIFN21,K8V(4!?C8O6MMA:::#^(YZR6:UF+I98"U1]&B+H;PKA/$M(A MIU3]"TG$7C._U%[S>9AD076' U#S-2NIV'7GN?XA/X]+FL0;PAO0SKXUGXA> M$E2_6&%*2Q%"070'PJT*^G4;['NY27ER^QW)^/DX=6(,UW5<']W^$<)_>3P2":DK#T%^Q%FU7QM3(;[+ M>K[=O[4F(VJW:! %U7UVG-K+'NN5NHR$'*' 7D$.J9-/V*!S746.^&\$<=MU MR'OS=9=4E]6J4JK44K ZV011>TLO::5%JE7(-0OO5Z)!ZKTC&G#"J]'"SOOX MQ/6:T.1%%,RY37AYMH2[)KQ*TJ3DZ2O,E$@YD@*HPZR HL!133#,):NI?=S: M0^O&('/+K45^J!G5-B&LCEVI^UDC!JHCS1A-"V0BH3ED+S3C@N;MCQZ#>NMJ M;-J!+^!+'AX@U;QJI1"H%VY"J#@.VS\-&_+MW^79AF^>UB>1N"O5=(%>$E0_ M6&'*IZQ8$"!V?>N35L&=_UU2U>:HJTA+'3%\#.OM*[')28!UK9!:#'J@I?DB M#C !JK,.QW]\?!7P\Q*3"C:[%]D"BTP^0CAZ#JK/-."DPX-<3"PQ5#D1>19D M-B,2JZI)W/6>MK6%Q)5ZCR3"NZ3$:5W/]WI/ECF7Y4-BLQA^FZ=I_H4I/NUP MU+L@:MQG9_LA4)U_[E9*IR#X[S7SYEC\8E/(25QHB.CH1YF0*"29U+_;VYI8 M-S^-"O;;J.Q^W$C,@T^TF=Y55\=BD&-\ET G:X566\ZPD#$RYR.X(5JR] MF*5!=;H35#F9OE42Y4626HU-(%$J%,,L$>; \6.T[3%-N)VR^7-[DBSJ#:8#G85(G%E/CQ9'@D/ M^7"I7#PQ$\.H"I@$+K@M'6XT$:QHD CHQ2%VU75+)CE0O64!J:GZ4\UFJH3> M]HJ/,-^7R ^H3U0ROE7;/HH9JUX25']88L>.4/I31%@Y*ZQU]'MF$FB*VQ_YZP3F)1.'$RWT6,Y. M:J"Z:QIF\V''P49=;0&MA GK!W;$'0Q= WH!DZ6I TE_MS(8H:IHU!,#2QL9 MHYDF_=#S/)QH;_\8[*[7FV>2:O8XW M'Z2E)A63J/YT.V.ZS #;WGF'W*W3G M.:>"3OH\#[<*E@!'-\E,D=6D1%HH;D!**>C57+'Q98HN*%8< %Q[>+S+H!@4 MG@'2O>:D.'=W8-,%U;T' #=_VLJ$/P"]VRPS^=7.=U92H(/I$!UAQ&BJD XJBJ$,W'$ MY8/>H?#QKU<)Y1>!TYM(7%'[D.)RG=/MP_)&_Z$X:8'JI$F0I<_GXU]1HXUJ M==3HLV_I)O2WQ/X_Y[DP67R7;).2Z/M-)0:MHPP853U3BZ-:/G0_%!23U/3I MC"3 O7TE/.6+%Y+!N3\<#:]PAF/L.L:/I&'UA0M4ZTA?J0'KI%O*=V5<.VDD M#;F3U%"MG52I!>^DCW^])%5EI^*A?#7Y,*4,870G?$W_(S3 M?(N7)'K.\C3?)*289Y&Z1XS"H+K%!>FX;QH=U%="3"MD_RSIGGS(TYC-@HN< MS7OW6],G8Y8&U4-.4,==Q)40UT*=&H2OZ#YGHQ]/2.-5&UZ([OXCC1BH?C%C M5.V-M>)(R$.IQ=TE=9C6E]U264P60/7>P?#=$US,:^D SZX5"8-3(6F>[*1S8<"CT!4!5PN1=DA'+C75:05!];$,I[9A4N9]< M <:U=-=)$:5YL:<\!6^_W6+ZROZ0;+)DG40X:RYSX^S-TR1B<=G-UQUK$D^+ MDESX4<9 ]>LI6B)=W=3:1(LUJJV*/W9V46<8-991SW3P.[M^]S>DE+I)B ML19%X2JG8Z+(,<9@4>0$+3'=[L6(,2;#*V)VD3#,'_=,0^?(;+=C?\+*YQ:? M-F-4[ HP:2B?]2U.J)B+-C4 )*V$\QJ,+O&";.APU9[Y9VE]TTD+5$=.@BRM8];*S4%D MWF/]HN%Q9R%$)W[$]#=2BKMQJLU:%NS^1-)X>(G]N!/=M$!UXB3(XT[LE)OC ME7Q.\,S449*ADAM N+)PGG-UUV15-K6?'GM7^0Q"KK&(K[-T.G!=A#M\#HH7 M&G!RQ+DJNS):--"M0AS%J"")ZF6/1,"];S4^Y2L?%T@),_G^2N(N"UP=H"AD M0+UW T!YVLU$^R7_@H48?*V8][K2J_2>@7K3"F"J-7 N$LR1="=KNE\+-#>S=-F+0 M2XZ?]JLVG#?77=()@NH=&TII::D)&G+41FB5,BDLA][\[&U;V4K, M&D1!]:X=IWE/3BHL$+A?9 =DZ!E9&&K?:)&:>X=V_C5D)-W('G%_.U.'> M\"FH5ZZ$IIEEHEG(@*X&<6E\Q9=P7_&ETRN^!)*)Q*:Z>3KH1*T+'6'@ !CWJ<0YU'6,%-C?8*%\\I*8IF+=,VIDKRH#K#$:QUG!65 M8+EF>W%?D"&W?S+HFI0X24D\SWB=(/$"9JM\7WX@&:$XG67Q+-XF6<(KU/)C MF_55*XXGJ(ZW#HH'9VF:^8Q5\S.H]SM(_!"J?PFQGT+#WT+UCX5>*>AE;/.K M#,9,&3T&U=5J;'))@2XEG=^[$":O:$THF^)6,R]UC*>2 ?6Z#0#E9;-*%%6R M(:.^NNKH8E\6)>Z82A M]XV$U*EWN!:L_KEE+\NU>SI9X+TC 77I'*X$K&]81.'<-ZTL]+X9 W7J&QY; M :ET<)<719/1XQB-:U1 ]90[7G/?#NRCH/TCRG>T!^K&'3)\"JH'E-#D,F:D?]POU*$AR^D5A0BH5ZW'ISPT M!.'H2IL>1VC]V5D2!$=RH-Z_!:0V-9#%3HW/"3AB?Z \"*SK"8[?_^ AJ)>N M0C9^TT*&D;P2"GCO2$**YK"-)2/6J@"J$US1:DI?\V/"[0EP$$FR-]M=FK\2 MPN\Y>B+T11QISU]XI43-PJ]= U2/.<.5SDPTBF(WI%9%K6[(3INS\8Q-?^CB M2T9B-B.->/LWTC"N$0/5/6:,XSYII%'.Q?EAHEH^2*1:W9U:W.:4L6*;%$5. M7Y4YJWI)4'UAA2E%L[6"N,!]UZJ$RU?EX=Y'7(I;!JXUI0?ZST&]?@TX94B[ MK>50'.C$<)NH*7;,Z@QG?4[&2 S4>S=C-"2<5IN%4:,0Y$1C,TA=)Y1$S#,> M,([;54%UUW3<^I&]-0%OC.^O6C.O0&B"4U'/OKXJ>OE,JLK9CBOUKC9 ]?41 M#3"OY3?&JBL"&!&JBN','JH,AE[>_UM.?WM)TE2S339Z#*K3U-BDVTT:J:"W MF7QA[7AM_IG/,QY.\LPJ49#\@0'6W&OBJ >J7R:"'G?8^^_?OT>M$JIKMG.U MH'O+@U(>^EP9M1BH_C%CE#:3FTHD=YE#*+(I(6M_3HZYIJ)<$U3U6F-KZ,;BG M$;#089,^8*^4!+Q(DGM]I,"5D89+48NL2;81EYN8U]9&PJ#ZP06I=9V-GX=H M$HA67/$\I74?Q&URTAF_05PXDO!56%<#K8NK!X]!,4"-38Z?A93;)WAX#^]7 M:1*9.G@DX*U_E<"Z2NG]I[!Z5P5-KGS.A8*ZU]X&EW!%ZMH,:BE8+]P$T;A+ M5^7ZA:O-4"4H]BOHCU^_+ 'JU6OA22D?55;EH-Y_D!H^:<[WKUTG/\S^RJ': 914*_*H7#[C*F&]^ F_D =1YYA.:J!Z M:1IF>3;::O/YSYKIHY(9:&9"S\P$VN&Z/(IO%YBL:7&QWJ?IYZL]I=Q+% 49 MAJL:D<_O/Z>KU%LG#;#7G6-#)JUG5E(("S'TZS59XWU:HCMNSO='U(&_9T+V MES^6 O7^M>"DA8 \NXA@=H/IY0-\Y98773T.[4WN$KQ*4I$J;70I/3E0+]D M3^=5"]XP#3Y']2KM3OKQ!%WFD2;\A=CC.>^'9- MQ)I9\D)NDPQG48+37J.ZYHZCJL.L?/XQ>%^> +Q42?X@XO/R[8&ZOPUG->]7OMGKV^5\ O=81)/4B2N"7R5R>E;8J25#\ M-0+4K%WA+ XXE'?8'VB^3DI>781GFBUV8N,_V\PB-@89^L2J!JJ#W-$JDNJ8 M)OI#RG3_6&76Y8TZPJT^@.Z[).N<7L_CO^Z)L=EB;ZX 7F9@S2IL\9FD@4R9'D-*:D%$MU/[Q/+O! ME-]Y7W!.DF*QGA5%SF9J);_3=KO#&9^I$6G2.TD92,<=AEFY&>UJ)<2)]BZ_ M7NQQ,+*U9_/&O6B2!=)I3A"EP^T&I1!?V@Y'O6+$=TG!(RY>N5CJ$8,HD YQ M02A],WJ=<(ODN'B^3?,O(HK^N>"UPITG#&ZZH$*5B9"E!79>S&S-]:MYPQ_V MS 0+1_X(; ;17$N]9J$6 U8=QBO9;);/5'=\]+UJ@Z59417!<)DA'FT7%!E. MV!PY-[&YWWO-(U%A_!WBN_"E6"8@S0^\0[VP%1>,2_6/A..1.)Z#=TF)T^0? M)+XF+R3-J[?!7-4$XAQE"(B?/QZ_[$,.M AIC'!V&6ZZH-S"1,CN8P2 ;[OG M_.HDWL5ZO''9IV&]8^4P-!QJ#E37']\*;:XT&PBDS=ZQ\U\WAB$0Y)'LVK=Q MF5.:?^$3O8/(<9 I4,0XK@5RQ>E=CQ:KUAYH/BC69#Z@E.2Z5+27+5!=>QDT'+-P$H1_2&N3?"A MO2ITS6/[JN)U9PCA-2]42]9K$HDU:/*5S0VR#4&4GTVK_APBR#_350TP OE0WC6W$ J#Y- MK5()EWU2G[D7)[T$EOI^G _\?"B)WW__PY\TV2@.FJ"^FDF M;4)Q(&W=_4) MSKR^2VA360B7C-@_VE^WJKW$=%YQ;,7&W+B>6",4;,O@FAJ^I=S^6 M^47I7<29?@P4P\[=1JD\3?U["%<_V-*NOCI&HF7>N^<,,#'57^HNH:=T8 [F M0 U9Q[?"W7D)JY 9XOZEU8]X^;/SNZY)/P:*7>=NX]&NBW0_"YF8HQ?7\_/] M=^@821OU0='G -CFJ)H3H#]:#<@0K'>O"9LW\_0L7C@NBV?;G):,D_P_ZYFW MNE?M>J!ZV1)(\GNZ7WI0)&0Q#%%J$%2KMI?OP"I"R420((W M0&5-Q+3MJ@2(_#*12 "9B;__U]/&[^PP#3T2_..[-]^__JZ# X>X7K#ZQW>? MYG?=>6\X_*X31BAPD4\"_(_O O+=?_WO__D_.NQ_?_]?=W>=!P_[[B^=/G'N MAL&2_*TS1AO\2^<]#C!%$:%_ZWQ&?LQ_0AX\']-.CVRV/HXP^T7ZX5\Z/W[_ M]O5CY^X.T.]G'+B$?IH-C_VNHV@;_O+JU=>O7[\/R Y])?1+^+U#-K .YQ&* MXO#8V^NGU_O_I,-NO,"CIN#OSNTXKT4M7OS\\\_OTI^>R#-43X]4O_PC7>O M#L,Y]LQ^ZTGH,R,)O5_"9'@CXJ H$;OR,QTA!?_7W8'LCO_H[LW;NW=OOG\* MW>\.X"<(4N+C&5YV^)],>L>OAING[R/LK%_Q7[SJ$::,;)1)DS7%RW]\QPA8 MQV_?O?[+N]>\VS^=T43/6Z:3H<=5ZKO.JQ*?' 81IMZF1P(7!R%VV5]"XGLN MBK#+=0-O1/2>AQX!3#K-QO>ZSQ&4GQFM%X.SPB85@3:\)^ MFV6MMT;!"H?#8+Y&[//$=YF=&?P1>]'S707.(-VV*#,4KA]\\K4V65WV5YV5 M= GP%0.\H*K^V;FW"KREYZ @ZCH.B8.(K693QK/C815:H+;5A\B$P&Q8Y#WZ M>$PBY:A$Y-4'C-/+0H^L00MS1D*E>L(&MO@I\*+P/64F [NZ>&OT53O^DRT_ M-2HY<&4/=0XW_4ZX( /6&WG&F-N(.:8[S\%32G8>][\F<90<-[.YILM,Q?Z; M<#]UURUP!W7*1>57ZLI!L[\Z6/+O?CAQB77D ^9_R49>S+NPE[J&^2 4NXSUS!084_U M#;;[%5%WX6VXY:D^8&EO]0UZ&(3<;"XHXA:SR]0M6*5GQJ5'KNZRJ>$?SSXH M<6H:?E&7LN%OF7? 6$VNWD;L!V=-\%.$ Q"POYR H7]X_?D0]U';NV=Z-"3 MCQZQG_3_.Z.Y('G5PJ@.2"Q8C\6#.J>X'%-68%WJ= AEPF=8'_I"U#D34_Z2 M=$_Q:IMXM'?.VO./$EY2LA&ALT>"" ::!8I]HATTN^S[+A_#@X]6Q7!>D #Q M?&,"T$)N3"':QZ%#O6WV"E@ [!DE$-^W1O$MX*UEF ]S9X97>W^4!,?[3[E= M$#0! O_.I*60S!\,T@ >".!Y:B#B?S'J> AX- 3Y?(U]/[TS 6EY$3T0 M]K^:A%W,IP7 )^<1?;:TP+'/- '"_Y,M\.>X-22!]!J"+>D4@'V.&(CZSR91 M%W!H%.]!X$+1/I*"]S_FP;Y@SQ#4#U[H(#\=T0/[62B'NX <"KF1/:>23:.P M_X81!8.>(89";F0;JF"Q9/-X.C@]QSI/!<78R*93Q)01; \G#4'$TVID^%Y20C$VLM>4,6<$YQ[CAR)_ M&+CXZ;_QLPSH'"D4:2-[3"E[1J">4F^#Z//<<]1&(T\+!=O(SE+.H!&T%^AI MZ#*NDK ]#I(:=&$3*/9&MI4@=HV(8!@XA&Y)YKBXQT,GZ7./N%*3KF@(%8>1 M_:8&ZT:$TG5=!E>X_V/D!?B-3!2%Y. [(G,"D+!I">QO]6!_"X?=R#Y4R:8E ML+_3@_T=''8C>U$EFR9A[[&_3NB"?!7<0 N)H9 ;V8LJ6#0)>++23&@2G)KF MYZM0S[6 0F]PBRIGUJC"IXL\1-L/E%"\#6Y7BYDSB?.4A!'R_Z^W57F2Q?10 MS UN7&6,MGW F,J='UJ(0HDN2*#X&MFK%K+3-J14T !-;(!+6*F M93Q'A-]]K$D@/8_-4T%Q-;*3%#'5MN'E0<2A<.IG?@V.8#-B5B_9:!G&7ZD7 ML1'TR&83!_LS&L&MF( 4"J^1[9^4O9:AGB!+66@;Y;!S%\%Z00($ULK,K9,>031@\.4E]/W'T0C$E%& C.ST9 M<\9L[PID>U>:MM?(CD_$E"%LT]AP-J,FC[ZW0N),,FD#<)Z-2<0EK+:=OY>D M_/"*PG23C..!_:48=@$I%' S*9(R]MJ&.G:]"+OID(X5A4Y53 6H*UM!!6 F MAQ+(M)'C_5^Q[_]W0+X&*U*V@4C"R784R;69MS63R2Y?6,SHHW@8WID6,F!(:K0> M.X"UKSYUZ^5Z;_:[88BC$,*FH(&I(K":\)_/;Q53#1C>FJ6'PG4WY7SR\*VCVV!C0V5B2XO#C!D%@MUAT. MH_W&.?LVX_\A7A!]9C^/:?+8%&.1,%,5R3V@4MT9*U1<1?2E8;-8&2YAT%EB M#18\+B]&$<,OTI%2RU13DO5?_=?C)'T#LMR[_X=VW1WS:K 45P&IN0+7Y="5$&>KPF-(DPW]X12\I7'34DC 8K(S578KK(<2SBW M6%YY1O6VKR8+<-?A\DJ]W9=S6G$Z9M,\L% T-%?\N^[;O.L\MLB,7V/[*FME MKJZXIE DHE3O8_5F-O/_'PGKLL+LG.UTDM+4\W^==A?;=-;QNHV>"A2V>I^(ZX44-"EQ-O@ MR4PE-^E;D2T/!XJ>(7[Q):6Y*O+U2+B8Z+ZL8=>]'HQ%P=?%U) M:B-CM90CY 78'2 :J$[W\K3F:NSKRZR83XM%DW*F7K5,%N?7%<,Y3R_9Z0A< MH&=93&_N08!R(BWFMU8!VYA,RNLH4+SFKT_L\(AD2A6=)9.^JY),>O:-#O^( MS6#1XVG(F(7XXI+5M$YZ[ TS%U\GAU0[[),E V ]; MY1Q)&AI/+(6+LM!%4F)B\=H[1WX2;?X1T2^8%XD B%/Q@/#8++%7#."59=7%U7ZLH#&YO-%*\P;,#CZCN_/ MJ>,9X!5W 1<6;W#2TTB<@B?3A@M"\_FE%21?R+3%TW@_WAX)Y1E*YW3F0>+PG%"_0$6U(SY.8S0VM91', O.1E,\6),;O' MJ4=XX=F8OTN3^A'%;X:>[H] [IWE: MV3/9/6" XTUU6PM22"MH A0;BR'Q=HHXOC BBH"X5A! M)_NS)?.+U+2, M<%YDW$]/@L!+WA <0LJFF"9'6*!X8V$;"_+2*ZB "@N+ M5Y][%'K.8?S<:AUXD,E1TLB"!/8*@E2B8;$D^YX?1Z=03Z@LI%Y(/>$U\!G68GOK?%+H^XRR2)'M.#9+Y#6MDUR\9@7/.^P'+O[IJK)GILQ## 1"9.S#:IG&7ZJ853 M2&X^9%A3.A*F&PG"V1]PIK4%G.?,X:<0<=9,W! SUF_5+M/RU+-% MU,)\@+#FA)&S;K',:L]+K-^(27PQZ>)2^8!ZFSS?S;Y+(TM/*QL+3JG?(NI+ M41J)8ILD1#\M1_?Z@OJ>L44N**'M9@I>=](C26 MH* OF$(6FPEVYT\SI\Y]/Z;,49DF2]QGY,?\QC?U][W_EX#4C_&"<%H>AS]9 MI@\Z/Q#?3^JGSK?(27Q4Y C*AO @\.8^9RRY 2S>9OFW?]X&#N6U'OLX_7.Q MIB1>K1.^'MF_W2EZYOAEN%)%3)?HSUCV1 DK4 &PZ].#M')_F(0W9:KX#X,P MHNE+Y264 =*IL6R+VC0"#EWK:TAV:)E*H N2FC/]54+9H;$4B;K6 2!DUS?# M!T^8.E[(UK+)MJQU+^C#7'9%;1-8B(S1^7IX\6-!)M3U D2?4PT<8T&MVUHZ M-IJSZ^UN3H?)E3U;Y MJ&LY6QT$[C74!4/A^H'MPP3UP'ZL5 ^,]=U).K^6B*0#&+JQ2/EVMDW:XQ!Y M/9!/3'##H* J""@!3+,GX]7!( +.'RB6PLMBJ]U@KF]S%Y7EA-!$VF]];S$T M6=+0_7>\?YO\@=#(UXI*E=&=_V.D/TPS.(U8S[&!OIWSZMD*GYDNP M-:0KVL!>C=)<'@L-@[-7NR%O)9?LT'S5MD:411/0*U:4\TE0AZ:(>C1?/:XE M59%#>NVZ JQ;K]^7^;IT;>J'O!S^M6F&_%F^*GJBZME\K;N6M 8&<2.7 >=# M.W[^4+8X"33)W#1.J<=^OT4^\\?CX@TPZ[5RI^9KV563?!T8M";TY @:A]$D M2-Y;!I@U,*!MD2 M"CA;I]CEL=(H\&31#WI=V% /K:KT2J%F\H!8&"MQ'F-+^Q[%#FLMRFV7MK"A MA%A5R4(PL6Z-O(B)WK_.(2J2S_57UL"":EW5)Z@:$9-2-'YU7_W*WHJ27C5M M8?4P>YEE_O(0#)D;$M82\2'MR8*"8G7%? 0L_BL;!I39XUX,"[;3S#UCYZG M/@HB7H_KC]A+7KKK'2MA=L,"9J6Q(C7T;D&ULI)2SP69U(:U=DG[$Z2-P4A73Z 6J4^V>L9;2 M*6WL&CDFOQS&_H@0.S'UHN?[.'!]+#P@!S>&BJW= U0-L>DP:_]"D>'DE*AZ M2&R$3M6BEE YMWO"6G5ZBC%J<4I*HDV*DA"%"BOO!RK =H\^ZYBH$/RN9,X> MK\(K.7;E.H0J2+M!@55GN#:B%FO*#&^/[FHMFE*R0ZBFM'NF6493*B%JW3%F MU]UQB[C?TSP0FB9\"YT\&3U4QNT>1.HM%VH\+)[L!;N(\[(4FANOR\;@-#5; M!:S#K/72AD%1_7 /+O=V@P?+R%T/LQ=Y-IP/7>>@= .7_\&MW0[YJKQH>!]0 MU6GPV*_4>; N2B]25?05HZH:-'A25_I:H &AVU]H?+!<8H=!=7B_=L; V[_' M,BEA,$IU!U6:!L\)2RE-!>PL=S?J, 8:%;#>-7@R6*,Y:+ Z5O4-WI@$#AMN MMHALMJ*=Y Z8M08WA@JTP9-"'8'JL-;@V6ZVDN#Q^/&RE* @7@C6%"J71NHA MZT),=+EK232B(H]JR8A;0@732%GB>@2C@J5QN612+Y,K4O&1OK[DJO0-E6TC M-8KKD6UU:!N1?JZ0+ANIGOIS\GU3U Y=5(<>%Z M9AX4IM9??$Y0";'S_8KL7F''31W7Z6[;]T+')V&<>8TZ+9?Z\\\_,J0[=YT3 M!?O'%#UW=F&'@;(D=,,/VS._KUX'-3M"KH_\+XEB)DK)_L$CXSZ'F<^?OCZ2 M/'G+6H(:5M^V 3C8;47/)/-A'G]K^*E0*&3G\^&,@\KO'&LBRRRG$_.%KLIZ&\;4A@&KK?SW!CY8AV_I#&/M$2Y+P>;*;W:DE:?1J#2Y@)*\]@6:\2Y M^A8,O%VU[;K_7A!>=T"LM1, %!J;HS,/:Z$JG*MK M;M3M*NM'C+BO(U;5,P+SB$H4]6RDM3[?#O=W%VR#$ ME;W?'+>U7@ZI4>^1.?:Q$^&#[,>H\+U41BL@!:-?_WYD SL!SJC\)08DQT&#$BERG&]#TE\38)% -(1-H +(OZ0R$T M9 '@N6UKE%R@GP:FE(*T 5@*]<<6:$@!P'/K,!2XG5MBFZ-$^6Y( *C M7?]]OY;.%_+6/L)=)V+[*_]YBCQ7!70A+1CO^J_C]?"6<-HR[,E&@8V(CT)I M6H3$8.#KOV_7 %[!:]MN#PG86,9,&78KM6T14X.QK_]*'>ALJC@U"'PRDLQD M!.%?V @LAOIOOTN(0<*W"0-T'!K<#(F;P$MQ-"$)*,H$RHX1J:39/Y\/56N[ MS!O>)%?J?6^YQ P"!RO%I-L'6&Z-[)KUY58.H]8/,\Y9^1PF%CBY4U\3GR$Z MBY0["LT^P()L9-NM+\AR&!D7Y!A'P\ A&]7Q(*PE6&B-[,_K$)H8#^.BRGFH MVB*3]0 672.;^CI$I\:G91$6& !^HKT_CU!(#]P8++A&S@?T!:>)BO%IE[QH M5';&"1J#9=;(&4,=DTV*2MOS##W&/J*\@#?DIDM"#I9+(T<0)>:2BG/S%D^X M&1;1@F70R%%$+?;,Y 'HP8YJ2$+9""R21HXE]$4"1*%6V2Q1^)@P%X=W*X2V M>P'Y47CXR4E2^Q_\?G0V!8^H[^DNR.#%((T<$A4/VM!B?N$1"J= ,248Z?H/ M$Z0H2J[@S9F>]/%83)NQX?!_)_>/UV=U(CY0V4LAE8'(WL M1\M-$# :EB3A#2CE*X\T$>^'7"+>##MDA^ESARP[K <28!*'_G.G^Q4QF;@= MWB4.PF24;>3E'<8S6>;XR0GK7 UA+5NY+TR_?QB0)$NOF-)\"+B.%+*7@(7L MM)V^-\/AH0I(G_TICKLO)#0/ODQ],F 7CK[E)+[K3!\# GQ+)?L64LFRTPA' MF&Z\((&(SRFUV!;,81.?BHIHS>:B*-&7LV@6[WZ,%V3PQ ]A M,//J@B6A3N)C"(V25@=FDU5T)0,!PP)Q??:(GR X67X@&]PC<1#1YQ'ZJB4S M>2]F,UTT?=VR(%D@2[:!^H/M3KVEY^Q'NT!/]SC 2R\*M>2I[LELVDP-,H6" M95:NS(#X*-@/<+C9\H)\;,#[4I9R;Z-D5V;3<"J)2BAQ/1C-.?(@ST5&;S87 MIR;AJ0$Q+R'H7BM';S;)ICD)F=V391<$@ODSM#/\1^S1(Z<*6ZG3WFS&34T2 MU ?,DKOCY+9WX;$5?R6_/WYW>7^I.,>"2_&Q:0MG*PP3\= M]A@L3*<^!EN/CT%R)2RC-W^E(\4\>YXAX:+M^^#KO*14ZXWZJK+%6JZWJTH3 M@??I=&0?$&CVGNZ"S#S<<.4NYJ#6J_@RP">Y&/P?$DV8.'$2N%.V?^(>>)]LD!>(Y=?,UPRK0;%D"Z7?#/\MEZS=KYQ';5?< M:HC)S488:'D ,G[;OF ZC =RS2HD-AMAH(V]%7>JA]%,*78CN@G("V1M3&<""! MIACDG+>=Q7-8>[P-YF<\W'OXC'SQ5) V,!Q" !0$@&<3DZ+0V8?,#%5#PZ$% ME<]#3,^1PI%)KTKD+0P'%%21A]G[D&1(GP*7^L^K.79BFCYF+XQ]%9.;#0W0 M$H&,7Q/X#YZH,Z6>(U/]#(W9"WLMI'. MHVL!+N:U9>3/Y]CSQR]1H@>]=;":%K[YS!JIVIB]$H?* <:Y)7=PPR#T&&@+ MBI*@W,SA5M%%W(^7%W'[YIU]^\Y9!ZW8RQL7,7TK)9Z.'[[G@1"2 M&[EB2O.'Z&K$L]6="IEH^RKN- KQ5=PEC7F@9:I2"+&I2[@"VZ&XC).TL EW M\:68;L+)2VDZ(@7,F0)XP3UJ!<)[&K-W4.4@/F.O[>#1V,=O7C_^ M^(8OWR[91EAR!24D-GL'I86Z@N'VBVMI24!&;_8&2DL(:K:-F)ID'-*B$D5T M9B^<2IB<(C8-FIT%W001T.ID:*94V.GEVS=H<%?P22,5R]D))A"*EBU:\;C&)-H/ M37$$I]$<*+(63HBJR4R"3>LF,-P\?1]A9YV:OO3OWXYLWEW;N_6 \ MF'5'I>P8^VJB1*__\NYUHDCSC__Z??_Q[F,8\43\ G5A5#FBZBKN+6F8:$2$ MGDA -L^)HM^]?G?'U'T9^_[OG.+TMSN'T-]/),GXDY\G%">,)LO]8(=!4K'R9B.HCGV]G*.S8?OQ\.'8:\[7G2ZO=[DTW@Q'+_O3">C86\X MF-;#>+%0J6CD,\NUF?%+@W.*2W!'69:=8ZM MF%\]$NPPC;Q''[,EM7A*Y=+]>Y/QY\%L,;P?#3KCR:+D)&IP 4E8Z0;I*S<9 MT,],H'!"'OO1ZL;F1?1HZIDS%=&X['*I[,;4)"XG,<#2"03.\"2^IYZ[PB." M LY['U-OQ_K/H1]Z^(%/1]/[A=!YV$X[HY[P^ZH,QIV[X>CX>*WV^2W>_(7Z$,U,Z#1X8LS"-I@&C8-'YEK M3]D@!SL^OGY,N3?"?D+<(E.0BR?^V%VPN<]F^^#S8+R8=_J?9MQY7GP8=*;L M%Y-^?>[SZ;OB,FG&FB[Z\6./TXUH^-+PG@ZYS&:$)/&A=Y$QO3$_O ML(:#/V+!VOJ7W&[T0WRRVCQ1C0W-,7N M4T)O\\*6C+N'MEZ$_!F3*MUE3'W"QS!@.H7#J,0B5[)SD]M8I=BE*ULE-.TX M)+MS5YBZ=]H>QB@?_F@[&\SH/ MBU0CAIW@JEO;/'\57)0_SP7U:,$A+E3XD--=#10-3U;^U"M;U1-[4S0Q?[J< MF*/)?,[=S73QK&\.9@W(P \&[: M88P?0_Q'S+I*/=PBU?\YYRY^NI\S]Y#MO?8[,-L.6[*6*.6KNV1>P@QO"8V. M6X 2IAS8F6US,,O"F 3(_7<<\J'7BDV)CHT?Q)16%.GB5QIBT\9 =DLDN=Y\ MFWNZ5W&]V?GSH;?__$9O.D\O:T^6%Y]\?B#T'H5>.%E.*6:*G,A5?4I3K.] Z=>?K-F@Z=#%UJ0"S"/B?)DS4Z>X?("S M+>@1*.CZLT.;%[040SNN')):*84[-5&P=^?/:9MR^[%;W$Q[UXLGY1X&.QQ& MR3HS#/A!GN=ZB"J]P>)[-MUNC1_=U!U#4Q)8TTM5\=S/!Z$+K_VKF8-O M^OX_X_W]ZD7K*5-3MHP@_R&.V._[GA\G]V#+)78BIL/#P/%C)NMAT$.^$Q^> MG4WHL'MY@2 J!5BHT6V,Q'#YJNH!!FV 5+F48>&$&C)VCDDR(TG:)R,6T1H6 MGS&)Y'P_$4"G6F#V61W^=E#(/%6&CKM')8.=H-3?L3FD]4T]M"&KM;)FO?HB M&+>P9N&QI:*A+5H"GP\YR2HXK+/68;TRY<^Z4L]AJISH[Z? @PA4ULK8Z2Y4 M& (1JI&P^<0V8^!Z/@I#KLC9V,<26SIU/P;O_.3.B]1C@^)S)>(>QUQ'V4;V M5^RMUDQ]NSM,T0H/GC!UO! G9>$/W$Z2TZDR&_S*GS%YZU=!6VJ"]\J5:8;Y MNY+,T^F1(-D;Q3S];LE:9%YV;TC#JGW;Y&5C VI7AR#L.&,6Q@F+#Z!R*=N MX/8&3J*LCG)7YG+U<80\GV]HS@MG5(I;O\AZJN,;5QC)W@ *5LS8;,RR>';F M,J[/(]P;F(@O+=3]+)JT7-@[N(MK"8'7Q,3T=J5YE M=+QR7 M.FOLQCX_'2";+0H\'&;O;=.5O' >YW.A>Q\&_4^C06?RT.E-/DZ[8QZPSF?W ML#_LSI+H]7U_#?BD+Z=$'N0^7>LZ4Z-#\[>292KB:3!XNU'4L9W:JGCE%X,0 M?E77@_ ^7I3$2_!O\8W?(&!+W7.X(!'R'PC-CEU]201H;(OH=14^GZBKYK7B M'6!Q3-3A]5<4,;\NG"Y^&T6N4#(\V$76P-@)O0Z,.0,+P*"1B.D10V6-$8V& MPV&/T*T,=A&ML62&2HC+.6\$;/;_GD=Y^ 4=.(E=F_HHXL=JT\5 I?/ ML9" MSJNIOQ8R30EG2#';#;HC;^-%6"6-8F(@_/6_BE,5?AGOC>$=4H1]M>+GZ( H MU_\F2V64BSEN!N#S):6' N0BO94UUP:ZN-J]N@J@:$,*#Q0%#M:30JX-5 J6 MK;@P*)HR-O\2MEO!//?T!KY9(,6V%D'Q"\,A2"%DL\2DER147 MC]2?? W8DKGVMH="GYEC':FT-3JYHMA&;6CLB!;;WYB-$4UC98JNXH2U3P_W M;9UC\]O-V^61_T&#)LO>&@4KOLYF\D&E)_VJIM=SFZ9DY79OICQ*ARG2E=^0 M%>80J*[$)(VN5'H0UBR^WBH+7;/[^.0F?DP[)'-X_YQMO9>6JU?1??35V,0]YGG MAYPN:.V%"WI;YDA90UC,54;7;!>;VN*)6M@B.IDB*N75I!TK, #=%<6)FLE, M&Z2=>6LG5Z2,:8/#T,BM2#J+^1X=!+Z$W%@A3WW,E4Q;O+"D:<3[/44X#,/X M=.A:6.:PD/YZ+C)D_#9S/')LF"1*IX.&LU-EOT&SP]M M.!H2RKY$Q$, M,>$Q?)%J0:,#^![]W73>IW(Z8_?626H')\6V!Y1B-U)\,^81.S/+0X.I8D2 MY[%XM.#&5_C>E"8PC2Q7QS$<]D@*,9S(KN[5IF(V&L3V(Z)?F UX]/$^7IL- M[@/V78@+!FU[C6\GZ>%B\29R09&+#T\&3-'S67&7PN/>X@;7^X:1% '#2SYS M&'>81AX;4O*V V25SSU-VYN,/P]FB^']:- 93Q8UKNNW-TYN 8P6/%ER"W&\ MA3CJ!<<=WZ4;>>C1\Y/E&QSJ*&Y\I=+48='BT,>B0:NOKV6M;)$G6&]S$I5Q MU\2=]J7#(KM*%=&:CUM4:U+&$,I9MMCUOP5\ZP9\VQBU> OXO@5\6Q/T\PT% M?-_B&V_QC5:(SMKXQH-CA/:>T3'4#.05BEM=49P=% *+[1PO'DP"/N3)^&L0 A9+D/D=24A3=R.XJL_>Q9Q1VA_ +1RZ]5*Y)Y22K_SE MEX\H2@KAR2131'U% =QB9J]"0H=20C/&,$Q*YRWL#_16LM"@%_#@/6$WM:XA M#S.7!-(54EY%++>,R490Y1$@W!0*=';_"LZ)XBIBJXN8:@2]@YNV(-.8.FL4 MXO-3RF)$U:WLCX0&L=$@\F=OT$Z6A[$4 RXD-E9X6P=G!:O-*C:F&X42)Q1 M('^R0V$S3#67&7F8%)*%JHC.6)5R[6S(0@8M=M1:R8-,8L=,>V> 1,@Z7JFS M1;!]'#K4VZ;)4MWMEA+DK#^%V%V0/F;>Z88!EG4)I.<1)3HS5]]>7S5*8V7Q MQ#[CB;\D[$38_4Q\)@"?[2&S3X*_YPN O Y F=Z@&F##)KL\6M>B C,O_/) M,>N\(B@@.<[]#'U=DGJ32[8]!F0Y?/N]666S_ULV'\_ MZ(PFW?&\TQWW._W!;/BYNQA^'G0>AN/NN#?LCCJC8?=^.!HN?KOE %U'#E#V M!4_V=[1:4;S:UP^8X1T.8OS ILPQ%.57+UKWXC B&TSUWA(NV[LMT0)U9!+5 M@<**"@+4]'2ENG2H#%406!QLM+@O 3V^>BU MBZL7-[=% V ZKBJN7LQC$W9TX'.U'/'M+)4:T$)"\Y930[>RE[!BKBVVGS,> MMJXRE1DB6^9$@U8QPZW%Z4?)* &6[IS.%O'EU*Y8"G69J2;]<[)E&L<'"_#, M<[3&0B\%.(N\< &3%ANVEY=MU*0C>$M(NB4DW1*2;@E)=BGFY9JT4')ED M"/MU0SUQQ6ULD;N^Q@/DVZ3[F_N:S%T3$IL+\@3 EG/=%#PWXA=/*7$P=D,^ MZP\!3/*H,GD+ZY._E1Q8OWJUEE]L0_ [*+_X)65&M)Z;;$. .S@WN75)VYA# M:O;9,*,YI"VDZ9D-+P>EZ5DV"^I-.#4;;JY(.'U)*TTKR94&\]TE@Z\H5[9$ M62O5*\FL-)B?7X6[!I>V3*++/5.#T^U(L6V5D%]%9K^2W9>5164V^5\WB>HE M+7/7E6=J0RT"DWFFMYQS&ZL.O)2<\^S)W^G,(2EM[RT][';#?1^L7E.KRFX@.5,'NA:XKATJE65"/0+9YJQZ$%U.NKDC!O^FUYC2QY6R;4 M..8W78=W;],WUJ4WKH7T5U#10,%!([.FS5(('QD U$-^>M79C^GQF#C]W%8,:K&PP^#\:+>:?_:<:?,5]\&'2F[!>3?K,/F9_&(N9+_IZY7@^V M3)=V3.#KY!'HU":#=&0ZAT):AR)\NP_NMX(!60).>AK918: X M'2^)X#U<\AQS? 7Q9CR33=;@94E"RFK5J@ ZTNB3#?("+7D)\"XVV0+W\5GP95FL%ZRER0@7D$)EKWPUL+#8A7\1B:OE[%81>Q:GZM\R M5>V0PSV)(K(!IP<4DAL+&1*@+1")A%6+3=I'C+A=D#AG1]HFXF"Q X)7"#.0F)C$5PE@59P;?$ZG^^@ MLU5I W/!:TKP-\"@,?U!=/]5T'+:HX:"FK]V2-0 M4%6<6KR,IC%U/;3U(N0K$[3/XUI%S:PO;P%CH\&IP3;Z#D=DQ=^]Q=YJ'6&W MN\.4_6#_&BY;3S8DF$?$^5(\7S2[L+^:A3Y/+0E(2Q1E0#>8P" ;O?6V:TPX MD,CO;GCRJ?QH\)S2_AH2PJ%;+Y5>3#D"4XJWR'-Y4E00RA<340O[:U$H6Q65+/2 L'G6H7 ]"3Z@0)H1DJ6Z MHMH4>>8LEL293PGVH:^J)D0ABR\TB['5I"N#U284#%24<>5B,,4A'O'CT4:G M%EQ3P9 M_1443E!P\*(7DK-:$<-@&_/J@)/C9/:"U4?B8K]*A0W-7J^IP$)U])J\)$@+ M$G*3S%W5P1.FCA<*5B%%DRNH;J!FHKWEB'_7QV%X^#9L82IH=1UU"Z#.LD.@D2TX!MQL[="4DZ;/0C*G+K*BZ_)6T"! MMN0P2,)UDUL9YKEO/9J TB]^0"13[?Z2%@JQV? ..:<6[U1:J;S_UH80C]I+ M[S<5-E#H^1[^Y(]!*'T\7BA,MQ.H*,V>S)3$QN()>!A\W]MY+@[<;G@*%=/T MZ+6[@LK$>''>MG M(AMTR%0K7;YYB-(,.]C;R>>1R)DG)U:TBK2JA"JA3;52?;7+=YN\_\&3LK U3IBF+&UVI M]""L5:U:V[84U7G*TF:V2%*IH3 9VE]&\CRY3RV]8GIC670P^ 4BD_%N\:YG MFIQYX6!_*P\0FJB%^?J?9<0FY]]BP;V\TARE%SQY&0X;ZQ[?RG#4ZK3W]^?V M"A.6'" 749HO]*FH?2!CT&(;=7[SV(VC-:&"\%%!9DRVS?54/%#QW=KE=C=P M)W$4\K+^7K""7W%?MKN*P@9P &P^=ILF>*QQY#F9M+_,&=R[$F=PG3^?=7L[ MD[N=R=W.Y*[!R;V=R;V,+E9W*M1%-:L+]M M*9;2S)YLAID7[/%8LU3[/@5>= @KDX1&_"#;ELT&\\5LV%L,^ND.;=[Y-!XN MYIWWL^Z8__ 6+*&7"Y4IXIQ)S/C5B]93PD0>>>#8FN](]S&2*YRV]@V2+==J$X5 M]/8FT)5O:O/2@8[X$,@TM8W]="&S.+MLV#<@)?_Y UMT1+X?,@_ M!RCGT-[=](5SF/B&@.=K):W,[ZQ!>II_VE:)A,4;M<-54>9N*)M$ KF?%#:] MGFT<$(72N[IM\M(:&Q"-+,V'/[LR/,\@&J8%TQY1B-U]"'^7)WFN$G#!-]AZ MG=I_SUH'EU=C'K*\':L_U:L8X&[M+W-?#Y]E;<[/J2]R[P"<5 MB./Z;)G&YTPZLHW:,6W(+5:T*]XD-U+$J"8[U/)&>5'US1 K3!D0M/J,F=8' M33[2U:@Y*P'[U1FTK4?K-V>@3DV^'5:;,=. [X6>^>E,)P!:==HP\.=,/IO6 ML 73A/P*[)?1P^5&:FW5?[#5X &S+>KP<@ZV--2OD4+B]AQM?0-J*]D3\6"Q M1C:6D(Z-OJY7[]X2CN.+U3+M/8X:L]HWE]!/&GV2L(W]I1[V+^3&> _!@@PV M6Y\\8QQV W>.Z2YY0YOP*L@TNWA([I/_(KM/3F^2YYW%I#/X.!U-?AL,YIWN MN-^9#V:?A[U!9SJ;?![V![-Y9_)I,5^P7PW'[V\WSN4S5E++S*1Y,1%F>(,\ M'A[=(T'"1HS\D;?$0B=6*SNE[J]>?29*W8#NE0$S.(<%%V& +D,)7NT1:NJS+'*^M)D$;S\><(D MP+):>-(&YM-2JJEN9B4 --(0;;\=Q=?B9Y ,@W,URAL4" Y8-H2"*/6G"-G M38R=2K8BE#PX+8GE@<143RK9%E#3U6#5DP:EDL>F+:%X.\VIDFUA[K'J5H22 MP\;B>\($!]#6X;8?.*%@<37I5+&AKKN5#CG R[8_.?R>1!'93);)>-7B*"2W MQ>]69']+6+78\BW(%BR=/*VQ('<]T8B8M%@N%U= E.MNF#3Z>5ZDO3UL:FY M"ILM2F)!TIY->??PC#W;!%G59=.\:"_9_Q7EV]<)J,5Z<^6103:EW=<5%%3? M>0-8AS/#!1@%UG4]/9O,+(()N396A5)N-1 F=[F_#S@9(\J?*=Z=-NV92)>_ MYB)=>+6$#Y,1CU_YCS_]]/;-7__6&?SSTW#QVS&"I7/L\1;+4[HQB>1/ P*;FC\%5.M9QDQJ 6+Q MYF_NK0)OZ3DHB(:,A3!*:I2R#4O\&'JNARC @L+[L&7BE36D<$XMOM8:!,RU M?PX7)$+^ Z'9L0->3E4WMD;(FJJ=/R)6\]J$K9UC)Z;\U5(41T#>Z[ M--"6<=(:U*IH40"%K8LH:4 M]@8$?&7NU6P37CI,P%;TC,X60WDE'H[ICN_\MLXV3-)C%9 M:CX;HT@E,H9*RF(C*\(T?O0]!X1I(:6YJB=@3"4<-A.ID'ZJ*P/SD@9Z:-Q@ M6*\"QF*NF@3P'@#@O2Z #;I_, #OK\?W8)9H1?A9"W_SUN<5%*>(@FXB%2UM M6>)*^R(*_C)'D;8)]>)$[7STVJ?FQU*2J6)(-=JP/H8M3>7050)"5@:E9< M9:54@W":W 54$T[C,FG2J5@C'BJ'J1=&GL,,K%%[+K*7DK^+49+#0.'_8V_YIWH+O^\1L"4 MI#74)C=8D4%?2\5!5$J<+#;0B^=OY1'[LD89PF.FWKUM KZ].B^4[.W5>9NV M,-_@L_/76GFEK"G-ET_YR<;9=2N?8H4<6BR?\K;Q,E.W^BFEZZ?4_XJ0GFR: M*J!2?!3VM&7;AP2#R?*![5 6:Q2E@2P?T Y/$?V,_+@HJ9(?&4$;6U_N1(>9 M!J5Q2(]!A_R88MP+R.RO(%(\;NMMSEG)@G 8AO$I?UQ9S.%(?T75/&0,-WD? M'W8=!_N8IIAL2%Q8-.-TTUU(;W\M# 4#C9KZM)+39'D8@,BJY^FNHOR$F,%& M\#R?*).@A\*UC\/P'H6%.RS61M'$6 Z2#LH@MAL!//EB:I"2:F133),?%6,M MIC86.*\#LXK91DW$OM@;S$[DB('X-O):I[:Q$+!JL4=R\$0EZG\DSM,:R[K3 M]T1$C#83J4J)@[$;/K !\VF'@N0UL(@X7XK57]K 6"BPSA0 L-P(U'W\&+%I M%SC>%ODR3Z^0T%Q(L ZV$AY-ULE&OH=)*G&0N?&1KI_P3LP]^U!B9=7% MIH4-5.KKRBV0O(6YQ,'R^Z=BKJU;(@Z#3H?;#=SL:T9GZ8_,6>/1*6@EV):5 MZPDJ6CNVQF50LMB2GFML-X[6A+*=D\8Q:+:-N8#RJF>A>S99;?<]MCER,.KU !6MPWU^*+^M%?7:44<""UL,%PO90\=IPHF;!^&I_9I,\XC)C7,,/,(Z<) MZ_REL+(5YBMW#;Z_M$ #:L+18DVYJ+/^@+STH+0;?<2(5Q[G?/098)JK?;5^ MS2695WZRHA2"IBO4.VOLQCZ>+-\S4T>1S_8;77?C!1XO%YZD!Z2F+]P7FC^. M.U.P_J=AT'_TVC0F3QTW@_&@UEWU.F.^YUN_^-P/)PO9MW%\/.@,_C7 M=#">#^;'*O8UUJY7L2.O9 ]O;=NLSKXOV(TBZCW&J0T[#/W^>8PB]NL%6:RQ M1Q_BP.$$RJKW%3LV7Q-?5R/R2T(U!&[U\W7>QBRMNU=>75^';U40OGY?+U(3 M*N!A<:'^HS[?/Q_&K(YGEC2R1?1E)T!.VA)>FTA#52TOLB14:%MC\;D04'/F M5P^11BZ'%LS9#E$RS!X)!CN@: LT%G-6ZWURB\#'A(0[O5@AM$WOU"OM1 M>/A)@GB"]OX'OW?=)#@[9-ME\6'1GKB(UOX0=,G@K=_S=]U_Q_O2_$4'&')O M0MGVBN+3H4!8+,LI)4L0 M'J+E:.T/GI<,WGK9L.5TAWW %+H@M#_87C1RZT4R#-C^CT>3 J22I[4_/%\R M>.ME,\-;Y"6%USXB+XAP )23O)W](?] 1JR77Q\S;!TO19;MSS:$N[+)/P%2 MA+2^H@P!.!@O])8_C=I,63V\O8(D(HOB^\2;X\ U6J]9ICY^R%.E1<* M<0:(!EZP"K,NC4RBDD;VWSM"N+!^YO5YK53LZ@I.VNR*KAT![%N7M7D1Y7S( M9CM/191O^S2[L/\V4I\GZV?F!3_I^*57E,4-KNF>4L:RZ<#\^#'$?\2LJ\&. MN[;[4YLQS_'F9UT%QT _O,X= WVZGP_^^6DP7G0&G]E_3Y'VG6-'YJ4K2@C9]GB3"9)M%/1I MIPMZ6^9*W8:QF-O,<8?MX@0\P"!H88M(90JJE%>39FZ.G9AZ_*W.:4R=-0IQ M=T5QXD#)#!Z@F;&05R6..<,'!J&1Y*,'GQ":%(\IQCK[>^OO%R[&:_W*<4CD M>""45U%-BJGQ1"GYC8^XT17=#RA9;ZCT,0^)=;ONCH?"%FO\)8W])_<%@[;T MF)Z+.GT:A>?&2,Q.(>%5'+E+6&Q$I=]3?C^SKW):#.8%B?V'W_DQ-PA@*S6Z MS5;KA)7H-I.+.R(H"-EJ(#@.WI.=4]F?-U,X[":5F.W:N%AG;& "[3VCL#^+ M)3?D!M$;,G,=,M+)UP"[JK*^0F+[LTEDHV_2ZSKY>LRB;[PP)/19\NB;C-[^ M! X% PVO9!]YGH@7/??%AB!'=05I%87CMM3)/2^EO'\)L+ <8:Y&>H;X.IZ; M4/!J\=Z[U=<.3;YGH>"@D4DD#D+9_X;_A]>R8#_Y_U!+ 0(4 Q0 ( ^( M8U<&PD'4LND *YL# * " 0 !E>#DY+3$N:'1M4$L! M A0#% @ #XAC5SHAINC>!@ <@< L ( !VND &9I M;E\P,#$N:G!G4$L! A0#% @ #XAC5YHB>4%$9P *$D$ L M ( !X? &9O"TR,#(S,#8S,"YXP$ X3]!HMG 1KP4 % @ '$I0$

&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " /B&-7 MWR$G&Y(! #Y%0 $P @ $-"0$ 6T-O;G1E;G1?5'EP97-= :+GAM;%!+!08 *P K *0+ #0"@$ ! end XML 46 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 47 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 48 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 163 222 1 true 54 0 false 10 false false R1.htm 00000001 - Document - Cover Sheet http://smx.tech/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Interim Condensed Consolidated Statements of Financial Position (Unaudited) Sheet http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition Interim Condensed Consolidated Statements of Financial Position (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Sheet http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Statements 3 false false R4.htm 00000004 - Statement - Interim Condensed Consolidated Changes in Shareholders' Equity - (Unaudited) Sheet http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity- Interim Condensed Consolidated Changes in Shareholders' Equity - (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Interim Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows Interim Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 995511 - Disclosure - GENERAL Sheet http://smx.tech/role/General GENERAL Notes 6 false false R7.htm 995512 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://smx.tech/role/SignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 995513 - Disclosure - CONVERTIBLE NOTES Notes http://smx.tech/role/ConvertibleNotes CONVERTIBLE NOTES Notes 8 false false R9.htm 995514 - Disclosure - BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY Sheet http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiability BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY Notes 9 false false R10.htm 995515 - Disclosure - MATERIAL EVENTS DURING THE PERIOD Sheet http://smx.tech/role/MaterialEventsDuringPeriod MATERIAL EVENTS DURING THE PERIOD Notes 10 false false R11.htm 995516 - Disclosure - SHAREHOLDERS??? EQUITY Sheet http://smx.tech/role/ShareholdersEquity SHAREHOLDERS??? EQUITY Notes 11 false false R12.htm 995517 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES Sheet http://smx.tech/role/GeneralAndAdministrativeExpenses GENERAL AND ADMINISTRATIVE EXPENSES Notes 12 false false R13.htm 995518 - Disclosure - LOSS PER SHARE Sheet http://smx.tech/role/LossPerShare LOSS PER SHARE Notes 13 false false R14.htm 995519 - Disclosure - SUBSEQUENT EVENTS Sheet http://smx.tech/role/SubsequentEvents SUBSEQUENT EVENTS Notes 14 false false R15.htm 995520 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://smx.tech/role/SignificantAccountingPoliciesPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 15 false false R16.htm 995521 - Disclosure - GENERAL (Tables) Sheet http://smx.tech/role/GeneralTables GENERAL (Tables) Tables http://smx.tech/role/General 16 false false R17.htm 995522 - Disclosure - SHAREHOLDERS??? EQUITY (Tables) Sheet http://smx.tech/role/ShareholdersEquityTables SHAREHOLDERS??? EQUITY (Tables) Tables http://smx.tech/role/ShareholdersEquity 17 false false R18.htm 995523 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables) Sheet http://smx.tech/role/GeneralAndAdministrativeExpensesTables GENERAL AND ADMINISTRATIVE EXPENSES (Tables) Tables http://smx.tech/role/GeneralAndAdministrativeExpenses 18 false false R19.htm 995524 - Disclosure - LOSS PER SHARE (Tables) Sheet http://smx.tech/role/LossPerShareTables LOSS PER SHARE (Tables) Tables http://smx.tech/role/LossPerShare 19 false false R20.htm 995525 - Disclosure - SUBSEQUENT EVENTS (Tables) Sheet http://smx.tech/role/SubsequentEventsTables SUBSEQUENT EVENTS (Tables) Tables http://smx.tech/role/SubsequentEvents 20 false false R21.htm 995526 - Disclosure - SCHEDULE OF COMPANIES SUBSIDIARIES (Details) Sheet http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails SCHEDULE OF COMPANIES SUBSIDIARIES (Details) Details 21 false false R22.htm 995527 - Disclosure - GENERAL (Details Narrative) Sheet http://smx.tech/role/GeneralDetailsNarrative GENERAL (Details Narrative) Details http://smx.tech/role/GeneralTables 22 false false R23.htm 995528 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://smx.tech/role/SignificantAccountingPoliciesDetailsNarrative SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://smx.tech/role/SignificantAccountingPoliciesPolicies 23 false false R24.htm 995529 - Disclosure - CONVERTIBLE NOTES (Details Narrative) Notes http://smx.tech/role/ConvertibleNotesDetailsNarrative CONVERTIBLE NOTES (Details Narrative) Details http://smx.tech/role/ConvertibleNotes 24 false false R25.htm 995530 - Disclosure - BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY (Details Narrative) Sheet http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY (Details Narrative) Details http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiability 25 false false R26.htm 995531 - Disclosure - MATERIAL EVENTS DURING THE PERIOD (Details Narrative) Sheet http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative MATERIAL EVENTS DURING THE PERIOD (Details Narrative) Details http://smx.tech/role/MaterialEventsDuringPeriod 26 false false R27.htm 995532 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details) Sheet http://smx.tech/role/ScheduleOfShareCapitalDetails SCHEDULE OF SHARE CAPITAL (Details) Details 27 false false R28.htm 995533 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical) Sheet http://smx.tech/role/ScheduleOfShareCapitalDetailsParenthetical SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical) Details 28 false false R29.htm 995534 - Disclosure - SCHEDULE OF RESTRICTED SHARES UNITS GRANTED (Details) Sheet http://smx.tech/role/ScheduleOfRestrictedSharesUnitsGrantedDetails SCHEDULE OF RESTRICTED SHARES UNITS GRANTED (Details) Details 29 false false R30.htm 995535 - Disclosure - SCHEDULE OF SHARE OPTION GRANTED (Details) Sheet http://smx.tech/role/ScheduleOfShareOptionGrantedDetails SCHEDULE OF SHARE OPTION GRANTED (Details) Details 30 false false R31.htm 995536 - Disclosure - SCHEDULE OF OPTIONS TO EMPLOYEES AND SERVICE PROVIDERS OUTSTANDING (Details) Sheet http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails SCHEDULE OF OPTIONS TO EMPLOYEES AND SERVICE PROVIDERS OUTSTANDING (Details) Details 31 false false R32.htm 995537 - Disclosure - SHAREHOLDERS??? EQUITY (Details Narrative) Sheet http://smx.tech/role/ShareholdersEquityDetailsNarrative SHAREHOLDERS??? EQUITY (Details Narrative) Details http://smx.tech/role/ShareholdersEquityTables 32 false false R33.htm 995538 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details) Sheet http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details) Details 33 false false R34.htm 995539 - Disclosure - SCHEDULE OF LOSS PER SHARE (Details) Sheet http://smx.tech/role/ScheduleOfLossPerShareDetails SCHEDULE OF LOSS PER SHARE (Details) Details 34 false false R35.htm 995540 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://smx.tech/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://smx.tech/role/SubsequentEventsTables 35 false false All Reports Book All Reports ex99-1.htm form6-k.htm smx-20230630.xsd smx-20230630_cal.xml smx-20230630_def.xml smx-20230630_lab.xml smx-20230630_pre.xml fin_001.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full true true JSON 51 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ex99-1.htm form6-k.htm": { "nsprefix": "SMX", "nsuri": "http://smx.tech/20230630", "dts": { "inline": { "local": [ "ex99-1.htm", "form6-k.htm" ] }, "schema": { "local": [ "smx-20230630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.ifrs.org/taxonomy/2023-03-23/full_ifrs/full_ifrs-cor_2023-03-23.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "smx-20230630_cal.xml" ] }, "definitionLink": { "local": [ "smx-20230630_def.xml" ] }, "labelLink": { "local": [ "smx-20230630_lab.xml" ] }, "presentationLink": { "local": [ "smx-20230630_pre.xml" ] } }, "keyStandard": 134, "keyCustom": 88, "axisStandard": 15, "axisCustom": 1, "memberStandard": 7, "memberCustom": 46, "hidden": { "total": 73, "http://smx.tech/20230630": 26, "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 44, "http://fasb.org/us-gaap/2023": 1, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 163, "entityCount": 1, "segmentCount": 54, "elementCount": 476, "unitCount": 10, "baseTaxonomies": { "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full": 413, "http://xbrl.sec.gov/dei/2023": 12, "http://fasb.org/us-gaap/2023": 4 }, "report": { "R1": { "role": "http://smx.tech/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form6-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form6-k.htm", "first": true, "unique": true } }, "R2": { "role": "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "longName": "00000002 - Statement - Interim Condensed Consolidated Statements of Financial Position (Unaudited)", "shortName": "Interim Condensed Consolidated Statements of Financial Position (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:CashAndCashEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:OtherCurrentReceivables", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R3": { "role": "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "longName": "00000003 - Statement - Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited)", "shortName": "Interim Condensed Consolidated Statements of Comprehensive Loss (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:ResearchAndDevelopmentExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:ResearchAndDevelopmentExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R4": { "role": "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-", "longName": "00000004 - Statement - Interim Condensed Consolidated Changes in Shareholders' Equity - (Unaudited)", "shortName": "Interim Condensed Consolidated Changes in Shareholders' Equity - (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "AsOf2021-12-31_ifrs-full_IssuedCapitalMember", "name": "ifrs-full:Equity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_ifrs-full_IssuedCapitalMember", "name": "ifrs-full:Equity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R5": { "role": "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows", "longName": "00000005 - Statement - Interim Condensed Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Interim Condensed Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R6": { "role": "http://smx.tech/role/General", "longName": "995511 - Disclosure - GENERAL", "shortName": "GENERAL", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R7": { "role": "http://smx.tech/role/SignificantAccountingPolicies", "longName": "995512 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES", "shortName": "SIGNIFICANT ACCOUNTING POLICIES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R8": { "role": "http://smx.tech/role/ConvertibleNotes", "longName": "995513 - Disclosure - CONVERTIBLE NOTES", "shortName": "CONVERTIBLE NOTES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R9": { "role": "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiability", "longName": "995514 - Disclosure - BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY", "shortName": "BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R10": { "role": "http://smx.tech/role/MaterialEventsDuringPeriod", "longName": "995515 - Disclosure - MATERIAL EVENTS DURING THE PERIOD", "shortName": "MATERIAL EVENTS DURING THE PERIOD", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DisclosureOfMaterialEventsDuringThePeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DisclosureOfMaterialEventsDuringThePeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R11": { "role": "http://smx.tech/role/ShareholdersEquity", "longName": "995516 - Disclosure - SHAREHOLDERS\u2019 EQUITY", "shortName": "SHAREHOLDERS\u2019 EQUITY", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R12": { "role": "http://smx.tech/role/GeneralAndAdministrativeExpenses", "longName": "995517 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES", "shortName": "GENERAL AND ADMINISTRATIVE EXPENSES", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R13": { "role": "http://smx.tech/role/LossPerShare", "longName": "995518 - Disclosure - LOSS PER SHARE", "shortName": "LOSS PER SHARE", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:EarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R14": { "role": "http://smx.tech/role/SubsequentEvents", "longName": "995519 - Disclosure - SUBSEQUENT EVENTS", "shortName": "SUBSEQUENT EVENTS", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R15": { "role": "http://smx.tech/role/SignificantAccountingPoliciesPolicies", "longName": "995520 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies)", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R16": { "role": "http://smx.tech/role/GeneralTables", "longName": "995521 - Disclosure - GENERAL (Tables)", "shortName": "GENERAL (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R17": { "role": "http://smx.tech/role/ShareholdersEquityTables", "longName": "995522 - Disclosure - SHAREHOLDERS\u2019 EQUITY (Tables)", "shortName": "SHAREHOLDERS\u2019 EQUITY (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R18": { "role": "http://smx.tech/role/GeneralAndAdministrativeExpensesTables", "longName": "995523 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables)", "shortName": "GENERAL AND ADMINISTRATIVE EXPENSES (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R19": { "role": "http://smx.tech/role/LossPerShareTables", "longName": "995524 - Disclosure - LOSS PER SHARE (Tables)", "shortName": "LOSS PER SHARE (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:EarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:EarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R20": { "role": "http://smx.tech/role/SubsequentEventsTables", "longName": "995525 - Disclosure - SUBSEQUENT EVENTS (Tables)", "shortName": "SUBSEQUENT EVENTS (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DisclosureOfLossPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:DisclosureOfLossPerShareExplanatory", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R21": { "role": "http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails", "longName": "995526 - Disclosure - SCHEDULE OF COMPANIES SUBSIDIARIES (Details)", "shortName": "SCHEDULE OF COMPANIES SUBSIDIARIES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "21", "firstAnchor": { "contextRef": "From2023-01-012023-06-30_custom_SecurityMattersPTYLtdMember", "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-06-30_custom_SecurityMattersPTYLtdMember", "name": "ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R22": { "role": "http://smx.tech/role/GeneralDetailsNarrative", "longName": "995527 - Disclosure - GENERAL (Details Narrative)", "shortName": "GENERAL (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "22", "firstAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-06-30_custom_EquityLineAgreementMember", "name": "SMX:StockIssuedDuringPeriodValueConsiderationOfIssuanceOfCommonStock", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R23": { "role": "http://smx.tech/role/SignificantAccountingPoliciesDetailsNarrative", "longName": "995528 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "shortName": "SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:FairValueBasedOnQuotedOpeningSharePrice", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "SMX:DescriptionOfAccountingPolicyForReverseAcquisitionTransactionExplanatory", "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:FairValueBasedOnQuotedOpeningSharePrice", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "SMX:DescriptionOfAccountingPolicyForReverseAcquisitionTransactionExplanatory", "SMX:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R24": { "role": "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "longName": "995529 - Disclosure - CONVERTIBLE NOTES (Details Narrative)", "shortName": "CONVERTIBLE NOTES (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "24", "firstAnchor": { "contextRef": "AsOf2023-02-28", "name": "ifrs-full:NotionalAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "SMX:DisclosureOfMaterialEventsDuringThePeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-06-30", "name": "SMX:FairValueOfConvertibleNotes", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R25": { "role": "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "longName": "995530 - Disclosure - BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY (Details Narrative)", "shortName": "BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "25", "firstAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:ParValuePerShare", "unitRef": "EuroPerShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-06-30_custom_BridgeLoanAgreementsMember", "name": "SMX:WarrantsTerm", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R26": { "role": "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "longName": "995531 - Disclosure - MATERIAL EVENTS DURING THE PERIOD (Details Narrative)", "shortName": "MATERIAL EVENTS DURING THE PERIOD (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "26", "firstAnchor": { "contextRef": "AsOf2023-02-28", "name": "ifrs-full:NotionalAmount", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "span", "p", "SMX:DisclosureOfMaterialEventsDuringThePeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-02-012023-02-28", "name": "SMX:PurchasePricePrePaidAdvanceDescription", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "SMX:DisclosureOfMaterialEventsDuringThePeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R27": { "role": "http://smx.tech/role/ScheduleOfShareCapitalDetails", "longName": "995532 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details)", "shortName": "SCHEDULE OF SHARE CAPITAL (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "27", "firstAnchor": { "contextRef": "AsOf2023-06-30_custom_DeferredSharesMember", "name": "ifrs-full:NumberOfSharesAuthorised", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-06-30_custom_DeferredSharesMember", "name": "ifrs-full:NumberOfSharesAuthorised", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R28": { "role": "http://smx.tech/role/ScheduleOfShareCapitalDetailsParenthetical", "longName": "995533 - Disclosure - SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical)", "shortName": "SCHEDULE OF SHARE CAPITAL (Details) (Parenthetical)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "parenthetical", "menuCat": "Details", "order": "28", "firstAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:ParValuePerShare", "unitRef": "EuroPerShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-06-30_ifrs-full_PreferenceSharesMember", "name": "ifrs-full:ParValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R29": { "role": "http://smx.tech/role/ScheduleOfRestrictedSharesUnitsGrantedDetails", "longName": "995534 - Disclosure - SCHEDULE OF RESTRICTED SHARES UNITS GRANTED (Details)", "shortName": "SCHEDULE OF RESTRICTED SHARES UNITS GRANTED (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:NumberOfOutstandingShareOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-06-30_ifrs-full_RestrictedShareUnitsMember", "name": "ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R30": { "role": "http://smx.tech/role/ScheduleOfShareOptionGrantedDetails", "longName": "995535 - Disclosure - SCHEDULE OF SHARE OPTION GRANTED (Details)", "shortName": "SCHEDULE OF SHARE OPTION GRANTED (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:NumberOfOutstandingShareOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R31": { "role": "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails", "longName": "995536 - Disclosure - SCHEDULE OF OPTIONS TO EMPLOYEES AND SERVICE PROVIDERS OUTSTANDING (Details)", "shortName": "SCHEDULE OF OPTIONS TO EMPLOYEES AND SERVICE PROVIDERS OUTSTANDING (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:NumberOfOutstandingShareOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2023-06-30_custom_OptionsOutstandingOneMember", "name": "ifrs-full:NumberOfOutstandingShareOptions", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R32": { "role": "http://smx.tech/role/ShareholdersEquityDetailsNarrative", "longName": "995537 - Disclosure - SHAREHOLDERS\u2019 EQUITY (Details Narrative)", "shortName": "SHAREHOLDERS\u2019 EQUITY (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:ExplanationOfFactThatSharesHaveParValue", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "SMX:ExplanationOfFactThatSharesHaveParValue", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true, "unique": true } }, "R33": { "role": "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "longName": "995538 - Disclosure - SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)", "shortName": "SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:AdjustmentsForSharebasedPayments", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-012023-06-30_custom_GeneralAndAdministrativeExpensesMember", "name": "SMX:TransactionCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "SMX:DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory", "ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R34": { "role": "http://smx.tech/role/ScheduleOfLossPerShareDetails", "longName": "995539 - Disclosure - SCHEDULE OF LOSS PER SHARE (Details)", "shortName": "SCHEDULE OF LOSS PER SHARE (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-06-30", "name": "ifrs-full:WeightedAverageShares", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "ifrs-full:DisclosureOfEarningsPerShareExplanatory", "ifrs-full:EarningsPerShareExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } }, "R35": { "role": "http://smx.tech/role/SubsequentEventsDetailsNarrative", "longName": "995540 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "AsOf2023-06-30", "name": "ifrs-full:NumberOfSharesIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-07-27_custom_NonadjustingEventMember", "name": "SMX:FloorPrice", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "td", "tr", "table", "ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "body", "html" ], "reportCount": 1, "baseRef": "ex99-1.htm", "unique": true } } }, "tag": { "ifrs-full_EarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EarningsPerShareExplanatory", "presentation": [ "http://smx.tech/role/LossPerShare" ], "lang": { "en-us": { "role": { "label": "LOSS PER SHARE" } }, "en": { "role": { "documentation": "The disclosure of earnings per share." } } }, "auth_ref": [ "r48" ] }, "SMX_RedeemableWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "RedeemableWarrants", "crdr": "credit", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Redeemable warrants", "documentation": "Redeemable warrants." } } }, "auth_ref": [] }, "ifrs-full_EntitysTotalForBusinessCombinationsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForBusinessCombinationsMember", "presentation": [ "http://smx.tech/role/GeneralDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used." } } }, "auth_ref": [ "r100", "r101" ] }, "ifrs-full_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAbstract", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Shareholders\u2019 equity (deficit)" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "SMX_EquityPurchaseAgreementAxis": { "xbrltype": "stringItemType", "nsuri": "http://smx.tech/20230630", "localname": "EquityPurchaseAgreementAxis", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Purchase Agreement [Axis]", "verboseLabel": "EquityPurchaseAgreementAxis [Axis]", "documentation": "Equity Purchase Agreement [Axis]" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "ifrs-full_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Research and development expenses, net" } }, "en": { "role": { "documentation": "The amount of expenditure directly attributable to research or development activities, recognised in profit or loss." } } }, "auth_ref": [ "r54" ] }, "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NonadjustingEventsAfterReportingPeriodAxis", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non-adjusting events after reporting period [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r32" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "ifrs-full_NonadjustingEventsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NonadjustingEventsMember", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used." } } }, "auth_ref": [ "r32" ] }, "SMX_EquityPurchaseAgreementDomain": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "EquityPurchaseAgreementDomain", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "auth_ref": [] }, "ifrs-full_EntitysTotalForRelatedPartiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForRelatedPartiesMember", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used." } } }, "auth_ref": [ "r39" ] }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodExplanatory", "presentation": [ "http://smx.tech/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "SUBSEQUENT EVENTS" } }, "en": { "role": { "documentation": "The disclosure of non-adjusting events after the reporting period. [Refer: Non-adjusting events after reporting period [member]]" } } }, "auth_ref": [ "r32" ] }, "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents", "crdr": "debit", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Exchange rate differences on cash and cash equivalent" } }, "en": { "role": { "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]" } } }, "auth_ref": [ "r59", "r60" ] }, "SMX_PercentageOfWeightedAveragePriceOfCommonStock": { "xbrltype": "percentItemType", "nsuri": "http://smx.tech/20230630", "localname": "PercentageOfWeightedAveragePriceOfCommonStock", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of weighted average price of common stock", "documentation": "Percentage of weighted average price of common stock." } } }, "auth_ref": [] }, "SMX_PercentageOfCommonStock": { "xbrltype": "percentItemType", "nsuri": "http://smx.tech/20230630", "localname": "PercentageOfCommonStock", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Percentage of common stock", "documentation": "Percentage of common stock." } } }, "auth_ref": [] }, "ifrs-full_EntitysTotalForSubsidiariesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EntitysTotalForSubsidiariesMember", "presentation": [ "http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used." } } }, "auth_ref": [ "r44", "r47", "r80" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r304" ] }, "ifrs-full_NoncurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "verboseLabel": "Lease liabilities", "label": "Non-current lease liabilities" } }, "en": { "role": { "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r86" ] }, "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable", "presentation": [ "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of non-adjusting events after reporting period [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period." } } }, "auth_ref": [ "r32" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r2", "r3", "r5", "r115", "r116", "r117", "r118", "r119", "r120", "r121", "r122", "r123", "r124", "r125", "r126", "r127", "r128", "r129", "r130", "r131", "r132", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r175", "r176", "r179", "r183", "r184", "r185", "r216", "r223", "r333" ] }, "ifrs-full_Equity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Equity", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-", "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total Shareholders\u2019 equity (deficit)", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "label": "Equity" } }, "en": { "role": { "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities." } } }, "auth_ref": [ "r17", "r20", "r64", "r66", "r81", "r82", "r83" ] }, "SMX_PurchasePricePrePaidAdvanceDescription": { "xbrltype": "stringItemType", "nsuri": "http://smx.tech/20230630", "localname": "PurchasePricePrePaidAdvanceDescription", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Purchase price pre paid advance description", "documentation": "Purchase price pre paid advance description." } } }, "auth_ref": [] }, "ifrs-full_SalesAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SalesAndMarketingExpense", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Selling and marketing expenses" } }, "en": { "role": { "documentation": "The amount of expense relating to the marketing and selling of goods or services." } } }, "auth_ref": [ "r323" ] }, "ifrs-full_EquityAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityAndLiabilities", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and shareholders\u2019 equity (deficit)", "label": "Equity and liabilities" } }, "en": { "role": { "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]" } } }, "auth_ref": [ "r17" ] }, "SMX_SubscriptionPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://smx.tech/20230630", "localname": "SubscriptionPricePerShare", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subscription price per share", "documentation": "Subscription price per share." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory", "presentation": [ "http://smx.tech/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF SHARE OPTION GRANTED" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r96" ] }, "ifrs-full_NoncurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilities", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current liabilities", "label": "Non-current liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]" } } }, "auth_ref": [ "r19", "r74", "r208" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory", "presentation": [ "http://smx.tech/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF OPTIONS TO EMPLOYEES AND SERVICE PROVIDERS OUTSTANDING" } }, "en": { "role": { "documentation": "The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r97" ] }, "SMX_NumberOfWarrantsIssued": { "xbrltype": "sharesItemType", "nsuri": "http://smx.tech/20230630", "localname": "NumberOfWarrantsIssued", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of warrants issued", "documentation": "Number of warrants issued." } } }, "auth_ref": [] }, "ifrs-full_LineItemsByFunctionMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "LineItemsByFunctionMember", "presentation": [ "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for the standard value of the \u2018Attribution of expenses by nature to their function' axis if no other member is used." } } }, "auth_ref": [ "r315", "r317" ] }, "ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable", "presentation": [ "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of number and weighted average remaining contractual life of outstanding share options [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the number and weighted average remaining contractual life of outstanding share options." } } }, "auth_ref": [ "r97" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r225" ] }, "ifrs-full_NoncurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentLiabilitiesAbstract", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current liabilities" } } }, "auth_ref": [] }, "SMX_NumberOfSubscriptionShares": { "xbrltype": "sharesItemType", "nsuri": "http://smx.tech/20230630", "localname": "NumberOfSubscriptionShares", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Number of warrants issued", "documentation": "Number of subscription shares.", "label": "NumberOfSubscriptionShares" } } }, "auth_ref": [] }, "SMX_DescriptionOfExpectedExpectedTermOptionsGranted": { "xbrltype": "durationItemType", "nsuri": "http://smx.tech/20230630", "localname": "DescriptionOfExpectedExpectedTermOptionsGranted", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expected term", "documentation": "Description of expected expected term options granted." } } }, "auth_ref": [] }, "ifrs-full_EmployeeBenefitsExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EmployeeBenefitsExpense", "crdr": "debit", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Related share based expenses" } }, "en": { "role": { "documentation": "The expense of all forms of consideration given by an entity in exchange for a service rendered by employees or for the termination of employment." } } }, "auth_ref": [ "r6", "r31", "r193" ] }, "ifrs-full_NoncurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssetsAbstract", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Non-current assets" } } }, "auth_ref": [] }, "SMX_AddtionalEquityFundOfConvertiblePercent": { "xbrltype": "percentItemType", "nsuri": "http://smx.tech/20230630", "localname": "AddtionalEquityFundOfConvertiblePercent", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible percentage", "documentation": "Addtional equity fund of convertible percent." } } }, "auth_ref": [] }, "ifrs-full_ReserveOfExchangeDifferencesOnTranslation": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ReserveOfExchangeDifferencesOnTranslation", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation reserve" } }, "en": { "role": { "documentation": "A component of equity representing exchange differences on translation of financial statements recognised in other comprehensive income and accumulated in equity. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r38" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "SMX_PaymentOfCashPercent": { "xbrltype": "percentItemType", "nsuri": "http://smx.tech/20230630", "localname": "PaymentOfCashPercent", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payment of cash percent", "documentation": "Payment of cash percent." } } }, "auth_ref": [] }, "ifrs-full_NoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NoncurrentAssets", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total non-current assets", "label": "Non-current assets [Default Label]" } }, "en": { "role": { "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]" } } }, "auth_ref": [ "r18", "r72", "r208" ] }, "SMX_NumberOfSharesOnCashlessBasis": { "xbrltype": "sharesItemType", "nsuri": "http://smx.tech/20230630", "localname": "NumberOfSharesOnCashlessBasis", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares on cashless basis", "documentation": "Number of shares on cashless basis." } } }, "auth_ref": [] }, "SMX_ConvertiableNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "ConvertiableNotes", "crdr": "debit", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertiable notes", "documentation": "Convertiable notes." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "SMX_NumberOfSharesIssuedAndOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://smx.tech/20230630", "localname": "NumberOfSharesIssuedAndOutstanding", "presentation": [ "http://smx.tech/role/ScheduleOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Number of shares issued and outstanding", "documentation": "Number of shares issued and outstanding." } } }, "auth_ref": [] }, "SMX_WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019": { "xbrltype": "durationItemType", "nsuri": "http://smx.tech/20230630", "localname": "WeightedAverageRemainingContractualLifeOfExercisableShareOptions2019", "presentation": [ "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life of exercisable share options", "documentation": "Weighted average remaining contractual life of exercisable share options 2019." } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r228" ] }, "SMX_ExplanationOfFactThatSharesHaveParValue": { "xbrltype": "stringItemType", "nsuri": "http://smx.tech/20230630", "localname": "ExplanationOfFactThatSharesHaveParValue", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Explanation of fact that shares have par value", "documentation": "Explanation of fact that shares have par value." } } }, "auth_ref": [] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r229" ] }, "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseInCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Increase (decrease) in cash and cash equivalents", "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes" } }, "en": { "role": { "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]" } } }, "auth_ref": [ "r62" ] }, "ifrs-full_EquityMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EquityMember", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-", "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/ScheduleOfLossPerShareDetails", "http://smx.tech/role/ScheduleOfShareCapitalDetails", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used." } } }, "auth_ref": [ "r11" ] }, "SMX_WarrantsAccelerationAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "WarrantsAccelerationAmount", "crdr": "credit", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants acceleration amount", "documentation": "Warrants acceleration amount." } } }, "auth_ref": [] }, "SMX_ExerciseOfWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://smx.tech/20230630", "localname": "ExerciseOfWarrants", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise of warrants", "documentation": "Exercise of warrants." } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r233" ] }, "SMX_DescriptionOfAccountingPolicyForApplicationOfAccountingPoliciesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smx.tech/20230630", "localname": "DescriptionOfAccountingPolicyForApplicationOfAccountingPoliciesExplanatory", "presentation": [ "http://smx.tech/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Application of accounting policies", "documentation": "Description Of Accounting Policy For Application Of Accounting Policies Explanatory." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r236" ] }, "SMX_DescriptionOfAccountingPolicyForReverseStockSplitExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smx.tech/20230630", "localname": "DescriptionOfAccountingPolicyForReverseStockSplitExplanatory", "presentation": [ "http://smx.tech/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Reverse stock split", "documentation": "Description Of Accounting Policy For Reverse Stock Split Explanatory." } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r285" ] }, "SMX_EmployeesAndServiceProvidersMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "EmployeesAndServiceProvidersMember", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Employees And Service Providers [Member]", "documentation": "Employees And Service Providers [Member]" } } }, "auth_ref": [] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r245", "r257", "r267", "r292" ] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Other Performance Measure Amount" } } }, "auth_ref": [ "r277" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "presentation": [ "http://smx.tech/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Additional capital raising", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r1", "r220", "r341" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r271" ] }, "SMX_TwentyTwentyTwoIncentiveEquityPlanMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "TwentyTwentyTwoIncentiveEquityPlanMember", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2022 Incentive Equity Plan [Member]", "documentation": "2022 Incentive Equity Plan [Member]" } } }, "auth_ref": [] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r285" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r226" ] }, "SMX_DescriptionOfAccountingPolicyForReverseAcquisitionTransactionExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smx.tech/20230630", "localname": "DescriptionOfAccountingPolicyForReverseAcquisitionTransactionExplanatory", "presentation": [ "http://smx.tech/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Reverse acquisition transaction", "documentation": "Description Of Accounting Policy For Reverse Acquisition Transaction Explanatory." } } }, "auth_ref": [] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r297" ] }, "SMX_DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smx.tech/20230630", "localname": "DisclosureOfDetailedInformationAboutGeneralAndAdministrativeExpenseExplanatory", "presentation": [ "http://smx.tech/role/GeneralAndAdministrativeExpensesTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES", "documentation": "Disclosure Of Detailed Information About General And Administrative Expense Explanatory." } } }, "auth_ref": [] }, "SMX_EmployeesDirectorsAndServiceProvidersMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "EmployeesDirectorsAndServiceProvidersMember", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Employees Directors And Service Providers [Member]", "documentation": "Employees Directors And Service Providers [Member]" } } }, "auth_ref": [] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r278" ] }, "SMX_DisclosureOfLossPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smx.tech/20230630", "localname": "DisclosureOfLossPerShareExplanatory", "presentation": [ "http://smx.tech/role/SubsequentEventsTables" ], "lang": { "en-us": { "role": { "verboseLabel": "SCHEDULE OF LOSS PER SHARE", "documentation": "Disclosure Of Loss Per Share Explanatory.", "label": "DisclosureOfLossPerShareExplanatory" } } }, "auth_ref": [] }, "SMX_OptionsOutstandingOneMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "OptionsOutstandingOneMember", "presentation": [ "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Exercise price one [member]", "documentation": "Exercise price one [member]" } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "SMX_ShareIssuedPricePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://smx.tech/20230630", "localname": "ShareIssuedPricePerShare", "presentation": [ "http://smx.tech/role/GeneralDetailsNarrative", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share price", "documentation": "Share issued price per share." } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r272" ] }, "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Volatility rate", "verboseLabel": "Expected volatility" } }, "en": { "role": { "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time." } } }, "auth_ref": [ "r98" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r278" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r237" ] }, "SMX_OptionsOutstandingTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "OptionsOutstandingTwoMember", "presentation": [ "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Options Outstanding Two [Member]", "documentation": "Options Outstanding Two [Member]" } } }, "auth_ref": [] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r278" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r240", "r252", "r262", "r287" ] }, "SMX_RedemptionPercentageOfBusinessCombination": { "xbrltype": "percentItemType", "nsuri": "http://smx.tech/20230630", "localname": "RedemptionPercentageOfBusinessCombination", "presentation": [ "http://smx.tech/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Redemption percentage of business combination", "documentation": "Redemption percentage of business combination." } } }, "auth_ref": [] }, "SMX_RemainingFundsInTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "RemainingFundsInTrustAccount", "crdr": "credit", "presentation": [ "http://smx.tech/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Remaining funds in trust account", "documentation": "Remaining funds in trust account." } } }, "auth_ref": [] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Name" } } }, "auth_ref": [ "r278" ] }, "SMX_OptionsOutstandingThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "OptionsOutstandingThreeMember", "presentation": [ "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Options Outstanding Three [Member]", "documentation": "Options Outstanding Three [Member]" } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Individual [Axis]" } } }, "auth_ref": [ "r249", "r258", "r268", "r285", "r293", "r297", "r305" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r310" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r278" ] }, "SMX_StockIssuedDuringPeriodValueConsiderationOfIssuanceOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "StockIssuedDuringPeriodValueConsiderationOfIssuanceOfCommonStock", "crdr": "credit", "presentation": [ "http://smx.tech/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Consideration of issuance of common stock", "documentation": "Stock issued during period value consideration of issuance of common stock." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r237" ] }, "SMX_FairValueBasedOnQuotedOpeningSharePrice": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "FairValueBasedOnQuotedOpeningSharePrice", "crdr": "credit", "presentation": [ "http://smx.tech/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value based on the quoted opening share price", "documentation": "Fair value based on quoted opening share price." } } }, "auth_ref": [] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "auth_ref": [ "r249", "r258", "r268", "r285", "r293", "r297", "r305" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r278" ] }, "SMX_FairValueOfShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "FairValueOfShares", "crdr": "credit", "presentation": [ "http://smx.tech/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of the shares", "documentation": "Fair value of shares." } } }, "auth_ref": [] }, "SMX_OptionsOutstandingFourMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "OptionsOutstandingFourMember", "presentation": [ "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Options Outstanding Four [Member]", "documentation": "Options Outstanding Four [Member]" } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r224" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r296" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r278" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "auth_ref": [ "r239", "r251", "r261", "r286" ] }, "SMX_OptionsOutstandingFiveMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "OptionsOutstandingFiveMember", "presentation": [ "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Options Outstanding Five [Member]", "documentation": "Options Outstanding Five [Member]" } } }, "auth_ref": [] }, "SMX_MarketableSecuritiesHeldInTrustAccount": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "MarketableSecuritiesHeldInTrustAccount", "crdr": "debit", "presentation": [ "http://smx.tech/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Marketable securities held in a trust account", "documentation": "Marketable securities held in trust account." } } }, "auth_ref": [] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r279" ] }, "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property, plant and equipment", "label": "Purchase of property, plant and equipment, classified as investing activities" } }, "en": { "role": { "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]" } } }, "auth_ref": [ "r203" ] }, "SMX_FixedConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://smx.tech/20230630", "localname": "FixedConversionPrice", "presentation": [ "http://smx.tech/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fixed conversion price", "documentation": "Fixed conversion price." } } }, "auth_ref": [] }, "SMX_IfrsStatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://smx.tech/20230630", "localname": "IfrsStatementLineItems", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/GeneralDetailsNarrative", "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-", "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails", "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails", "http://smx.tech/role/ScheduleOfLossPerShareDetails", "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails", "http://smx.tech/role/ScheduleOfRestrictedSharesUnitsGrantedDetails", "http://smx.tech/role/ScheduleOfShareCapitalDetails", "http://smx.tech/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smx.tech/role/ShareholdersEquityDetailsNarrative", "http://smx.tech/role/ShareholdersEquityTables", "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "IfrsStatementLineItems [Line Items]" } } }, "auth_ref": [] }, "SMX_GeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "GeneralAndAdministrativeExpensesMember", "presentation": [ "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "General And Administrative Expenses [Member]" } } }, "auth_ref": [] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r296" ] }, "SMX_ReverseStockSplitMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "ReverseStockSplitMember", "presentation": [ "http://smx.tech/role/ScheduleOfLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Reverse stock split [Member]", "documentation": "Reverse stock split [Member]" } } }, "auth_ref": [] }, "SMX_WarrantsToPurchaseOrdinaryShares": { "xbrltype": "sharesItemType", "nsuri": "http://smx.tech/20230630", "localname": "WarrantsToPurchaseOrdinaryShares", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants to purchase ordinary shares", "documentation": "Warrants to purchase ordinary shares." } } }, "auth_ref": [] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r281" ] }, "SMX_DiscountRate": { "xbrltype": "percentItemType", "nsuri": "http://smx.tech/20230630", "localname": "DiscountRate", "presentation": [ "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Discount rate", "documentation": "Discount rate." } } }, "auth_ref": [] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Determination Date" } } }, "auth_ref": [ "r241", "r253", "r263", "r288" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r280" ] }, "ifrs-full_OtherExpenseByNature": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherExpenseByNature", "crdr": "debit", "calculation": { "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Others" } }, "en": { "role": { "documentation": "The amount of expenses that the entity does not separately disclose in the same statement or note when the entity uses the 'nature of expense' form for its analysis of expenses. [Refer: Expenses, by nature]" } } }, "auth_ref": [ "r31", "r193" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r284" ] }, "ifrs-full_FinanceCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceCosts", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Finance expenses" } }, "en": { "role": { "documentation": "The amount of costs associated with financing activities of the entity." } } }, "auth_ref": [ "r28" ] }, "SMX_SecuritiesPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "SecuritiesPurchaseAgreementMember", "presentation": [ "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Securities Purchase Agreement [Member]", "documentation": "Securities Purchase Agreement [Member]" } } }, "auth_ref": [] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r239", "r251", "r261", "r286" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r282" ] }, "SMX_ExercisePriceOfWarrants": { "xbrltype": "perShareItemType", "nsuri": "http://smx.tech/20230630", "localname": "ExercisePriceOfWarrants", "presentation": [ "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Exercise price", "documentation": "Exercise price of warrants." } } }, "auth_ref": [] }, "SMX_ConvertibleNotesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "ConvertibleNotesCurrent", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Convertible notes", "documentation": "Convertible notes current." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r283" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r283" ] }, "ifrs-full_FinanceIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinanceIncome", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Finance income" } }, "en": { "role": { "documentation": "The amount of income associated with interest and other financing activities of the entity." } } }, "auth_ref": [ "r323" ] }, "SMX_SharePurchasePrice": { "xbrltype": "perShareItemType", "nsuri": "http://smx.tech/20230630", "localname": "SharePurchasePrice", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Share purchase price", "verboseLabel": "Exercise price of warrants", "documentation": "Share purchase price." } } }, "auth_ref": [] }, "SMX_PrepaidAdvanceCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "PrepaidAdvanceCurrent", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Pre-paid advance", "documentation": "Prepaid advance current." } } }, "auth_ref": [] }, "SMX_WarrantsTerm": { "xbrltype": "durationItemType", "nsuri": "http://smx.tech/20230630", "localname": "WarrantsTerm", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants term", "verboseLabel": "Excepted terms", "documentation": "Warrants term." } } }, "auth_ref": [] }, "SMX_WarrantsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "WarrantsCurrent", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Warrants", "documentation": "Warrants current." } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r242", "r254", "r264", "r289" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r297" ] }, "SMX_FairValueOfConvertibleNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "FairValueOfConvertibleNotes", "crdr": "debit", "presentation": [ "http://smx.tech/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of convertible notes", "documentation": "Fair value of convertible notes." } } }, "auth_ref": [] }, "SMX_BridgeLoansAndDerivativeFinancialLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "BridgeLoansAndDerivativeFinancialLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Bridge loans and derivative financial liabilities", "documentation": "Bridge loans and derivative financial liabilities current." } } }, "auth_ref": [] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r242", "r254", "r264", "r289" ] }, "SMX_BridgeLoansAndDerivativeFinancialLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "BridgeLoansAndDerivativeFinancialLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "verboseLabel": "Bridge loans and derivative financial liabilities", "documentation": "Bridge loans and derivative financial liabilities non current.", "label": "BridgeLoansAndDerivativeFinancialLiabilitiesNoncurrent" } } }, "auth_ref": [] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r273" ] }, "SMX_FairValueOfBonousWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "FairValueOfBonousWarrants", "crdr": "credit", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of the bonous Warrants", "documentation": "Fair value of bonous warrants." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "SMX_LongTermPayablesNonCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "LongTermPayablesNonCurrent", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Long term payables", "documentation": "Long term payables non current." } } }, "auth_ref": [] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r243", "r255", "r265", "r290" ] }, "SMX_ShareOfLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "ShareOfLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Share of net loss of associated companies" } } }, "auth_ref": [] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r273" ] }, "SMX_FairValueOfRedeemableWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "FairValueOfRedeemableWarrants", "crdr": "credit", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value of the redeemable warrants", "verboseLabel": "[custom:FairValueOfRedeemableWarrants-0]", "documentation": "Fair value of redeemable warrants." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory", "presentation": [ "http://smx.tech/role/ShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "SHAREHOLDERS\u2019 EQUITY" } }, "en": { "role": { "documentation": "The entire disclosure for share capital, reserves and other equity interest." } } }, "auth_ref": [ "r24" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r235", "r237", "r250" ] }, "ifrs-full_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangeAxis", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Range [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r84", "r88", "r97", "r209", "r210", "r331" ] }, "SMX_ListingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "ListingExpenses", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Listing expenses", "documentation": "Listing expenses." } } }, "auth_ref": [] }, "SMX_ProceedsFromLoansAndWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "ProceedsFromLoansAndWarrants", "crdr": "debit", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from loans and warrants", "documentation": "Proceeds from loans and warrants." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r250" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r244", "r256", "r266", "r291" ] }, "ifrs-full_ProceedsFromIssuingOtherEquityInstruments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssuingOtherEquityInstruments", "crdr": "debit", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Net proceeds" } }, "en": { "role": { "documentation": "The cash inflow from issuing equity instruments that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r204" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "ifrs-full_TopOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TopOfRangeMember", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Top of range [member]" } }, "en": { "role": { "documentation": "This member stands for top of a range." } } }, "auth_ref": [ "r84", "r88", "r97", "r209", "r210", "r331" ] }, "ifrs-full_CurrentPrepaidExpenses": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentPrepaidExpenses", "crdr": "debit", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Pre-paid advance", "label": "Current prepaid expenses" } }, "en": { "role": { "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised." } } }, "auth_ref": [ "r317" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFunctionalCurrencyExplanatory", "presentation": [ "http://smx.tech/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Functional currency" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for the currency of the primary economic environment in which the entity operates." } } }, "auth_ref": [ "r318" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r250" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r303" ] }, "ifrs-full_CategoriesOfRelatedPartiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CategoriesOfRelatedPartiesAxis", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Categories of related parties [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r39" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ifrs-full_ConsiderationPaidReceived": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ConsiderationPaidReceived", "crdr": "credit", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Aggregated received amount" } }, "en": { "role": { "documentation": "The amount of consideration paid or received in respect of both obtaining and losing control of subsidiaries or other businesses. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r61" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslationOtherThanTranslationOfForeignOperations", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Foreign currency translation" } }, "en": { "role": { "documentation": "The amount of other comprehensive income, net of tax, related to exchange differences on translation of the financial statements of a parent company or a stand-alone entity to a different presentation currency. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r30" ] }, "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Trade payables" } }, "en": { "role": { "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]" } } }, "auth_ref": [ "r196", "r321" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r311" ] }, "ifrs-full_DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfAttributionOfExpensesByNatureToTheirFunctionTable", "presentation": [ "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of attribution of expenses by nature to their function [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to attribution of expenses by nature to analysis of expenses by function in the statement of profit or loss." } } }, "auth_ref": [ "r315", "r317" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "SMX_NumberOfSharesIssuedWarrants": { "xbrltype": "sharesItemType", "nsuri": "http://smx.tech/20230630", "localname": "NumberOfSharesIssuedWarrants", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares issued warrants", "verboseLabel": "Shares issued warrants", "documentation": "Number of shares issued warrants." } } }, "auth_ref": [] }, "ifrs-full_TradeAndOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TradeAndOtherPayables", "crdr": "credit", "presentation": [ "http://smx.tech/role/SignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Trade, other payables and warrants" } }, "en": { "role": { "documentation": "The amount of trade payables and other payables. [Refer: Trade payables; Other payables]" } } }, "auth_ref": [ "r16" ] }, "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive loss, net of tax", "label": "Other comprehensive income that will be reclassified to profit or loss, net of tax" } }, "en": { "role": { "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r199", "r200" ] }, "ifrs-full_CashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashAndCashEquivalents", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "periodStartLabel": "Cash and cash equivalents at beginning of period", "periodEndLabel": "Cash and cash equivalents at end of period" } }, "en": { "role": { "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]" } } }, "auth_ref": [ "r15", "r62", "r77" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r226" ] }, "ifrs-full_ProfessionalFeesExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfessionalFeesExpense", "crdr": "debit", "calculation": { "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Professional services" } }, "en": { "role": { "documentation": "The amount of fees paid or payable for professional services." } } }, "auth_ref": [ "r317" ] }, "ifrs-full_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ComprehensiveIncome", "weight": 1.0, "order": 1.0 }, "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-", "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "http://smx.tech/role/ScheduleOfLossPerShareDetails" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Loss after income tax for the period attributable to shareholders", "label": "Loss after income tax for the period", "verboseLabel": "Net Loss", "terseLabel": "Net loss attributable to the owners of the Company" } }, "en": { "role": { "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]" } } }, "auth_ref": [ "r8", "r25", "r58", "r65", "r67", "r108", "r109", "r208", "r212" ] }, "ifrs-full_DescriptionOfInputsToOptionPricingModelShareOptionsGranted": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfInputsToOptionPricingModelShareOptionsGranted", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Option granted description" } }, "en": { "role": { "documentation": "The description of inputs to the option pricing model for share options granted. [Refer: Option pricing model [member]]" } } }, "auth_ref": [ "r98" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r226" ] }, "ifrs-full_ParValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ParValuePerShare", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/GeneralDetailsNarrative", "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Implied value", "verboseLabel": "Par value per share", "terseLabel": "Par value" } }, "en": { "role": { "documentation": "The nominal value per share." } } }, "auth_ref": [ "r22" ] }, "ifrs-full_IncomeTaxExpenseContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncomeTaxExpenseContinuingOperations", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Income tax" } }, "en": { "role": { "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]" } } }, "auth_ref": [ "r29", "r34", "r35", "r36", "r40", "r79", "r107" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r226" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r226" ] }, "ifrs-full_OtherCurrentPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentPayables", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other payables" } }, "en": { "role": { "documentation": "The amount of current payables that the entity does not separately disclose in the same statement or note." } } }, "auth_ref": [ "r319" ] }, "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis", "presentation": [ "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Attribution of expenses by nature to their function [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r315", "r317" ] }, "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfClassesOfShareCapitalExplanatory", "presentation": [ "http://smx.tech/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF SHARE CAPITAL" } }, "en": { "role": { "documentation": "The disclosure of classes of share capital. [Refer: Share capital [member]]" } } }, "auth_ref": [ "r23" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r313" ] }, "ifrs-full_ProfitLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossBeforeTax", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Loss before income tax", "label": "Profit (loss) before tax" } }, "en": { "role": { "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r102", "r193", "r194", "r214", "r215" ] }, "ifrs-full_OtherCurrentReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherCurrentReceivables", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Other current receivables" } }, "en": { "role": { "documentation": "The amount of current other receivables. [Refer: Other receivables]" } } }, "auth_ref": [ "r197" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r275" ] }, "ifrs-full_BottomOfRangeMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BottomOfRangeMember", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bottom of range [member]" } }, "en": { "role": { "documentation": "This member stands for the bottom of a range." } } }, "auth_ref": [ "r84", "r88", "r97", "r209", "r210", "r331" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r276" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r277" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r274" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "ifrs-full_TypesOfAntidilutiveInstrumentsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfAntidilutiveInstrumentsAxis", "presentation": [ "http://smx.tech/role/ScheduleOfRestrictedSharesUnitsGrantedDetails", "http://smx.tech/role/ShareholdersEquityDetailsNarrative", "http://smx.tech/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Types of antidilutive instruments [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r51" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r274" ] }, "ifrs-full_WagesAndSalaries": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WagesAndSalaries", "crdr": "debit", "calculation": { "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Wages and salaries related" } }, "en": { "role": { "documentation": "A class of employee benefits expense that represents wages and salaries. [Refer: Employee benefits expense]" } } }, "auth_ref": [ "r324" ] }, "ifrs-full_TypesOfContractsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfContractsAxis", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/GeneralDetailsNarrative", "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Types of contracts [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r211", "r213" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r275" ] }, "ifrs-full_CountryOfIncorporationOrResidenceOfSubsidiary": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CountryOfIncorporationOrResidenceOfSubsidiary", "presentation": [ "http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Country of Incorporation" } }, "en": { "role": { "documentation": "The country in which a subsidiary of the entity is incorporated. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r42", "r45", "r68", "r69" ] }, "ifrs-full_TypesOfContractsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TypesOfContractsMember", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/GeneralDetailsNarrative", "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of contracts with customers. It also represents the standard value for the 'Types of contracts' axis if no other member is used." } } }, "auth_ref": [ "r211", "r213" ] }, "ifrs-full_IncreaseDecreaseThroughConversionOfConvertibleInstruments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughConversionOfConvertibleInstruments", "crdr": "credit", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-" ], "lang": { "en-us": { "role": { "label": "Conversion of convertible notes to shares" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the conversion of convertible instruments." } } }, "auth_ref": [ "r316" ] }, "ifrs-full_PaymentsForDebtIssueCosts": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsForDebtIssueCosts", "crdr": "credit", "presentation": [ "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Repayment of debt" } }, "en": { "role": { "documentation": "The cash outflow for debt issue costs." } } }, "auth_ref": [ "r326" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure Name" } } }, "auth_ref": [ "r277" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r304" ] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r276" ] }, "ifrs-full_DescriptionOfApproachUsedToDetermineDiscountRates": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfApproachUsedToDetermineDiscountRates", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Description of approach used to determine discount rates" } }, "en": { "role": { "documentation": "The description of the approach used to determine discount rates when applying IFRS 17." } } }, "auth_ref": [ "r87" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r276" ] }, "ifrs-full_BusinessCombinationsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BusinessCombinationsAxis", "presentation": [ "http://smx.tech/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business combinations [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r100" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r276" ] }, "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of lease liabilities", "label": "Payments of lease liabilities, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r207" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r148", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173" ] }, "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughExerciseOfOptions", "crdr": "credit", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-" ], "lang": { "en-us": { "role": { "label": "Exercise of options" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from the exercise of options." } } }, "auth_ref": [ "r316" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r226" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r277" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Material Terms of Trading Arrangement" } } }, "auth_ref": [ "r304" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019", "presentation": [ "http://smx.tech/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Weighted average exercise price, outstanding beginning balance", "periodEndLabel": "Weighted average exercise price, outstanding ending balance", "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r90", "r94" ] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r277" ] }, "ifrs-full_FinancialLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "FinancialLiabilitiesMember", "presentation": [ "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]" } } }, "auth_ref": [ "r103", "r104", "r113", "r114" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "label": "Measure [Axis]" } } }, "auth_ref": [ "r277" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019", "presentation": [ "http://smx.tech/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Weighted average exercise price, Exercisable", "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r95" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019", "presentation": [ "http://smx.tech/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, exercised" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r92" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019", "presentation": [ "http://smx.tech/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, expired" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r93" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r226" ] }, "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019", "presentation": [ "http://smx.tech/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average exercise price, granted" } }, "en": { "role": { "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r91" ] }, "ifrs-full_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "EarningsPerShareAbstract", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Loss per share attributable to shareholders" } } }, "auth_ref": [] }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis", "presentation": [ "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Ranges of exercise prices for outstanding share options [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r97" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Termination Date" } } }, "auth_ref": [ "r306" ] }, "ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageFairValueAtMeasurementDateShareOptionsGranted", "crdr": "credit", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Fair value" } }, "en": { "role": { "documentation": "The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r99" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Arrangement Duration" } } }, "auth_ref": [ "r307" ] }, "SMX_YorkvilleMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "YorkvilleMember", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Yorkville [Member]", "documentation": "Yorkville [Member]" } } }, "auth_ref": [] }, "ifrs-full_RangesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesMember", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used." } } }, "auth_ref": [ "r84", "r88", "r97", "r209", "r210", "r331" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "auth_ref": [ "r273" ] }, "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RangesOfExercisePricesForOutstandingShareOptionsMember", "presentation": [ "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails" ], "lang": { "en": { "role": { "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Ranges [member]]" } } }, "auth_ref": [ "r97" ] }, "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Risk-free interest rate", "verboseLabel": "Risk-free rate" } }, "en": { "role": { "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]" } } }, "auth_ref": [ "r98" ] }, "SMX_NonadjustingEventMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "NonadjustingEventMember", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Non adjusting Event [Member]", "documentation": "Non adjusting Event [Member]" } } }, "auth_ref": [] }, "ifrs-full_ClassesOfFinancialLiabilitiesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfFinancialLiabilitiesAxis", "presentation": [ "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Classes of financial liabilities [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r103", "r104", "r113", "r114" ] }, "ifrs-full_DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShareTable", "presentation": [ "http://smx.tech/role/ScheduleOfRestrictedSharesUnitsGrantedDetails", "http://smx.tech/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Disclosure of instruments with potential future dilutive effect not included in calculation of diluted earnings per share [table]" } } }, "auth_ref": [ "r325" ] }, "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": { "xbrltype": "durationItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019", "presentation": [ "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average remaining contractual life of outstanding share options" } }, "en": { "role": { "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]" } } }, "auth_ref": [ "r97" ] }, "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfOptionLifeShareOptionsGranted", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Options granted" } }, "en": { "role": { "documentation": "The option life of share options granted." } } }, "auth_ref": [ "r98" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Aggregate Available" } } }, "auth_ref": [ "r308" ] }, "us-gaap_LoansPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansPayable", "crdr": "credit", "presentation": [ "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Loans payable", "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer)." } } }, "auth_ref": [ "r0", "r4", "r340" ] }, "ifrs-full_WeightedAverageShares": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "WeightedAverageShares", "presentation": [ "http://smx.tech/role/ScheduleOfLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average number of ordinary shares used in calculating basic and diluted loss per share" } }, "en": { "role": { "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor." } } }, "auth_ref": [ "r50" ] }, "SMX_StandbyEquityPurchaseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "StandbyEquityPurchaseAgreementMember", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "SEPA [Member]", "documentation": "SEPA [Member]" } } }, "auth_ref": [] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r238", "r309" ] }, "SMX_FirstInstallmentMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "FirstInstallmentMember", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "First Installment [Member]", "documentation": "First Installment [Member]" } } }, "auth_ref": [] }, "ifrs-full_ProfitLossFromOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProfitLossFromOperatingActivities", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossBeforeTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Operating loss", "label": "Profit (loss) from operating activities" } }, "en": { "role": { "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r202", "r323" ] }, "ifrs-full_CurrentLeaseLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLeaseLiabilities", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Lease liabilities" } }, "en": { "role": { "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]" } } }, "auth_ref": [ "r86" ] }, "ifrs-full_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": "ifrs-full_ProfitLossFromOperatingActivities", "weight": -1.0, "order": 3.0 }, "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "General and administrative expenses", "totalLabel": "Total" } }, "en": { "role": { "documentation": "The amount of expense relating to general and administrative activities of the entity." } } }, "auth_ref": [ "r317" ] }, "SMX_PaymentsForShareIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "PaymentsForShareIssued", "crdr": "credit", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Capital raise fee", "documentation": "Payments for share issued." } } }, "auth_ref": [] }, "SMX_SecondInstallmentMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "SecondInstallmentMember", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Second Installment [Member]", "documentation": "Second Installment [Member]" } } }, "auth_ref": [] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r238", "r309" ] }, "ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfVestingRequirementsForSharebasedPaymentArrangement", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Vesting period description" } }, "en": { "role": { "documentation": "The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]]" } } }, "auth_ref": [ "r89" ] }, "ifrs-full_CurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilities", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Current liabilities [Default Label]" } }, "en": { "role": { "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period." } } }, "auth_ref": [ "r19", "r73", "r208" ] }, "SMX_UnderwritingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "UnderwritingAgreementMember", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Underwriting Agreement [Member]", "documentation": "Underwriting Agreement [Member]" } } }, "auth_ref": [] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r238", "r309" ] }, "SMX_WarrantSharePriceCashlessExercise": { "xbrltype": "perShareItemType", "nsuri": "http://smx.tech/20230630", "localname": "WarrantSharePriceCashlessExercise", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant share price cashless exercise", "documentation": "Warrant share price cashless exercise." } } }, "auth_ref": [] }, "ifrs-full_ShorttermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ShorttermBorrowings", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_CurrentLiabilities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Borrowings from related parties" } }, "en": { "role": { "documentation": "The amount of current borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r319" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "SMX_WarrantBMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "WarrantBMember", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant B [Member]", "documentation": "Warrant B [Member]" } } }, "auth_ref": [] }, "ifrs-full_CurrentLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentLiabilitiesAbstract", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "auth_ref": [] }, "SMX_WarrantAMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "WarrantAMember", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant A [Member]", "documentation": "Warrant A [Member]" } } }, "auth_ref": [] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r301" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProportionOfOwnershipInterestInSubsidiary", "presentation": [ "http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Percentage Owned" } }, "en": { "role": { "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r43", "r46", "r70" ] }, "ifrs-full_ClassesOfShareCapitalAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfShareCapitalAxis", "presentation": [ "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/GeneralDetailsNarrative", "http://smx.tech/role/ScheduleOfShareCapitalDetails", "http://smx.tech/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Classes of share capital [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r23" ] }, "SMX_UnderwriterWarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "UnderwriterWarrantMember", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Underwriter Warrant [Member]", "documentation": "Underwriter Warrant [Member]" } } }, "auth_ref": [] }, "ifrs-full_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_EquityAndLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities" } }, "en": { "role": { "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r17", "r81", "r82", "r83", "r108", "r111" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "ifrs-full_ClassesOfShareCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ClassesOfShareCapitalMember", "presentation": [ "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/GeneralDetailsNarrative", "http://smx.tech/role/ScheduleOfShareCapitalDetails", "http://smx.tech/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used." } } }, "auth_ref": [ "r23" ] }, "SMX_DeferredSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "DeferredSharesMember", "presentation": [ "http://smx.tech/role/ScheduleOfShareCapitalDetails" ], "lang": { "en-us": { "role": { "label": "Deferred Shares [Member]", "documentation": "Deferred Shares [Member]" } } }, "auth_ref": [] }, "ifrs-full_NotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotionalAmount", "presentation": [ "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Principal amount" } }, "en": { "role": { "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument." } } }, "auth_ref": [ "r317" ] }, "ifrs-full_IntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Intangible assets, net" } }, "en": { "role": { "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]" } } }, "auth_ref": [ "r14", "r53" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "ifrs-full_NotesAndOtherExplanatoryInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NotesAndOtherExplanatoryInformationAbstract", "lang": { "en-us": { "role": { "label": "Notes and other explanatory information [abstract]" } } }, "auth_ref": [] }, "ifrs-full_PreferenceSharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PreferenceSharesMember", "presentation": [ "http://smx.tech/role/ScheduleOfShareCapitalDetails", "http://smx.tech/role/ScheduleOfShareCapitalDetailsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preference shares [member]" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are senior in some aspects to ordinary shares, but subordinate to debt instruments in terms of claim. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r322" ] }, "SMX_TwentyTwentyTwoConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "TwentyTwentyTwoConvertibleNotesMember", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "2022 Convertible Notes [Member]", "documentation": "2022 Convertible Notes [Member]" } } }, "auth_ref": [] }, "SMX_PrivateWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "PrivateWarrantsMember", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Private Warrants [Member]" } } }, "auth_ref": [] }, "ifrs-full_BorrowingsInterestRate": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsInterestRate", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Interest rate", "verboseLabel": "Borrowings, interest rate" } }, "en": { "role": { "documentation": "The interest rate on borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r331" ] }, "ifrs-full_DilutedEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DilutedEarningsLossPerShare", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "http://smx.tech/role/ScheduleOfLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Diluted loss per share attributable to shareholders", "verboseLabel": "Diluted loss per share attributable to shareholdersDiluted loss per share attributable to shareholders" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]" } } }, "auth_ref": [ "r48", "r49" ] }, "ifrs-full_PropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "PropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net" } }, "en": { "role": { "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]" } } }, "auth_ref": [ "r13", "r37" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r302" ] }, "SMX_PublicWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "PublicWarrantsMember", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Public Warrants [Member]" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase (decrease) in other receivables" } }, "en": { "role": { "documentation": "Adjustments for decrease (increase) in other operating receivables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r327" ] }, "ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDerivativeFinancialInstrumentsExplanatory", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiability" ], "lang": { "en-us": { "role": { "label": "BRIDGE LOANS AND DERIVATIVE FINANCIAL LIABILITY" } }, "en": { "role": { "documentation": "The disclosure of derivative financial instruments. [Refer: Derivatives [member]]" } } }, "auth_ref": [ "r314" ] }, "ifrs-full_BorrowingsMaturity": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BorrowingsMaturity", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Maturity date", "verboseLabel": "Borrowings maturity" } }, "en": { "role": { "documentation": "The maturity of borrowings. [Refer: Borrowings]" } } }, "auth_ref": [ "r331" ] }, "SMX_OrdinarySharesOneMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "OrdinarySharesOneMember", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ordinary Shares One [Member]", "documentation": "Ordinary Shares One [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "SMX_OrdinarySharesTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "OrdinarySharesTwoMember", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ordinary Shares Two [Member]", "documentation": "Ordinary Shares Two [Member]" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r246", "r258", "r268", "r293" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase in trade payables" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in trade and other payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Trade and other payables; Profit (loss)]" } } }, "auth_ref": [ "r329" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r247", "r259", "r269", "r294" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Name" } } }, "auth_ref": [ "r305" ] }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory", "presentation": [ "http://smx.tech/role/GeneralTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF COMPANIES SUBSIDIARIES" } }, "en": { "role": { "documentation": "The disclosure of subsidiaries. [Refer: Subsidiaries [member]]" } } }, "auth_ref": [ "r44", "r47", "r80" ] }, "ifrs-full_NumberOfOutstandingShareOptions": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfOutstandingShareOptions", "presentation": [ "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails", "http://smx.tech/role/ScheduleOfRestrictedSharesUnitsGrantedDetails", "http://smx.tech/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Number of options outstanding, beginning balance", "periodEndLabel": "Number of options outstanding, ending balance", "label": "Number of outstanding shares" } }, "en": { "role": { "documentation": "The number of share options outstanding in a share-based payment arrangement." } } }, "auth_ref": [ "r90", "r94", "r97" ] }, "SMX_WarrantsExpirationDate": { "xbrltype": "durationItemType", "nsuri": "http://smx.tech/20230630", "localname": "WarrantsExpirationDate", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrants expiration date", "documentation": "Warrants expiration date." } } }, "auth_ref": [] }, "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable", "presentation": [ "http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Disclosure of subsidiaries [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to subsidiaries." } } }, "auth_ref": [ "r44", "r47", "r80" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash flow from financing activities", "label": "Cash flows from (used in) financing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity." } } }, "auth_ref": [ "r57", "r63" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "auth_ref": [ "r296" ] }, "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement", "presentation": [ "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails", "http://smx.tech/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "periodEndLabel": "Number of options, Exercisable", "label": "Number of exercisable shares" } }, "en": { "role": { "documentation": "The number of share options exercisable in a share-based payment arrangement." } } }, "auth_ref": [ "r95" ] }, "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r312" ] }, "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement", "presentation": [ "http://smx.tech/role/ScheduleOfRestrictedSharesUnitsGrantedDetails", "http://smx.tech/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of options, vested", "negatedTerseLabel": "Number of options, exercised", "label": "Number of share options exercised in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options exercised in a share-based payment arrangement." } } }, "auth_ref": [ "r92" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r246", "r258", "r268", "r293" ] }, "ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement", "presentation": [ "http://smx.tech/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Number of options, expired", "label": "Number of share options expired in share-based payment arrangement" } }, "en": { "role": { "documentation": "The number of share options expired in a share-based payment arrangement." } } }, "auth_ref": [ "r93" ] }, "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfFinancialInstrumentsExplanatory", "presentation": [ "http://smx.tech/role/ConvertibleNotes" ], "lang": { "en-us": { "role": { "label": "CONVERTIBLE NOTES" } }, "en": { "role": { "documentation": "The entire disclosure for financial instruments." } } }, "auth_ref": [ "r105" ] }, "ifrs-full_AdjustmentsForSharebasedPayments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForSharebasedPayments", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 2.0 }, "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows", "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based compensation", "label": "Share based compensation" } }, "en": { "role": { "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r328" ] }, "ifrs-full_AnalysisOfIncomeAndExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AnalysisOfIncomeAndExpenseAbstract", "lang": { "en-us": { "role": { "label": "Analysis of income and expense [abstract]" } } }, "auth_ref": [] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r246", "r258", "r268", "r293" ] }, "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": { "xbrltype": "decimalItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement", "presentation": [ "http://smx.tech/role/ScheduleOfRestrictedSharesUnitsGrantedDetails", "http://smx.tech/role/ScheduleOfShareOptionGrantedDetails" ], "lang": { "en-us": { "role": { "label": "Number of options, granted" } }, "en": { "role": { "documentation": "The number of share options granted in a share-based payment arrangement." } } }, "auth_ref": [ "r91" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r234" ] }, "ifrs-full_NumberOfSharesAuthorised": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesAuthorised", "presentation": [ "http://smx.tech/role/ScheduleOfShareCapitalDetails", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares authorized" } }, "en": { "role": { "documentation": "The number of shares authorised." } } }, "auth_ref": [ "r21" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash flow used in investing activities", "label": "Cash flows from (used in) investing activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents." } } }, "auth_ref": [ "r57", "r63" ] }, "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "auth_ref": [] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r296" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r247", "r259", "r269", "r294" ] }, "ifrs-full_DepreciationAndAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DepreciationAndAmortisationExpense", "crdr": "debit", "calculation": { "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Depreciation and amortization", "label": "Depreciation and amortisation expense" } }, "en": { "role": { "documentation": "The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives." } } }, "auth_ref": [ "r6", "r31", "r78", "r106", "r112", "r193" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r246", "r258", "r268", "r293" ] }, "ifrs-full_NumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "NumberOfSharesIssued", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/GeneralDetailsNarrative", "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/ShareholdersEquityDetailsNarrative", "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares issued", "verboseLabel": "Number of shares", "terseLabel": "Options to purchase shares" } }, "en": { "role": { "documentation": "The number of shares issued by the entity." } } }, "auth_ref": [ "r316" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r232" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r246", "r258", "r268", "r293" ] }, "SMX_NumberOfWarrantCashlessExercised": { "xbrltype": "sharesItemType", "nsuri": "http://smx.tech/20230630", "localname": "NumberOfWarrantCashlessExercised", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of warrant cashless exercised", "documentation": "Number of warrant cashless exercised." } } }, "auth_ref": [] }, "ifrs-full_CashFlowsFromUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivities", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash flow used in operating activities", "label": "Cash flows from (used in) operating activities" } }, "en": { "role": { "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]" } } }, "auth_ref": [ "r57", "r63" ] }, "ifrs-full_AntidilutiveInstrumentsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AntidilutiveInstrumentsMember", "presentation": [ "http://smx.tech/role/ScheduleOfRestrictedSharesUnitsGrantedDetails", "http://smx.tech/role/ShareholdersEquityDetailsNarrative", "http://smx.tech/role/ShareholdersEquityTables" ], "lang": { "en": { "role": { "documentation": "This member stands for antidilutive instruments. Instruments are antidilutive when their conversion to ordinary shares would increase earnings per share or decrease loss per share from continuing operations. The calculation of diluted earnings per share does not assume conversion, exercise, or other issue of potential ordinary shares that would have an antidilutive effect on earnings per share. It also represents the standard value for the \u2018Types of antidilutive instruments' axis if no other member is used." } } }, "auth_ref": [ "r51" ] }, "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "auth_ref": [] }, "ifrs-full_ExercisePriceShareOptionsGranted2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExercisePriceShareOptionsGranted2019", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Exercise price", "label": "Exercise price, share options granted" } }, "en": { "role": { "documentation": "The exercise price of share options granted." } } }, "auth_ref": [ "r98" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r231" ] }, "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExercisePriceOfOutstandingShareOptions2019", "presentation": [ "http://smx.tech/role/ScheduleOfOptionsToEmployeesAndServiceProvidersOutstandingDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Exercise price", "label": "Exercise price of outstanding share options" } }, "en": { "role": { "documentation": "The exercise price of outstanding share options." } } }, "auth_ref": [ "r97" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromBorrowingsClassifiedAsFinancingActivities", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from bridge loans", "verboseLabel": "Proceeds from borrowings, classified as financing activities" } }, "en": { "role": { "documentation": "The cash inflow from borrowings obtained. [Refer: Borrowings]" } } }, "auth_ref": [ "r205" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r230" ] }, "ifrs-full_MeasurementAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "MeasurementAxis", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Measurement [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r55", "r56", "r81" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Exercise Price" } } }, "auth_ref": [ "r300" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r248", "r260", "r270", "r295" ] }, "ifrs-full_CashOnHand": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CashOnHand", "crdr": "debit", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Cash" } }, "en": { "role": { "documentation": "The amount of cash held by the entity. This does not include demand deposits." } } }, "auth_ref": [ "r330" ] }, "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": { "xbrltype": "percentItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ExpectedDividendAsPercentageShareOptionsGranted", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Expected dividend yield" } }, "en": { "role": { "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted." } } }, "auth_ref": [ "r98" ] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r227" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r305" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r296" ] }, "ifrs-full_DisclosureOfGeneralAndAdministrativeExpenseExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGeneralAndAdministrativeExpenseExplanatory", "presentation": [ "http://smx.tech/role/GeneralAndAdministrativeExpenses" ], "lang": { "en-us": { "role": { "label": "GENERAL AND ADMINISTRATIVE EXPENSES" } }, "en": { "role": { "documentation": "The disclosure of general and administrative expenses. [Refer: Administrative expenses]" } } }, "auth_ref": [ "r314" ] }, "SMX_ForeignCurrencyTranslationMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "ForeignCurrencyTranslationMember", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-" ], "lang": { "en-us": { "role": { "label": "Foreign Currency Translation [Member]", "documentation": "Foreign Currency Translation [Member]" } } }, "auth_ref": [] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r296" ] }, "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory", "presentation": [ "http://smx.tech/role/General" ], "lang": { "en-us": { "role": { "label": "GENERAL" } }, "en": { "role": { "documentation": "The entire disclosure for general information about financial statements." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "SMX_EquityLineAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "EquityLineAgreementMember", "presentation": [ "http://smx.tech/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Equity Line Agreement [Member]", "documentation": "Equity Line Agreement [Member]" } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Adoption Date" } } }, "auth_ref": [ "r306" ] }, "SMX_SecurityMattersPTYLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "SecurityMattersPTYLtdMember", "presentation": [ "http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Security Matters PTY Ltd [Member]", "documentation": "Security Matters PTY Ltd [Member]" } } }, "auth_ref": [] }, "ifrs-full_Assets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "Assets", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets" } }, "en": { "role": { "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits." } } }, "auth_ref": [ "r17", "r81", "r82", "r83", "r108", "r110" ] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInOtherOperatingPayables": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInOtherOperatingPayables", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Increase in other payables" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in other operating payables to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]" } } }, "auth_ref": [ "r327" ] }, "ifrs-full_ProceedsFromExerciseOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromExerciseOfWarrants", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance of warrants" } }, "en": { "role": { "documentation": "The cash inflow from the exercise of share purchase warrants." } } }, "auth_ref": [ "r326" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r296" ] }, "ifrs-full_AggregatedMeasurementMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AggregatedMeasurementMember", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used." } } }, "auth_ref": [ "r55", "r56", "r81" ] }, "ifrs-full_TravelExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "TravelExpense", "crdr": "debit", "calculation": { "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Travel expenses" } }, "en": { "role": { "documentation": "The amount of expense arising from travel." } } }, "auth_ref": [ "r317" ] }, "SMX_BusinessCombinationAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "BusinessCombinationAgreementMember", "presentation": [ "http://smx.tech/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Business Combination Agreement [Member]", "documentation": "Business Combination Agreement [Member]" } } }, "auth_ref": [] }, "ifrs-full_ProceedsFromIssueOfBondsNotesAndDebentures": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssueOfBondsNotesAndDebentures", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of convertible notes" } }, "en": { "role": { "documentation": "The cash inflow from the issuing of bonds, notes and debentures." } } }, "auth_ref": [ "r326" ] }, "SMX_LionheartMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "LionheartMember", "presentation": [ "http://smx.tech/role/GeneralDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lionheart [Member]", "documentation": "Lionheart [Member]" } } }, "auth_ref": [] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Title" } } }, "auth_ref": [ "r305" ] }, "ifrs-full_ProceedsFromIssueOfOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ProceedsFromIssueOfOrdinaryShares", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance of shares in the SPAC transaction, net" } }, "en": { "role": { "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]" } } }, "auth_ref": [ "r326" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r250" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r133", "r134", "r135", "r136", "r146", "r147", "r170", "r171", "r172", "r177", "r178", "r180", "r181", "r182", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r217", "r218", "r219", "r221", "r222", "r332", "r334", "r335", "r336", "r337", "r338", "r339" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r237" ] }, "ifrs-full_BasicEarningsLossPerShare": { "xbrltype": "perShareItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "BasicEarningsLossPerShare", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss", "http://smx.tech/role/ScheduleOfLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Basic loss per share attributable to shareholders" } }, "en": { "role": { "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)." } } }, "auth_ref": [ "r48", "r49" ] }, "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of detailed information about borrowings [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to details of borrowings." } } }, "auth_ref": [ "r331" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r237" ] }, "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory", "presentation": [ "http://smx.tech/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Issue of a unit of financial instruments" } }, "en": { "role": { "documentation": "The description of the entity's material accounting policy information for financial instruments. [Refer: Financial instruments, class [member]]" } } }, "auth_ref": [ "r318" ] }, "ifrs-full_CurrentAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssetsAbstract", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "auth_ref": [] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "auth_ref": [ "r133", "r134", "r135", "r136", "r146", "r147", "r170", "r171", "r172", "r177", "r178", "r180", "r181", "r182", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r217", "r218", "r219", "r221", "r222", "r332", "r334", "r335", "r336", "r337", "r338", "r339" ] }, "ifrs-full_CurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CurrentAssets", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Current assets [Default Label]" } }, "en": { "role": { "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]" } } }, "auth_ref": [ "r18", "r71", "r208" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r148", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r172", "r173" ] }, "ifrs-full_RestrictedShareUnitsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RestrictedShareUnitsMember", "presentation": [ "http://smx.tech/role/ScheduleOfRestrictedSharesUnitsGrantedDetails", "http://smx.tech/role/ShareholdersEquityDetailsNarrative", "http://smx.tech/role/ShareholdersEquityTables" ], "lang": { "en-us": { "role": { "label": "Restricted share units [member]" } }, "en": { "role": { "documentation": "This member stands for a class of antidilutive instrument representing restricted share units." } } }, "auth_ref": [ "r325" ] }, "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Disclosure of disaggregation of revenue from contracts with customers [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers." } } }, "auth_ref": [ "r85" ] }, "ifrs-full_DisclosureOfEarningsPerShareExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEarningsPerShareExplanatory", "presentation": [ "http://smx.tech/role/LossPerShareTables" ], "lang": { "en-us": { "role": { "label": "SCHEDULE OF LOSS PER SHARE" } }, "en": { "role": { "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r52" ] }, "ifrs-full_RetainedEarnings": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarnings", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Accumulated losses" } }, "en": { "role": { "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r198", "r200" ] }, "ifrs-full_InsuranceExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InsuranceExpense", "crdr": "debit", "calculation": { "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Insurance" } }, "en": { "role": { "documentation": "The amount of expense arising from purchased insurance." } } }, "auth_ref": [ "r317" ] }, "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory", "lang": { "en-us": { "role": { "label": "Disclosure of events after reporting period [text block]" } }, "en": { "role": { "documentation": "The entire disclosure for events after the reporting period." } } }, "auth_ref": [ "r33" ] }, "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions", "crdr": "credit", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-" ], "lang": { "en-us": { "role": { "label": "Share-based compensation" } }, "en": { "role": { "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]" } } }, "auth_ref": [ "r10" ] }, "ifrs-full_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RetainedEarningsMember", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-" ], "lang": { "en-us": { "role": { "label": "Retained earnings [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit." } } }, "auth_ref": [ "r11", "r195" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "auth_ref": [ "r303" ] }, "ifrs-full_RepairsAndMaintenanceExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepairsAndMaintenanceExpense", "crdr": "debit", "calculation": { "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Office and maintenance" } }, "en": { "role": { "documentation": "The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts." } } }, "auth_ref": [ "r323" ] }, "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Repayment of bridge loans", "label": "Repayments of borrowings, classified as financing activities" } }, "en": { "role": { "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]" } } }, "auth_ref": [ "r206" ] }, "SMX_StockIssuedDuringPeriodValueRecapitalizationDueToIssuanceOfSharesFollowingSpacTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "StockIssuedDuringPeriodValueRecapitalizationDueToIssuanceOfSharesFollowingSpacTransaction", "crdr": "credit", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-" ], "lang": { "en-us": { "role": { "label": "Recapitalization due to issuance of shares following the SPAC transaction, net", "documentation": "Stock issued during period value recapitalization due to issuance of shares following spac transaction." } } }, "auth_ref": [] }, "SMX_StockIssuedDuringPeriodValueConversionOfBridgeLoansToShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "StockIssuedDuringPeriodValueConversionOfBridgeLoansToShares", "crdr": "credit", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-" ], "lang": { "en-us": { "role": { "label": "Conversion of bridge loans to shares", "documentation": "Stock issued during period value conversion of bridge loans to shares." } } }, "auth_ref": [] }, "SMX_PrepaidAdvance": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "PrepaidAdvance", "crdr": "debit", "presentation": [ "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Pre-paid advance", "documentation": "Prepaid advance.", "label": "PrepaidAdvance" } } }, "auth_ref": [] }, "SMX_IssueOfEquityOne": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "IssueOfEquityOne", "crdr": "credit", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-" ], "lang": { "en-us": { "role": { "label": "Issuance of Security Bundle, net (See note 5.2)", "documentation": "Issue of equity one." } } }, "auth_ref": [] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://smx.tech/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForDepreciationAndAmortisationExpense", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization" } }, "en": { "role": { "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]" } } }, "auth_ref": [ "r328" ] }, "ifrs-full_ComponentsOfEquityAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfEquityAxis", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-", "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative", "http://smx.tech/role/ScheduleOfLossPerShareDetails", "http://smx.tech/role/ScheduleOfShareCapitalDetails", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Components of equity [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r11" ] }, "SMX_ProceedsFromIssuanceOfStock": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "ProceedsFromIssuanceOfStock", "crdr": "credit", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of stock", "documentation": "Proceeds from issuance of stock." } } }, "auth_ref": [] }, "SMX_StockIssuedDuringPeriodValueConversionOfWarrantsToOrdinarySharesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "StockIssuedDuringPeriodValueConversionOfWarrantsToOrdinarySharesNet", "crdr": "credit", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-" ], "lang": { "en-us": { "role": { "label": "Conversion of warrants A to ordinary shares, net (See note 5.2)", "documentation": "Stock issued during period value conversion of warrants to ordinary shares net." } } }, "auth_ref": [] }, "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "SignificantInvestmentsInSubsidiariesAxis", "presentation": [ "http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Subsidiaries [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r44", "r47", "r80" ] }, "SMX_LionheartIIICorpMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "LionheartIIICorpMember", "presentation": [ "http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Lion heart III Corp [Member]", "documentation": "Lion heart III Corp [Member]" } } }, "auth_ref": [] }, "SMX_DebtPrincipalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "DebtPrincipalAmount", "crdr": "debit", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative", "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Principal amount", "label": "Debt principal smount", "documentation": "Debt principal amount." } } }, "auth_ref": [] }, "SMX_IssuanceOfSharesForDirectors": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "IssuanceOfSharesForDirectors", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 14.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Issuance of shares for directors", "documentation": "Issuance of shares for directors.", "label": "IssuanceOfSharesForDirectors" } } }, "auth_ref": [] }, "SMX_AdjustmentsForFinancialExpensesDueToBridgeLoansPrincipalAmounts": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "AdjustmentsForFinancialExpensesDueToBridgeLoansPrincipalAmounts", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Financial expenses due to bridge loans principal amounts", "documentation": "Adjustments for financial expenses due to bridge loans principal amounts." } } }, "auth_ref": [] }, "SMX_SMXCircularEconomyPlatformPTELtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "SMXCircularEconomyPlatformPTELtdMember", "presentation": [ "http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "SMX Circular Economy Platform PTE Ltd [Member]", "documentation": "SMX Circular Economy Platform PTE Ltd [Member]" } } }, "auth_ref": [] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "auth_ref": [ "r303" ] }, "SMX_AdjustmentsForInterestOnLeases": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "AdjustmentsForInterestOnLeases", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest on leases", "documentation": "Adjustments for interest on leases.", "label": "AdjustmentsForInterestOnLeases" } } }, "auth_ref": [] }, "SMX_SMXIrelandLimitedMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "SMXIrelandLimitedMember", "presentation": [ "http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "SMX Ireland Limited [Member]", "documentation": "SMX Ireland Limited [Member]" } } }, "auth_ref": [] }, "ifrs-full_ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTaxAbstract", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Items that will be reclassified to profit or loss:" } } }, "auth_ref": [] }, "ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "InvestmentsInSubsidiariesJointVenturesAndAssociates", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_NoncurrentAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition" ], "lang": { "en-us": { "role": { "label": "Investment in associated companies" } }, "en": { "role": { "documentation": "The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]" } } }, "auth_ref": [ "r41" ] }, "ifrs-full_ComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "ComprehensiveIncome", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-", "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "negatedTotalLabel": "Total comprehensive loss", "label": "Total comprehensive loss for the period" } }, "en": { "role": { "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners." } } }, "auth_ref": [ "r7", "r27", "r65", "r67", "r75", "r208" ] }, "SMX_NumberOfIssuedAndOutstandingOrdinarySharesPercentage": { "xbrltype": "percentItemType", "nsuri": "http://smx.tech/20230630", "localname": "NumberOfIssuedAndOutstandingOrdinarySharesPercentage", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of issued and outstanding ordinary shares percentage", "documentation": "Number of issued and outstanding ordinary shares percentage." } } }, "auth_ref": [] }, "ifrs-full_IssuedCapital": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapital", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition": { "parentTag": "ifrs-full_Equity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfFinancialPosition", "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Issued capital and additional paid in capital", "verboseLabel": "Issued ordinary shares value" } }, "en": { "role": { "documentation": "The nominal value of capital issued." } } }, "auth_ref": [ "r198" ] }, "SMX_TransactionCost": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "TransactionCost", "crdr": "debit", "calculation": { "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Transaction cost", "documentation": "Transaction cost." } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncome", "crdr": "credit", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-" ], "lang": { "en-us": { "role": { "label": "Other comprehensive loss for the period" } }, "en": { "role": { "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]" } } }, "auth_ref": [ "r9", "r26", "r30", "r76" ] }, "SMX_ProvisionOfBorrowingToRelatedParties": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "ProvisionOfBorrowingToRelatedParties", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Provision of borrowing to related parties", "documentation": "Provision of borrowing to related parties." } } }, "auth_ref": [] }, "SMX_AdjustmentsForRevaluationOfConvertibleNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "AdjustmentsForRevaluationOfConvertibleNotes", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Revaluation of convertible notes", "documentation": "Adjustments forRevaluationOfConvertibleNotes" } } }, "auth_ref": [] }, "SMX_SMXIsraelLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "SMXIsraelLtdMember", "presentation": [ "http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "SMX Israel Ltd [Member]", "documentation": "SMX Israel Ltd [Member]" } } }, "auth_ref": [] }, "SMX_ShareInEarningsLossesOfAssociatedCompaniesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "ShareInEarningsLossesOfAssociatedCompaniesNet", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "verboseLabel": "Share of net loss of associated companies", "documentation": "Share in earnings losses of associated companies net.", "label": "ShareInEarningsLossesOfAssociatedCompaniesNet" } } }, "auth_ref": [] }, "SMX_WeightedAverageNumberOfOrdinarySharesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smx.tech/20230630", "localname": "WeightedAverageNumberOfOrdinarySharesAbstract", "presentation": [ "http://smx.tech/role/ScheduleOfLossPerShareDetails" ], "lang": { "en-us": { "role": { "label": "Weighted average number of ordinary shares", "documentation": "Weighted average number of ordinary shares [Abstract]" } } }, "auth_ref": [] }, "ifrs-full_IssueOfConvertibleInstruments": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssueOfConvertibleInstruments", "crdr": "credit", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Issue of convertible instruments", "verboseLabel": "Aggregate amount of convertible instruments issued" } }, "en": { "role": { "documentation": "The change in equity resulting from the issuing of convertible instruments." } } }, "auth_ref": [ "r316" ] }, "SMX_FloorPrice": { "xbrltype": "perShareItemType", "nsuri": "http://smx.tech/20230630", "localname": "FloorPrice", "presentation": [ "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Floor price", "documentation": "Floor price." } } }, "auth_ref": [] }, "ifrs-full_OtherComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OtherComprehensiveIncomeAbstract", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfComprehensiveLoss" ], "lang": { "en-us": { "role": { "label": "Other comprehensive loss:" } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityAbstract", "auth_ref": [] }, "SMX_SecurityMattersCanadaLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "SecurityMattersCanadaLtdMember", "presentation": [ "http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Security Matters Canada Ltd [Member]", "documentation": "Security Matters Canada Ltd [Member]" } } }, "auth_ref": [] }, "ifrs-full_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of cash flows [abstract]" } } }, "auth_ref": [] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r299" ] }, "ifrs-full_IssueOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssueOfEquity", "crdr": "credit", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-" ], "lang": { "en-us": { "role": { "label": "Issuance of shares, net" } }, "en": { "role": { "documentation": "The increase in equity through the issue of equity instruments." } } }, "auth_ref": [ "r10" ] }, "SMX_DebtConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://smx.tech/20230630", "localname": "DebtConversionPrice", "presentation": [ "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Debt conversion price", "documentation": "Debt conversion price." } } }, "auth_ref": [] }, "SMX_SpacTransactionListingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "SpacTransactionListingCosts", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "SPAC transaction - listing costs", "documentation": "Spac transaction listing costs.", "label": "SpacTransactionListingCosts" } } }, "auth_ref": [] }, "SMX_WarrantSharePriceCashExercise": { "xbrltype": "perShareItemType", "nsuri": "http://smx.tech/20230630", "localname": "WarrantSharePriceCashExercise", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Warrant share price cash exercise", "documentation": "Warrant share price cash exercise." } } }, "auth_ref": [] }, "SMX_DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smx.tech/20230630", "localname": "DescriptionOfAccountingPolicyForBasisOfPreparationExplanatory", "presentation": [ "http://smx.tech/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of preparation", "documentation": "Description Of Accounting Policy For Basis Of Preparation Explanatory." } } }, "auth_ref": [] }, "SMX_SecurityMattersFranceLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "SecurityMattersFranceLtdMember", "presentation": [ "http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Security Matters France Ltd [Member]", "documentation": "Security Matters France Ltd [Member]" } } }, "auth_ref": [] }, "SMX_AdvancePaymentForEquityNet": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "AdvancePaymentForEquityNet", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Advance payment for equity, net (see Note 5.1)", "documentation": "Advance payment for equity net." } } }, "auth_ref": [] }, "SMX_InvestorOwnedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://smx.tech/20230630", "localname": "InvestorOwnedPercentage", "presentation": [ "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Investor owned percentage", "documentation": "Investor owned percentage." } } }, "auth_ref": [] }, "ifrs-full_StatementOfChangesInEquityTable": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfChangesInEquityTable", "presentation": [ "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/GeneralDetailsNarrative", "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-", "http://smx.tech/role/ScheduleOfLossPerShareDetails", "http://smx.tech/role/ScheduleOfShareCapitalDetails", "http://smx.tech/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Statement of changes in equity [table]" } }, "en": { "role": { "documentation": "Schedule disclosing information related to changes in equity." } } }, "auth_ref": [ "r11" ] }, "SMX_CapitalizedDevelopmentCostClassifiedAsInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "CapitalizedDevelopmentCostClassifiedAsInvestingActivities", "crdr": "credit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Capitalized development cost", "documentation": "Capitalized development cost classified as investing activities.", "label": "CapitalizedDevelopmentCostClassifiedAsInvestingActivities" } } }, "auth_ref": [] }, "SMX_GrossProceeds": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "GrossProceeds", "crdr": "debit", "presentation": [ "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Gross proceeds", "documentation": "Gross proceeds." } } }, "auth_ref": [] }, "SMX_ProceedsFromIssuanceOfSecurityBundleNet": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "ProceedsFromIssuanceOfSecurityBundleNet", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of Security Bundle, net", "documentation": "Proceeds from issuance of security bundle net." } } }, "auth_ref": [] }, "SMX_SMXBeveragesPtyLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "SMXBeveragesPtyLtdMember", "presentation": [ "http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "SMX Beverages Pty Ltd [Member]", "documentation": "SMX Beverages Pty Ltd [Member]" } } }, "auth_ref": [] }, "SMX_ProceedsFromIssuanceOfDerivativeFinancialLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "ProceedsFromIssuanceOfDerivativeFinancialLiability", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Issuance of derivative financial liability", "documentation": "Proceeds from issuance of derivative financial liability." } } }, "auth_ref": [] }, "ifrs-full_CharacteristicsOfDefinedBenefitPlansAxis": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CharacteristicsOfDefinedBenefitPlansAxis", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Characteristics of defined benefit plans [axis]" } }, "en": { "role": { "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table." } } }, "auth_ref": [ "r201" ] }, "ifrs-full_CharacteristicsOfDefinedBenefitPlansMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "CharacteristicsOfDefinedBenefitPlansMember", "presentation": [ "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en": { "role": { "documentation": "This member stands for all defined benefit plans when disaggregated by characteristics of defined benefits plans. It also represents the standard value for the 'Characteristics of defined benefits plans' axis if no other member is used." } } }, "auth_ref": [ "r201" ] }, "SMX_BridgeLoanAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "BridgeLoanAgreementsMember", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bridge loan agreements [member]", "documentation": "Bridge loan agreements [member]" } } }, "auth_ref": [] }, "ifrs-full_IssuedCapitalMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapitalMember", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedChangesInShareholdersEquity-" ], "lang": { "en-us": { "role": { "label": "Issued capital [member]" } }, "en": { "role": { "documentation": "This member stands for a component of equity representing issued capital." } } }, "auth_ref": [ "r11" ] }, "ifrs-full_OrdinarySharesMember": { "xbrltype": "domainItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "OrdinarySharesMember", "presentation": [ "http://smx.tech/role/ConvertibleNotesDetailsNarrative", "http://smx.tech/role/GeneralDetailsNarrative", "http://smx.tech/role/ScheduleOfShareCapitalDetails", "http://smx.tech/role/ScheduleOfShareCapitalDetailsParenthetical", "http://smx.tech/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Ordinary shares [member]" } }, "en": { "role": { "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used." } } }, "auth_ref": [ "r48", "r322" ] }, "SMX_DisclosureMaterialEventsDuringPeriodAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smx.tech/20230630", "localname": "DisclosureMaterialEventsDuringPeriodAbstract", "lang": { "en-us": { "role": { "label": "Material Events During Period" } } }, "auth_ref": [] }, "ifrs-full_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of financial position [abstract]" } } }, "auth_ref": [] }, "SMX_YahalomaTechnologiesIncMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "YahalomaTechnologiesIncMember", "presentation": [ "http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "Yahaloma Technologies Inc [Member]", "documentation": "Yahaloma Technologies Inc [Member]" } } }, "auth_ref": [] }, "SMX_ConversionOfBridgeLoansAndDerivativeFinancialLiabilityToOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "ConversionOfBridgeLoansAndDerivativeFinancialLiabilityToOrdinaryShares", "crdr": "credit", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of bridge loans and derivative financial liability to ordinary shares", "documentation": "Conversion of bridge loans and derivative financial liability to ordinary shares." } } }, "auth_ref": [] }, "SMX_PaymentsForPromissoryNotes": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "PaymentsForPromissoryNotes", "crdr": "credit", "presentation": [ "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Payments for promissory notes", "documentation": "Payments for promissory notes." } } }, "auth_ref": [] }, "SMX_NoncashTransactionsDuringPeriodAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smx.tech/20230630", "localname": "NoncashTransactionsDuringPeriodAbstract", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Appendix A \u2013 Non-Cash transactions during the period:", "documentation": "Non cash transactions during period abstract." } } }, "auth_ref": [] }, "ifrs-full_IssuedCapitalOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "IssuedCapitalOrdinaryShares", "crdr": "credit", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriodDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Issued capital, ordinary shares" } }, "en": { "role": { "documentation": "The nominal value of capital arising from issuing ordinary shares. [Refer: Issued capital]" } } }, "auth_ref": [ "r320" ] }, "SMX_ConversionOfLiabilityToOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "ConversionOfLiabilityToOrdinaryShares", "crdr": "credit", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of liability to ordinary shares (see Note 5.1)", "documentation": "Conversion of liability to ordinary shares." } } }, "auth_ref": [] }, "SMX_TrueGoldConsortiumPtyLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "TrueGoldConsortiumPtyLtdMember", "presentation": [ "http://smx.tech/role/ScheduleOfCompaniesSubsidiariesDetails" ], "lang": { "en-us": { "role": { "label": "True Gold Consortium Pty Ltd [Member]", "documentation": "True Gold Consortium Pty Ltd [Member]" } } }, "auth_ref": [] }, "SMX_ConversionOfWarrantsToOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "ConversionOfWarrantsToOrdinaryShares", "crdr": "credit", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of warrants to ordinary shares (see note 5.2)", "documentation": "Conversion of warrants to ordinary shares." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Rule 10b5-1 Arrangement Adopted" } } }, "auth_ref": [ "r304" ] }, "SMX_ExerciseOfOptionsAndWarrantsToOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "ExerciseOfOptionsAndWarrantsToOrdinaryShares", "crdr": "credit", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Exercise of options and warrants to ordinary shares", "documentation": "Exercise of options and warrants to ordinary shares." } } }, "auth_ref": [] }, "SMX_DebtMaturityDate": { "xbrltype": "dateItemType", "nsuri": "http://smx.tech/20230630", "localname": "DebtMaturityDate", "presentation": [ "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Maturity date", "documentation": "Debt maturity date.", "label": "DebtMaturityDate" } } }, "auth_ref": [] }, "SMX_ConversionOfConvertibleNotesToOrdinaryShares": { "xbrltype": "monetaryItemType", "nsuri": "http://smx.tech/20230630", "localname": "ConversionOfConvertibleNotesToOrdinaryShares", "crdr": "credit", "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Conversion of convertible notes to ordinary shares", "documentation": "Conversion of convertible notes to ordinary shares." } } }, "auth_ref": [] }, "us-gaap_AdvertisingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdvertisingExpense", "crdr": "debit", "calculation": { "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails": { "parentTag": "ifrs-full_GeneralAndAdministrativeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://smx.tech/role/ScheduleOfGeneralAndAdministrativeExpensesDetails" ], "lang": { "en-us": { "role": { "label": "Advertising, Public and Investors Relations", "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line." } } }, "auth_ref": [ "r174" ] }, "SMX_ConvertibleNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "ConvertibleNotesMember", "presentation": [ "http://smx.tech/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertible Notes [Member]", "documentation": "Convertible Notes [Member]" } } }, "auth_ref": [] }, "SMX_GeneralAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smx.tech/20230630", "localname": "GeneralAbstract", "lang": { "en-us": { "role": { "label": "General" } } }, "auth_ref": [] }, "SMX_ElevenLendersMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "ElevenLendersMember", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Eleven Lenders [Member]", "documentation": "Eleven Lenders [Member]" } } }, "auth_ref": [] }, "SMX_NumberOfSharesConverted": { "xbrltype": "sharesItemType", "nsuri": "http://smx.tech/20230630", "localname": "NumberOfSharesConverted", "presentation": [ "http://smx.tech/role/SubsequentEventsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Number of shares converted", "documentation": "Number of shares converted." } } }, "auth_ref": [] }, "SMX_ConvertiableNoteAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "ConvertiableNoteAgreementsMember", "presentation": [ "http://smx.tech/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Convertiable Note Agreements [Member]", "documentation": "Convertiable Note Agreements [Member]" } } }, "auth_ref": [] }, "SMX_SignificantAccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smx.tech/20230630", "localname": "SignificantAccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Significant Accounting Policies" } } }, "auth_ref": [] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "label": "Non-Rule 10b5-1 Arrangement Terminated" } } }, "auth_ref": [ "r304" ] }, "SMX_BonusWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "BonusWarrantsMember", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bonus Warrants [Member]", "documentation": "Bonus Warrants [Member]" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInDerivativeFinancialLiabilities", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Revaluation of financial liabilities at fair value" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in derivative financial liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Derivative financial liabilities; Profit (loss)]" } } }, "auth_ref": [ "r329" ] }, "SMX_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smx.tech/20230630", "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory", "presentation": [ "http://smx.tech/role/SignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "SIGNIFICANT ACCOUNTING POLICIES", "documentation": "Disclosure Of Summary Of Significant Accounting Policies Explanatory." } } }, "auth_ref": [] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r298" ] }, "SMX_DisclosureOfMaterialEventsDuringThePeriodExplanatory": { "xbrltype": "textBlockItemType", "nsuri": "http://smx.tech/20230630", "localname": "DisclosureOfMaterialEventsDuringThePeriodExplanatory", "presentation": [ "http://smx.tech/role/MaterialEventsDuringPeriod" ], "lang": { "en-us": { "role": { "label": "MATERIAL EVENTS DURING THE PERIOD", "documentation": "Disclosure Of Material Events During The Period Explanatory." } } }, "auth_ref": [] }, "SMX_ShareholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smx.tech/20230630", "localname": "ShareholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Shareholders Equity", "verboseLabel": "Schedule Of Share Option Granted" } } }, "auth_ref": [] }, "SMX_RedeemableWarrantsMember": { "xbrltype": "domainItemType", "nsuri": "http://smx.tech/20230630", "localname": "RedeemableWarrantsMember", "presentation": [ "http://smx.tech/role/BridgeLoansAndDerivativeFinancialLiabilityDetailsNarrative", "http://smx.tech/role/ConvertibleNotesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Redeemable Warrants [Member]", "documentation": "Redeemable Warrants [Member]" } } }, "auth_ref": [] }, "SMX_LossPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smx.tech/20230630", "localname": "LossPerShareAbstract", "lang": { "en-us": { "role": { "label": "Loss Per Share" } } }, "auth_ref": [] }, "ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "https://xbrl.ifrs.org/taxonomy/2023-03-23/ifrs-full", "localname": "AdjustmentsForIncreaseDecreaseInOtherLiabilities", "crdr": "debit", "calculation": { "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows": { "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://smx.tech/role/InterimCondensedConsolidatedStatementsOfCashFlows" ], "lang": { "en-us": { "role": { "label": "Decrease in other liabilities" } }, "en": { "role": { "documentation": "Adjustments for increase (decrease) in other liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other liabilities; Profit (loss)]" } } }, "auth_ref": [ "r329" ] }, "SMX_GeneralAndAdministrativeExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://smx.tech/20230630", "localname": "GeneralAndAdministrativeExpensesAbstract", "lang": { "en-us": { "role": { "label": "General And Administrative Expenses" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r6": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_104&doctype=Standard", "URIDate": "2023-03-23" }, "r7": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_a&doctype=Standard", "URIDate": "2023-03-23" }, "r8": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_i&doctype=Standard", "URIDate": "2023-03-23" }, "r9": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r10": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r11": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106&doctype=Standard", "URIDate": "2023-03-23" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "51", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_51&doctype=Standard", "URIDate": "2023-03-23" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_a&doctype=Standard", "URIDate": "2023-03-23" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_c&doctype=Standard", "URIDate": "2023-03-23" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_i&doctype=Standard", "URIDate": "2023-03-23" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "54", "Subparagraph": "k", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_54_k&doctype=Standard", "URIDate": "2023-03-23" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "69", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_69&doctype=Standard", "URIDate": "2023-03-23" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_a&doctype=Standard", "URIDate": "2023-03-23" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_b&doctype=Standard", "URIDate": "2023-03-23" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "81A", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_81A_c&doctype=Standard", "URIDate": "2023-03-23" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_b&doctype=Standard", "URIDate": "2023-03-23" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82_d&doctype=Standard", "URIDate": "2023-03-23" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "91", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_91_a&doctype=Standard", "URIDate": "2023-03-23" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "99", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_99&doctype=Standard", "URIDate": "2023-03-23" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Paragraph": "21", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&anchor=para_21&doctype=Standard", "URIDate": "2023-03-23" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "10", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI", "URIDate": "2023-03-23" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "79", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_79&doctype=Standard", "URIDate": "2023-03-23" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_i&doctype=Standard", "URIDate": "2023-03-23" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "81", "Subparagraph": "c", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2023-en-r&anchor=para_81_c_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "73", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2023-en-r&anchor=para_73_e&doctype=Standard", "URIDate": "2023-03-23" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "21", "IssueDate": "2023-01-01", "Paragraph": "52", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2023-en-r&anchor=para_52_b&doctype=Standard", "URIDate": "2023-03-23" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "24", "IssueDate": "2023-01-01", "Paragraph": "19", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2023-en-r&anchor=para_19&doctype=Standard", "URIDate": "2023-03-23" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "26", "IssueDate": "2023-01-01", "Paragraph": "35", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2023-en-r&anchor=para_35_b_viii&doctype=Standard", "URIDate": "2023-03-23" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard", "URIDate": "2023-03-23" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_16_b&doctype=Standard", "URIDate": "2023-03-23" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "27", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2023-en-r&anchor=para_17_b&doctype=Standard", "URIDate": "2023-03-23" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "66", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_66&doctype=Standard", "URIDate": "2023-03-23" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_67&doctype=Standard", "URIDate": "2023-03-23" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_b&doctype=Standard", "URIDate": "2023-03-23" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2023-03-23" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Section": "Disclosure", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI", "URIDate": "2023-03-23" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "118", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_118_e&doctype=Standard", "URIDate": "2023-03-23" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "38", "IssueDate": "2023-01-01", "Paragraph": "126", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2023-en-r&anchor=para_126&doctype=Standard", "URIDate": "2023-03-23" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "40", "IssueDate": "2023-01-01", "Paragraph": "32A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2023-en-r&anchor=para_32A&doctype=Standard", "URIDate": "2023-03-23" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "41", "IssueDate": "2023-01-01", "Paragraph": "50", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2023-en-r&anchor=para_50&doctype=Standard", "URIDate": "2023-03-23" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "10", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_10&doctype=Standard", "URIDate": "2023-03-23" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "18", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_18_b&doctype=Standard", "URIDate": "2023-03-23" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "25", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_25&doctype=Standard", "URIDate": "2023-03-23" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "28", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_28&doctype=Standard", "URIDate": "2023-03-23" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "40", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_40_a&doctype=Standard", "URIDate": "2023-03-23" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "50", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_50_d&doctype=Standard", "URIDate": "2023-03-23" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_a&doctype=Standard", "URIDate": "2023-03-23" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "24", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_24_b&doctype=Standard", "URIDate": "2023-03-23" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "32", "Subparagraph": "a", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2023-en-r&anchor=para_32_a_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "12", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_12_b&doctype=Standard", "URIDate": "2023-03-23" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "19B", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_19B_b&doctype=Standard", "URIDate": "2023-03-23" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "19B", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_19B_c&doctype=Standard", "URIDate": "2023-03-23" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "ix", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B12", "Subparagraph": "b", "Clause": "viii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B13", "Subparagraph": "g", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B4", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_a&doctype=Standard", "URIDate": "2023-03-23" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_b&doctype=Standard", "URIDate": "2023-03-23" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "93", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93_e&doctype=Standard", "URIDate": "2023-03-23" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "14", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2023-en-r&anchor=para_33_b&doctype=Standard", "URIDate": "2023-03-23" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "114", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_114&doctype=Standard", "URIDate": "2023-03-23" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "16", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2023-en-r&anchor=para_47_b&doctype=Standard", "URIDate": "2023-03-23" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "117", "Subparagraph": "c", "Clause": "iii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_117_c_iii&doctype=Standard", "URIDate": "2023-03-23" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "120", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_120&doctype=Standard", "URIDate": "2023-03-23" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_a&doctype=Standard", "URIDate": "2023-03-23" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "ii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_ii&doctype=Standard", "URIDate": "2023-03-23" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "iv", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_iv&doctype=Standard", "URIDate": "2023-03-23" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "v", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_v&doctype=Standard", "URIDate": "2023-03-23" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vi", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vi&doctype=Standard", "URIDate": "2023-03-23" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "Clause": "vii", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b_vii&doctype=Standard", "URIDate": "2023-03-23" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_b&doctype=Standard", "URIDate": "2023-03-23" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "45", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_45_d&doctype=Standard", "URIDate": "2023-03-23" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a_i&doctype=Standard", "URIDate": "2023-03-23" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "2", "IssueDate": "2023-01-01", "Paragraph": "47", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2023-en-r&anchor=para_47_a&doctype=Standard", "URIDate": "2023-03-23" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B64", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B64&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r101": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "3", "IssueDate": "2023-01-01", "Paragraph": "B67", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2023-en-r&anchor=para_B67&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r102": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "5", "IssueDate": "2023-01-01", "Paragraph": "33", "Subparagraph": "b", "Clause": "i", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2023-en-r&anchor=para_33_b_i&doctype=Standard", "URIDate": "2023-03-23" }, "r103": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "42I", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_42I&doctype=Standard", "URIDate": "2023-03-23" }, "r104": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_6&doctype=Standard", "URIDate": "2023-03-23" }, "r105": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Section": "Scope", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI", "URIDate": "2023-03-23" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_e&doctype=Standard", "URIDate": "2023-03-23" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "Subparagraph": "h", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23_h&doctype=Standard", "URIDate": "2023-03-23" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_c&doctype=Standard", "URIDate": "2023-03-23" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_d&doctype=Standard", "URIDate": "2023-03-23" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_e&doctype=Standard", "URIDate": "2023-03-23" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "7.2.34", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.34&doctype=Standard", "URIDate": "2023-03-23" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "IFRS", "Number": "9", "IssueDate": "2023-01-01", "Paragraph": "7.2.42", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2023-en-r&anchor=para_7.2.42&doctype=Standard", "URIDate": "2023-03-23" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "720", "SubTopic": "35", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r193": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "102", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_102&doctype=Standard", "URIDate": "2023-03-23" }, "r194": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "103", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_103&doctype=Standard", "URIDate": "2023-03-23" }, "r195": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "108", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_108&doctype=Standard", "URIDate": "2023-03-23" }, "r196": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "70", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_70&doctype=Standard", "URIDate": "2023-03-23" }, "r197": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_b&doctype=Standard", "URIDate": "2023-03-23" }, "r198": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r199": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "82A", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_82A&doctype=Standard", "URIDate": "2023-03-23" }, "r200": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "IG6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_IG6&doctype=Implementation%20Guidance", "URIDate": "2023-03-23" }, "r201": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "138", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_138_b&doctype=Standard", "URIDate": "2023-03-23" }, "r202": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "32", "IssueDate": "2023-01-01", "Paragraph": "IE33", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2023-en-r&anchor=para_IE33&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r203": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "16", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_16_a&doctype=Standard", "URIDate": "2023-03-23" }, "r204": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_a&doctype=Standard", "URIDate": "2023-03-23" }, "r205": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_c&doctype=Standard", "URIDate": "2023-03-23" }, "r206": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_d&doctype=Standard", "URIDate": "2023-03-23" }, "r207": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17_e&doctype=Standard", "URIDate": "2023-03-23" }, "r208": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "12", "IssueDate": "2023-01-01", "Paragraph": "B10", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2023-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r209": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "B6", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_B6&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r210": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "13", "IssueDate": "2023-01-01", "Paragraph": "IE63", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_IE63&doctype=Illustrative%20Examples", "URIDate": "2023-03-23" }, "r211": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "15", "IssueDate": "2023-01-01", "Paragraph": "B89", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2023-en-r&anchor=para_B89_d&doctype=Appendix&subtype=B", "URIDate": "2023-03-23" }, "r212": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "113", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_113_b&doctype=Standard", "URIDate": "2023-03-23" }, "r213": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "17", "IssueDate": "2023-01-01", "Paragraph": "96", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_96_a&doctype=Standard", "URIDate": "2023-03-23" }, "r214": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "23", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_23&doctype=Standard", "URIDate": "2023-03-23" }, "r215": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "IFRS", "Number": "8", "IssueDate": "2023-01-01", "Paragraph": "28", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2023-en-r&anchor=para_28_b&doctype=Standard", "URIDate": "2023-03-23" }, "r216": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r217": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r218": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r219": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r220": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r221": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r222": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r223": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r224": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r225": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r226": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r227": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r228": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r229": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r230": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r231": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r232": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r233": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r234": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r235": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r236": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r237": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r238": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r239": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r240": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r241": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r242": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r243": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r244": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r245": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r246": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r247": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r248": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r249": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r250": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r251": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r252": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r253": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r254": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r255": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r256": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r257": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r258": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r259": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r260": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r261": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r262": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r263": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r264": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r265": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r266": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r267": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r268": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r269": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r270": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r271": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r272": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r273": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r274": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r275": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r276": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r277": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r278": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r279": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r280": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r281": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r282": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r283": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r284": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r285": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r286": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r287": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r288": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r289": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r290": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r291": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r292": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r293": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r294": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r295": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r296": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r297": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r298": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r299": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r300": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r301": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r302": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r303": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r304": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r305": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r306": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r307": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r308": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r309": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r310": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r311": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r312": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r313": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r314": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "10", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_10_e&doctype=Standard", "URIDate": "2023-03-23" }, "r315": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "104", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_104&doctype=Standard", "URIDate": "2023-03-23" }, "r316": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "106", "Subparagraph": "d", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_106_d&doctype=Standard", "URIDate": "2023-03-23" }, "r317": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "112", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_112_c&doctype=Standard", "URIDate": "2023-03-23" }, "r318": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "117", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_117&doctype=Standard", "URIDate": "2023-03-23" }, "r319": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "55", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_55&doctype=Standard", "URIDate": "2023-03-23" }, "r320": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "Subparagraph": "e", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78_e&doctype=Standard", "URIDate": "2023-03-23" }, "r321": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "78", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_78&doctype=Standard", "URIDate": "2023-03-23" }, "r322": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "79", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_79_a&doctype=Standard", "URIDate": "2023-03-23" }, "r323": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "1", "IssueDate": "2023-01-01", "Paragraph": "85", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard", "URIDate": "2023-03-23" }, "r324": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "19", "IssueDate": "2023-01-01", "Paragraph": "9", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2023-en-r&anchor=para_9&doctype=Standard", "URIDate": "2023-03-23" }, "r325": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "33", "IssueDate": "2023-01-01", "Paragraph": "70", "Subparagraph": "c", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2023-en-r&anchor=para_70_c&doctype=Standard", "URIDate": "2023-03-23" }, "r326": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "17", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_17&doctype=Standard", "URIDate": "2023-03-23" }, "r327": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "a", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a&doctype=Standard", "URIDate": "2023-03-23" }, "r328": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "Subparagraph": "b", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_b&doctype=Standard", "URIDate": "2023-03-23" }, "r329": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "20", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20&doctype=Standard", "URIDate": "2023-03-23" }, "r330": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IAS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "45", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2023-en-r&anchor=para_45&doctype=Standard", "URIDate": "2023-03-23" }, "r331": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "IFRS", "Number": "7", "IssueDate": "2023-01-01", "Paragraph": "7", "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_7&doctype=Standard", "URIDate": "2023-03-23" }, "r332": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r333": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r334": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r335": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r336": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r337": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r338": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r339": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r340": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r341": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" } } } ZIP 52 0001493152-23-039346-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-039346-xbrl.zip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